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Erythropoietin Enhances the Protective Effect of Cellular 
Therapy in the Infarcted Myocardium## 829-4·206A
Homing of 111In-oxine Radiolabelled Endothelial Progenitor 
Cells in Ischemic or Inﬂammed Mice Hindlimbs: 
Differential Cytokine and Chemokine Proﬁle## 948-
31·121A
Local Delivery of Bone Marrow Derived Stromal Cells 
Engineered to Overexpress Prostacyclin Synthase 
Enhanced Collateral Perfusion in Hindlimb Ischemia## 
823-5·341A
Low-dose Erythropoietin Treatment Preserves Cardiac 
Function and Mobilizes Endothelial Progenitor Cells in 
Rats With Ischemic Heart Failure## 820-8·74A
Natural History of Patients With Refractory Angina##1021-
255·231A
Novel Injectable Alginate Biomaterial Attenuates Progressive 
Infarct Expansion and Preserves Left Ventricular Systolic 
and Diastolic Function Late after Myocardial Infarction## 
820-5·73A
Paracrine Effects of Endothelial Progenitor Cells on Acutely 
Infarcted Myocardium## 814-3·190A
Phosphoinositide 3-kinase γ Modulates Vascular Endothelial 
Growth Factor Release and Collateral Vessel 
Development Following Hindlimb Ischemia##909-
176·291A
Regulation of Endothelial Progenitor Cell (EPC) Survival and 
Vasculogenesis by Peroxisome Proliferator-activated 
Receptor-Delta (PPAR-δ) Activation## 823-6·342A
Sildenaﬁl Enhances Angiogenesis After Mice Hindlimb 
Ischemia##909-175·291A
Simultaneous Application of Prostaglandin E1 Enhances the 
Arteriogenesis by Sustained-release of Basic Fibroblast 
Growth Factor in the Rabbit Hindlimb Ischemic 
Model##912-191·295A
Synchrotron Radiation Coronary Microangiography for 
Morphometric and Physiological Evaluation of 
Myocardial Neovascularization Induced by Cell-Based 
Transplantation##909-178·292A
Systemic Hypoxia Without Ischemic Organ Damage can 
Mobilize Endothelial Progenitor Cells in Human 
Peripheral Blood by Increased Levels of VEGF, 
MCP-1 and SDF-1: A Novel Insight of Hypoxic 
Preconditioning##933-164·302A
The Prognostic Value of Endoglin, a Marker of 
Neoangiogenesis, in Acute Myocardial Infarction## 
856-8·234A
Therapeutic Angiogenesis Using Novel Vascular Endothelial 
Growth Factor-E / Human Placental Growth Factor 
Chimera Genes##933-169·303A
Therapeutic Potential of Human Unrestricted Somatic Stem 
Cells Isolated from Placental Cord Blood for Concurrent 
Cardiomyogenesis and Vasculogenesis With Functional 
Regenerative Recovery Post Myocardial Infarction## 
814-6·191A
Transplantation of Autologous Endothelial Progenitor Cells is 
Safe, Feasible and Effective for Vascular Regeneration 
in No-Option Patients with Chronic Critical Limb 
Ischemia##934-176·304A
Angiography
64-Slice Computed Tomography Angiography Detects Graft 
and Coronary Artery Stenosis in Patients With Previous 
Coronary Artery Bypass Graft Surgery## 970-1·124A
Acute Coronary Syndrome With Troponin Elevation But 
Non-Signiﬁcant Coronary Artery Disease: A Benign 
Condition?##975-247·201A
Association of TIMI Risk Score and Extent of Coronary 
Artery Disease in Patients With ST-Elevation Myocardial 
Infarction: A CLARITY TIMI-28 Substudy##1018-
221·222A
Chronic Kidney Disease Is a Powerful Predictor of Adverse 
Outcomes in Patients With Abnormal Myocardial 
Perfusion Imaging and Insigniﬁcant Coronary Artery 
Disease## 926-11·107A
Comparison of the effects of Nicorandil and Cocktail 
to Prevent Radial Artery Spasm During Coronary 
Angiography##979-181·332A
Coronary Angiography Is a Strong Predictor of Cardiovascular 
Events in Patients With End-Stage Renal Disease##905-
237·163A
Development of Venous Stenosis and Occlusion After 
Pacemaker Implantation## 969-134·23A
Diagnostic Accuracy of Multislice CT Coronary Angiography 
in Patients Presenting With Non Diagnostic Chest Pain## 
970-14·127A
Do Duplex Ultrasound Velocities Accurately Reﬂect 
Angiographic Stenosis in Recently Stented Carotid 
Arteries?##1025-184·369A
Failure to Use Percutaneous Coronary Intervention in Patients 
With an Acute Coronary Syndrome and Congestive 
Heart Failure. The Global Registry of Acute Coronary 
Events##1032-56·86A
Fluvastatin Reduces Coronary Plaque and Increases Lumen 
Volume: Assessment by Multislice CT## 970-11·126A
How Reliable Are Pre-Hospital and Admission ECGs to 
Predict Recent Coronary Artery Occlusion in Patients 
With Successfully Resuscitated Out-Of-Hospital Cardiac 
Arrest?##906-241·164A
Increasing Occurrence of Multivessel Intervention and 
Multiple Stent Placement From 1999 to 2004. The Global 
Registry of Acute Coronary Events##990-150·261A
Late Angiographic Stent Thrombosis (LAST) After Bare-Metal 
Stent Versus Drug-Eluting Stent Implantation##956-160·317A
Minimal Coronary Artery Calcium Score Alone Fails to 
Reliably Detect Signiﬁcant Lesions in Acute Chest Pain 
Patients## 807-5·114A
Noninvasive Coronary Angiography Performed With 4-Slice, 
12-Slice, 16-Slice and 64-Slice CT: Comparison of 
Diagnostic Accuracy## 970-39·130A
Noninvasive Coronary Angiography: Agreement of 64-Slice 
Cardiovascular Computed Tomography and Selective 
Catheter Angiography## 970-13·127A
Prevalence of Tako-Tsubo Syndrome and Description of Partial 
and Circular Patterns##975-249·201A
The Use of Contrast Improves Positive Predictive Value and 
Result Determinability in Routine Dobutamine Stress 
Echocardiography## 827-6·132A
Usefulness of 64-slice Multi Detector Computed Tomography 
to Improve Diagnostic Yield in Patients With Chest Pain 
and Negative or Equivocal Exercise Treadmill Tests## 
807-6·114A
Wall Motion Score by Stress Echocardiography Is Superior to 
Angiographic Jeopardy Score for Risk Stratiﬁcation and 
Prognosis## 948-46·124A
Angioplasty
Prolonged Adenovirus and Adeno-associated Virus-mediated 
Gene Delivery to Rabbit Iliac Arteries Using Gene-
Eluting Stents: A Direct Comparison##934-177·304A
A Comparison of Quality of Life Scores in Patients With Stable 
Angina Pectoris After Medical Treatment Compared With 
Angioplasty or Coronary Bypass Surgery: 48-Months 
of Follow-Up Outcomes of a Randomized Clinical Trial 
(MASS I I)##990-151·262A
A Comprehensive Approach to the Development of Risk 
Adjustment Models for Fatal and Non Fatal Outcomes 
Following Contemporary PCI: A Report From the 
Blue Cross Blue Shield of Michigan Cardiovascular 
Consortium##923-150·252A
A Novel Enoxaparin Regime for ST-Elevation Myocardial 
Infarction Patients Undergoing Primary Purcutaneous 
Coronary Intervention: Intravenous but Not Subcutaneous 
Enoxaparin Achieves Adequate Anti-Xa Levels##1020-
243·227A
A Phase 1/2 Trial of TG100-115, a Phosphatidylinositol-
3 Kinase Inhibitor, in Acute ST-Segment Elevation 
Myocardial Infarction Patients Treated by Percutaneous 
Coronary Intervention Indicates Acceptable Safety and 
Pharmacokinetics at the Initial Dose Level## 857-4·235A
A Prehospital Diagnostic Strategy Reduces Time to Treatment 
and Mortality in Real Life Patients With ST-Elevation 
Myocardial Infarction Treated With Primary Percutaneous 
Coronary Intervention## 815-3·192A
A Randomized Trial Comparing Primary PCI With or Without 
On-Site Surgery for Acute Myocardial Infarction in the 
Netherlands: From Randomization to Clinical Practice## 
815-6·193A
A Routine Intervention Strategy in Patients With Non-ST 
Segment Elevation Acute Coronary Syndromes Is Not 
Superior to a Selective Intervention Strategy: A Meta-
Analysis of Randomized Controlled Trials## 811-4·257A
Additional Ballooning Versus no Additional Ballooning After 
Drug-Eluting Stent Implantation in Routine Clinical 
Practice##998-247·217A
Adjunctive Use of the Rinspiration System for Fluidic 
Thrombectomy During Primary Angioplasty: The 
Rinspiration International Registy##952-237·185A
Age Related Outcomes in Patients Undergoing Transfer for 
Direct Percutanous Coronary Intervention in ST-Elevation 
Myocardial Infarction##904-224·160A
Angiographic Success Rates With Chronic Total Occlusions 
- Little Change Despite a Decade of Experience##923-
152·252A
Anti-thrombotic Effect of Bivalirudin Compared With 
Eptiﬁbatide and Heparin in Diabetic Patients Undergoing 
Angioplasty: An Ex-vivo Human Study##1023-171·366A
Blockade of RAGE With a New Fusion Protein Suppresses 
Neointimal Formation in Both Diabetic and Non-Diabetic 
Rats After Vascular Injury##956-171·320A
Blood Transfusion in Patients Undergoing Primary 
Percutaneous Coronary Intervention for Acute Myocardial 
Infarction: Analysis From the CADILLAC Trial##996-
241·215A
CABG and PCI Rates Differ Between Genders Even With 
Similar Coronary Anatomy: A Computer Based Patient 
Simulation Explores the Gender Gap##1013-145·266A
Carotid Angioplasty and Stenting under Protection. Short Term 
Outcomes in High and Low Risk Patients##979-180·332A
Clinical Pathway as a Strategy of Improving Care to Patients 
With an Acute Myocardial Infarction. From a Randomised 
Trial to Clinical Practice## 847-6·268A
Cost Beneﬁt Analysis of Treatment of Symptomatic 
Multivessel Coronary Disease With Preserved 
Left Ventricular Function. The Five-Year MASS II 
Report##999-254·218A
Day-case Procedures Are Safe in the Majority of Patients 
Undergoing Elective Percutaneous Coronary 
Intervention##1036-147·269A
Decision Support for Coronary Revascularization##1013-
146·266A
Distal Embolism During Native Vessel and Vein Graft 
Coronary Intervention With a Vascular Protection Device: 
Predictors of High-Risk Lesions##995-229·213A
Do All Patients With ST-Segment Elevation Myocardial 
Infarction Beneﬁt From Invasive Treatment? The Simple 
Risk-Score Derived From PL-ACS Registry##973-
235·198A
Do the Traditional Risk Factors of Vessel Size, Lesion Length 
and Diabetes Mellitus Predict Restenosis With TAXUS 
Stents? Insights From a TAXUS Meta-Analysis##954-
249·188A
Does Hospital PTCA Volume Inﬂuence Mortality and 
Complication Rates in the Era of PTCA With Systematic 
Stenting? Results of the Greater Paris Area PTCA 
Registry## 815-4·192A
Does Rescue Angioplasty Improve Outcomes? A Quantitative 
Review of Randomized trials##929-236·174A
Driving Times and Distances to Hospitals With Percutaneous 
Coronary Intervention in the U.S.: Implications for Pre-
Hospital Triage of Patients With ST-Elevation Myocardial 
Infarction## 811-3·256A
Effect of Amlodipine on the Restenosis and Clinical Outcome 
in Patients With Coronary Artery Disease After 
Angioplasty : Results From the Cardiovascular Events 
Follow-Up Trial in Kokura (CAVEFT-Kokura)##999-
255·218A
Effect of CKMB Elevation After Successful PCI on One-Year 
Mortality##971-220·194A
Effects of Percutaneous Transluminal Angioplasty (PTA) 
and Endovascular Brachytherapy(EVBT) on Vascular 
Remodeling of Human Femoropopliteal Artery: 2-Years 
Follow-Up by Noninvasive MR Plaque Imaging##1002-
183·349A
Endovascular Therapy as First Revascularization Procedure in 
Ischemic Diabetic Foot##979-184·333A
Field Triage Directly to the Catheter Laboratory Safely Reduce 
Time to Reperfusion and Infarct Size in Patients With ST-
Elevation Myocardial Infarction## 815-5·192A
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Five-Year Follow-Up of the Medicine, Angioplasty or Surgery 
Study (mass-ii): A Randomized Controlled Clinical Trial 
of 3 Therapeutic Strategies for Multivessel Coronary 
Artery Disease##976-254·202A
Fondaparinux Is Associated With Substantially Less Major 
Bleeding and Vascular Access Site Complications 
Compared With Enoxaparin in Patients With Acute 
Coronary Syndrome Undergoing Percutaneous Coronary 
Intervention: Insights from the OASIS 5 Trial## 821-
5·205A
Fondaparinux Is Associated With Substantially Less Major 
Bleeding and Vascular Access Site Complications 
Compared With Enoxaparin in Patients With Acute 
Coronary Syndrome Undergoing Percutaneous Coronary 
Intervention: Insights from the OASIS 5 Trial## 821-
5·205A
Gender and Racial Differences in Invasive Diagnostic and 
Interventional Cardiac Procedures in the Management 
of Acute Myocardial Infarction: 15-Year Trends in a 
Statewide Database##904-230·161A
Hospitalization Costs of Tenecteplase-Facilitated Angioplasty 
Versus Thrombolysis-Alone in Acute Myocardial 
Infarction##929-239·174A
Impact of Intra-plaque Enhancement in Multislice Computed 
Tomography on Coronary Flow After Percutaneous 
Coronary Intervention## 970-15·127A
Impact of Renal Insufﬁciency on the Long-Term Outcomes 
Following Percutaneous Coronary Intervention With 
Sirolimus-Eluting Stents##954-251·188A
Impact of Restrictive Access to Clopidogrel Following 
Coronary Stent Implantation on Patient Health 
Outcomes## 811-8·257A
Impact of Time to Presentation and Reperfusion Modality on 
the Efﬁcacy of Adenosine During Reperfusion Therapy 
for Acute Myocardial Infarction: The AMISTAD-2 
Trial##929-241·175A
In-Hospital Outcomes in Patients With ACS Treated With 
Sirolimus and Paclitaxel Drug Eluting Stents: Experience 
From the ACC-NCDR Database##923-155·253A
Incidence of, Predictors of, and Outcomes Related to 
Discontinuation of Thienopyridine Therapy at 1-Month 
After Coronary Stenting in AMI## 857-8·236A
Increased In-Hospital and Long-Term Morbidity and Mortality 
in Patients With Gastrointestinal Bleeding Following 
Percutaneous Coronary Intervention##997-242·216A
Inﬂuence of Number of Vessels Disease in Prognosis and 
Therapeutic Results in Chronic Coronary Artery Disease 
After Medical, Bypass Surgery or Angioplasty: 3-Years 
Follow-Up of the Mass I I Study##955-256·189A
Intracoronary Streptokinase Infusion Just Following 
Primary Percutaneous Coronary Intervention Improves 
Microvascular Perfusion and Integrity in Patients With 
Acute Myocardial Infacrtion##929-237·174A
Isolated Elevation in Troponin-T Following Percutaneous 
Coronary Intervention Is Associated With Higher Long-
Term Mortality## 850-5·221A
Long Distance Transfer for Direct Percutaneous Coronary 
Intervention: A Facilitated Approach##929-238·174A
Lower Mortality With Paramedics Interpreting the 
Electrocardiogram Coupled to Primary Percutaneous 
Angioplasty for ST-Segment Elevation Myocardial 
Infarction## 815-7·193A
Minimising Door to Balloon Times and Day/Night Variation 
in Primary Percutaneous Coronary Angioplasty With 
Ambulance Triage, and Direct Transfer to the Cardiac 
Catheterisation Laboratory##973-238·198A
Mortality Beneﬁt of Drug-Eluting Stent Use in Clinical 
Practice##928-225·171A
Myeloperoxidase May Contribute to the No-reﬂow 
Phenomenon in Patients With Acute Myocardial 
Infarction##972-226·196A
On-site PCI Versus PCI After Transfer in Rural Germany: 
Network Logistics for Patients With ST-Elevation 
Myocardial Infarction (STEMI)##1021-256·231A
Optimal Antiplatelet Therapy After DES Implantation in 
Patients Requiring Long-Term Anticoagulation##999-
256·219A
Overlapping Sirolimus-Eluting Stents: Analysis From the 
Matrix Registry##976-259·203A
Percutaneous Coronary Intervention Increases Endothelial 
Progenitor Cell Mobilisation in Patients With Ischemic 
Heart Disease##910-179·292A
Percutaneous Transluminal Angioplasty of the Subclavian 
Arteries##1002-184·349A
Pregnancy-associated Plasma Protein A: An Instant Rising 
Biomarker in Patients With ST-Elevation Myocardial 
Infarction##971-215·193A
Prevalence and Clinical Impact of Angiographic Stent Fracture 
and Stent Hinge Movement After Sirolimus-eluting Stent 
(SES) Implantation in Complex PCI##976-257·203A
Primary Percutaneous Coronary Intervention for Acute 
Myocardial Infarction in Women Versus Men 1995-
2004##952-235·184A
Primary Thrombosuction With Export Aspiration Catheter 
During Percutaneous Coronary Intervention in Acute 
Coronary Syndrome: Acute Results and In-Hospital 
Outcomes##998-248·217A
Protection of Distal Embolization in High-Risk Patients 
With Acute ST-Segment Elevation Myocardial 
Infarction##952-241·186A
Randomized Trial of Sirolimus- Versus Paclitaxel-Eluting 
Stents for the Treatment of Acute ST-Elevation 
Myocardial Infarction##952-232·184A
Renal Dysfunction Negates the Beneﬁt of Primary 
Percutaneous Coronary Intervention Over Fibrinolytic 
Therapy in the Treatment of ST Segment Elevation 
Myocardial Infarction##904-227·160A
Rescue Angioplasty versus Conservative Management for 
Failed Thrombolysis in Acute Myocardial Infarction: A 
Meta-Analysis##929-235·173A
Rescue Angioplasty Versus Conservative Treatment in 
Patients with Failed Fibrinolysis- No Late Survival 
Beneﬁt. The Final Analysis of the Middlesbrough 
Early Revascularisation to Limit Infarction (MERLIN) 
Randomised Trial##929-232·173A
Rescue Percutaneous Coronary Intervention After Failed 
Fibrinolysis: A Meta-Analysis of Randomized Controlled 
Trials##929-234·173A
Risk Score for Prediction of Major Bleeding After 
Percutaneous Coronary Intervention##1021-257·231A
Rotational Atherectomy With Sirolimus Eluting Stents Versus 
Rotational Atherectomy With Bare Metal Stents for 
Complex Coronary Calciﬁc Lesions##956-161·317A
Similar Mortality After Prehospital Thrombolysis or 
Primary PCI in Patients With ST-Elevation Myocardial 
Infarction Diagnosed in the Prehospital Phase. Results of 
PREMIR##952-234·184A
Strong Impact of Mechanical Coronary Intervention on 
Cardiac Rupture After Acute Myocardial Infarction: The 
Kochi Acute Myocardial Infarction (KAMI) Study##952-
238·185A
The Impact of Complete Revascularization on Long-
Term Outcomes in Elderly Patients With Coronary 
Artery Disease Undergoing Percutaneous Coronary 
Intervention##976-253·202A
The Impact of Metabolic Syndrome and Diabetes on Long-
Term Outcomes Following Percutaneous Coronary 
Intervention##961-201·326A
The Impact of Reduced Left Ventricular Function on Long-
Term Outcomes in Diabetes Mellitus Patients With 
Coronary Artery Disease Undergoing Percutaneous 
Coronary Intervention##905-240·164A
The Impact of the Deep Echo Attenuation on Coronary Flow 
After Percutaneous Coronary Intervention## 843-3·219A
The Impact of the Thrombus Aspiration on the Final TIMI 
Flow in Patients with ST-Elevation Myocardial Infarction 
(STEMI)##952-240·185A
The MITRA-Score: A New Score for the Quality of Care 
in Patients With Acute ST Elevation Myocardial 
Infarction##973-232·197A
The Safety and Outcome of the Multiple, Very Long Sirolimus-
Eluting Stent Implantation in the the Real World Clinical 
Practice##976-260·203A
Angioscopy
C-Reactive Protein May Be Absorbed Through Yellow Plaque 
and Lead to the Formation of Vulnerable Plaque##978-
178·332A
Comparison between Culprit and Nonculprit Lesions in 
Patients with Multiple Plaque Ruptures and Acute 
Coronary Syndrome##951-231·183A
Do CT-low-dense Coronary Artery Plaques Represent Plaque 
Vulnerability? Study by Intravascular Ultrasound and 
Coronary Angioscopy## 970-2·125A
Malondialdehyde-modiﬁed LDL(MDA-LDL) Is a Novel 
Marker as Instability of Coronary Plaque: Angioscopic 
Analysis##951-227·183A
Progression of Coronary Artery Stenosis during 6 Months Was 
Associated With the Number of Yellow Plaques Detected 
by Baseline Angioscopy##930-244·175A
Yellow Color Plaques Were Still Observed Among the 
Sirolimus Eluting Stent Struts at 3 and 6-Month Follow-
Up Via Coronary Angioscope##910-183·293A
Angiotensin II
Additive Beneﬁcial Effects of Fenoﬁbrate Combined with 
Candesartan in the Treatment of Hypertriglyceridemic, 
Hypertensive Patients## 845-4·359A
Angiotensin II Acutely Increases Diastolic Distensibility: 
A Protein Kinase C and Na+/H+ Exchanger-mediated 
Effect##1031-47·84A
Angiotensin Receptor 1 Blocker Reduces Atherosclerotic 
Changes of Aortic Valve in Hypercholesterolemic Rabbit 
Model## 844-4·284A
Antiplatelet Effects of Angiotensin-Converting Enzyme 
(ACE) Inhibitors and Angiotensin II Subtype 1 Receptor 
Blockers (ARBs): Modiﬁed Ex Vivo Platelet Aggregation 
of 374 Cardiovascular Patients##1023-166·365A
Association of the Deletion/Insertion Polymorphism of 
the Angiotensin-Converting Enzyme With Cardiac 
Conduction, Repolarization, and Function in A 
Population-based Study##918-50·37A
Beneﬁcial Effects of Dual Angiotensin-II Suppression With 
ACE-inhibitor and Angiotensin Receptor Blocker on 
BNP, CRP and Glucose Regulation in Patients With 
Symptomatic Heart Failure##959-189·323A
Candesartan Improves Outcome in Patients With Low Ejection 
Fraction Heart Failure, Irrespective of Background Dose 
of ACE Inhibitor: An Analysis of the CHARM-Added 
Trial## 809-5·52A
Chymase Inhibitor Improves Left Ventricular Dysfunction 
Under Long-Term Angiotensin-Converting Enzyme 
Inhibition in Heart Failure##919-99·42A
Comparative Metabolic Effects of Ramipril and Candesartan in 
the Treatment of Hypertensive Patients##942-96·49A
Difference in Left Ventricular Reverse Remodeling in 
Response to Angiotensin Receptor Blockade Alone or 
in Combination With Spironolactone in Patients With 
Systolic Dsyfunction: Insight From Serial Prospective 
CMR Study##919-59·39A
Effect of Angiotensin Blockade on the Degree of Organic 
Mitral Regurgitation: A Randomized Clinical Trial##962-
25·279A
Effects of Aggrenox and Telmisartan Versus Clopidogrel 
and Aspirin in Combination on Platelet Activity in 
Diabetic Patients: An ex vivo Outlook to the PRoFESS 
Trial##1023-167·365A
Effects of Angiotensin II Type 1 Receptor Antagonist on Atrial 
Fibrillation Stability in Genetically Identical Goats## 
924-142·9A
Effects of Angiotensin-II Receptor Blockers on Coronary 
Atherosclerosis in Patients With Acute Myocardial 
Infarction Taking Angiotensin-Coverting-Enzyme 
Inhibitors: An Intravascular Ultrasound (IVUS) 
Study##996-239·215A
High Hemoglobin was Associated With Cardiovascular 
Events, Low Hemoglobin With All-Cause Mortality, and 
Large Fall in Hemoglobin With Both in Patients With 
Hypertension and Left Vetricular Hypertrophy. The LIFE 
Study## 848-5·361A
Incidence and Predictors of Hyperkalemia in Patients With 
Heart Failure - An Analysis of the Candesartan in Heart 
failure - Assessment of Reduction in Mortality and 
morbidity (CHARM) Program## 809-4·52A
Irbesartan Reduces Left Atrial Stunning After Electrical 
Cardioversion of Atrial Fibrillation## 924-141·9A
Losartan Combined With Simvastatin Shows Additive 
Beneﬁcial Effects on Inﬂammation in the Treatment of 
Hypercholesterolemic, Hypertensive Patients## 845-
5·359A
Molecular Dissection of Human LOX-1 Promoter: Nucleotides 
and Transcription Factors Requirement During 
Transactivation## 822-3·340A
Olmesartan Inhibits NF-�B Activity and Attenuates Hypoxia-
Induced Left Ventricular Remodeling in Apolipoprotein 
E-Knockout Mice##913-198·296A
Prevention of Atrial Fibrillation Via Abrogation of the 
Renin-Angiotensin System: A Pooled Meta-Analysis of 
Randomized Controlled Clinical Trials## 924-140·9A
Reduced Renal Function is Associated With Increased 
Effectiveness of ACE Inhibitor Therapy in Patients With 
Chronic Stable Coronary Disease in the Prevention 
of Events With ACE inhibition (PEACE) Trial##905-
232·162A
The Effect of Pre-Admission Use of Angiotensin Converting 
Enzyme Inhibitor/Angiotensin II Receptor Blocker and/or 
Beta-Blocker Therapy on Hospital Acute Decompensated 
Heart Failure Hospital Mortality##1032-55·86A
The Effect of Ramipril and Valsartan on Aortic Stiffness and 
Wave Reﬂections in Patients With Successful Coarctation 
Repair##1011-116·244A
The Forkhead Transcription Factor, FOXO3a Controls Vascular 
Smooth Muscle Cells Proliferation through Modulation 
of an Angiogenic Immediate Early Gene, CYR61##933-
170·303A
Antiarrhythmia agents
Appearance of Right Ventricular Activation Delay by 
Pilsicainide Challenge Impaired Myocardial Performance 
Index in Brugada Syndrome## 948-42·123A
Efﬁcacy and Safety of Extra Class IC Doses for Pharmacologic 
Cardioversion in Patients Maintained on Class IC Drugs 
for Atrial Fibrillation##938-200·309A
Efﬁcacy and Tolerance of RSD1235 in the Treatment of 
Atrial Fibrillation or Atrial Flutter: Results of a Phase 
III, Randomized, Placebo-controlled, Multicenter Trial## 
804-3·10A
Preprocedual Statin Administration Can Reduce Thrombosis 
Reaction in Both Acute Myocardial Infarction and Stable 
Angina - Histologic Evaluation## 855-4·379A
Procainamide - Propafenone - Amiodarone: A Comparative 
Study of Their Efﬁcacy And Safety For the Conversion of 
Recent Onset Atrial Fibrillation## 804-4·10A
Antibodies
Endothelial Dysfunction and Increased Carotid Intima-Media 
Thickness in Primary Antiphospholipid Syndrome##1001-
179·348A
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High Frequency of Anti-heart Autoantibodies in Acute 
Myocardial Infarction With Angiographically Normal 
Coronary Arteries: Evidence for Undiagnosed Immune-
mediated Myocarditis##987-104·71A
Anticoagulants
A Comparison of Bleeding Complications Associated With 
Warfarin and Coumadin Among Patients Undergoing 
Device Implantation## 969-137·23A
A Novel Enoxaparin Regime for ST-Elevation Myocardial 
Infarction Patients Undergoing Primary Purcutaneous 
Coronary Intervention: Intravenous but Not Subcutaneous 
Enoxaparin Achieves Adequate Anti-Xa Levels##1020-
243·227A
Adverse Impact of Bleeding in Patients With Acute Coronary 
Syndromes##972-230·197A
Are There Gender Differences in Risk of Ischemic Stroke in 
Patients with Atrial Fibrillation Who Are Anticoagulated? 
Results from the AFFIRM Trial## 804-6·10A
Atrial Fibrillation: Bridging of Chronically Anticoagulated 
Patients With Low Molecular Weight Heparin Prior to 
Interventional Procedures: Experience in 455 Patients 
From the Brave-registry## 849-6·362A
Catheter Ablation of Atrial Fibrillation or Left Atrial Flutter 
Under Uninterrupted Oral Anticoagulation## 838-4·30A
Cerebrovascular Thromboembolic Events After Mitral Valve 
Repair: Implication for Treatment of Patients with Mitral 
Regurgitation##917-25·273A
Clopidogrel is Associated With a Reduced Thrombogenic 
Response in Radiofrequency Ablation Procedures 
Compared to Aspirin## 901-143·5A
Combining Warfarin and Antiplatelet Therapy After Coronary 
Stenting in the Global Registry of Acute Coronary Events: 
Is it Safe and Effective to Use Just One Antiplatelet 
Agent?##923-149·252A
Fondaparinux Is Associated With Substantially Less Major 
Bleeding and Vascular Access Site Complications 
Compared With Enoxaparin in Patients With Acute 
Coronary Syndrome Undergoing Percutaneous Coronary 
Intervention: Insights from the OASIS 5 Trial## 821-
5·205A
Fondaparinux Is Associated With Substantially Less Major 
Bleeding and Vascular Access Site Complications 
Compared With Enoxaparin in Patients With Acute 
Coronary Syndrome Undergoing Percutaneous Coronary 
Intervention: Insights from the OASIS 5 Trial## 821-
5·205A
Fondaparinux Versus Enoxaparin in Patients With Acute 
Coronary Syndromes Without ST-Segment Elevation: 
Impact of Risk According to the GRACE Score##1018-
223·223A
Impact of Chronic Oral Anticoagulation on Baseline 
Characteristics, Management, and Outcomes of Patients 
With Acute Myocardial Infarction. Data From the Rico 
Survey##904-229·161A
Is the Non-inferiority Claim for Bivalirudin in Percutaneous 
Coronary Intervention Warranted? REPLACE-2 
Revisited##923-145·251A
Late Clinical Outcomes With Aspirin, Coumadin or Both 
After Acute Coronary Syndromes (Late Outcomes of the 
ASPECT-2 Trial)##999-259·219A
Low Molecular Weight Heparin in Chronically Anticoagulated 
Patients After Mechanical Valve Replacement Prior to 
Interventions With High-Risk of Bleeding: Experience in 
104 Patients From the BRAVE-Registry## 824-7·282A
Nadroparin Versus Unfractionated Heparin for Anticoagulation 
of all Cause Atrial Fibrillation: Final Results of the 
NADROPAF Trial## 1015-141·35A
Optimal Antiplatelet Therapy After DES Implantation in 
Patients Requiring Long-Term Anticoagulation##999-
256·219A
Patient Safety Suffers at Nursing Shift Changes: Error 
Rate Peaks for Intravenous Unfractionated Heparin 
Administration##946-153·255A
Pharmacogenetic Warfarin-Dosing Algorithm Is Substantially 
Improved When Both VKORC1 and CYP2C9 Gene 
Variants Are Considered##908-159·288A
Prolonged Heparin Exposure, Development of 
Thrombocytopenia, Use of GP IIb/IIIa Inhibitors, and 
History of Renal Dysfunction Predict Moderate or 
Severe Bleeding: A Report From the Complications 
After Thrombocytopenia Caused by Heparin (CATCH) 
Registry##923-146·251A
Should Warfarin Be Monitored by Anticoagulation Clinics or 
by Physician Practices?##968-149·259A
The Oldest Old Patients Have a Lower Chance for Receiving 
Guidelines Recommended Atrial Fibrillation Therapy. 
The Experience of the Euro Heart Survey on Atrial 
Fibrillation##946-145·253A
Thrombocytopenia Is Associated With Adverse Outcomes 
Following Treatment With Either Enoxaparin or 
Unfractionated Heparin in Patients Presenting With Acute 
Coronary Syndromes: A TIMI 11B Substudy##1018-
225·223A
Thrombolysis of Massive Pulmonary Embolism: Efﬁcacy and 
Safety of Adjunctive Therapy With Enoxaparin in Patients 
Older Than 75 Years##958-180·321A
Unfractionated and Low-Molecular-Weight Heparin as 
Adjuncts to Thrombolysis in Aspirin-Treated Patients 
With ST-Elevation Acute Myocardial Infarction: A Meta-
Analysis of the Randomized Trials##1020-247·228A
Warfarin Therapy Initiated Before Transesophageal 
Echocardiography Detected Left Atrial Thrombus Is More 
Beniﬁcial Than When Started After## 1017-2·152A
Antihypertensive therapy
Aliskiren, an Oral Renin Inhibitor, Provides Dose-Dependent 
Efﬁcacy, and Placebo-Like Tolerability in Patients With 
Hypertension##1027-191·370A
Are High-Risk Hypertensive Patients Prescribed Concomitant 
Statin Therapy? Prescription Patterns in Patients Initiating 
Antihypertensive Therapy in the United States##1021-
251·230A
C-Reactive Protein Levels Is the Major Determinant 
of microalbuminuria in Essential Hypertensive 
Patients##982-200·336A
Effect of Amlodipine and Enalapril on Cardiovascular Events 
in Normotensive Coronary Artery Disease Patients with 
Concomitant Statin Use in the CAMELOT Trial##938-
202·310A
Effect of Amlodipine and Enalapril on Cardiovascular Events 
in Patients With Insulin Resistance and Diabetes in the 
CAMELOT Trial##938-199·309A
The Cost-Effectiveness of Perindopril in Reducing 
Cardiovascular Events in Patients With Stable Coronary 
Artery Disease Using Data From the EUROPA 
Study##968-155·260A
Antioxidants
5-Methyl-Tetrahydrofolic Acid Rapidly Improves Endothelial 
Function and Superoxide Production in Human 
Atherosclerosis: Effects on Tetrahydrobiopterin-
Dependent eNOS Coupling## 841-4·356A
A Randomized Double Blind, Placebo Controlled Trial to 
Investigate the Effect of Intravenous N-Acetylcysteine 
in Preventing Renal Dysfunction Following 
Cardiopulmonary Bypass in High Risk Patients##940-
19·274A
Attenuation of LV Dysfunction by A PPAR-alpha Agonist in 
Hypertensive Rats is Associated With Down-regulation of 
Redox-regulated Transcription Factors##1007-47·75A
Combination of Aspirin and Pravastatin Dramatically Reduces 
Oxidative Stress and the Expression of LOX-1 and 
Adhesion Molecules: Novel Insight Into the Mechanism 
of Action of Aspirin and Statins## 822-5·340A
Rapid Effects of 5-Methyl-Tetrahydrofolic Acid on Endothelial 
Function and Vascular Superoxide Production in Human 
Coronary Artery Disease##933-171·303A
The Impact of Cardiovascular Risk Factors on Oxidative Stress 
in Humans##1005-203·353A
Aorta
Angiotensin Converting Enzyme Inhibition Reduces Aortic 
Stiffness in Stable Coronary Artery Disease. Results of the 
Peace Hemodynamic Study##1001-176·347A
Aortic Pulse Wave Velocity Is Associated With Presence and 
Quantity of Coronary Artery Calcium: A Community-
Based Study## 801-5·313A
Diabetic Plaque Inﬂammation and Neovascularization 
Are Associated With Increased Reparative Collagen 
Content: Implication for Plaque Progression in Diabetic 
Atherosclerosis##912-193·295A
Increased Aortic Characteristic Impedance Contributes to 
Increased Central Aortic Pulse Pressure in Young Women 
With Type 1 Diabetes##1025-181·368A
Novel Velocity Vector Imaging Ultrasound Technique 
Demonstrates Asymmetric Deformation in the Normal 
Aortic Root## 925-38·102A
Risk Factors Associated With Mortality and Re-Operation in 
252 Patients With AVR for Congenital Bicuspid Aortic 
Valve Disease## 824-6·282A
Simple Risk Model to Predict Surgical Mortality in Acute Type 
A Aortic Dissection: The IRAD Score##940-21·274A
The Inﬂection Point Is Not a Reliable Method for the 
Determination of the Augmentation Index## 802-5·315A
Aortic coarctation
Outcomes of Stent Implantation for Native and Recurrent 
Coarctation of the Aorta (COA): Classiﬁcation and 
Implications of Aortic Wall Injury##945-111·239A
The Effect of Ramipril and Valsartan on Aortic Stiffness and 
Wave Reﬂections in Patients With Successful Coarctation 
Repair##1011-116·244A
Aortic diseases
Association of Low Fetuin-A and Inﬂammation With the 
Severity of Aortic Valve Calciﬁcation##1030-26·287A
Bicuspid Aortic Valve Phenotype Predicts Aortic Elastic 
Properties## 803-6·276A
Partial False Lumen Thrombosis as a Predictor of Mortality 
in Patients with Type B Acute Aortic Dissection: 
Insights from The International Registry of Acute Aortic 
Dissection (IRAD)## 802-7·315A
Pulmonary Autograft Dilatation After Ross Procedure: 
Incidence of and Risk Factors##922-109·237A
Risk Factors Associated With Mortality and Re-Operation in 
252 Patients With AVR for Congenital Bicuspid Aortic 
Valve Disease## 824-6·282A
Simple Risk Model to Predict Surgical Mortality in Acute Type 
A Aortic Dissection: The IRAD Score##940-21·274A
Trends and Predictors of Outcome in Circulatory Arrest for 
Adult Cardiac Surgery: A Decade of Experience (1996-
2005)##940-25·275A
Aortic regurgitation
Biochemical Markers of Collagen Turnover in Asymptomatic 
Aortic Regurgitation With Normal EF and LV 
Dimension## 844-5·285A
The Incidence of Aortic Regurgitation After Percutaneous 
Aortic Valve Implantation##1006-22·283A
Toward More Predictable Repair of Regurgitant Aortic Valves: 
A Logical, Segmental Approach##917-24·273A
Aortic valve sclerosis
Features of the Metabolic Syndrome and Diabetes Mellitus 
as Predictors of Aortic Valve Calciﬁcation as Detected 
by Electron Beam Computed Tomography in the Multi-
Ethnic Study of Atherosclerosis##1030-27·287A
Speciﬁc Effects of Statins on Gene- Proﬁling in Human End- 
Stage Stenotic Calciﬁed Aortic Valves##1030-23·286A
Aortic valve stenosis
Angiotensin Receptor 1 Blocker Reduces Atherosclerotic 
Changes of Aortic Valve in Hypercholesterolemic Rabbit 
Model## 844-4·284A
Aortic Valve Replacement in Patients With Moderate to 
Severe Aortic Stenosis Does Not Prevent Bleeding From 
Gastrointestinal Arteriovenous Malformations##1030-
22·286A
Are There Gender-Related Differences in Presentation 
and Management of Patients with Severe Aortic 
Stenosis?##1030-21·286A
Association of Low Fetuin-A and Inﬂammation With the 
Severity of Aortic Valve Calciﬁcation##1030-26·287A
Atherosclerosis of the Aorta Is Strongly Associated With 
Calciﬁc Aortic Valve Stenosis Independently of Classical 
Atherosclerosis Risk Factors##1030-25·287A
Comorbidities in Severe Aortic Valve Stenosis: Do Renal 
Dysfunction, Anemia or Diabetes Mellitus Predict Long-
Term Outcome?##1030-24·287A
Comparison of 64-Slice Computed Tomography and 
Transthoracic Echocardiography in Quantiﬁcation of 
Native Aortic Valve Stenosis## 832-5·135A
Human Degenerative Valve Disease is Associated with 
Upreguation of Lrp5 Receptor Mediated Bone 
Formation## 844-3·284A
Impact of Gender on Left Atrial and Ventricular Response 
to Asymptomatic Aortic Valve Stenosis. The SEAS 
Study##1030-19·285A
Long-Term Outcome of Asymptomatic Bicuspid Aortic Valve 
in the Community## 803-5·276A
Normalization of Nonuniform Contraction of the Left Ventricle 
Early After Aortic Valve Replacement in Patients With 
Severe Aortic Stenosis## 925-43·103A
Prognostic Value of N-terminal Pro B-type Natriuretic Peptide 
(NT-proBNP) in Conservatively Treated Patients With 
Valvular Aortic Stenosis##1030-20·286A
Real-Time 3-Dimensional Echocardiography for the 
Calculation of Left Ventricular Volumes in Fetuses 
With Aortic Stenosis Being Considered for In-Utero 
Intervention: An In-Vivo, and In-Vitro Validation Study## 
852-5·249A
Risk Factors Associated With Mortality and Re-Operation in 
252 Patients With AVR for Congenital Bicuspid Aortic 
Valve Disease## 824-6·282A
Aortocoronary bypass
Does Platelet Hyperactivity Exist After Off-Pump Compared 
to On-Pump Coronary Artery Bypass Surgery?##955-
259·190A
Genomic Association of Graft Failure of the Left Internal 
Thoracic Artery for Myocardial Revascularization##907-
247·165A
Impact of Early Clopidogrel Use on Angiographic and Clinical 
Outcomes Following Coronary Artery Bypass Surgery: 
Findings from PREVENT IV##932-257·178A
Apolipoproteins
Effects of Torcetrapib and/or Atorvastatin on HDL and LDL 
Particle Size and Composition: Results From a Phase 2 
Trial##981-195·335A
In Vivo Real-Time Vessel Imaging and Ex vivo 3D 
Reconstruction of Atherosclerotic Plaque in 
Apolipoprotein E-Knockout Mice Using Synchrotron 
Radiation Microscopy##977-172·330A
Apoptosis
A Novel Caspase Inhibitor, VX-166, Reduces Myocardial 
Infarction in the Rat##927-218·170A
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Allogeneic Mesenchymal Stem Cells Restore Early Tissue 
Perfusion in Regions of Ischemically Damaged 
Myocardium## 993-3·142A
Apoptosis Is Increased in Diabetes Atherosclerosis Independent 
of Plaque Lipid Content##977-167·329A
Deletion of Tumor Necrosis Factor α Receptor 1 Is Protective 
in A Mouse Model of Hindlimb Ischemia##933-168·302A
Ghrelin Protects Myocardium Against Ischemia/Reperfusion 
Injury via Inhibiting Myocardial Apoptosis##937-
195·308A
Increased Presence of Pro-Coagulant Apoptotic Bodies in 
Lipid-Rich and Vulnerable Atheroma: A Vehicle to 
Propagate Cell Death and Pro-Coagulant Potential?##977-
165·329A
Local Stress Concentration Around Calciﬁed Apoptotic 
Macrophages in the Fibrous Cap: A New Hypothesis 
for the Rupture of Coronary Thin-cap Atheroma 
Lesions##977-162·328A
Manganese Superoxide Dismutase Polymorphism Affects the 
Oxidized LDL-Induced Apoptosis of Macrophages and 
Coronary Artery Disease## 822-6·340A
Myocyte Bag-1 Provides Endogenous Cardioprotection 
Following Relocation From the Cytoplasm to the Nuclei 
in the Rat Heart Exposed to in vivo Ischemia/Reperfusion 
Injury##994-219·211A
Small HDL Particles Exert Potent Protection of Human 
Endothelial Cells Against Apoptosis: Relevance to 
Metabolic Syndrome##1000-162·344A
Strain Related Alterations of the Phosphoinositide 3-Kinase/
Akt/BAD Survival Pathway##1007-50·76A
T Cell Receptor Signaling and Synapse Formation in T Cells 
From Patients With Acute Coronary Syndrome##977-
160·328A
Arrhythmias
A Common Polymorphism H558R in SCN5A is Associated 
with Lone Atrial Fibrillation## 826-6·25A
A Novel Locus for Familial Atrial Fibrillation on Chromosome 
10p11-q21## 804-8·11A
Appearance of Right Ventricular Activation Delay by 
Pilsicainide Challenge Impaired Myocardial Performance 
Index in Brugada Syndrome## 948-42·123A
Atrial Arrhythmias Post Atricure Radiofrequency Ablation for 
Atrial Fibrillation: Findings During Catheter Ablation## 
901-140·4A
Biventricular Pacing Reduces Incidence of Microvolt T Wave 
Alternans in Patients With Congestive Heart Failure## 
1015-126·32A
Cardiac Kir2.x Channels in Homomeric and Heteromeric 
Composition Are Markedly Activated by Adrenergic 
�3-Receptors: Role of Protein Kinases A and C## 901-
128·2A
Circumferential Pulmonary Vein Ablation. Early Experience 
on Remote Magnetic Navigation Versus Standard 
Technique## 838-3·30A
Determination of Atrial Flutter Type Using Interactive ECG 
Analysis## 992-130·27A
Do Endurance Exercise-Induced Sinus Node Dysfunction 
and Arrhythmias Persist? A Case-Matched Long-Term 
Follow-Up Study of 62 Former Professional Cyclists## 
1015-133·34A
Do Symptoms Predict Atrial Fibrillation Episodes in Patients 
With Paroxysmal Atrial Fibrillation?## 1015-134·34A
Does Gender Alter the Efﬁcacy of Implantable Cardioverter 
Deﬁbrillators?## 947-129·15A
Early Electromechanical Changes Following Acute Coronary 
Artery Microembolization##950-216·180A
Effects of Angiotensin II Type 1 Receptor Antagonist on Atrial 
Fibrillation Stability in Genetically Identical Goats## 
924-142·9A
Genetic Analysis of Hyperpolarization-activated and Cyclic 
Nucleotide-gated Cation Channels 4 (HCN4) in Patients 
With Bradyarrhythmia## 901-134·3A
Is Incidence in Arrhythmias Different in LVADs With 
Continuous Versus Pulsatile Flow?##988-106·71A
QTc Variability in Patients With Long QT Syndrome: The 
Importance of the Maximum QTc Value From Follow-
Up Electrocardiograms in Predicting Cardiac Events## 
992-124·26A
Renin-Angiotensin-Aldosterone System Antagonism Decreases 
the Incidence of Ventricular Dysrrhythmias Following 
Myocardial Infarction: Lessons From GUSTO-V##996-
240·215A
Risk Prediction With Cardiac Troponin T Versus Biochemical 
Markers Associated With Cardiac Remodeling##959-
191·324A
Signiﬁcant Low-Voltage ECG and Impaired Systolic Cardiac 
Function in Neonatal Mice Expressing Connexin 31 
Instead of 43## 901-126·1A
The Effects of Caffeine on the Inducibility of Atrial 
Fibrillation##913-197·296A
Arrhythmias, treatment of
Cardiac Pacemaker Precursor Cells Can Be Obtained From 
Human Endometrial Mesenchymal Stem Cells for 
Biological Pacemaker Cell Transplantation.## 901-
131·2A
Circumferential Pulmonary Vein Ablation. Early Experience 
on Remote Magnetic Navigation Versus Standard 
Technique## 838-3·30A
Does Reduction in Left Atrial Diameter During 
Antihypertensive Treatment Reduce New-Onset Atrial 
Fibrillation in Hypertensive Patients with Left Ventricular 
Hypertrophy: The LIFE Study## 924-139·9A
Does the Point of Closest Approach Between the Esophagus 
and the Posterior Left Atrium Move with the Cardiac 
Cycle?## 901-139·4A
Early Experience Of Pulmonary Vein Antral Isolation Using 
an Open Irrigation Ablation Catheter for the Treatment 
of Atrial Fibrillation: Immediate Short Term Results of a 
Randomized Study## 992-142·30A
Heat Shock Proteins Prevent Atrial Tachycardia Remodeling 
and Atrial Fibrillation Promotion## 826-4·25A
Intraoperative Cooled-tip Radiofrequency Linear Atrial 
Ablation to Treat Permanent Atrial Fibrillation## 838-
5·30A
Left Atrial Functional Reserve Can Predict the Long 
Term Prognosis of the Cardioverted Chronic Atrial 
Fibrillation?## 1017-4·153A
Long-Term Follow-Up in Patients With Percutaneous Left 
Atrial Appendage Transcatheter Occlusion System 
(PLAATO): Risk of Thrombus Formation and 
Development of Pulmonary Venous Obstruction After 
Percutaneous Left Atrial Appendage Occlusion## 1015-
142·36A
Predictors of Mortality in Patients Receiving Implantable 
Deﬁbrillators## 947-132·16A
Presence and Type of Provocable Non Pulmonary Triggers for 
Atrial Fibrillation: Inﬂuence of Gender and Arrhythmia 
Presentation## 947-139·17A
Procainamide - Propafenone - Amiodarone: A Comparative 
Study of Their Efﬁcacy And Safety For the Conversion of 
Recent Onset Atrial Fibrillation## 804-4·10A
Remote Radiofrequency Ablation of Left Sided Accessory 
Pathways Using the Retrograde Transaortic Approach: 
A Comparison of Catheters With Different Magnetic 
Mass## 901-142·5A
Safety and Efﬁcacy of Remote Ablation by Magnetic Catheter 
in Patients With WPW Syndrome## 901-141·4A
Sustained Polymorphic Arrhythmias Induced by Programmed 
Ventricular Stimulation Have Prognostic Value in Patients 
Receiving Deﬁbrillators for Primary Prevention of Sudden 
Cardiac Death## 924-128·6A
Arterial stiffness
Angiotensin Converting Enzyme Inhibition Reduces Aortic 
Stiffness in Stable Coronary Artery Disease. Results of the 
Peace Hemodynamic Study##1001-176·347A
Aortic Pulse Wave Velocity Is Associated With Presence and 
Quantity of Coronary Artery Calcium: A Community-
Based Study## 801-5·313A
Arterial Stiffness in Subjects With White Coat Versus 
Sustained Hypertension##1004-195·351A
Association Between Low-grade Inﬂammation and Arterial 
Stiffness in Patients With Essential Hypertension##982-
196·336A
Atheromatous Coronary Plaque Has Lower Distensibility Than 
Fibrous Plaque: Comparison of Intravascular Ultrasound 
Imaging and Histo-Pathological Analysis##1024-
176·367A
Effect of Low-grade Inﬂammation on Arterial Stiffness 
in Subjects With White Coat Versus Sustained 
Hypertension##1004-192·351A
Gender Difference of Small and Large Artery Elasticity in 
Relation to Pulse Pressure##1001-174·347A
Gender Differences in Pressure Wave Reﬂection Changes With 
Healthy Aging: A Population-Based Study in Hispanic 
Mestizos## 835-4·342A
Increased Aortic Characteristic Impedance Contributes to 
Increased Central Aortic Pulse Pressure in Young Women 
With Type 1 Diabetes##1025-181·368A
Increased Arterial Stiffness: A Major Determinant of the 
White-Coat Effect##982-197·336A
Inﬂuence of Pravastatin on Carotid Artery Structure and 
Function in Dyslipidemic HIV-Infected Patients Under 
Antiretroviral Therapy##980-187·334A
Leucocyte Count Is a Marker of Arterial Wave Reﬂections in 
Apparently Healthy Individuals##1005-202·353A
Long- Term Sildenaﬁl Administration Improves Aortic 
Stiffness and Wave Reﬂections in Patients With Erectile 
Dysfunction of Vascular Origin##1026-188·370A
Measures of Arterial Stiffness and Wave Reﬂection Predict 
Walking Distance in Patients With Peripheral Arterial 
Disease##1000-168·345A
Neointimal Hyperplasia But Not Pathological Vascular Wall 
Structural Changes (Fibrin Deposition and Inﬂammation) 
Inﬂuence Maximal Vasodilation in Porcine Coronary 
Arteries 1-Month After Implantation of Stents##910-
182·293A
Non-Dipping Status Is Accompanied by a State of 
Hypoadiponectinemia, and Arterial Stiffening in 
Essential Hypertensive Subjects: A Link to Subclinical 
Atherosclerotic Processes##1004-194·351A
Obstructive Sleep Apnea Impairs Arterial Stiffness in 
Hypertensive Patients: Potential Additive Effects to 
Atherosclerosis##915-211·299A
Progressive Decrease in Large and Small Artery Elasticity With 
the Presence of Multiple Components of the Metabolic 
Syndrome##939-210·312A
Relation of Insulin-like Growth Factor-1 and Insulin-like 
Growth Factor Binding Protein-3 to Carotid Intima-media 
Thickness and Elasticity in Younger Adults: The Bogalusa 
Heart Study##961-203·326A
Selective Cyclooxygenase-2 Inhibition by Celecoxib Abrogates 
the Acute Smoking-Induced Vascular Dysfunction## 
841-3·356A
The Heterogeneous Inﬂuence of Metabolic Risk Factors on 
Arterial Elasticity##1001-173·346A
Usefulness of Arterial Stiffness Evaluation for the Differential 
Diagnosis of Hypertrophic Cardiomyopathy From 
Hypertensive Heart Disease##920-102·43A
Arteries
Prolonged Adenovirus and Adeno-associated Virus-mediated 
Gene Delivery to Rabbit Iliac Arteries Using Gene-
Eluting Stents: A Direct Comparison##934-177·304A
Angiotensin Converting Enzyme Inhibition Reduces Aortic 
Stiffness in Stable Coronary Artery Disease. Results of the 
Peace Hemodynamic Study##1001-176·347A
Effect of Vasa Vasorum Flow on Local Aortic Wall Heat 
Production in a Rabbit Model: New Insights in the 
Vulnerable Plaque##978-177·332A
Endothelial Function Is Increasingly More Impaired in the 
Leg Compared to the Arm in Groups With Increasing 
Risk: Assessment Using Magnetic Resonance Imaging## 
841-8·357A
Expression and Function of Toll-like Receptors in Different 
Vascular Beds: Towards Understanding Target Tissue 
Susceptibility in Vascular Inﬂammation## 802-3·314A
Femoral Pseudoaneurysms: Management with Percutaneous 
Thrombin Injections##1002-181·348A
Gender Difference in the Impact of Multiple Cardiovascular 
Risk Factors on the Femoral Artery Intima-Media 
Thickness in Asymptomatic Young Adults: The Bogalusa 
Heart Study##1000-169·346A
Long- Term Sildenaﬁl Administration Improves Aortic 
Stiffness and Wave Reﬂections in Patients With Erectile 
Dysfunction of Vascular Origin##1026-188·370A
Obesity is Independently Associated With Increased 
Ventricular Systolic Tension: A Population-Based 
Study##982-199·336A
The Heterogeneous Inﬂuence of Metabolic Risk Factors on 
Arterial Elasticity##1001-173·346A
Vascular Dendritic Cells as Gatekeepers in Vascular 
Inﬂammation##934-174·304A
Aspirin
Aspirin Resistance Is Strongly Associated With Increased 
Platelet Turnover##908-170·290A
Combination of Aspirin and Pravastatin Dramatically Reduces 
Oxidative Stress and the Expression of LOX-1 and 
Adhesion Molecules: Novel Insight Into the Mechanism 
of Action of Aspirin and Statins## 822-5·340A
Impact of Chronic, Daily Antiplatelet Therapy on Embolic 
Events in Infective Endocarditis##984-19·279A
Inconsistency in the Prevalence of Platelet Aspirin Resistance 
as Measured by COX-1 Non-Speciﬁc Assays in Patients 
Treated With 81, 162 and 325 mg Aspirin##908-169·290A
Increased Platelet Sensitivity and Cyclooxygenase-2 
Expression in Aspirin Resistance##908-171·290A
Late Clinical Outcomes With Aspirin, Coumadin or Both 
After Acute Coronary Syndromes (Late Outcomes of the 
ASPECT-2 Trial)##999-259·219A
Patterns and Predictors of Aspirin Use Among Patients on 
Chronic Anti-Inﬂammatory Drugs##1029-211·375A
Platelet Aspirin Resistance in an ED Population With 
Suspected Acute Coronary Syndromes##995-227·212A
Platelet Aspirin Resistance in Patients With Coronary Artery 
Disease Is Rare at all Aspirin Doses When Measured by 
COX-1 Speciﬁc Assays##908-162·288A
Reduced Platelet Sensitivity to Aspirin in Type 2 Diabetic 
Subjects Compared to Non-Diabetics##1023-165·364A
The Active Metabolite of Prasugrel (CS-747) Inhibits ADP-
Stimulated Thrombo-inﬂammatory Markers of Platelet 
Activation: Modulation by Other Blood Cells and 
Calcium, But Not by Aspirin##1023-161·364A
The Role of Platelet Activity in Patients With Patent Versus 
Occluded Coronary Artery Bypass Grafts. Prague-4 Trial 
Subanalysis##1023-164·364A
Use and Effectiveness of Perioperative Cardiac Medical 
Therapy Among Patients Undergoing Coronary Artery 
Bypass Graft Surgery##940-24·275A
Assisted circulation
A Novel Microaxial Venous Assist Device for Enhancing 
Pulmonary Flow and Reducing Venous Pressure Within 
the Total Cavopulmonary Connection: Computational 
Fluid Dynamics Studies##922-115·238A
Development and In Vivo Testing of a Simple Subcutaneous 
Circulatory Support Device##988-107·71A
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Effect of Enhanced External Counterpulsation on Erectile 
Dysfunction in Patients With Medically Refractory 
Angina##1022-218·232A
Effects of Left Ventricular Assist Devices With Different Flow 
Characteristics on Vasopressin Levels##988-105·71A
Is Incidence in Arrhythmias Different in LVADs With 
Continuous Versus Pulsatile Flow?##988-106·71A
Metoprolol Rescues Depressed Myocardial Contractility in 
Chronically Unloaded Hearts##1034-105·91A
The Impact of Enhanced External Counterpulsation Treatment 
on Emergency Room Visits and Hospitalizations##1022-
220·232A
The Impact of Patient Selection on Long-Term Outcomes of 
Left-ventricular Assist Device Implantation as Destination 
Therapy for End-Stage Heart Failure## 825-4·75A
Atherectomy
Better Coronary Flow in Culprit Lesions With Deep 
Echo Attenuation Treated by Directional Coronary 
Atherectomy##995-225·212A
Elevated Levels of Neopterin Show a Positive Relationship 
With the Severity of Acute Coronary Syndromes##1018-
229·224A
Enhanced Expression of Natriuretic Peptide Receptors in 
Accumulated Neutrophils and Macrophages at the 
Sites of Coronary Unstable Plaques in Acute Coronary 
Syndromes##972-223·195A
Increased Presence of Pro-Coagulant Apoptotic Bodies in 
Lipid-Rich and Vulnerable Atheroma: A Vehicle to 
Propagate Cell Death and Pro-Coagulant Potential?##977-
165·329A
Pathological Analysis of the Culprit Lesions with Unique 
Intra Plaque Enhancement in Multislice Computed 
Tomography## 832-6·135A
Rotational Atherectomy With Sirolimus Eluting Stents Versus 
Rotational Atherectomy With Bare Metal Stents for 
Complex Coronary Calciﬁc Lesions##956-161·317A
Atherosclerosis
A New Strategy for Atherosclerosis Using Sendai Virus 
Mediated Delivery of Paraoxonase##909-177·292A
Additive Beneﬁcial Effects of Fenoﬁbrate Combined with 
Candesartan in the Treatment of Hypertriglyceridemic, 
Hypertensive Patients## 845-4·359A
Adiposity and Atherogenic Inﬂammatory Response to 
Endotoxin in Humans##937-193·308A
Antinanobacterial Antibody Titer Is an Independent Risk 
Factor for Coronary Artery Calciﬁcation##1000-167·345A
Apo A1-LDL Complex in Coronary Artery Disease - Oxidized 
Lipoprotein and Inﬂammation##930-248·176A
Apoptosis Is Increased in Diabetes Atherosclerosis Independent 
of Plaque Lipid Content##977-167·329A
Association Between Carotid Intima-Media Thickness and 
Aortic Arch Plaque Thickness in the Elderly##980-
188·334A
Association Between Toll-Like Receptors on Circulating 
Monocytes and the Presence and Extent of Coronary 
Artery Disease in Patients With Stable Angina: 
Comparison With High-Sensitivity C-Reactive 
Protein##930-243·175A
Association of High Density Lipoprotein Levels and Carotid 
Atherosclerotic Plaque Burden and Lipid Content by 
High-resolution Magnetic Resonance Imaging## 993-
1·142A
Association of High Molecular Weight Form of Adiponectin 
With Endothelial Function in Healthy Young Men##933-
161·301A
Atheromatous Coronary Plaque Has Lower Distensibility Than 
Fibrous Plaque: Comparison of Intravascular Ultrasound 
Imaging and Histo-Pathological Analysis##1024-
176·367A
Atherosclerosis of the Aorta Is Strongly Associated With 
Calciﬁc Aortic Valve Stenosis Independently of Classical 
Atherosclerosis Risk Factors##1030-25·287A
Atherosclerosis Regression With Selective Estrogen Receptor 
Modulator Therapy: An In Vivo Study of Raloxifene 
by Magnetic Resonance Imaging and Micro-Computed 
Tomography##913-196·296A
Atorvastatin but Not Vitamin C, Affects Endothelial Function, 
Asymmetric-Dimethyl-Arginine Levels and Inﬂammatory 
Process, in Patients With Diabetes Mellitus Type 2, and 
Low Cholesterol Level##1003-189·350A
Atrial Fibrillation Is Associated With Reversible Impairment of 
Endothelial Function## 853-5·376A
Beneﬁt of Early Statin Therapy During Acute Coronary 
Syndromes: A Meta-Analysis## 821-5·205A
Beneﬁt of Early Statin Therapy During Acute Coronary 
Syndromes: A Meta-Analysis## 821-5·205A
Circulating Levels of Osteopontin Predicts Future Cardiac 
Events in Patients With Chronic Stable Angina## 801-
3·313A
Clinical Signiﬁcance of Large and Small Low-Density 
Lipoprotein-Cholesterol Concentrations in Patients 
With Various Types of Coronary Heart Diseases##1014-
212·355A
Combination Therapy With Motexaﬁn Gadolinium and 
Ascorbate Stabilizes Plaques in Fat-Fed Apolipoprotein E 
Knockout Mice##937-192·308A
Comparison of MRI Based Measurement of Atherosclerotic 
Plaque Burden in Patients With and Without 
Cardiovascular Disease##912-195·296A
Complex Plaques and Coronary Plaque Progression in Patients 
With Acute Myocardial Infarction##977-163·329A
Coronary Artery Lesions with Intra-plaque Enhancement in 
Multidetector Spiral Computed Tomography## 970-
6·125A
Coronary Atherosclerosis by Intravascular Ultrasound in 
Women With Suspected Myocardial Ischemia, but No 
or Minimal Angiographic Disease: A Report From 
the NHLBI-Sponsored Women’s Ischemia Syndrome 
Evaluation Study (WISE) Study##977-164·329A
Coronary Calciﬁcation and Left Atrial Size Are of Additive 
Incremental Value to the Framingham Risk Score for the 
Prediction of Cardiovascular Events##983-204·337A
Determinants of Arterial Wall Remodeling During Lipid 
Lowering Therapy. Serial IVUS Observations from the 
REVERSAL Trial.##957-174·320A
Diabetic Plaque Inﬂammation and Neovascularization 
Are Associated With Increased Reparative Collagen 
Content: Implication for Plaque Progression in Diabetic 
Atherosclerosis##912-193·295A
Discrimination of Human Coronary Thrombus Types by 
Optical Coherence Tomography in Vitro## 843-6·220A
Dual-frequency Intravascular Ultrasound Imaging: A Novel 
Approach to Plaque Vulnerability## 948-30·120A
Early Comprehensive Characterisation of the Vascular 
Response to Statin Treatment Using MRI## 845-7·359A
Echo-attenuation in the Target Lesion Before Perutaneous 
Coronary Intervention and Incidence of Angiographic 
Slow Flow##951-230·183A
Effect of Atorvastatin on Atheromatic Plaque Temperature and 
Systemic Inﬂammatory Status in Patients With Coronary 
Artery Disease##981-191·334A
Effect of Pitavastatin Therapy on the Thoracic Aorta in 
Hypercholesterolemic Patients Evaluated With Integrated 
Backscatter and Wall Thickness by Transesophageal 
Echocardiography## 1017-7·153A
Effect of Vasa Vasorum Flow on Local Aortic Wall Heat 
Production in a Rabbit Model: New Insights in the 
Vulnerable Plaque##978-177·332A
Effects of Angiotensin-II Receptor Blockers on Coronary 
Atherosclerosis in Patients With Acute Myocardial 
Infarction Taking Angiotensin-Coverting-Enzyme 
Inhibitors: An Intravascular Ultrasound (IVUS) 
Study##996-239·215A
Effects of Insulin Dependence in Patients With Type 2 Diabetes 
Mellitus and Advanced Atherosclerosis, on Inﬂammatory 
Process, Thrombotic Mechanisms and Endothelial 
Function##961-202·326A
Effects of Mental Stress on Brachial-Ankle Pulse Wave 
Velocity##1001-175·347A
Effects of Nicotinic Acid on Monocytes: Potential Implications 
for Atherosclerosis##977-171·330A
Effects of Optimal Versus High Normal Blood Pressure on 
Progression of Coronary Atherosclerosis: Insight From the 
CAMELOT Study## 835-7·343A
Effects of Percutaneous Transluminal Angioplasty (PTA) 
and Endovascular Brachytherapy(EVBT) on Vascular 
Remodeling of Human Femoropopliteal Artery: 2-Years 
Follow-Up by Noninvasive MR Plaque Imaging##1002-
183·349A
Effects of Torcetrapib and/or Atorvastatin on HDL and LDL 
Particle Size and Composition: Results From a Phase 2 
Trial##981-195·335A
Erythropoietin Therapy Improves Vascular Dysfunction in Pre-
dialysis Chronic Renal Failure Patients: A Novel Strategy 
for Atherosclerosis Prevention## 853-8·377A
Ethnic Differences in the Prognostic Value of Coronary Artery 
Calciﬁcation: Data from an Observational Cohort of 
14,812 Patients## 970-33·129A
Expression and Function of Toll-like Receptors in Different 
Vascular Beds: Towards Understanding Target Tissue 
Susceptibility in Vascular Inﬂammation## 802-3·314A
First Human Experience with Intracoronary Red Light 
Irradiation for the Treatment of High Risk Non-Culprit 
Atheromatic Plaques##952-233·184A
Follow-Up LDL-cholesterol Level as an Independent Predictor 
of Changes of Coronary Atherosclerotic Plaque Size: 
A Serial Intravascular Ultrasound Analysis##1024-
178·367A
Gadoﬂourine M Enhances Atherosclerotic Plaque Lesions in 
Apolipoprotein E Knockout Mice Through tnteraction 
With Extracellular Matrix Proteins## 993-13·144A
Gender Difference in the Impact of Multiple Cardiovascular 
Risk Factors on the Femoral Artery Intima-Media 
Thickness in Asymptomatic Young Adults: The Bogalusa 
Heart Study##1000-169·346A
Global Risk Factors and Treatment Intensity in Elderly Patients 
With Atherosclerosis: The Experience of the International 
REACH Registry##916-258·168A
High Levels of Subclinical Atherosclerosis in Rural South 
Asian Indians Could be Explained by Impaired Protection 
by HDL##1001-178·348A
High-dose Folic Acid Supplementation Improves Atherogenic 
Process in Predialysing Chronic Renal Failure 
Independent of Homocysteine-lowering##1000-164·345A
Identiﬁcation of Plaque Composition in Multislice Computed 
Tomography## 970-35·129A
Impact of Antiphospholipid Antibodies on Cardiovascular 
Disease in Systemic Lupus Erythematosus## 803-7·277A
Impact of Elevated Troponin T level at Admission on the 
Non-Culprit Plaque Progression in Clinical Unstable 
Angina Pectoris: A Volumetric Intravascular Ultrasound 
Analysis##951-229·183A
Impact of Intra-plaque Enhancement in Multislice Computed 
Tomography on Coronary Flow After Percutaneous 
Coronary Intervention## 970-15·127A
In Vivo Real-Time Vessel Imaging and Ex vivo 3D 
Reconstruction of Atherosclerotic Plaque in 
Apolipoprotein E-Knockout Mice Using Synchrotron 
Radiation Microscopy##977-172·330A
Increased Presence of Pro-Coagulant Apoptotic Bodies in 
Lipid-Rich and Vulnerable Atheroma: A Vehicle to 
Propagate Cell Death and Pro-Coagulant Potential?##977-
165·329A
Increasing Concentrations of Prasugrel’s Active Metabolite 
Produce Increased Inhibition of Platelet Aggregation## 
855-6·379A
Inﬂuence of Pravastatin on Carotid Artery Structure and 
Function in Dyslipidemic HIV-Infected Patients Under 
Antiretroviral Therapy##980-187·334A
Intra-Plaque Hemorrhage in Diabetic Atherosclerosis is 
Characterized by Increased Microvessel Complexity, 
Intra-luminal Macrophages, and Intra-luminal Red Blood 
Cells.##978-176·331A
Intraperitoneal Administration of Anti-Angio-Associated 
Migratory Cell Protein-Antibody Inhibits Neointima 
Formation After Vascular Injury in Apolipoprotein E 
Knockout Mice##933-172·303A
Intravascular Ultrasound-Based Imaging of Vasa Vasorum 
for the Detection of Vulnerable Atherosclerotic 
Plaque##1012-146·264A
Lectin-like Oxidized LDL Receptor-1 (LOX-1) as a Novel 
Receptor for Remnant-like Lipoprotein Particles (RLPs) 
in Vascular Smooth Muscle Cells## 822-4·340A
Limitation of Ankle-Brachial Blood Pressure Index for 
Diagnosis of Peripheral Vascular Disease in Young and 
Middle Age Adults: The Bogalusa Heart Study##911-
189·294A
Lipopolysaccharide Induces CXCR6 Expression in Human 
Coronary Artery Smooth Muscle Cells in TLR4 
Dependent Myd88-TIRAP-TRIF-TRAF6 Mediated 
ERK1/2 Activation##933-160·301A
Lipoprotein-associated Phospholipase A2 (Lp-PLA2) in 
Chronic Kidney Disease: Results From the RRI-CKD 
Study## 854-7·378A
Local Delivery of Bone Marrow Derived Stromal Cells 
Engineered to Overexpress Prostacyclin Synthase 
Enhanced Collateral Perfusion in Hindlimb Ischemia## 
823-5·341A
Local Stress Concentration Around Calciﬁed Apoptotic 
Macrophages in the Fibrous Cap: A New Hypothesis 
for the Rupture of Coronary Thin-cap Atheroma 
Lesions##977-162·328A
Long-Term Administration of Pioglitazone Reverses 
Arteriosclerotic Processes in Type-2 Diabetics##957-
176·321A
Losartan Combined With Simvastatin Shows Additive 
Beneﬁcial Effects on Inﬂammation in the Treatment of 
Hypercholesterolemic, Hypertensive Patients## 845-5·359A
Modulation of NK Receptors on NK (CD3-/CD56+), T (CD3+/
CD56-) and NKT-like (CD3+/CD56+) Cells in Coronary 
Artery Disease##977-170·330A
Molecular Dissection of Human LOX-1 Promoter: Nucleotides 
and Transcription Factors Requirement During 
Transactivation## 822-3·340A
Obstructive Sleep Apnea Impairs Arterial Stiffness in 
Hypertensive Patients: Potential Additive Effects to 
Atherosclerosis##915-211·299A
Osteoprotegerin as a Novel Biomarker of Atherosclerosis: 
Independent Association With Coronary Artery Calcium 
in the Dallas Heart Study## 801-4·313A
Oxidative Stress Is a Mechanism Underlying the Obesity 
Related Risk of Atherosclerosis in Healthy Adults##935-
183·306A
Periodontal Disease and Endothelial Function## 853-4·376A
Plasma Asymmetric Dimethylarginine is an Independent 
Marker for the Presence and Severity of Peripheral Artery 
Disease##911-186·294A
Positive Coronary Artery Remodeling in Women With No or 
Minimal Angiographic Disease: Intravascular Ultrasound 
Findings From the NHLBI-Sponsored Women’s Ischemia 
Syndrome Evaluation (WISE) Study##978-173·331A
Positron Emission Tomography Can Identify Arterial Segments 
with Vulnerable Plaque Leading to Arterial Thrombosis## 
926-7·106A
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Predictors of Non-Calciﬁed Plaques of Coronary Arteries in 
422 Subjects by Multislice Computed Tomography Using 
Logistic Regression Models##930-242·175A
Prognostic Value of Serum Gamma-Glutamyl Transferase 
Activity in Coronary Artery Disease##1029-213·375A
Progression of Calciﬁed Coronary Atherosclerosis: Role 
of Traditional Risk Factors, CRP, and Non-calciﬁed 
Atherosclerosis## 970-16·127A
Proteasome Inhibition: A New Road to Coronary 
Atherogenesis?##977-166·329A
Quantitation and Distribution of Lipoprotein-Associated 
Phospholipase A
2 
and Oxidized Low Density Lipoprotein 
in Atherosclerotic Lesions of Carotid Endarterectomy 
Tissues##1000-170·346A
Radial Artery Patency in CABG and Factors Affecting Long 
Term Outcome##932-255·178A
RANTES Is an Independent Determinant of Outcome in 
Patients With Unstable Angina Pectoris##1019-235·225A
Rapid Effects of 5-Methyl-Tetrahydrofolic Acid on Endothelial 
Function and Vascular Superoxide Production in Human 
Coronary Artery Disease##933-171·303A
Signiﬁcance of Calciﬁed and Non Calciﬁed Plaques of 
Coronary Arteries for Presence of Myocardial Infarction 
Evaluated by Multislice Computed Tomography## 970-
43·131A
Signiﬁcance of Lipid-content in Determining the Pattern 
of Coronary Arterial Remodeling: An Intravascular 
Ultrasound Study With Tissue Characterization by use of 
Wavelet Analysis##1024-177·367A
Synergistic Interaction Between Hypercholesterolemia and 
Diabetes Signaling Through Phosphatidylinositol 3-
Kinase/Akt/PKB and Nuclear Factor kB in a Porcine 
Model of Coronary Atherosclerosis##977-169·330A
The Association Between Coffee Consumption and 
Inﬂammatory Markers, in Healthy Individuals: The 
ATTICA Study##935-182·306A
The CYBA Genotype Is Associated With Altered NADPH 
Oxidase Activity in Patients With Cardiovascular 
Disease## 822-7·340A
The Effect of One-Year of Chelation Therapy on Coronary 
Volume Score## 970-10·126A
The Effectiveness of Blinding of an Active Angiotensin 
Converting Enzyme Inhibitor at a Single Center in the 
Prevention of Events With Angiotensin Converting 
Enzyme Inhibition (PEACE) Trial##938-198·309A
The Forkhead Transcription Factor, FOXO3a Controls Vascular 
Smooth Muscle Cells Proliferation through Modulation 
of an Angiogenic Immediate Early Gene, CYR61##933-
170·303A
The Impact of Cardiovascular Risk Factors on Oxidative Stress 
in Humans##1005-203·353A
The Reduction of Inﬂammatory Biomarkers by Statin, Fibrate, 
and Combination Therapy Among Diabetic Patients With 
Mixed Dyslipidemia: The DIACOR Study## 854-5·377A
The Relation Between Aortic Distensibility and Calciﬁed 
Aortic Atherosclerosis: Cardiovascular MRI and CT 
Correlations##1000-166·345A
The Role of Platelet Activity in Patients With Patent Versus 
Occluded Coronary Artery Bypass Grafts. Prague-4 Trial 
Subanalysis##1023-164·364A
Use of Beta-Blockers and Progression of Coronary 
Atherosclerosis: An Intravascular Ultrasound Analysis 
from the CAMELOT Study##957-175·320A
Usefulness of Membrane Type 1-matrix Metalloproteinase 
Measurement In Vivo as a Novel Indicator of 
Atherogenesis##933-166·302A
Very Low-Fat Japanese Diet and Daily Exercise Reduce 
Plasma Lipid Levels With Small Dose of Statins 
and is Effective for Regression of Coronary 
Atherosclerosis##1014-209·354A
Athletes
Do Endurance Exercise-Induced Sinus Node Dysfunction 
and Arrhythmias Persist? A Case-Matched Long-Term 
Follow-Up Study of 62 Former Professional Cyclists## 
1015-133·34A
Left Ventricular Remodeling Index Assessed by Real-Time 
Three-Dimensional Echocardiography in Various 
Pathophysiologic Conditions## 839-4·146A
Sudden Cardiac Death in Athletes: Rates of 
Deﬁbrillation##906-243·165A
Atrial ﬁbrillation
A Common Polymorphism H558R in SCN5A is Associated 
with Lone Atrial Fibrillation## 826-6·25A
A Novel Locus for Familial Atrial Fibrillation on Chromosome 
10p11-q21## 804-8·11A
A Simple Algorithm for Accurate Detection of Atrial 
Fibrillation in an Ambulatory Monitor##1012-151·265A
Acute Heart Failure Asociated With Atrial Fibrillation: A 
Distinct Disorder and Not Just a Fast Pulse Rate?##1032-
54·86A
Acute Left Atrial Reverse Remodeling After Pulmonary 
Venous Ablation: Evaluation With Tissue Doppler 
Myocardial Velocities## 805-7·111A
Anatomical Remodeling of Left Atria in Subjects with 
Chronic and Paroxysmal Atrial Fibrillation Evaluated by 
Multislice Computed Tomography## 1015-138·35A
Are There Gender Differences in Risk of Ischemic Stroke in 
Patients with Atrial Fibrillation Who Are Anticoagulated? 
Results from the AFFIRM Trial## 804-6·10A
Assessement of Intraventricular Asynchrony in Patients 
With Atrial Fibrillation Using Tri-plane Tissue Doppler 
Imaging## 846-3·147A
Atrial Arrhythmias Post Atricure Radiofrequency Ablation for 
Atrial Fibrillation: Findings During Catheter Ablation## 
901-140·4A
Atrial Fibrillation Is a Long-Term Predictor of Poor Outcome 
in Acute Myocardial Infarction##975-250·201A
Atrial Fibrillation Is Associated With Reversible Impairment of 
Endothelial Function## 853-5·376A
Atrial Fibrillation: Bridging of Chronically Anticoagulated 
Patients With Low Molecular Weight Heparin Prior to 
Interventional Procedures: Experience in 455 Patients 
From the Brave-registry## 849-6·362A
Autonomic Heart Plexus Localization With Epicardial and 
Endocardial Cardioneurostimulation## 838-6·30A
Biochemical Markers of Collagen Turnover in Atrial 
Fibrillation## 1015-137·34A
Blacks Are Less Susceptible to Atrial Fibrillation Despite an 
Adverse Risk Proﬁle: A Meta-Analysis## 1015-130·33A




 Receptors: A Physiologic Role in Mediating 
ATP-evoked Current and Regulation in Human Atrial 
Fibrillation## 901-135·3A
Catheter Ablation of Atrial Fibrillation or Left Atrial Flutter 
Under Uninterrupted Oral Anticoagulation## 838-4·30A
Characteristics of Cavotricuspid Isthmus-Dependent Flutter 
Following Left Atrial Ablation of Atrial Fibrillation## 
947-141·18A
Circumferential Pulmonary Vein Ablation. Early Experience 
on Remote Magnetic Navigation Versus Standard 
Technique## 838-3·30A
Clinical Signiﬁcance of Early Recurrences of Atrial Fibrillation 
or Atrial Flutter After Pulmonary Vein Antrum and 
Superior Vena Cava Isolations## 838-7·31A
Comparison of Left Atrial Volume and Left Atrial Appendage 
Contribution in Patients With and Without Persistent 
Atrial Fibrillation## 970-4·125A
Diabetes, Insulin, and the Prevalence of Atrial Fibrillation and 
Flutter in a Large Heart Failure Population## 804-7·10A
Do Implantable Cardioverter-Deﬁbrillator Patients Have 
Adequate Rate Control During Atrial Tachyarrhythmias? 
Results From a New Continuous Long-Term Monitoring 
System## 1015-135·34A
Do Symptoms Predict Atrial Fibrillation Episodes in Patients 
With Paroxysmal Atrial Fibrillation?## 1015-134·34A
Does Hormone Therapy Impact Stroke Risk Among Women 
With Atrial Fibrillation?Results from the AFFRIM trial## 
1015-131·33A
Does Reduction in Left Atrial Diameter During 
Antihypertensive Treatment Reduce New-Onset Atrial 
Fibrillation in Hypertensive Patients with Left Ventricular 
Hypertrophy: The LIFE Study## 924-139·9A
Does the Point of Closest Approach Between the Esophagus 
and the Posterior Left Atrium Move with the Cardiac 
Cycle?## 901-139·4A
Early Experience Of Pulmonary Vein Antral Isolation Using 
an Open Irrigation Ablation Catheter for the Treatment 
of Atrial Fibrillation: Immediate Short Term Results of a 
Randomized Study## 992-142·30A
Effect of Cardiac Resynchronization on the Incidence of Atrial 
Fibrillation in Patients with Severe Heart Failure##1008-
53·77A
Effect of Left Atrial Decompression by Percutaneous 
Mitral Commissurotomy on Atrial Electrophysiologic 
Properties## 1015-139·35A
Effects of Catheter Ablation for Atrial Fibrillation on Left and 
Right Atrial Volume and Function## 947-140·18A
Effects of Two Different Catheter Ablation Techniques on Spectral 
Characteristics of Atrial Fibrillation## 947-143·18A
Efﬁcacy and Safety of Extra Class IC Doses for Pharmacologic 
Cardioversion in Patients Maintained on Class IC Drugs 
for Atrial Fibrillation##938-200·309A
Efﬁcacy and Tolerance of RSD1235 in the Treatment of 
Atrial Fibrillation or Atrial Flutter: Results of a Phase 
III, Randomized, Placebo-controlled, Multicenter Trial## 
804-3·10A
Electrogram Features Are Superior to Clinical Characteristics 
for Predicting Atrial Fibrillation After Coronary Artery 
Bypass Graft Surgery## 813-3·12A
Favourable Effect of Mitral Balloon Valvuloplasty on the 
Incidence of Atrial Fibrillation in Patients With Severe 
Mitral Stenosis##1006-24·283A
First Experience With Cryoballoon Technique and Long-Term 
Success of Pulmonary Vein Isolation With Cryotechnique 
Only## 992-140·29A
Heat Shock Proteins Prevent Atrial Tachycardia Remodeling 
and Atrial Fibrillation Promotion## 826-4·25A
Impaired Atrial Coronary Flow Reserve in Patients With Lone 
Paroxysmal Atrial Fibrillation##1024-174·366A
In-Vivo Sympathetic Nerve Stimulation Induces Ectopic Beats 
and Focal Atrial Tachycardia from Thoracic Veins in 
Dogs: Insights From Sympathetic Nerve Recording and 
High Density Mapping## 901-132·3A
Intraoperative Cooled-tip Radiofrequency Linear Atrial 
Ablation to Treat Permanent Atrial Fibrillation## 838-
5·30A
Irbesartan Reduces Left Atrial Stunning After Electrical 
Cardioversion of Atrial Fibrillation## 924-141·9A
Is Pulmonary Vein Isolation (PVI) a Better Therapeutic Option 
than Atrioventricular Node Ablation (AVNA) and Direct 
Current Cardioversion (DCC)? Mortality Differences in 
Patients with Atrial Fibrillation## 947-138·17A
Left Atrial Functional Reserve Can Predict the Long 
Term Prognosis of the Cardioverted Chronic Atrial 
Fibrillation?## 1017-4·153A
Left Atrial Volume is a Predictor of Atrial Fibrillation 
Recurrence After Catheter Ablation## 902-6·95A
Left Ventricle Diastolic Dysfunction, and Aortic Stiffening in 
Hypertension: The Web of Causative Interrelationships of 
Atrial Fibrillation##982-201·337A
Long History and Frequent Episodes of Paroxysmal 
Atrial Fibrillation in Patients Without Structural 
Heart Disease Do Not Lead to Deterioration of Atrial 
Electrophysiology## 992-135·28A
Long-Term Follow-Up in Patients With Percutaneous Left 
Atrial Appendage Transcatheter Occlusion System 
(PLAATO): Risk of Thrombus Formation and 
Development of Pulmonary Venous Obstruction After 
Percutaneous Left Atrial Appendage Occlusion## 1015-
142·36A
Nadroparin Versus Unfractionated Heparin for Anticoagulation 
of all Cause Atrial Fibrillation: Final Results of the 
NADROPAF Trial## 1015-141·35A
Neither Ramipril Nor Vitamin E Reduce the Incidence of Atrial 
Fibrillation. Results of the HOPE Study## 924-138·8A
Obesity Increases the Risk of Conversion of Paroxysmal 
to Chronic Atrial Fibrillation: Data From a 21-Year 
Community-Based Study## 849-7·363A
Open Irrigated-tip Technology Versus Intracardiac Echo 
Guided Energy Delivery Using an 8 Mm Tip Catheter 
For Pulmonary Vein Isolation in Patients With Atrial 
Fibrillation: A Randomized Comparison## 992-139·29A
Patients With Severely Reduced Ejection Fractions and Atrial 
Fibrillation Have No Beneﬁt from Rhythm Control: An 
Analysis of the AFFIRM Study## 851-7·93A
Persistence of Iatrogenic Atrial Septal Defect after 
Pulmonary Vein Isolation with Transseptal Puncture - an 
Underestimated Risk?## 992-141·29A
Pharmacogenetic Warfarin-Dosing Algorithm Is Substantially 
Improved When Both VKORC1 and CYP2C9 Gene 
Variants Are Considered##908-159·288A
Predictors of Death in Patients With Atrial Fibrillation: The 
Role of Echocardiography## 902-1·94A
Presence and Type of Provocable Non Pulmonary Triggers for 
Atrial Fibrillation: Inﬂuence of Gender and Arrhythmia 
Presentation## 947-139·17A
Prevalence of Atrial Fibrillation and Flutter by Different HMG-
CoA Reductase Inhibitors and Doses in Heart Failure## 
816-4·61A
Prevention of Atrial Fibrillation Via Abrogation of the 
Renin-Angiotensin System: A Pooled Meta-Analysis of 
Randomized Controlled Clinical Trials## 924-140·9A
Procainamide - Propafenone - Amiodarone: A Comparative 
Study of Their Efﬁcacy And Safety For the Conversion of 
Recent Onset Atrial Fibrillation## 804-4·10A
Prognostic Signiﬁcance of Interleukin-2 for the 
Pharmacological Cardioversion of Recent Onset Atrial 
Fibrillation## 1015-136·34A
Prognostic Value of Signal Average Electrocardiogram in 
Predicting the Occurrence of Atrial Fibrillation. A Meta-
Analysis## 992-134·28A
Pulmonary Vein Size Greater Than 1.7cm Measured on 
Transesophageal Echocardiography Predicts Recurrence 
of Atrial Fibrillation After Cardioversion## 1017-5·153A
Reduction in Left Atrial Volume and Improvement in Left 
Atrial Ejection Fraction Does Not Predict Decline in 
Recurrence of Atrial Fibrillation Following Pulmonary 
Vein Ablation as Assessed by Echocardiography## 902-
8·95A
Reversible Impairment of Coronary Blood Flow and 
Coronary Flow Reserve in Patients With Chronic Atrial 
Fibrillation##978-179·332A
Rhythm Versus Rate Control for Atrial Fibrillation in Post-MI 
Patients With Heart Failure: Results from the VALIANT 
Trial##919-95·41A
Risk of Hemorrhagic Stroke in Atrial Fibrillation: Is There an 
Ethnic Difference in Its Incidence and in the Effect of 
Warfarin?## 849-8·363A
Risk of Ischemic Stroke in Atrial Fibrillation: Is There an 
Ethnic Difference in Its Incidence and in the Efﬁcacy of 
Warfarin?## 1015-140·35A
Should Warfarin Be Monitored by Anticoagulation Clinics or 
by Physician Practices?##968-149·259A
Stroke Prevention Technology for Patients With Non-Valvular 
AF - Worldwide Experience with the New WATCHMAN 
LAA System## 1015-143·36A
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The Effects of Caffeine on the Inducibility of Atrial 
Fibrillation##913-197·296A
The Oldest Old Patients Have a Lower Chance for Receiving 
Guidelines Recommended Atrial Fibrillation Therapy. 
The Experience of the Euro Heart Survey on Atrial 
Fibrillation##946-145·253A
The Outcomes of Thyrotoxicosis Related New-Onset Atrial 
Fibrillation## 804-5·10A
Transient ST-Segment Depression Only During Paroxysms of 
Atrial Fibrillation in Patients Without History of Coronary 
Artery Disease. What Non-invasive Test to Unmask 
Severe Underlying Coronary Artery Disease?## 1016-
40·150A
Typical Atrial Flutter is Associated with Obstructive Sleep 
Apnea## 1015-132·33A
Atrial ﬂutter
Characteristics of Cavotricuspid Isthmus-Dependent Flutter 
Following Left Atrial Ablation of Atrial Fibrillation## 
947-141·18A
Determination of Atrial Flutter Type Using Interactive ECG 
Analysis## 992-130·27A
Diabetes, Insulin, and the Prevalence of Atrial Fibrillation and 
Flutter in a Large Heart Failure Population## 804-7·10A
Prevalence of Atrial Fibrillation and Flutter by Different HMG-
CoA Reductase Inhibitors and Doses in Heart Failure## 
816-4·61A
Typical Atrial Flutter is Associated with Obstructive Sleep 
Apnea## 1015-132·33A
Atrial function
Acute Left Atrial Reverse Remodeling After Pulmonary 
Venous Ablation: Evaluation With Tissue Doppler 
Myocardial Velocities## 805-7·111A
Determinants of Left Atrial Function by Strain Rate Imaging in 
Healthy Subjects## 925-42·103A
Diastolic Dysfunction in Hypertrophic Cardiomyopathy 
Is Related to Myocardial Fibrosis as Determined by 
Cardiovascular Magnetic Resonance##943-101·50A
Difference in the Left Atrial Function Between Patients 
With Hypertensive Hypertrophy and Hypertrophic 
Cardiomyopathy Evaluated by Tissue Strain Imaging## 
948-18·120A
Effects of Catheter Ablation for Atrial Fibrillation on Left and 
Right Atrial Volume and Function## 947-140·18A
Elevated Right Atrial Pressure After Heart Transplantation Is 
Associated With Increased Long Term Mortality##990-
154·262A
Impaired Atrial Coronary Flow Reserve in Patients With Lone 
Paroxysmal Atrial Fibrillation##1024-174·366A
Left Atrial Emptying Rate: A Marker of Hypertrophy and 
Diastolic Dysfunction in Patients With Hypertrophic 
Cardiomyopathy##943-104·51A
Left Atrial Functional Reserve Can Predict the Long 
Term Prognosis of the Cardioverted Chronic Atrial 
Fibrillation?## 1017-4·153A
Left Atrial Mechanics in Type 2 Diabetics## 948-17·120A
Left Atrial Volume Mirrors Diastolic Dysfunction Caused by 
Hypertension Alone##942-60·47A
Reduction in Left Atrial Volume and Improvement in Left 
Atrial Ejection Fraction Does Not Predict Decline in 
Recurrence of Atrial Fibrillation Following Pulmonary 
Vein Ablation as Assessed by Echocardiography## 902-
8·95A
Relationship Between Left Atrial and Left Ventricular Function 
in Hypertrophic Cardiomyopathy: A Real Time 3D 
Echocardiographic Study##943-103·50A
Success of Surgical Left Atrial Appendage Occlusion 
Techniques Assessed by Transesophageal 
Echocardiography## 1017-1·152A
Atrial tachycardia
In-Vivo Sympathetic Nerve Stimulation Induces Ectopic Beats 
and Focal Atrial Tachycardia from Thoracic Veins in 
Dogs: Insights From Sympathetic Nerve Recording and 
High Density Mapping## 901-132·3A
Microreentry as a Mechanism of Focal Atrial Tachycardia## 
947-142·18A
Atrioventricular node
Connexin30.2 Containing Gap Junction Channels Decelerate 
AV-nodal Conduction## 901-123·1A
Is Pulmonary Vein Isolation (PVI) a Better Therapeutic Option 
than Atrioventricular Node Ablation (AVNA) and Direct 
Current Cardioversion (DCC)? Mortality Differences in 
Patients with Atrial Fibrillation## 947-138·17A
Autonomic agents
The Effects of Caffeine on the Inducibility of Atrial 
Fibrillation##913-197·296A
Autonomic nervous system
Autonomic Heart Plexus Localization With Epicardial and 
Endocardial Cardioneurostimulation## 838-6·30A
Autonomic Markers as Predictors of Non-Fatal Acute Coronary 
Events After Myocardial Infarction##998-246·216A
Characteristics of Heart Rate Changes in Response to Sleep-
Disordered Breathing among Cardiac Patients## 992-
132·27A
Comparison of Autonomic Control Between Atrial Septal 
Defect and Ventricular Septal Defect Based on Heart Rate 
Variability and Respiration##1011-113·244A
Cyclooxygenase Products Sensitize Muscle Mechanoreceptors 
in Heart Failure Patients##986-99·69A
Effects of Mental Stress on Brachial-Ankle Pulse Wave 
Velocity##1001-175·347A
Electrical Stimulation of Sympathetic Nervous System 
Delivered Through the Pulmonary Artery Increases 
Contractility##985-51·65A
Heart Rate Turbulence as a Marker of Severity of Congestive 
Heart Failure## 992-127·26A
Heart Rate Turbulence Onset After Atrial Premature 
Complexes Does Not Reﬂect Cardiac Autonomic 
Regulations in Postinfarction Patients## 992-126·26A
Importance and Signiﬁcance of Baroreﬂex Sensitivity(BRS) 
to Predict Prognosis of Chronic Heart Failure With 
Preserved Systolic Function##919-92·40A
In-Vivo Sympathetic Nerve Stimulation Induces Ectopic Beats 
and Focal Atrial Tachycardia from Thoracic Veins in 
Dogs: Insights From Sympathetic Nerve Recording and 
High Density Mapping## 901-132·3A
Increased Heart Rate is Associated with Reduced Regional 
Myocardial Function in Cardiovascular Asymptomatic 
Population: The Multi-Ethnic Study of Atherosclerosis## 
993-4·142A
Repeated Thermal Therapy Improves the Abnormality of 
Sympathetic Nervous System in Patients With Chronic 
Heart Failure##1008-90·78A
The Effects of Caffeine on the Inducibility of Atrial 
Fibrillation##913-197·296A
Baroreceptors
Ace Gene Copies Number Impairs Hemodynamic Responses 
to Hypertension in Mice##960-193·324A
Autonomic Markers as Predictors of Non-Fatal Acute Coronary 




-Adrenergic cAMP Signaling Is Uncoupled After Acute 
Treatment of Anthrax Lethal Toxin in Cardiomyocytes in 
Normal Rats##1032-99·89A
Molecular Basis in the Development of Alcoholic 





New in-vivo Canine Model of Drug-induced Long-QT
1
 
Syndrome: Beta-adrenergic Challenges Trigger Torsade 
De Pointes## 901-136·3A
The Functional Interaction Between CREB and C/EBPb 
Mediate beta AR Stimulation Induced IL-18 Binding 
Protein Expression in Cardiomyocytes##1031-49·84A
Beta-adrenergic receptor blockers
Adverse Cardiovascular Outcomes With Atenolol in Clinical 
Trials in Hypertension: An Updated Meta-Analysis## 
848-7·361A
Association Between Study Drug Dose and Survival/
Hospitalization in Relation to Initiation of Treatment 
for Chronic Heart Failure With Bisoprolol Followed by 
Additional Enalapril Compared to the Opposite Sequence: 
Results of the Randomized CIBIS-III Trial##919-91·40A
Beta Adrenergic Blockers Reduce the Risk of Mortality 
Associated with Elevated Troponin T in Patients with 
Acutely Decompensated Congestive Heart Failure##1032-
53·85A
Carvedilol Use at Discharge in Patients Hospitalized for Heart 
Failure is Associated with Markedly Improved Survival## 
809-8·53A
Cocaine-Related Chest Pain-Utility of TIMI Risk Stratiﬁcation 
and Effects of Beta Blockers on Outcome##1029-
205·373A
Effect of Metoprolol CR/XL on Diurnal Variation in 
Pulmonary Artery Pressure Measured Noninvasively 
Using First in Human Implant Responding to Ultrasonic 
Signals##1026-190·370A
Effect of Metoprolol CR/XL on Pulmonary Artery Pressure 
in Patients With Heart Failure Measured Using First in 
Human Implantable Device Responding to Ultrasonic 
Signal##938-201·310A
Effect on New York Heart Association Class and Signs/
Symptoms of Heart Failure of Initiation of Treatment 
for Chronic Heart Failure With Bisoprolol Followed by 
Additional Enalapril Compared to the Opposite Sequence: 
Results of the Randomized CIBIS-III Trial## 809-6·53A
Effects of Mental Stress on Brachial-Ankle Pulse Wave 
Velocity##1001-175·347A
Effects of Verapamil on the Short-Term Electrophysiological 
Remodeling of Superior Vena Cava in Human## 924-
137·8A
Genotype of the Beta-Adrenergic Receptor Polymorphism 
Was a Strong Risk Factors for Neurally Mediated 
Syncope##913-201·297A
High Hemoglobin was Associated With Cardiovascular 
Events, Low Hemoglobin With All-Cause Mortality, and 
Large Fall in Hemoglobin With Both in Patients With 
Hypertension and Left Vetricular Hypertrophy. The LIFE 
Study## 848-5·361A
Home Uptitration of Beta-blockers by Heart Failure 
Clinic Patients With Telephone Advice: A British 
experience##1036-152·270A
Impact of Early Beta-Blocker Therapy for Acute Myocardial 
Infarction on In-Hospital Mortality## 857-7·235A
Mechanisms of Chronotropic Incompetence in Patients With 
Congestive Heart Failure Taking Beta-blockers##919-
57·39A
Metoprolol Prevents Progression of Diastolic Dysfunction 
in Patients With Asymptomatic Left Ventricular 
Systolic Dysfunction: Observations From the REVERT 
Trial##942-95·49A
Metoprolol Rescues Depressed Myocardial Contractility in 
Chronically Unloaded Hearts##1034-105·91A
Once-Daily Carvedilol Is Effective in Treating 
Hypertension##1027-195·371A
Pyrroloquinoline Quinone (PQQ) and/or Metoprolol Decrease 
Infarct Size and Improve Mitochondrial Function in a Rat 
Model of Ischemia/Reperfusion##994-216·210A
The Betareceptor Blocker Nebivolol Inhibits Angiotensin 
II-Induced Aortic and Cardiac Superoxide Formation 
and Expression and Activity of the Vascular NADPH 
Oxidase##1027-196·371A
The Clinical Effectiveness of Clinical Practice Guidelines 
in Managing Acute Coronary Syndromes: A 10 Year 
Perspective##928-226·171A
The Effect of Pre-Admission Use of Angiotensin Converting 
Enzyme Inhibitor/Angiotensin II Receptor Blocker and/or 
Beta-Blocker Therapy on Hospital Acute Decompensated 
Heart Failure Hospital Mortality##1032-55·86A
Underuse of ACE Inhibitors, Beta-blockers and Spironolactone 
in Patients With Heart Failure Is Primarily Due to Lack of 
Initiation of Treatment##919-98·42A
Use and Effectiveness of Perioperative Cardiac Medical 
Therapy Among Patients Undergoing Coronary Artery 
Bypass Graft Surgery##940-24·275A
Use of Beta-Blockers and Progression of Coronary 
Atherosclerosis: An Intravascular Ultrasound Analysis 
from the CAMELOT Study##957-175·320A
Biology, developmental
Microbiologic Trends of Purulent Pericarditis: A Single Center 
Experience from 1994 to 2004##1033-102·90A
Blood cells
A Novel Method for Enumerating Circulating Endothelial 
Progenitor Cells Based on ALDH Activity##933-
165·302A
Blood Type and the Age of the Red Cells Transfused 
Affects Mortality After Percutaneous Coronary 
Intervention##997-245·216A
Bone Marrow-derived Stem Cell Interactions With Adult 
Cardiomyocytes and Skeletal Myoblasts in Culture##941-
48·44A
COMP-angiopoietin 1 Enhances the Engraftment of the 
Mobilized Peripheral Blood Stem Cells to Ischemic Tissue 
by Induction of Adhesion Molecules## 856-6·234A
Even Mild Reductions in Baseline Hemoglobin Concentration 
Increase the Risk of Death Among Cardiovascular 
Patients With Normal Ejection Fraction and no History of 
Myocardial Infarction##935-180·305A
Hypoxia-Induced Differential Expression of Angiogenesis 
Genes by Umbilical Cord Blood-derived CD34+/CD133+ 
Progenitor Cells## 814-5·191A
Leucocyte Count Is a Marker of Arterial Wave Reﬂections in 
Apparently Healthy Individuals##1005-202·353A
Modulation of NK Receptors on NK (CD3-/CD56+), T (CD3+/
CD56-) and NKT-like (CD3+/CD56+) Cells in Coronary 
Artery Disease##977-170·330A
Reduction of Nitrite to Nitric Oxide in Ischemic Heart 
Is Catalyzed by Distinct Blood-Borne and Tissue 
Elements##994-221·211A
Risk Scores Combining the Complete Blood Count and Basic 
Metabolic Proﬁle Are Highly Predictive of Death in 
Both Independent Training and Test Populations##961-
205·327A
Role of Platelets in Homing of Endothelial Progenitor Cells to 
the Site of Vascular Injury##909-174·291A
Short- and Long-term Outcomes of Cardiac Surgery for 
Observant Jehovah Witnesses##940-26·275A
The Active Metabolite of Prasugrel (CS-747) Inhibits ADP-
Stimulated Thrombo-inﬂammatory Markers of Platelet 
Activation: Modulation by Other Blood Cells and 
Calcium, But Not by Aspirin##1023-161·364A
The Deleterious Impact of Blood Transfusion on Mortality in 
Patients With ST-Elevation Myocardial Infarction##973-
234·198A
Usefulness of Membrane Type 1-matrix Metalloproteinase 
Measurement In Vivo as a Novel Indicator of 
Atherogenesis##933-166·302A
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Blood coagulation
Alimentary Lipemia Enhances Procoagulatory Effects 
of Inﬂammation in Patients With a History of Acute 
Myocardial Infarction Complicated by Ventricular 
Fibrillation##950-218·181A
Assessment of the Markers of Platelet and Coagulation 
Activation Following Transcatheter Closure of 
Patent Foramen Ovale in Patients with Cryptogenic 
Stroke##945-115·240A
Cardiac Amyloidosis is Associated with a High Frequency of 
Intracardiac Thrombus Formation##1009-104·81A
Plasma Levels of Fibrinogen, Plasminogen Activator Inhibitor 
-1, and Von Willebrand Factor Are Increased in Patients 
With Erectile Dysfunction##1023-170·365A
Prolonged Heparin Exposure, Development of 
Thrombocytopenia, Use of GP IIb/IIIa Inhibitors, and 
History of Renal Dysfunction Predict Moderate or 
Severe Bleeding: A Report From the Complications 
After Thrombocytopenia Caused by Heparin (CATCH) 
Registry##923-146·251A
Should Anticoagulation Be Used During Routine Diagnostic 
Coronary Angiography?##1023-169·365A
Systemic Oxygen Saturation and Coagulation Factor 
Abnormalities Before and After the Fontan 
Procedure##1011-111·244A
Blood ﬂow
Endothelial Function Is Increasingly More Impaired in the 
Leg Compared to the Arm in Groups With Increasing 
Risk: Assessment Using Magnetic Resonance Imaging## 
841-8·357A
High Resolution Myocardial Perfusion Imaging in Mice by 
Microbubble Depot and Delayed Opaciﬁcation## 1016-
41·151A
Improvement in Exercise Capacity After Inspiratory 
Muscle Training Is Associated With Reduced Dyspnea 
and Enhanced Limb Blood Flow in Chronic Heart 
Failure##1005-207·354A
Inﬂuence of Hemodialysis on the Blood Flow of AV Shunt 
and Contralateral Sides of Internal Thoracic Artery## 
902-42·101A
Myocardial Heat Production is Invesrely Correlated with the 
Systolic Perfomance of Left Ventricle.##919-56·39A
Preservation of Diastolic Kinetic Energy: A Marker of 
Ventricular Efﬁciency?##942-98·49A
Prognostic Value of Rubidium-82 Perfusion Positron Emission 
Tomography in Patients with Obesity## 812-7·115A
Synchrotron Radiation Coronary Microangiography for 
Morphometric and Physiological Evaluation of 
Myocardial Neovascularization Induced by Cell-Based 
Transplantation##909-178·292A
The Inﬂection Point Is Not a Reliable Method for the 
Determination of the Augmentation Index## 802-5·315A
Blood pressure
Absence of Clinical Hypotension with Eplerenone in Post-
acute Myocardial Infarction Patients With Heart Failure 
and Left Ventricular Systolic Dysfunction: Results from 
EPHESUS##1020-242·227A
Ace Gene Copies Number Impairs Hemodynamic Responses 
to Hypertension in Mice##960-193·324A
Baseline Systolic Blood Pressure Predicts Response to Cardiac 
Resynchronization Therapy in Heart Failure Patients## 
969-142·24A
Calculating LDL and Blood Pressure Goals Per ATP III and 
JNC VII Just Prior to an Ofﬁce Visit Helps Close the Gap 
Between Guidelines and Practice##1036-149·270A
Can An Assessment of Subjective Well Being Predict 
Outcomes in Patients with Hypertension and Coronary 
Artery Disease? A Report from the INternational 
VErapamil-SR/Trandolapril Study (INVEST)##915-
212·300A
Contribution of Obesity to Elevated Blood Pressure in 
Uncomplicated Diabetics: 26-Year of Follow-Up 
Study##1004-197·352A
Darusentan Antihypertensive Effect in Patients With Resistant 
Hypertension##915-208·299A
Direct and Acute Cardiotoxicity of Ultraﬁne Air 
Pollutants##1031-48·84A
Effects of Optimal Versus High Normal Blood Pressure on 
Progression of Coronary Atherosclerosis: Insight From the 
CAMELOT Study## 835-7·343A
Gender Difference of Small and Large Artery Elasticity in 
Relation to Pulse Pressure##1001-174·347A
Gender Differences in Pressure Wave Reﬂection Changes With 
Healthy Aging: A Population-Based Study in Hispanic 
Mestizos## 835-4·342A
Improved LV Relaxation Measured by Tissue Doppler 2 Years 
After Gastric Bypass Surgery##942-91·48A
Isosorbide Dinitrate-Hydralazine Decreased Blood Pressure 
in Patients with High But Not Low Blood Pressure 
and Improved Survival Independent of Baseline Blood 
Pressure in African American Heart Failure Trial## 
809-3·52A
Limitation of Ankle-Brachial Blood Pressure Index for 
Diagnosis of Peripheral Vascular Disease in Young and 
Middle Age Adults: The Bogalusa Heart Study##911-
189·294A
Prognostic Signiﬁcance of Systolic Blood Pressure Increase 
in Patients Referred for Exercise Stress Testing## 1017-
11·154A
Role of Volume Load in Heritability of Left Ventricular Mass: 
The Hypergen Offspring Study## 835-3·342A
Subclinical Target Organ Damage in Masked and White-Coat 
Hypertension##982-198·336A
The Inﬂection Point Is Not a Reliable Method for the 
Determination of the Augmentation Index## 802-5·315A
Blood pressure determination
Gender Difference of Small and Large Artery Elasticity in 
Relation to Pulse Pressure##1001-174·347A
Bradycardia
Genetic Analysis of Hyperpolarization-activated and Cyclic 
Nucleotide-gated Cation Channels 4 (HCN4) in Patients 
With Bradyarrhythmia## 901-134·3A
Noninvasive Electrophysiological Study of Ivabradine (NESI) 
in Patients With Dual Chamber Pacemakers: Effects on 
Ventricular Repolarization## 992-129·27A
Possibility of Electrical Bridging over AV Groove by the 
Artiﬁcial Epicardiac Accessory Pathway in a Rat Model 
of Atrio-Ventricular Block## 826-5 ·25A
Brain
Acute Changes in N-terminal pro-Brain Natriuretic Peptide 
Induced by Dobutamine Stress Echocardiography## 
948-45·124A
Mesenteric Regional Oximetry in Neonates Undergoing 
Cardiac Surgery: A New Assessment Methodology 
of Systemic Oxygen Delivery Using Near-Infared 
Spectroscopy##989-110·242A
Calcium
Antinanobacterial Antibody Titer Is an Independent Risk 
Factor for Coronary Artery Calciﬁcation##1000-167·345A
Association of Low Fetuin-A and Inﬂammation With the 
Severity of Aortic Valve Calciﬁcation##1030-26·287A
Chronic Therapy with Cardiac Contractility Modulation 
Electrical Signals Normalizes mRNA Expression of the 
Sodium-Calcium Exchanger and its Modulators GATA-4 
and FOG-2 in Dogs With Chronic Heart Failure##1007-
49·76A
Ethnic Differences in the Prognostic Value of Coronary Artery 
Calciﬁcation: Data from an Observational Cohort of 
14,812 Patients## 970-33·129A
Features of the Metabolic Syndrome and Diabetes Mellitus 
as Predictors of Aortic Valve Calciﬁcation as Detected 
by Electron Beam Computed Tomography in the Multi-
Ethnic Study of Atherosclerosis##1030-27·287A
Increased Expression of Phospholemman in Left Ventricular 
Myocardium of Explanted Failed Human Hearts and in 
Dogs with Experimentally-Induced Heart Failure##963-
50·54A
Intracellular Calcium Transient Dynamics and the Mechanism 
of Shock-Induced Ventricular Fibrillation and 
Deﬁbrillation in Rabbit Hearts## 901-133·3A
Isolation and Characterization Cardiac Progenitor Cells 
from Human Adipose Tissue Derived Stem Cells Using 
Lentiviral Cardiac Promoter/Marker Expression##941-
50·45A
Lack of Correlation Between Coronary Artery Calcium and 
Myocardial Perfusion Imaging## 926-12·107A
Local Stress Concentration Around Calciﬁed Apoptotic 
Macrophages in the Fibrous Cap: A New Hypothesis 
for the Rupture of Coronary Thin-cap Atheroma 
Lesions##977-162·328A
Minimal Coronary Artery Calcium Score Alone Fails to 
Reliably Detect Signiﬁcant Lesions in Acute Chest Pain 
Patients## 807-5·114A
Mitral Annular Calciﬁcation Predicts Mortality and Coronary 
Artery Disease in Patients With End Stage Renal 
Disease## 902-39·100A
Parathyroid Hormone, Endothelial Dysfunction and Arterial 
Stiffness in Chronic Renal Disease##912-192·295A
Prevalence of Obstructive Lesions Detected by CT Coronary 
Angiography in Patients with Absent to Minimal 
Coronary Artery Calciﬁcation##1021-252·230A
Study of Coronary Calcium Score by Multislice Computed 
Tomography in Relation to Endothelial Function, C-
Reactive Protein, and Interleukin-6 in Asymptomatic 
Individuals## 970-36·129A
ZnT-1, A Missing Link in the Regulation of Cardiac L-Type 
Calcium Channels## 901-129·2A
Calcium channel blocking drugs
Amlodipine Modulates the MEK1 and ERK Pathway to 
Induce Vascular Smooth Muscle Cell Differentiation In 
Vivo##956-169·319A
Effects of Amlodipine or Enalapril Versus Placebo on Rates 
of Cardiovascular Hospitalization and Costs Among 
Coronary Artery Disease Patients With Normal Blood 
Pressure: Findings From the CAMELOT Economic 
Substudy## 848-8·361A
Effects of Verapamil on the Short-Term Electrophysiological 
Remodeling of Superior Vena Cava in Human## 924-
137·8A
Cardiac anatomy
Does Reduction in Left Atrial Diameter During 
Antihypertensive Treatment Reduce New-Onset Atrial 
Fibrillation in Hypertensive Patients with Left Ventricular 
Hypertrophy: The LIFE Study## 924-139·9A
Cardiac arrest
Cooling Blankets Are Effective for Achieving Therapeutic 
Hypothermia and Improving Survival-to-discharge 
Following Cardiac Arrest for Patients With All 
Arrhythmia Types##906-245·165A
Evaluation of Cardiac Arrest During Severe Chronic 
Obstructive Pulmonary Disease (COPD) 
Exacerbations##931-252·177A
Increased Sudden Death Risk Conferred by LVH is 
Independent of Age and Left Ventricular Dysfunction: 
A Three-Year Community-Wide Study in Patients with 
Established Signiﬁcant Coronary Artery Disease## 924-
134·8A
Mild Therapeutic Hypothermia After Cardic Arrest: A 
Nationwide Survey on the Implementation of the ILCOR 
Guidelines in Intensive Care Units##906-242·164A
Use of Semiautomatic Deﬁbrillators by Minimally Trained 
Lay Persons in Cardiac Emergencies: Is It Safe?##906-
244·165A
Cardiac mapping
Beneﬁcial Effect of Combined Intramyocardial and 
Intracoronary Administration of Autologous Stem 
Cells on Global and Regional Left Ventricular Function 
and Myocardial Perfusion in Patients With Ischaemic 
Cardiomyopathy##934-173·304A
Quantitative Myocardial Magnetic Resonance Perfusion: 
Comparison With Invasive Physiologic Assessments and 
Quantitative Coronary Angiography## 993-17·145A
Three Dimensional Activation Patterns During Ventricular 
Fibrillation in Swine Heart## 924-125·6A
Cardiac output
Enhancement of Cardiac Rotation as a Possible Mechanism 
of During Dobutamine Stress Echocardiography: A 
Compensatory Mechanism for Decreased Myocardial 
Strain Under Tachycardia?## 948-29·120A
Flow-volume Loops From Three-Dimensional 
Echocardiography: A Novel Technique for Assessment of 
Left Ventricular Function and Hemodynamics## 991-
44·141A
Impedance Cardiography as a Predictor of Clinical Outcome in 
Heart Failure Patients##1008-91·79A
Measurement of Cardiac Output by Real-Time 3-D 
Echocardiography in Patients Undergoing Assessment for 
Cardiac Transplantation## 991-45·141A
Mesenteric Regional Oximetry in Neonates Undergoing 
Cardiac Surgery: A New Assessment Methodology 
of Systemic Oxygen Delivery Using Near-Infared 
Spectroscopy##989-110·242A
Pediatric Impedance Cardiography: Is it reliable?##989-
111·242A
Radial Artery Pulse Wave Analysis Corresponds to Echo 
Doppler Measures of Cardiac Function in Patients 
Undergoing Atrioventricular and Ventriculo-Ventricular 
Optimization of Biventricular Pacemaker## 969-124·20A
Reliability of Cardiac Index Monitoring With an Analysis of 
Peripheral Arterial Waveform During Varing Loading 
Condition in Vivo##1012-149·265A
Role of Inducible NO in Sepsis Related Hemodynamic 
Impairment Assessed by High-frequency 
Echocardiography in a Murine Model##1031-51·85A
Urocortin 2 Infusion in Healthy Humans Induces 
Marked Hemodynamic, Neurohormonal, and Renal 
Responses##938-203·310A
Cardiac pacing artiﬁcial
Acute Hemodynamic Effects of Right and Left Ventricular 
Pacing in the Normal Heart: Implications for Cardiac 
Pacing in Children##967-112·241A
An Evaluation of Optimal AV Delays During Exercise in Heart 
Failure Patients Receiving Cardiac Resynchronization 
Therapy## 1015-124·31A
Atrial Versus Dual Chamber Pacing in Sinus Node Disease## 
969-140·24A
Attenuation of Cardiac Remodeling After Recent Myocardial 
Infarction Through Biventricular Pacing## 1015-127·32A
Device Erosions Are Not Associated With Systemic 
Infections## 969-136·23A
Evolution of the Paced and Nonpaced QRS Duration With 
Chronic Right Ventricular Pacing in Pediatric Patients 
With and Without Structural Heart Disease## 992-
128·27A
Permanent His Bundle Pacing Does Not Induce Dyssynchrony. 
An Intrapatient Comparison## 969-138·23A
Practices and Opinions of Morticians Regarding Postmortem 
Implantable Device Analysis and Retrieval## 947-
124·14A
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Cardiac resynchronization
A Biphasic Improvement Following Cardiac Resynchronisation 
Therapy## 1017-17·155A
A Novel, Simpliﬁed Two-Dimensional Echocardiographic 
Measure of Left Ventricular Dyssynergy Predicts Patient 
Response to Cardiac Resynchronization Therapy##1008-
98·80A
Acute Hemodynamic Effects of Right and Left Ventricular 
Pacing in the Normal Heart: Implications for Cardiac 
Pacing in Children##967-112·241A
Assessement of Intraventricular Asynchrony in Patients 
With Atrial Fibrillation Using Tri-plane Tissue Doppler 
Imaging## 846-3·147A
Assessment of “Dyssynchrony” in Normal Subjects by 
Myocardial Velocity, Displacement and Strain## 948-
16·120A
Assessment of Anatomical Relationship Between Papillary 
Muscle and Coronary Veins by Multi-detector Computed 
Tomography## 970-40·130A
Assessment of Longitudinal, Radial and Circumferential 
Dyssynchrony Using Speckle Tracking and Tissue 
Doppler in Patients With Systolic Heart Failure and 
Narrow QRS## 831-5·134A
Baseline Dyssynchrony Derived by Strain Imaging Correlates 
With the Effect of Cardiac Resynchronization Therapy at 
1-Month Follow-Up## 925-36·102A
Baseline Systolic Blood Pressure Predicts Response to Cardiac 
Resynchronization Therapy in Heart Failure Patients## 
969-142·24A
Bedside Tool to Predict Risk of Postoperative Dialysis: 
Results in 358,296 Patients Undergoing Coronary Bypass 
Surgery##940-20·274A
Biventricular Pacing Mode is Associated With a Higher 
Mortality Rate in Cardiac Resynchronization 
Therapy##1008-55·77A
Biventricular Pacing Reduces Incidence of Microvolt T Wave 
Alternans in Patients With Congestive Heart Failure## 
1015-126·32A
Can Displacement or Strain Imaging Predict a Favorable 
Response to Cardiac Resynchronization Therapy?## 
948-4·117A
Cardiac Resynchronization Device Placement During 
Hospitalization for Heart Failure is Associated With a 
Signiﬁcant Improvement in Early Clinical Outcomes## 
818-6·19A
Cardiac Resynchronization Therapy (CRT) In Patients With 
Left Ventricular Dysfunction and Narrow QRS Complex: 
Sequential Echocardiographic Dyssynchrony Analysis 
and Correlation with Improvements in Heart Failure 
Symptoms## 1015-123·31A
Cardiac Resynchronization Therapy Reduces the Need 
for Shocks in Patients With Automated Implantable 
Cardioverter Deﬁbrillators## 947-135·17A
Comparison of Heart Failure Adverse Event Rates Between 
Alternative Cardiac Resynchronization Therapy Pacing 
Modalities## 818-3·19A
Comparison of Reverse Ventricular Remodeling Between 
Surgical Direct Epicardial and Tranvenous Coronary 
Sinus Lead Placement for Cardiac Resynchronization 
Therapy## 1015-125·32A
Comparison of Various Dyssynchrony Parameters of 
Echocardiography in the Canine Model of Heart Failure 
With Dyssynchrony## 948-9·118A
Coronary Sinus Lead Extraction Is Safe Even With Prolonged 
Lead Inplant Duration## 969-133·22A
Correlation Between Acute Effect of Cardiac 
Resynchronization Therapy and Mechanical 
Dyssynchrony Measured by Tissue Velocity and Strain 
Parameters## 902-7·95A
Deﬁnition of Optimal Left Ventricular Lead Position in 
Cardiac Resynchronisation Therapy Using Myocardial 
Deformation Imaging## 810-4·11A
Do Simple Clinical and Echocardiographic Parameters Predict 
Long Term Responsiveness to Cardiac Resynchronization 
Therapy? Results From the CARE-HF Trial##1008-
52·76A
Does Left Bundle Branch Block Indicate a Better Response 
to Cardiac Resynchronization Therapy in Heart Failure 
Patients with Echocardiographic Evidence of Mechanical 
Asynchrony?## 969-127·21A
Doppler Derived Strain Measurements for Evaluation of 
Effects of Biventricular Pacing: Comparison With Right 
Ventricular Pacing Using Oxygen-15 Positron Emission 
Tomography## 948-3·117A
Effect of Cardiac Resynchronization on the Incidence of Atrial 
Fibrillation in Patients with Severe Heart Failure##1008-
53·77A
Effect of Different Cardiac Resynchronization Therapy 
Pacing Modalities on Ventricular Tachycardia/Ventricular 
Fibrillation Events in Heart Failure Patients## 947-
125·14A
Effect of Postero-lateral Scar Tissue on Clinical and 
Echocardiographic Improvement Following Cardiac 
Resynchronization Therapy## 810-6·12A
Effects of Differents Pacing Modes on Right Ventricular 
Function in Cardiac Resynchronization Patients## 1015-
128·32A
Evaluation of Left Ventricle Pressure Derivative Enhanced 
by Multi Site Pacing in Patients With Heart Failure## 
969-132·22A
Evolution of the Paced and Nonpaced QRS Duration With 
Chronic Right Ventricular Pacing in Pediatric Patients 
With and Without Structural Heart Disease## 992-
128·27A
Exercise Training in Addition to Cardiac Resynchronisation 
Therapy to Maximise Patient Beneﬁt## 1017-18·156A
Impact of Pulmonary Hypertension on Left Ventricular Reverse 
Remodeling and Long-term Outcome in Patients with 
Cardiac Resynchronization Therapy## 1015-129·33A
Improvement of Diastolic Function Is related to Left 
Ventricular Reverse Remodeling After Mid-Term Cardiac 
Resynchronization Therapy##942-58·46A
Improvement of Obstructive Sleep Apnea in Heart Failure 
Patients After Cardiac Resynchronization##964-90·57A
Inﬂuence of Location of Scar Tissue in Cardiac 
Resynchronization Therapy## 969-129·21A
Integration of Three-Dimensional Coronary Venous 
Angiography with Three-Dimensional Echocardiography 
for Biventricular Device Implantation## 969-125·21A
Intraventricular Dyssynchrony Measured by Tissue Velocity 
Does Not Change Acutely After CRT## 925-41·103A
Is Cardiac Resynchronisation Therapy Effective in Patients 
With Less Severe Symptoms?## 851-8·93A
Is Echocardiographic Atrio-Ventricular Optimization in 
Patients With Biventricular Pacemakers Needed? An 
Acute Hemodynamic Study## 805-6·111A
Left Ventricular Lead Positioning Over Infarcted Myocardium 
Results in Less Improvement in Ejection Fraction in 
Patients With Ischemic Cardiomyopathy Following 
Cardiac Resynchronization Therapy## 810-7·12A
Long-Term Effect of Repeated Sequential VV Optimization in 
Patients with CRT-Therapy?##1008-89·78A
Magnetic Resonance Imaging Based Characterization of 
Mechanical Dyssynchrony and Cardiac Resynchronization 
Therapy in Right Bundle Branch Block## 810-3·11A
Methodological Issues of QRS Duration Measurements in 
Candidates for Cardiac Resynchronization Therapy## 
992-138·29A
Normalization of Left Ventricular Ejection Fraction After 
Cardiac Resynchronization Therapy Is More Frequent 
in Patients With Non-Ischemic Cardiomyopathy## 969-
131·22A
Permanent His Bundle Pacing Does Not Induce Dyssynchrony. 
An Intrapatient Comparison## 969-138·23A
Prognostic Value of Cardiac Sympathetic Activity Evaluated 
by Scintigraphics 123I-MIBG Imaging Pre and Post 
Resynchronization Therapy## 926-30·109A
Radial Artery Pulse Wave Analysis Corresponds to Echo 
Doppler Measures of Cardiac Function in Patients 
Undergoing Atrioventricular and Ventriculo-Ventricular 
Optimization of Biventricular Pacemaker## 969-124·20A
Reduced Ventricular Volumes and Improved Systolic 
Performance with Cardiac Resynchronization Therapy: 
A Comparison of Simultaneous Biventricular Pacing vs. 
Sequential Biventricular Pacing vs. Left Univentricular 
Pacing## 969-123·20A
Right Ventricular Dysfunction and Adverse Outcome in 
Patients Receiving Cardiac Resynchronization Therapy## 
851-3·92A
Risk Factors for Ventricular Arrhythmias in Heart Failure 
Patients## 947-131·15A
Risk for Early Heart Failure Hospitalization or Death After 
Cardiac Resynchronization Therapy## 947-137·17A
Robotic Epicardial Cardiac Resynchronization Is Superior 
to Endovascular Implantation in Promoting Reverse 
Remodelling## 810-8·12A
Signiﬁcant Relation of Corrected QT Dispersion to 
Improvement of Symptoms in Patients Who Received 
Cardiac Resynchronization Therapy##1008-92·79A
The Haemodynamic Response to Changes in Atrioventricular 
and Interventricular Delay of Cardiac Resynchronization 
Therapy Closely Fits a Parabola, Which May Allow More 
Efﬁcient Optimization## 969-130·22A
The Incidence of Intraventricular Dyssynchrony in Patients 
With Dilated Cardiomyopathy With Narrow QRS 
Duration: Studied by Tissue Doppler and Strain 
Image##1008-96·80A
The Long-Term Cost-Effectiveness of Cardiac 
Resynchronization Therapy With or Without an 
Implantable Cardioverter-Deﬁbrillator: Model 
Based Analyses Based on Results From the CArdiac 
REsynchronization In Heart Failure Trial## 851-6·92A
Three-Dimensional Echocardiographic Indices of Left 
Ventricular Dysynchrony: Normal Values## 991-31·138A
Tissue Doppler Imaging for Cardiac Resynchronization 
Therapy Are the Current Guidelines Sufﬁcient## 902-
33·99A
Utility of Electronic Reprogrammable Vectors in Biventricular 
Devices## 947-134·16A
Ventricular Dyssynchrony Assessment With Equilibrium 
Radionuclide Angiography Phase Analysis Predicts 
Outcome After Cardiac Resynchronization Therapy## 
969-128·21A
Cardiac surgery
A Comparison of Quality of Life Scores in Patients With Stable 
Angina Pectoris After Medical Treatment Compared With 
Angioplasty or Coronary Bypass Surgery: 48-Months 
of Follow-Up Outcomes of a Randomized Clinical Trial 
(MASS I I)##990-151·262A
Adenosine Regulation With Acadesine Improves Two-Year 
Survival After Reperfusion-Induced MI## 857-3·235A
Antibiotic Proﬁlaxis is Essential in Surgical Procedures of 
Cardiac Implantable Devices## 969-135·23A
Antiplatelet Treatment with P2Y
12
 Receptor Antagonist 
Decreases Blood Loss in a Canine CABG Model with 
Cardiopulmonary Bypass##955-258·190A
Aortic Valve Replacement in Patients With Moderate to 
Severe Aortic Stenosis Does Not Prevent Bleeding From 
Gastrointestinal Arteriovenous Malformations##1030-
22·286A
Are There Gender-Related Differences in Presentation 
and Management of Patients with Severe Aortic 
Stenosis?##1030-21·286A
Clinical Presentation and Management of Patients With Severe 
Mitral Regurgitation: Are There Differences Between 
Men and Women?##962-24·279A
Decision Support for Coronary Revascularization##1013-
146·266A
Does Real Time Three-Dimensional Dobutamine Stress 
Echocardiography Is the Method of Choice in Patients 
Qualiﬁcation Towards Severe Ischemic Mitral 
Regurgitation to Cardiosurgical Treatment?## 991-
43·140A
Evaluation of Robotic Coronary Surgery by Intraoperative 
Angiography in Combination With Postoperative 
Multislice Computer Tomography##932-254·177A
Gender Differences in Hospital Survival Rates for Medicare 
Beneﬁciaries Undergoing CABG: Hospital Performance 
Rankings Matter##990-152·262A
Genomic Association of Graft Failure of the Left Internal 
Thoracic Artery for Myocardial Revascularization##907-
247·165A
Impact of Admission Serum Glucose Level on In-Hospital 
Outcomes Following Coronary Artery Bypass Grafting 
Surgery##955-257·190A
Impact of Mitral Valve Anuloplasty Combined with 
Revascularization in Patients with Functional Ischemic 
Mitral Regurgitation##955-260·190A
Inﬂuence of Mitral Valve Morphology and Functional 
Disorder on the Repair of Functional Ischemic Mitral 
Insufﬁciency##917-22·272A
Inﬂuence of Number of Vessels Disease in Prognosis and 
Therapeutic Results in Chronic Coronary Artery Disease 
After Medical, Bypass Surgery or Angioplasty: 3-Years 
Follow-Up of the Mass I I Study##955-256·189A
Intraoperative Cooled-tip Radiofrequency Linear Atrial 
Ablation to Treat Permanent Atrial Fibrillation## 838-
5·30A
Long-Term Result of Metabolic Syndrome with Patients 
Undergoing Coronary Artery Bypass Grafting##939-
207·311A
Long-Term Safety of Intramyocardial Injection of Autologous 
Bone Marrow Cells for Severe Ischemic Heart 
Disease##907-246·165A
Preoperative Exercise Capacity Predicts Survival and Persistent 
Symptoms After Surgery for Chronic Nonischemic Mitral 
Regurgitation##962-26·279A
Progressive Reversal of LV Remodeling in Postinfarct Patients 
Underwent Left Ventricular Aneurysmectomy: The Dor 
Procedure## 816-8·62A
Renal Insufﬁciency, Braunwald Class and Long-Term 
Outcomes in Patients Undergoing Coronary Artery Bypass 
Grafting for Acute Coronary Syndromes##975-248·201A
Right Ventricular Remodeling as a Result of Pulmonary Valve 
Replacement in Adult Fallot Patients Is Closely Related to 
Baseline Right Ventricular Size##1011-115·244A
Risk Factors Associated With Mortality and Re-Operation in 
252 Patients With AVR for Congenital Bicuspid Aortic 
Valve Disease## 824-6·282A
Short- and Long-term Outcomes of Cardiac Surgery for 
Observant Jehovah Witnesses##940-26·275A
Sinus of Valsalva Aneurysms-47 Years of Experience##922-
112·237A
Stem Cell Therapy Increases Myocardial Perfusion in Patients 
Undergoing Incomplete Coronary Artery Bypass 
Surgery##907-248·166A
Success of Surgical Left Atrial Appendage Occlusion 
Techniques Assessed by Transesophageal 
Echocardiography## 1017-1·152A
Survival After Coronary Revascularization, With and Without 
Mitral Valve Repair, in Patients With Ischemic Mitral 
Regurgitation. Importance of Pre-operative Myocardial 
Viability##962-21·278A
The RV to PA Conduit in the Modiﬁed Norwood Procedure: A 
Caveat##922-116·238A
Toward More Predictable Repair of Regurgitant Aortic Valves: 
A Logical, Segmental Approach##917-24·273A
Trends and Predictors of Outcome in Circulatory Arrest for 
Adult Cardiac Surgery: A Decade of Experience (1996-
2005)##940-25·275A
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Use and Effectiveness of Perioperative Cardiac Medical 
Therapy Among Patients Undergoing Coronary Artery 
Bypass Graft Surgery##940-24·275A
What Are the Characteristics of Patients With Severe, 
Symptomatic, Mitral Regurgitation Who Are Denied 
Surgery?##917-19·272A
Cardiac volume
Assessment of Left Ventricular Function in Patients with 
Ischemic Heart Disease and Heart Failure by Three-
Dimensional Echocardiography and Cardiac Magnetic 
Resonance Imaging## 839-7·147A
Flow-volume Loops From Three-Dimensional 
Echocardiography: A Novel Technique for Assessment of 
Left Ventricular Function and Hemodynamics## 991-
44·141A
Test-Retest Variability of Three-Dimensional 
Echocardiography for Serial Evaluation of Patients With 
Ischemic Heart Disease and Congestive Heart Failure## 
991-30·137A
Three-Dimensional Echocardiographic Indices of Left 
Ventricular Dysynchrony: Normal Values## 991-31·138A
Utility of Real-Time 3-D Echocardiography for Predicting 
Adverse Events in the MADIT-II Post-Myocardial 
Infarction Patient Population## 839-8·147A
Cardiology practice/management
Calculating LDL and Blood Pressure Goals Per ATP III and 
JNC VII Just Prior to an Ofﬁce Visit Helps Close the Gap 
Between Guidelines and Practice##1036-149·270A
Cardiology Specialty Care is Associated With Higher 
Quality Performance for Patients Admitted With Heart 
Failure##946-147·254A
Characteristics Predicting Successful Weight Reduction in 
Overweight and Obese Post Infarction Patients## 849-
4·362A
Home Uptitration of Beta-blockers by Heart Failure 
Clinic Patients With Telephone Advice: A British 
experience##1036-152·270A
Impact of Novel Critical Care Pathway for Management of 
Acute Coronary Syndrome Leads to Markedly Improved 
Compliance With Guidelines and Decreased Angina 
Symptoms at 12-Month Follow-Up## 847-5·268A
Inappropriate Left Ventricular Mass Identiﬁes Hypertensive 
Patients With High-Risk Cardiac Phenotype## 835-
8·343A
NT-proBNP Predicts Perioperative Cardiac Events in Patients 
Undergoing Noncardiac Surgery##1005-200·352A
R Wave Frontal Plane Right Axis Deviation on the Admission 
Electrocardiogram in Patients With Acute Myocardial 
Infarction: A Strong Independent Predictor of Increased 
Mortality Both In-Hospital and in Early Follow-up##973-
233·197A
The Fate of Randomized Trials Presented at the American 
College of Cardiology Meeting 1999-2002: What Follows 
the 15 Minute Presentation?##923-147·251A
Cardiomyopathies, dilated
Augmented Nitric Oxide Release in the Coronary Circulation 
Parallels Myocardial Metabolic Stress in Patients with 
Dilated Cardiomyopathy##1033-104·91A
Baseline Dyssynchrony Derived by Strain Imaging Correlates 
With the Effect of Cardiac Resynchronization Therapy at 
1-Month Follow-Up## 925-36·102A
Correlation Between Acute Effect of Cardiac 
Resynchronization Therapy and Mechanical 
Dyssynchrony Measured by Tissue Velocity and Strain 
Parameters## 902-7·95A
Delayed Enhanced Magnetic Resonance Imaging Is a Predictor 
of Resistance to Medical Treatment in Non-Ischemic 
Dilated Cardiomyopathy## 993-18·145A
Differences in Protein-Protein Interactions as a Basis for the 
Contrasting Phenotypes of Hypertrophic and Dilated 
Cardiomyopathies Resulting From Different Mutations in 
the Same Sarcomeric Protein## 817-3·62A
Early Initiation of Perindopril Preserves Left Ventricular 
Ejection Fraction and Decreases Mortality in Duchenne 
Muscular Dystrophy: Results After Ten-Years Follow-
Up## 840-7·246A
Endogenous Stem Cell Circulation in Patients Suffering from 
Idiopathic Dilated Cardiomyopathy##941-47·44A
Gene Expression Proﬁling of Left Ventricular Tissue in 
Mdx Mice Showing Echocardiographic Evidence of 
Cardiomyopathy##918-48·37A
Intraventricular Dyssynchrony Measured by Tissue Velocity 
Does Not Change Acutely After CRT## 925-41·103A
Left Ventricular Apical Rotation is Impaired in Patients with 
Dilated Cardiomyopathy: Quantitative Analysis by Two-
Dimensional Tissue Tracking System## 902-15·97A
Left Ventricular Remodeling Index Assessed by Real-Time 
Three-Dimensional Echocardiography in Various 
Pathophysiologic Conditions## 839-4·146A
Magnetic Resonance-Based Evaluation of Cardiac 
Hypertrophy in the db/db Mouse## 993-10·144A
Mononuclear Bone Marrow Stem Cells Implant as an 
Alternative Treatment in Non-isquemic Dilated 
Cardiomyopathy##1008-97·80A
mRNA Expression and Protein Levels for Granulocyte Colony 
Stimulating Factor are Increased in Left Ventricular 
Myocardium of Patients With Heart Failure## 819-8·73A
Selective Secretion of MMP-8 and -9 in the Coronary 
Circulation in Parallel with BNP in Human Heart Failure 
## 819-4·72A
Signiﬁcance of 8-hydroxy-2’-deoxyguanosine Levels in 
Patients With Idiopathic Dilated Cardiomyopathy##987-
103·70A
The Variable Natural History of Idiopathic Dilated 
Cardiomyopathy##1009-103·81A
Xanthine Oxidase Inhibition Causes Reverse Remodeling in 
Rats with Dilated Cardiomyopathy##963-47·53A
Cardiomyopathies, hypertrophic
ACTN2-Encoded Alpha-Actinin 2: A Novel Hypertrophic 
Cardiomyopathy Susceptibility Gene## 817-5·63A
Abnormal Blood Pressure Response to Exercise and 
Oxygen Consumption in Patients With Hypertrophic 
Cardiomyopathy##920-103·43A
Adiponectin in Patients With Hypertrophic 
Cardiomyopathy##965-103·60A
Aging Modiﬁes Cardiac Phenotype of Mice Expressing 
Familial Hypertrophic Cardiomyopathy Linked Troponin 
T Mutants##965-100·59A
Alcohol Septal Ablation Is Safe and Effective in Patients 
With Left Ventricular Hypertrophy and Outﬂow Tract 
Obstruction##920-100·42A
Anomalous Papillary Muscles as the Predominant Cause 
of Left Ventricular Outﬂow Tract Obstruction in 
Hypertrophic Cardiomyopathy: A Novel Form of 
Disease?## 817-8·64A
Clinical Signiﬁcance of Delayed Enhancement on Magnetic 
Resonance Imaging in Patients With Hypertrophic 
Cardiomyopathy## 993-12·144A
Clinical Signiﬁcance of Penetrating Intra-myocardial 
Coronary Arteries in Patients With Apical Hypertrophic 
Cardiomyopathy##920-104·43A
Deﬁbrillation Thresholds in Patients with Hypertrophic 
Cardiomyopathy## 947-133·16A
Diastolic Dysfunction in Hypertrophic Cardiomyopathy 
Is Related to Myocardial Fibrosis as Determined by 
Cardiovascular Magnetic Resonance##943-101·50A
Difference in the Left Atrial Function Between Patients 
With Hypertensive Hypertrophy and Hypertrophic 
Cardiomyopathy Evaluated by Tissue Strain Imaging## 
948-18·120A
Differences in Protein-Protein Interactions as a Basis for the 
Contrasting Phenotypes of Hypertrophic and Dilated 
Cardiomyopathies Resulting From Different Mutations in 
the Same Sarcomeric Protein## 817-3·62A
Echocardiographic-Determined Septal Morphology in Z-Disc 
Hypertrophic Cardiomyopathy## 817-4·63A
Endocardial Radiofrequency Ablation of Septal Hypertrophy 
for Hypertrophic Obstructive Cardiomyopathy: A New 
Modality of Gradient Reduction?## 817-6·63A
Evidence for Differential Tissue Effects of Alcohol Septal 
Ablation and Surgical Septal Myectomy on Left 
Ventricular Myocardium## 817-7·63A
Extent of Delayed Hyperenhancement in Cardiovascular 
Magnetic Resonance was Associated With Chronic 
Left Ventricular Diastolic Burden in Patients With 
Hypertrophic Cardiomyopathy##943-100·50A
Growth Factors Inﬂuence Collagen Metabolism and 
Hypertrophy in Hypertrophic Cardiomyopathy##965-
104·60A
Impact of Positive Family History on Personal Risk 
of Sudden Death for Patients with Hypertrophic 
Cardiomyopathy##920-101·43A
Left Atrial Emptying Rate: A Marker of Hypertrophy and 
Diastolic Dysfunction in Patients With Hypertrophic 
Cardiomyopathy##943-104·51A
Left Ventricular Remodeling Index Assessed by Real-Time 
Three-Dimensional Echocardiography in Various 
Pathophysiologic Conditions## 839-4·146A
Mitral Valve Abnormalities in Patients Undergoing Myectomy: 
Echocardiographic Features, Surgical Therapies and 
Outcomes##917-26·273A
Mutations in the Genes for Sarcomeric Proteins in Japanese 
Patients With Elderly-Onset Sporadic Hypertrophic 
Cardiomyopathy##965-101·59A
Myocardial Fibrosis in Patients with Hypertrophic 
Cardiomyopathy: Correlation with Echocardiographic 
Measurements of Diastolic Dysfunction and Genetic 
Perturbations##942-59·47A
New Concepts of Myocardial Mechanics in Hypertrophic 
Cardiomyopathy## 948-13·119A
Phenotypic Comparison Between Myoﬁlament Positive and 
Myoﬁlament Negative Hypertrophic Cardiomyopathy 
Among Italians##965-102·59A
Prediction of Cardiac Events in Patients With Hypertrophic 
Cardiomyopathy: Usefulness of MIBG Myocardial 
Scintigraphy## 926-35·110A
Relationship Between Cardiopulmonary Exercise Testing and 
Pulmonary Pressures in Hypertrophic Cardiomyopathy## 
1017-30·156A
Relationship Between Left Atrial and Left Ventricular Function 
in Hypertrophic Cardiomyopathy: A Real Time 3D 
Echocardiographic Study##943-103·50A
Septal Myectomy: 324 Consecutive Procedures Without a 
Mortality##940-23·275A
The Inﬂuence of Myocardial Fibrosis by Delayed Enhanced 
MRI on Left Ventricular Diastolic Function in 
Hypertrophic Cardiomyopathy## 833-5·136A
Tissue Doppler Imaging Predicts NYHA Functional Class 
and Plasma BNP Levels in Patients With Hypertrophic 
Cardiomyopathy## 948-1·116A
Usefulness of Arterial Stiffness Evaluation for the Differential 
Diagnosis of Hypertrophic Cardiomyopathy From 
Hypertensive Heart Disease##920-102·43A
Usefulness of Three-Dimensional Echocardiographic 
Quantiﬁcation During Percutaneous Alcohol Septal 
Ablation for Hypertrophic Obstructive Cardiomyopathy## 
991-33·138A
Cardiomyopathies, other
Alteration in Iron Kinetics May Contribute to Doxorubicin 
Cardiotoxicity##987-100·70A
Cardiac Amyloidosis is Associated with a High Frequency of 
Intracardiac Thrombus Formation##1009-104·81A
Cardiac Magnetic Resonance Characterization of Thalassemia 
Intermedia Patients Confronted with Thalassemia Major 
Patients## 833-4·136A
Do Changes in Systolic Myocardial Velocities Precede 
Changes in Ejection Phase Indices of Ventricular Systolic 
Performance in Duchenne Muscular Dystrophy?##967-
113·241A
Down-regulation of Myocardial Fatty Acid Metabolism in 
Heart Failure Patients Is Dependent on Left Ventricular 
Chamber Size##1031-50·85A
Gene Expression Proﬁling in Fabry Cardiomyopathy##987-
101·70A
Intramyocardial Bone Marrow Stem Cells Transplantation 
for Non-ischemic Dilated Cardiomyopathy: 4 Months 
Follow-up##903-215·158A
Late Gadolinium Enhanced Cardiovascular Magnetic 
Resonance as a Novel Technique to Predict Major 
Adverse Cardiac Events in Patients With Left Ventricular 
Systolic Dysfunction Without Obstructive Coronary 
Artery Disease##943-102·50A
MRI for Diagnosis of Myocarditis by Global and Delayed 
Enhancement Techniques: Added Value to Diagnose 
Unsuspected Coronary Disease##1033-103·90A
Multislice Multiecho T2* Cardiovascular Magnetic 
Resonance Approach for the Detection of Myocardial 
Iron Distribution: Validation in Healthy Subjects and 
Thalassemia Major Patients## 993-8·143A
Myocardial Fibrosis assessed by Contrast-Enhanced 
Cardiovascular Magnetic Resonance and Prevalence of 
Malignant Ventricular Arrhythmias in Arrhythmogenic 
Right Ventricular Cardiomyopathy## 924-132·7A
PAMM (Parametric Analysis of Main Motion): First Evaluation 
of a New Parametric Imaging Method for Segmental Wall 
Motion Analysis## 902-38·100A
Paradoxical Decrease in Plasma N-Terminal-proBNP (NT-
proBNP) Levels in Patients Receiving Doxorubicin 
Chemotherapy and Declining Left Ventricular Ejection 
Fraction##986-57·66A
Radiofrequency Catheter Ablation of Frequent, Idiopathic 
Premature Ventricular Complexes: Effects on Left 
Ventricular Function## 924-133·7A
Signiﬁcant Low-Voltage ECG and Impaired Systolic Cardiac 
Function in Neonatal Mice Expressing Connexin 31 
Instead of 43## 901-126·1A
Single Center Experience With the HeartMate II Left 
Ventricular Assist System## 825-5·75A
The Utility of Cardiac Magnetic Resonance in Differentiating 
Hypertrophic Cardiomyopathy and Cardiac 
Amyloidosis## 993-5·143A
Tissue Doppler Is Superior to Conventional Echocardiography 
in the Diagnosis of Arrhythmogenic Right Ventricular 
Dysplasia/Cardiomyopathy## 846-8·149A
Transient Cardiac Apical Ballooning Syndrome: Prevalence 
and Clinical Implications of Right Ventricular 
Involvement##1009-102·81A
Cardiomyoplasty
Allogeneic Mesenchymal Stem Cells Restore Early Tissue 
Perfusion in Regions of Ischemically Damaged 
Myocardium## 993-3·142A
Cardiac Pacemaker Precursor Cells Can Be Obtained From 
Human Endometrial Mesenchymal Stem Cells for 
Biological Pacemaker Cell Transplantation.## 901-
131·2A
Human Menstrual Blood Derived Stem Cell Has a High 
Cardiomyogenic Potential; Possible New Cell Source for 
Cardiac Stem Cell Therapy##921-105·43A
Human Umbilical Cord Blood Derived Mesenchymal Stem 
Cell Has A Powerful Cardiomyogenic Potential In Vitro; 
A Novel Cell Source For Cardiac Stem Cell Based 
Therapy##921-107·44A
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Human Umbilical Cord Mononuclear Cells (HUCMC) 
Improve Left Ventricular Function and Reduce Infarct 
Size in a Mouse Model of Myocardial Infarction##941-
51·45A
Skeletal Myoblast Delivery of Angiopoietin-1 Versus Direct 
Adenoviral Angiopoietin-1 Injection## 856-7·234A
Cardiopulmonary resuscitation
Cooling Blankets Are Effective for Achieving Therapeutic 
Hypothermia and Improving Survival-to-discharge 
Following Cardiac Arrest for Patients With All 
Arrhythmia Types##906-245·165A
Evaluation of Cardiac Arrest During Severe Chronic 
Obstructive Pulmonary Disease (COPD) 
Exacerbations##931-252·177A
Mild Therapeutic Hypothermia After Cardic Arrest: A 
Nationwide Survey on the Implementation of the ILCOR 
Guidelines in Intensive Care Units##906-242·164A
Sudden Cardiac Death in Athletes: Rates of 
Deﬁbrillation##906-243·165A
Cardiovascular disease
Automated Pericardial Fat Quantiﬁcation in CT Data##1012-
145·264A
Beneﬁt of Early Statin Therapy During Acute Coronary 
Syndromes: A Meta-Analysis## 821-5·205A
Beneﬁt of Early Statin Therapy During Acute Coronary 
Syndromes: A Meta-Analysis## 821-5·205A
Better Guideline Compliance With Medical Therapy Seen in 
Patients With Prior Coronary Revascularization: Results 
From the Reduction of Atherothrombosis for Continued 
Health (REACH) Registry## 836-3·208A
C-Reactive Protein and Pro-Inﬂammatory Cytokines Are 
Elevated in Men With Erectile Dysfunction of Vascular 
Origin## 854-8·378A
Cardiovascular Risk Classiﬁcation in Hypertensive Patients 
With or Without Metabolic Syndrome: Results From the 
ICEBERG Study##939-209·311A
Cardiovascular Risk Factors and Events in the Lumbee Native 
Americans of North Carolina##916-252·167A
CV Knowledge and Risk Perceptions Among Underserved 
Individuals at Increased Risk for Cardiovascular 
Disease## 834-4·263A
Diabetes, Renal Function, and Cardiovascular Risk Following 
Myocardial Infarction: Lessons From The VALsartan In 
Acute myocardial iNfarcTion Trial (VALIANT)##998-
249·217A
Enhanced Self-Efﬁcacy but not Knowledge Predicts Increased 
Physical Activity##1036-154·270A
Ethnic Differences in the Effect of Polymorphisms in the 
Renin-Angiotensin System on Recurrent Cardiac Events 
in Post-Myocardial Infarction Patients##953-242·186A
Improvement of Metabolic Parameters with Rimonabant 
Beyond the Effect Attributable to Weight Loss Alone: 
Pooled 1-Year Data from the RIO (Rimonabant In Obesity 
and Related Metabolic Disorders) Program## 849-3·362A
Increased Platelet-Leukocyte Aggregation in Indian Asian 
Men: A Mechanism Contributing to Greater Cardiovasular 
Risk?##1023-163·364A
Intensive Multicomponent Smoking Cessation Intervention 
Decreases Mortality in Hospitalized High-Risk Cardiac 
Smokers##1029-212·375A
Intravascular Ultrasound-Based Imaging of Vasa Vasorum 
for the Detection of Vulnerable Atherosclerotic 
Plaque##1012-146·264A
Is the Female Advantage Lost Once Patients Have Established 
Atherothrombotic Disease##916-259·169A
Long-Term Prognosis of Patients With Isolate Myocardial 
Bridge##953-246·187A
Low Body Temperature at Hospital Discharge is a Marker 
of Poor Prognosis in Patients with Congestive Heart 
Failure##1032-94·88A
Meta-Analysis of the Association of Anemia, Chronic 
Kidney Disease (CKD), and Cardiovascular Disease 
(CVD)##968-154·260A
MRI for Diagnosis of Myocarditis by Global and Delayed 
Enhancement Techniques: Added Value to Diagnose 
Unsuspected Coronary Disease##1033-103·90A
Plasma Levels of Fibrinogen, Plasminogen Activator Inhibitor 
-1, and Von Willebrand Factor Are Increased in Patients 
With Erectile Dysfunction##1023-170·365A
Prognostic Signiﬁcance of Systolic Blood Pressure Increase 
in Patients Referred for Exercise Stress Testing## 1017-
11·154A
Prolonged Heparin Exposure, Development of 
Thrombocytopenia, Use of GP IIb/IIIa Inhibitors, and 
History of Renal Dysfunction Predict Moderate or 
Severe Bleeding: A Report From the Complications 
After Thrombocytopenia Caused by Heparin (CATCH) 
Registry##923-146·251A
Proteomic Proﬁling Reveals that Plasma Beta 2-Microglobulin 
is a Marker for Peripheral Arterial Disease## 802-4·314A
Reduction of Atherothrombosis for Continued Health 
(REACH) Registry Results: 1-Year Cardiovascular Event 
Rates in a Global Contemporary Registry of Over 68,000 
outpatients with Atherothrombosis##916-256·168A
Risk Factors for the Development of Coronary Artery 
Disease After Cardiac Transplantation. An Intravascular 
Ultrasound Study##1034-106·91A
Single Center Experience With the HeartMate II Left 
Ventricular Assist System## 825-5·75A
Socioeconomic Status, Inﬂammatory and Hemostatic Markers 
and Cardiovascular Events##983-205·338A
Statin Use and Low-Density Lipoprotein Cholesterol Goals in 
2004: How Are We Doing Applying National Cholesterol 
Education Program III Guidelines?## 836-5·209A
Synergistic Interaction Between Hypercholesterolemia and 
Diabetes Signaling Through Phosphatidylinositol 3-
Kinase/Akt/PKB and Nuclear Factor kB in a Porcine 
Model of Coronary Atherosclerosis##977-169·330A
The Inﬂuence of IIb/IIIa Agents on Mortality in Patients With 
Risk Factors for the Metabolic Syndrome Undergoing 
Percutaneous Coronary Revascularization##961-
199·326A
The Vasodilatory Action of Testosterone Is Independent of 
the Endothelium, Classic Androgen Receptor, Aromatase 
Activity, Nitric Oxide and Dilator Prostaglandins in 
Isolated Human Pulmonary Vessels##1000-163·344A
Up-Regulation of Pro-Platelet Basic Protein in Older Men 
with Obstructive Coronary Disease as Determined by 
Positron Emission Tomographic Perfusion Imaging: A 
New Noninvasive Marker for Coronary Artery Disease?## 
926-31·109A
Waist Circumference and Body Mass Index Are Both 
Independently Associated With Cardiovascular Disease. 
The International Day for the Evaluation of Abdominal 
Obesity (IDEA) Survey## 842-6·358A
Cardiovascular disease prevention
Adverse Cardiovascular Outcomes With Atenolol in Clinical 
Trials in Hypertension: An Updated Meta-Analysis## 
848-7·361A
C-Reactive Protein and Pro-Inﬂammatory Cytokines Are 
Elevated in Men With Erectile Dysfunction of Vascular 
Origin## 854-8·378A
Effect of Bariatric Surgery on Cardiovascular Risk Factors and 
Predicted Effect on Cardiovascular Events and Mortality 
in Class II-III Obesity## 842-8·358A
Effects of High-Dose Atorvastatin on HDL Anti-inﬂammatory/
Pro-inﬂammatory Function and Disease Activity in 
Patients With Rheumatoid Arthritis: Results of the Statin 
Anti-Rheumatic Activity (SARA) Pilot Study## 854-
6·378A
Enhanced Self-Efﬁcacy but not Knowledge Predicts Increased 
Physical Activity##1036-154·270A
High-dose Folic Acid Supplementation Improves Atherogenic 
Process in Predialysing Chronic Renal Failure 
Independent of Homocysteine-lowering##1000-164·345A
Hypertension and Hypercholesterolemia: Achievement 
of Treatment Targets in a Primary Prevention 
Population##1014-213·355A
Marked Risk Reduction in Coronary Heart Disease, Stroke and 
Total Mortality in Women ≥60 Years Old With Low-Dose 
Pravastatin for Primary Prevention in the Management of 
Elevated Cholesterol in the Primary Prevention Group of 
Adult Japanese (MEGA) Study##1014-208·354A
On-treatment Levels of HDL-C and the Ratio of LDL-C/HDL-
C as Predictors of Cardiovascular Events in the Treating 
to New Targets (TNT) Study##914-203·298A
Patients’ Pill Burden Predicts Adherence to Antihypertensive 
and Lipid-lowering Therapy## 834-6·263A
Plasma Levels of Fibrinogen, Plasminogen Activator Inhibitor 
-1, and Von Willebrand Factor Are Increased in Patients 
With Erectile Dysfunction##1023-170·365A
Socioeconomic Status, Inﬂammatory and Hemostatic Markers 
and Cardiovascular Events##983-205·338A
Statin Use and Low-Density Lipoprotein Cholesterol Goals in 
2004: How Are We Doing Applying National Cholesterol 
Education Program III Guidelines?## 836-5·209A
Statins in the Primary Prevention of Cardiovascular Diseases: 
Meta-analysis of Randomized Controlled Trials##981-
190·334A
The Impact of Over-the-Counter Simvastatin on the Number of 
Statin Prescriptions in the United Kingdom: A View from 
the General Practice Research Database## 808-7·316A
Using Telemedicine to Decrease Cardiovascular Risk in 
Underserved Populations##968-148·258A
Carotid arteries
Association Between Carotid Intima-Media Thickness and 
Aortic Arch Plaque Thickness in the Elderly##980-
188·334A
Association of High Density Lipoprotein Levels and Carotid 
Atherosclerotic Plaque Burden and Lipid Content by 
High-resolution Magnetic Resonance Imaging## 993-
1·142A
Cumulative Adverse Effects of Upper Respiratory Tract 
Infections on Carotid Artery Elasticity in Children With 
Type 1 Diabetes Mellitus##935-181·305A
ELOCAS Registry - 5-Year Results of Carotid Stenting in High 
Volume Centers in Patients with Asymptomatic Carotid 
Stenosis##980-189·334A
Endothelial Dysfunction and Increased Carotid Intima-Media 
Thickness in Primary Antiphospholipid Syndrome##1001-
179·348A
Expression and Function of Toll-like Receptors in Different 
Vascular Beds: Towards Understanding Target Tissue 
Susceptibility in Vascular Inﬂammation## 802-3·314A
First Report of the CASES-PMS Study: Patient Demographics 
and 30-Day Major Adverse Events for the Cordis 
PRECISE™ Nitinol Stent and Angioguard™ XP Emboli 
Capture Guidewire Condition of Approval Surveillance 
Study## 802-8·315A
Impact of Antiphospholipid Antibodies on Cardiovascular 
Disease in Systemic Lupus Erythematosus## 803-7·277A
Inﬂuence of Pravastatin on Carotid Artery Structure and 
Function in Dyslipidemic HIV-Infected Patients Under 
Antiretroviral Therapy##980-187·334A
Long-Term Results of Carotid Stent Implantation Up to 11-
Years in Patients With Carotid Stenosis##979-182·333A
Oxidative Stress Is a Mechanism Underlying the Obesity 
Related Risk of Atherosclerosis in Healthy Adults##935-
183·306A
Parathyroid Hormone, Endothelial Dysfunction and Arterial 
Stiffness in Chronic Renal Disease##912-192·295A
Progression of Calciﬁed Coronary Atherosclerosis: Role 
of Traditional Risk Factors, CRP, and Non-calciﬁed 
Atherosclerosis## 970-16·127A
Quantitation and Distribution of Lipoprotein-Associated 
Phospholipase A
2 
and Oxidized Low Density Lipoprotein 
in Atherosclerotic Lesions of Carotid Endarterectomy 
Tissues##1000-170·346A
Relation of Insulin-like Growth Factor-1 and Insulin-like 
Growth Factor Binding Protein-3 to Carotid Intima-media 
Thickness and Elasticity in Younger Adults: The Bogalusa 
Heart Study##961-203·326A
Stratiﬁcation of Coronary Risk Beyond the Framingham Risk 
Classiﬁcation: Ultrasound Assessment of Subclinical 
Disease in a Multiethnic Population##983-208·338A
Use of Portable Ultrasound to Measure Carotid Intima-Media 
Thickness##1025-180·368A
Carotid stenting
Austrian Risk Score for Carotid Stenting: A 3-Year Follow-
Up##980-185·333A
Carotid Angioplasty and Stenting under Protection. Short Term 
Outcomes in High and Low Risk Patients##979-180·332A
Carotid Stenting Induces Platelet Activation and a Pro-
inﬂammatory Response##1025-182·368A
Do Duplex Ultrasound Velocities Accurately Reﬂect 
Angiographic Stenosis in Recently Stented Carotid 
Arteries?##1025-184·369A
ELOCAS Registry - 5-Year Results of Carotid Stenting in High 
Volume Centers in Patients with Asymptomatic Carotid 
Stenosis##980-189·334A
First Report of the CASES-PMS Study: Patient Demographics 
and 30-Day Major Adverse Events for the Cordis 
PRECISE™ Nitinol Stent and Angioguard™ XP Emboli 
Capture Guidewire Condition of Approval Surveillance 
Study## 802-8·315A
Long-Term Results of Carotid Stent Implantation Up to 11-
Years in Patients With Carotid Stenosis##979-182·333A
Role of the Middle and Anterior Cerebral Arteries Assessment 
After Internal Carotid Artery Stenting##980-186·334A
Cell physiology
Conditional Expression of a Gain of Function Alpha-5 
Integrin in Adult Mouse Heart Increases Ventricular 
Automaticity## 901-127·1A
Regulation of Endothelial Progenitor Cell (EPC) Survival and 
Vasculogenesis by Peroxisome Proliferator-activated 
Receptor-Delta (PPAR-�) Activation## 823-6·342A
Upregulation of Functional Cardiac Beta
3
-Adrenergic 
Receptors and Chronic Anthrax Lethal Toxin-Induced 
Progressive Cardiac Depression: Insights Into the 
Underlying Molecular Mechanism##1007-51·76A
Cells
A Strategy of Retrograde Injection of Bone Marrow 
Mononuclear Cells Into the Myocardium for the 
Treatment of Ischemic Heart Disease##934-175·304A
Acute Vincristine Pretreatment Protects Adult Cardiac 
Myocytes From Oxidative Stress## 820-6·74A
Allogeneic and Syngenic Multipotent Adult Progenitor Cell 
Delivery Improves Cardiac Function After Myocardial 
Infarct##941-49·44A
Augmented Vascular Regeneration by Transplanted Human 
Stem Cell-Derived Vascular Progenitor Cells with 
Adrenomedullin##909-173·291A
Beneﬁcial Effect of Combined Intramyocardial and 
Intracoronary Administration of Autologous Stem 
Cells on Global and Regional Left Ventricular Function 
and Myocardial Perfusion in Patients With Ischaemic 
Cardiomyopathy##934-173·304A
Bone Marrow-derived Stem Cell Interactions With Adult 
Cardiomyocytes and Skeletal Myoblasts in Culture##941-
48·44A
Cardiac SP Cells Have Different Characteristics Distinct From 
Bone Marrow SP Cells##903-219·159A
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Effect of Autologous Bone Marrow-derived Mononuclear 
Cell Injection on Myocardial Function and Perfusion in 
Patients With Refractory Angina Pectoris and Chronic 
Ischemia##1022-216·231A
Effect of Stem Cells on Left Ventricle Wall Thickness 
and Capillary Density in Pigs Following Myocardial 
Infarction## 829-3·206A
Endogenous Stem Cell Circulation in Patients Suffering from 
Idiopathic Dilated Cardiomyopathy##941-47·44A
Genetically Modifying Marrow Stromal Stem Cells to Secrete 
Erythropoietin Enhances the Protective Effect of Cellular 
Therapy in the Infarcted Myocardium## 829-4·206A
Homing of 111In-oxine Radiolabelled Endothelial Progenitor 
Cells in Ischemic or Inﬂammed Mice Hindlimbs: 
Differential Cytokine and Chemokine Proﬁle## 948-
31·121A
Human Menstrual Blood Derived Stem Cell Has a High 
Cardiomyogenic Potential; Possible New Cell Source for 
Cardiac Stem Cell Therapy##921-105·43A
Human Umbilical Cord Blood Derived Mesenchymal Stem 
Cell Has A Powerful Cardiomyogenic Potential In Vitro; 
A Novel Cell Source For Cardiac Stem Cell Based 
Therapy##921-107·44A
Human Umbilical Cord Mononuclear Cells (HUCMC) 
Improve Left Ventricular Function and Reduce Infarct 
Size in a Mouse Model of Myocardial Infarction##941-
51·45A
Induction of Heart and Smooth Muscle-Speciﬁc Genes in 
Human Mesenchymal Stem Cells and Epicardium-
Derived Cells After Forced Myocardin Expression## 
823-4·341A
Intracoronary Mesenchymal Stem Cell or Endothelial 
Progenitor Cell Transfer Post Myocardial Infarction 
Prevents Negative Remodeling but Fails to Enhance 
Global Functional Recovery##949-221·180A
Intramyocardial Bone Marrow Stem Cells Transplantation 
for Non-ischemic Dilated Cardiomyopathy: 4 Months 
Follow-up##903-215·158A
Is There Additional Beneﬁt of Intracoronary Transplantation of 
Autologous Peripheral Blood Stem Cell in Patients With 
Acute Myocardial Infarction?##1020-248·229A
Isolation and Characterization Cardiac Progenitor Cells 
from Human Adipose Tissue Derived Stem Cells Using 
Lentiviral Cardiac Promoter/Marker Expression##941-
50·45A
Long-Term Safety of Intramyocardial Injection of Autologous 
Bone Marrow Cells for Severe Ischemic Heart 
Disease##907-246·165A
Molecular Basis in the Development of Alcoholic 





Mononuclear Bone Marrow Stem Cells Implant as an 
Alternative Treatment in Non-isquemic Dilated 
Cardiomyopathy##1008-97·80A
One Day Kinetics of Bone Marrow Mononuclear Cells in 
Acute and Chronic Myocardial Infarction: Transient 
Myocardial Homing or Persistent Engraftment After 
Intracoronary Injections in Human?## 829-6·206A
Paracrine Effects of Endothelial Progenitor Cells on Acutely 
Infarcted Myocardium## 814-3·190A
Stem Cell Therapy Increases Myocardial Perfusion in Patients 
Undergoing Incomplete Coronary Artery Bypass 
Surgery##907-248·166A
Stromal Cell-Derived Factor-1 Stimulates the Survival and 
Proliferation of Sca-1+ Mesenchymal Stem Cells Derived 
From Mouse Bone Marrow##994-217·210A
Tracking of Intra-Coronary Delivered Mesenchymal Stem 
Cells Using Magnetic Resonance Imaging in a Porcine 
Model of Myocardial Infarction##903-218·158A
Transmyocardial Laser Revascularization Combined With 
Stem Cell Therapy Increases Myocardial Perfusion 
and Functional Capacity in Patients With Refractory 
Angina##907-250·166A
Transplantation of Autologous Endothelial Progenitor Cells is 
Safe, Feasible and Effective for Vascular Regeneration 
in No-Option Patients with Chronic Critical Limb 
Ischemia##934-176·304A
Vascular Smooth Muscle Cells From Stable and Unstable 
Atherosclerotic Plaques Show Epigenetic Commitment 
Even After 25 Plating Passages##956-170·319A
Cellular mechanisms
Acute Vincristine Pretreatment Protects Adult Cardiac 
Myocytes From Oxidative Stress## 820-6·74A
Attenuation of LV Dysfunction by A PPAR-alpha Agonist in 
Hypertensive Rats is Associated With Down-regulation of 
Redox-regulated Transcription Factors##1007-47·75A
GLP-1 Depresses Myocardial Contractility, but Increases 
Myocardial Glucose Uptake in Isolated Rat Hearts 
Independent of cAMP or Akt-1 Activation##963-51·54A
Heat Shock Proteins Prevent Atrial Tachycardia Remodeling 
and Atrial Fibrillation Promotion## 826-4·25A
Long-Term Electrical Conduction Across Human Adult 
Mesenchymal Stem Cells Connecting Two Fields 
of Cultured Cardiomyocytes and the Effect of Cx43 
Knockdown by RNA Interference## 901-125·1A
Stromal Cell-Derived Factor-1 Stimulates the Survival and 
Proliferation of Sca-1+ Mesenchymal Stem Cells Derived 
From Mouse Bone Marrow##994-217·210A
Vascular Smooth Muscle Cells From Stable and Unstable 
Atherosclerotic Plaques Show Epigenetic Commitment 
Even After 25 Plating Passages##956-170·319A
ZnT-1, A Missing Link in the Regulation of Cardiac L-Type 
Calcium Channels## 901-129·2A
Central nervous system
What Speciﬁc Domains of Cognition Are Impaired in Patients 
With Chronic Heart Failure?##919-55·38A
Cerebrovascular circulation
Cerebrovascular Thromboembolic Events After Mitral Valve 
Repair: Implication for Treatment of Patients with Mitral 
Regurgitation##917-25·273A
Role of the Middle and Anterior Cerebral Arteries Assessment 
After Internal Carotid Artery Stenting##980-186·334A
Cholesterol
Effect of Post Fat Loading Remnant Like Particles-Cholesterol 
on Prognosis in Patients With Coronary Artery 
Disease##1014-214·355A
HDL Not Predictive of Longevity or Cardiovascular Events 
in Older Adults: Findings From the EPESE Study##968-
145·258A
LDL Control in Patients Undergoing Peripheral Arterial 
Revascularization Procedures Compared to Coronary 
Arterial Revascularization Procedures##968-151·259A
Low Serum Total Cholesterol Is Associated With Increased 
Mortality in Non-Ischemic Heart Failure##964-99·59A
National Improvements in the Recognition and Treatment of 
Patients at Increased Coronary Risk: The National Health 
and Nutrition Examination Survey, 1999 - 2002##916-
260·169A
Proteasome Inhibition: A New Road to Coronary 
Atherogenesis?##977-166·329A
The Addition of Niacin to Statin Therapy Produces an 
Atheroprotective Shift in Lipoprotein Subclasses and 
Inﬂammatory Markers in Patients With Coronary Artery 
Disease and Well-Controlled LDL-Cholesterol##1026-
185·369A
The Heterogeneous Inﬂuence of Metabolic Risk Factors on 
Arterial Elasticity##1001-173·346A
The Rosuvastatin Impact on Ventricular Remodeling Cytokines 
and Neurohormones (UNIVERSE) Study## 816-6·61A
Cholesterol screening
Calculating LDL and Blood Pressure Goals Per ATP III and 
JNC VII Just Prior to an Ofﬁce Visit Helps Close the Gap 
Between Guidelines and Practice##1036-149·270A
Impact of Triglyceride Lowering on HDL-c: Is There a 
Continuum of HDL-c Increase Beyond Fasting TG < 150 
mg/dl?## 849-5·362A
Lack of Relationship Between Body Mass Index and 
Atherogenic Dyslipidemia in Asian Indians##1026-
189·370A
Cholesterol-lowering drugs
Acute Coronary Syndromes Do Not Lower Lipid Levels##959-
186·323A
Are High-Risk Hypertensive Patients Prescribed Concomitant 
Statin Therapy? Prescription Patterns in Patients Initiating 
Antihypertensive Therapy in the United States##1021-
251·230A
Beneﬁt of Early Statin Therapy During Acute Coronary 
Syndromes: A Meta-Analysis## 821-5·205A
Beneﬁt of Early Statin Therapy During Acute Coronary 
Syndromes: A Meta-Analysis## 821-5·205A
Combination Statin and Fibrate Therapy Improves Lipoprotein 
Subparticle Proﬁles in Diabetic Patients With Mixed 
Dyslipidemia: The DIACOR Study##1014-210·355A
Determinants of Arterial Wall Remodeling During Lipid 
Lowering Therapy. Serial IVUS Observations from the 
REVERSAL Trial.##957-174·320A
Different Effects of Rosuvastatin and Simvastatin on 
Myocardial High-Energy Phosphate Metabolism## 
993-6·143A
Does More Aggressive Statin Therapy Increase Muscle and 
Liver Risk?##981-193·335A
Does the Presence of Hypertension Affect Cardiovascular 
Beneﬁts of Statin Therapy? Results From a Meta-
regression Analysis of 69,984 Patients##1027-193·371A
Early Comprehensive Characterisation of the Vascular 
Response to Statin Treatment Using MRI## 845-7·359A
Effect of Pitavastatin Therapy on the Thoracic Aorta in 
Hypercholesterolemic Patients Evaluated With Integrated 
Backscatter and Wall Thickness by Transesophageal 
Echocardiography## 1017-7·153A
Effect of Statin Therapy on Renal Function in Hypertensive 
African Americans##981-192·335A
Effects of Ezetimibe/Simvastatin Compared to Simvastatin 
Monotherapy in Reducing C-Reactive Protein and Low 
Density Lipoprotein-Cholesterol## 808-5·316A
Effects of High-Dose Atorvastatin on HDL Anti-inﬂammatory/
Pro-inﬂammatory Function and Disease Activity in 
Patients With Rheumatoid Arthritis: Results of the Statin 
Anti-Rheumatic Activity (SARA) Pilot Study## 854-
6·378A
Effects of Torcetrapib and/or Atorvastatin on HDL and LDL 
Particle Size and Composition: Results From a Phase 2 
Trial##981-195·335A
Ezetimibe/Simvastatin Versus Atorvastatin for Attainment of 
Apolipoprotein B and C-Reactive Protein Goals: A VYVA 
Substudy##981-194·335A
Intensive Lipid Lowering With Atorvastatin Is Associated 
With a Signiﬁcant Improvement in Renal Function: The 
Treating to New Targets (TNT) Study## 808-3·316A
Lipid Effects of Torcetrapib With and Without Atorvastatin 
Are Optimized by Morning Dosing: Results From 
Pharmacokinetic/Pharmacodynamic Analyses##1003-
186·349A
Lipid-Lowering Results From the First Large-Scale Trial 
of Statin Therapy in Hispanic-American Patients With 
Hypercholesterolemia: STARSHIP##1003-187·349A
Long-Term Monotherapy with Rosuvastatin Prevents 
Progressive Left Ventricular Dysfunction and Remodeling 
in Dogs with Heart Failure##964-94·58A
Long-Term Safety of Cholesterol Lowering Wth Pravastatin on 
Cancer Incidence in Patients With Coronary Heart Disease 
(CHD): The LIPID Trial Extension##975-251·201A
Marked Risk Reduction in Coronary Heart Disease, Stroke and 
Total Mortality in Women ≥60 Years Old With Low-Dose 
Pravastatin for Primary Prevention in the Management of 
Elevated Cholesterol in the Primary Prevention Group of 
Adult Japanese (MEGA) Study##1014-208·354A
On-treatment Levels of HDL-C and the Ratio of LDL-C/HDL-
C as Predictors of Cardiovascular Events in the Treating 
to New Targets (TNT) Study##914-203·298A
Profound Increase of HDL-c Levels (>50%) With Long-Term 
Niacin Treatment##914-204·298A
Statin Cools Down Temperature of Atherosclerotic Plaque 
in Patient With Coronary Artery Disease: Temperature 
Measurement and Intravasular Ultrasound Study##957-
173·320A
Statins in Acute Coronary Syndrome: A Meta-analysis##995-
224·212A
Statins in the Primary Prevention of Cardiovascular Diseases: 
Meta-analysis of Randomized Controlled Trials##981-
190·334A
Statins, Saphenous Vein Endothelial Function, and C-Reactive 
Protein in Patients With Coronary Artery Disease##907-
249·166A
The Addition of Niacin to Statin Therapy Produces an 
Atheroprotective Shift in Lipoprotein Subclasses and 
Inﬂammatory Markers in Patients With Coronary Artery 
Disease and Well-Controlled LDL-Cholesterol##1026-
185·369A
The Effects of Statin Copayments and Statin Adherence on 
Medical Care Utilization and Expenditures## 834-5·263A
The Impact of Over-the-Counter Simvastatin on the Number of 
Statin Prescriptions in the United Kingdom: A View from 
the General Practice Research Database## 808-7·316A
The Reduction of Inﬂammatory Biomarkers by Statin, Fibrate, 
and Combination Therapy Among Diabetic Patients With 
Mixed Dyslipidemia: The DIACOR Study## 854-5·377A
Triple-Therapy with a Statin, Fibrate and Ezetimibe Safely 
Allows More Diabetic Patients with Mixed Dyslipidemias 
to Reach NCEP Guidelines: An Analysis of The DIACOR 
Study## 808-6·316A
Very Low-Fat Japanese Diet and Daily Exercise Reduce 
Plasma Lipid Levels With Small Dose of Statins 
and is Effective for Regression of Coronary 
Atherosclerosis##1014-209·354A
Withdrawal Effect After 4-Year Statin Therapy on C-
reactive Protein Is Independent of LDL-cholesterol 
Change##1003-185·349A
Clinical trials
A Phase 1/2 Trial of TG100-115, a Phosphatidylinositol-
3 Kinase Inhibitor, in Acute ST-Segment Elevation 
Myocardial Infarction Patients Treated by Percutaneous 
Coronary Intervention Indicates Acceptable Safety and 
Pharmacokinetics at the Initial Dose Level## 857-4·235A
Adverse Cardiovascular Outcomes With Atenolol in Clinical 
Trials in Hypertension: An Updated Meta-Analysis## 
848-7·361A
Aliskiren, an Oral Renin Inhibitor, Provides Dose-Dependent 
Efﬁcacy, and Placebo-Like Tolerability in Patients With 
Hypertension##1027-191·370A
Beneﬁcial Effect of Combined Intramyocardial and 
Intracoronary Administration of Autologous Stem 
Cells on Global and Regional Left Ventricular Function 
and Myocardial Perfusion in Patients With Ischaemic 
Cardiomyopathy##934-173·304A
Bosentan Improves Hemodynamics and Exercise Capacity in 
Eisenmenger Physiology## 840-6·246A
C-reactive Protein Concentrations at Emergency Department 
Presentation Strongly Predict One Year Mortality in 
Dyspneic Patients##986-89·67A
Cardiac Troponin T in Heart Failure: Results from Val-
HeFT##986-58·66A
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Cardiovascular Events in Clinical Trials Involving Over 41,000 
Patients Evaluating the Cyclooxygenase-2 Inhibitor 
Celecoxib##1029-209·374A
Clinical Outcomes by Baseline Left Ventricular Ejection 
Fraction in the African-American Heart Failure Trial## 
837-7·83A
Conivaptan, a Novel Arginine Vasopressin Antagonist, 
Increased Serum Sodium Concentration in Patients 
With Heart Failure and Euvolemic or Hypervolemic 
Hyponatremia## 816-7·62A
Darusentan Antihypertensive Effect in Patients With Resistant 
Hypertension##915-208·299A
Direct Comparison of the Prognostic Value of Brain Natriuretic 
Peptide (BNP) and N-terminal ProBNP in a Large 
Population of Patients With Chronic and Symptomatic 
Heart Failure. The Valsartan In Heart Failure (Val-HeFT) 
Data## 819-3·71A
Effect of Angiotensin Blockade on the Degree of Organic 
Mitral Regurgitation: A Randomized Clinical Trial##962-
25·279A
Effect of Angiotension Receptor Blockade Alone or in 
Combination with Spironolactone on Left Ventricular 
Systolic and Diastolic Function in Chronic Heart 
Failure##942-53·45A
Effects of Aggrenox and Telmisartan Versus Clopidogrel 
and Aspirin in Combination on Platelet Activity in 
Diabetic Patients: An ex vivo Outlook to the PRoFESS 
Trial##1023-167·365A
Efﬁcacy and Tolerance of RSD1235 in the Treatment of 
Atrial Fibrillation or Atrial Flutter: Results of a Phase 
III, Randomized, Placebo-controlled, Multicenter Trial## 
804-3·10A
First Report of the CASES-PMS Study: Patient Demographics 
and 30-Day Major Adverse Events for the Cordis 
PRECISE™ Nitinol Stent and Angioguard™ XP Emboli 
Capture Guidewire Condition of Approval Surveillance 
Study## 802-8·315A
Five-Year Follow-Up of the Medicine, Angioplasty or Surgery 
Study (mass-ii): A Randomized Controlled Clinical Trial 
of 3 Therapeutic Strategies for Multivessel Coronary 
Artery Disease##976-254·202A
Fondaparinux Versus Enoxaparin in Patients With Acute 
Coronary Syndromes Without ST-Segment Elevation: 
Impact of Risk According to the GRACE Score##1018-
223·223A
Gender Difference in the QT Interval and Ventricular 
Tachycardia or Fibrillation in MADIT II## 924-135·8A
High Hemoglobin was Associated With Cardiovascular 
Events, Low Hemoglobin With All-Cause Mortality, and 
Large Fall in Hemoglobin With Both in Patients With 
Hypertension and Left Vetricular Hypertrophy. The LIFE 
Study## 848-5·361A
Insights Into the Change in Brain Natriuretic Peptide After ST-
Elevation Myocardial Infarction: Why Should it Be Better 
Than Baseline Brain Natriuretic Peptide?##973-236·198A
Intensive Multicomponent Smoking Cessation Intervention 
Decreases Mortality in Hospitalized High-Risk Cardiac 
Smokers##1029-212·375A
Is the Non-inferiority Claim for Bivalirudin in Percutaneous 
Coronary Intervention Warranted? REPLACE-2 
Revisited##923-145·251A
Isosorbide Dinitrate-Hydralazine Decreased Blood Pressure 
in Patients with High But Not Low Blood Pressure 
and Improved Survival Independent of Baseline Blood 
Pressure in African American Heart Failure Trial## 
809-3·52A
Lipid Effects of Torcetrapib With and Without Atorvastatin 
Are Optimized by Morning Dosing: Results From 
Pharmacokinetic/Pharmacodynamic Analyses##1003-
186·349A
Lipid-Lowering Results From the First Large-Scale Trial 
of Statin Therapy in Hispanic-American Patients With 
Hypercholesterolemia: STARSHIP##1003-187·349A
Long-Term Safety of Cholesterol Lowering Wth Pravastatin on 
Cancer Incidence in Patients With Coronary Heart Disease 
(CHD): The LIPID Trial Extension##975-251·201A
Microvascular Flow and Myocardial Perfusion After Acute MI 
Angioplasty in Anterior Versus Non-Anterior Infarcts: 
Results From the EMERALD Trial## 843-4·220A
Outcomes by Gender in the African-American Heart Failure 
Trial (A-HeFT)## 837-8·84A
Percutaneous Coronary Intervention in Patients Receiving 
Only a Single Subcutaneous Dose of Enoxaparin: Results 
From the SYNERGY Trial##1020-244·228A
Prospective, Randomized Controlled Trial Comparing 
the Effectiveness and Safety of a Vascular Closure 
Device and a Topically Applied Hemostatic System 
With Manual Compression in Patients Undergoing 
Cardiac Catheterization and Percutaneous Coronary 
Intervention##990-149·261A
Ranolazine Safety and Tolerability During Long Term 
Treatment of Stable Angina##999-253·218A
Rapid and Sustained Reductions of Plasma B-Type 
Natriuretic Peptide Concentrations in Patients with 
Acutely Decompensated Heart Failure Treated with 
Levosimendan: The REVIVE II Study##1032-57·86A
Risk Factors for Ventricular Arrhythmias in Heart Failure 
Patients## 947-131·15A
Statins in Acute Coronary Syndrome: A Meta-analysis##995-
224·212A
The Effectiveness of Blinding of an Active Angiotensin 
Converting Enzyme Inhibitor at a Single Center in the 
Prevention of Events With Angiotensin Converting 
Enzyme Inhibition (PEACE) Trial##938-198·309A
The Fate of Randomized Trials Presented at the American 
College of Cardiology Meeting 1999-2002: What Follows 
the 15 Minute Presentation?##923-147·251A
The Use of Contrast Improves Positive Predictive Value and 
Result Determinability in Routine Dobutamine Stress 
Echocardiography## 827-6·132A
The Veterans Affairs Computerized Patient Record System 
Provides an Identical Assessment of All Cause Mortality 
as Compared to Methods Used in Traditional Clinical 
Trials##1036-146·269A
Thrombocytopenia Is Associated With Adverse Outcomes 
Following Treatment With Either Enoxaparin or 
Unfractionated Heparin in Patients Presenting With Acute 
Coronary Syndromes: A TIMI 11B Substudy##1018-
225·223A
Transplantation of Autologous Endothelial Progenitor Cells is 
Safe, Feasible and Effective for Vascular Regeneration 
in No-Option Patients with Chronic Critical Limb 
Ischemia##934-176·304A
Withdrawal Effect After 4-Year Statin Therapy on C-
reactive Protein Is Independent of LDL-cholesterol 
Change##1003-185·349A
Cocaine
Cocaine-Related Chest Pain-Utility of TIMI Risk Stratiﬁcation 
and Effects of Beta Blockers on Outcome##1029-
205·373A
Collagen
Biochemical Markers of Collagen Turnover in Asymptomatic 
Aortic Regurgitation With Normal EF and LV 
Dimension## 844-5·285A
Biochemical Markers of Collagen Turnover in Atrial 
Fibrillation## 1015-137·34A
Collagen Content of Coronary Plaque Measured by 
Polarization Sensitive Optical Coherence Tomography 
(PS-OCT)## 948-32·121A
Collagen Turnover is Initiated in the Early Phase of Congestive 
Heart Failure##986-55·66A
Diabetic Plaque Inﬂammation and Neovascularization 
Are Associated With Increased Reparative Collagen 
Content: Implication for Plaque Progression in Diabetic 
Atherosclerosis##912-193·295A
Growth Factors Inﬂuence Collagen Metabolism and 
Hypertrophy in Hypertrophic Cardiomyopathy##965-
104·60A
Collateral circulation
Clinical Impact of Collateral Circulation on 30-Day Mortality 
for Acute Myocardial Infarction Complicating Heart 
Failure##951-226·182A
Effect Of Coronary Stenosis On Adjacent Bed Microvascular 
Flow Reserve: Assessment Using Myocardial Contrast 
Echocardiography ## 827-4·132A
Is There an Impaired Coronary Collateral Function in Patients 
With Diabetes Mellitus? Invasive Assessment in Chronic 
Total Coronary Occlusions##978-175·331A
Phosphoinositide 3-kinase γ Modulates Vascular Endothelial 
Growth Factor Release and Collateral Vessel 
Development Following Hindlimb Ischemia##909-
176·291A
Computer communication networks
Virtual Cardiac Symposia: World Wide Internet Based, 
Educational Forums for Cardiologists##1013-149·267A
Computer-assisted instruction
A Virtual Classroom is Superior to Traditional Training in 
Teaching Cardiac Auscultation##1013-148·267A
Closed-loop Automated Drug Delivery to Optimize Systemic 
Arterial Pressure, Cardiac Output, and Left Heart Filling 
Pressure in Discompensated Heart Failure##1012-
148·265A
Pediatric EKG: A Computer Aided Approach Reducing 
Common but Important Errors##1013-147·266A
The Impact of an Electronic Stethoscope as a Patient Simulator 
in Cardiac Auscultation##1013-150·267A
Contractility
Akt Overexpression Improves Cardiac Function and 
Ameliorates Heart Failure in Pressure Overload Animal 
Model Phosporilating Key Ca 2+ Handling Protein##1007-
48·76A
Beneﬁcial Impact of Cardiac-Isolated Recirculating Delivery 
of AAV-SERCA2a Gene Therapy in a Large Animal 
Model of Heart Failure## 820-4·73A
Beta
1
-Adrenergic cAMP Signaling Is Uncoupled After Acute 
Treatment of Anthrax Lethal Toxin in Cardiomyocytes in 
Normal Rats##1032-99·89A
Combined ANG-1 and VEGF Gene Transfer Enhances 
Perfusion and Improves Segmental Systolic Velocity in 
a Swine Chronic Myocardial Ischemic Model## 856-
5·234A
Effect of Growth Hormone on Cardiac Contractility in Patients 
With Growth Hormone Deﬁciency## 925-45·104A
Electrical Stimulation of Sympathetic Nervous System 
Delivered Through the Pulmonary Artery Increases 
Contractility##985-51·65A
Impact of Mesenchymal Stem Cell Therapy on Scar 
Composition and Cardiac Regional Function##903-
220·159A
Impact of the Change of Myocardial Velocity on Exercise-
Induced Functional Mitral Regurgitation in Patients with 
Non-Ischemic Cardiomyopathy## 806-8·113A
Improved LV Relaxation Measured by Tissue Doppler 2 Years 
After Gastric Bypass Surgery##942-91·48A
Molecular Basis in the Development of Alcoholic 





Myocardial Dysfunction and Neurohumoral Activation Without 
Remodeling in the Left Ventricle of Monocrotaline-
Induced Pulmonary Hypertensive Rats##963-49·54A
Upregulation of Functional Cardiac Beta
3
-Adrenergic 
Receptors and Chronic Anthrax Lethal Toxin-Induced 
Progressive Cardiac Depression: Insights Into the 
Underlying Molecular Mechanism##1007-51·76A
Contrast media
Effects of Transcranial Ultrasound and Intravenous 
Microbubbles on Blood Brain Barrier Permeability## 
1016-33·149A
Gadoﬂourine M Enhances Atherosclerotic Plaque Lesions in 
Apolipoprotein E Knockout Mice Through tnteraction 
With Extracellular Matrix Proteins## 993-13·144A
Impact of the Viable Rim and Periprocedural Necrosis on 
Functional Recovery After Revascularization in Patients 
With Chronic Ischemic Heart Disease: A Quantitative 
Delayed Contrast Enhanced MRI Study## 993-7·143A
Quantitative Assessment of Regional Left Ventricular Wall 
Motion From Real-Time 3D Echocardiography: Effects 
of Dual-Triggered Contrast Enhancement Tested Against 
Magnetic Resonance## 1016-46·152A
Time Course of Functional Recovery After Revascularization 
in Patients With Chronic Ischemic Left Ventricular 
Dysfunction: A Contrast Enhanced MRI Study## 833-
8·137A
Who Needs Gadolinium? Three-Dimensional Reconstruction 
Utilizing Steady State Free Precession Cardiac Magnetic 
Resonance in Congenital Heart Disease##989-115·243A
Coronary artery disease
5-Methyl-Tetrahydrofolic Acid Rapidly Improves Endothelial 
Function and Superoxide Production in Human 
Atherosclerosis: Effects on Tetrahydrobiopterin-
Dependent eNOS Coupling## 841-4·356A
64-Slice Computed Tomography Angiography Detects Graft 
and Coronary Artery Stenosis in Patients With Previous 
Coronary Artery Bypass Graft Surgery## 970-1·124A
64-Slice CT Angiography Is a Cost-saving Strategy for 
Patients With Mildly Abnormal Nuclear Stress Tests## 
807-4·113A
A Calculated Glomerular Filtration Rate or a Simple Serum 
Creatinine: Which is the Better Predictor of Mortality in 
Patients with Coronary Artery Disease?##983-203·337A
A Comparison of Quality of Life Scores in Patients With Stable 
Angina Pectoris After Medical Treatment Compared With 
Angioplasty or Coronary Bypass Surgery: 48-Months 
of Follow-Up Outcomes of a Randomized Clinical Trial 
(MASS I I)##990-151·262A
A Comprehensive Approach to the Development of Risk 
Adjustment Models for Fatal and Non Fatal Outcomes 
Following Contemporary PCI: A Report From the 
Blue Cross Blue Shield of Michigan Cardiovascular 
Consortium##923-150·252A
A Coronary Artery Calciﬁcation Score ≥ 400 Is Signiﬁcantly 
Associated With Myocardial Ischemia Independently of 
Framingham Risk Score##983-206·338A
A Novel Method for Enumerating Circulating Endothelial 
Progenitor Cells Based on ALDH Activity##933-
165·302A
A Study of Platelet Function Following Selective and 






Achieving Rapid Myocardial Infarction Reperfusion 
With Percutaneous Coronary Intervention Remains a 
Challenge, Especially in Women, Elderly, and Minorities: 
Results From American Heart Association Get With the 
Guidelines## 815-8·193A
Adenosine Stress Myocardial Contrast Perfusion Imaging: 
Comparison With Radionuclide SPECT## 1016-44·151A
Adenosine Triphosphate Stress Strain Measurements Before 
and After Percutaneous Coronary Interventions## 948-
14·119A
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After Adjustment for Confounding Variables, Treatment With 
Statin Therapy at Baseline but Not Low LDL-cholesterol 
Levels Results in Better Two-Year Outcome in Patients 
With Established Angiographic Coronary Disease##1026-
186·369A
Angiographic Severity of Coronary Artery Disease Is Not 
Related to the Duration of Type-2 Diabetes##905-
233·162A
Antinanobacterial Antibody Titer Is an Independent Risk 
Factor for Coronary Artery Calciﬁcation##1000-167·345A
Aortic Pulse Wave Velocity Is Associated With Presence and 
Quantity of Coronary Artery Calcium: A Community-
Based Study## 801-5·313A
Apo A1-LDL Complex in Coronary Artery Disease - Oxidized 
Lipoprotein and Inﬂammation##930-248·176A
Association Between Toll-Like Receptors on Circulating 
Monocytes and the Presence and Extent of Coronary 
Artery Disease in Patients With Stable Angina: 
Comparison With High-Sensitivity C-Reactive 
Protein##930-243·175A
Association of TIMI Risk Score and Extent of Coronary 
Artery Disease in Patients With ST-Elevation Myocardial 
Infarction: A CLARITY TIMI-28 Substudy##1018-
221·222A
Association of Variant Alleles of Paraoxonase and Endothelial 
Nitric Oxide Synthase Genes With Early Onset of First 
Myocardial Infarction##1021-253·230A
Atheromatous Coronary Plaque Has Lower Distensibility Than 
Fibrous Plaque: Comparison of Intravascular Ultrasound 
Imaging and Histo-Pathological Analysis##1024-
176·367A
Bayesian Application of Highly Sensitive C Reactive Protein 
Discriminates Risk of Death or Myocardial Infarction 
Among Simple Clinical Subroups of Patients Following 
Cardiac Catheterisation##983-212·339A
Bedside Tool to Predict Risk of Postoperative Dialysis: 
Results in 358,296 Patients Undergoing Coronary Bypass 
Surgery##940-20·274A
Better Coronary Flow in Culprit Lesions With Deep 
Echo Attenuation Treated by Directional Coronary 
Atherectomy##995-225·212A
Blood Type and the Age of the Red Cells Transfused 
Affects Mortality After Percutaneous Coronary 
Intervention##997-245·216A
C-Reactive Protein and Plaque Composition in Patients with 
Stable Angina Pectoris (An Intravascular Ultrasound-
Virtual Histology Study)##1000-171·346A
CABG and PCI Rates Differ Between Genders Even With 
Similar Coronary Anatomy: A Computer Based Patient 
Simulation Explores the Gender Gap##1013-145·266A
Can An Assessment of Subjective Well Being Predict 
Outcomes in Patients with Hypertension and Coronary 
Artery Disease? A Report from the INternational 
VErapamil-SR/Trandolapril Study (INVEST)##915-
212·300A
Can Stress Echocardiography With Tissue Characterization 
Evaluate Non-Critical Coronary Stenosis? A Validation 
Study Against Simultaneous Measurement of Fractional 
Flow Reserve## 925-39·102A
Can the Body Fat Composition Measurements Using Dual-
Energey X-ray Absorptiometry Predict Coronary Artery 
Disease in Both Sexes?##961-206·327A
Cardiovascular Magnetic Resonance Identiﬁcation of Adverse 
Cardiovascular Prognosis in Women Versus Men With 
Known or Suspected Ischemic Heart Disease## 833-
3·136A
Chronic Total Occlusion of Coroanry Artery Intervention 
Using the Novel Multidirectional Double Lumen 
Catheter##1022-219·232A
Chronotropic Incompetence in Patients on Beta Blocker 
Referred for Stress Echocardiography: Superiority of 
Heart Rate Reserve Over 85% Maximum Predicted Heart 
Rate## 828-6·133A
Circulating Levels of Osteopontin Predicts Future Cardiac 
Events in Patients With Chronic Stable Angina## 801-
3·313A
Clinical Feasibility of Quantitative Color-mapping of Shear 
Stress for Predicting Coronary Plaque Rupture Site With 
Use of Three-Dimensional Intravascular Ultrasound 
Imaging##951-225·182A
Clinical Implication in Metabolic Syndrome and Ankle-
brachial Pressure Index as the Predictor of Cardiovascular 
Disease##983-211·339A
Clinical Outcomes of Patients Undergoing Percutaneous 
Coronary Intervention on Weekends as Compared With 
Weekdays##946-149·254A
Clinical Outcomes With AZD6140, an Oral Reversible ADP 
Receptor Antagonist, Compared With Clopidogrel in 
Patients With Acute Coronary Syndromes (ACS)##974-
242·199A
Clinical Value of Hybrid PET/CT Cardiac Imaging: 
Complementary Roles of Multi-Detector CT Coronary 
Angiography and Stress PET Perfusion Imaging## 812-
5·115A
Comorbidities in Severe Aortic Valve Stenosis: Do Renal 
Dysfunction, Anemia or Diabetes Mellitus Predict Long-
Term Outcome?##1030-24·287A
Comparative Evaluation of Postangioplasty Systemic 
Inﬂammatory and Oxidative Stress Response of 
Sirolimus-eluting and Bare Metal Stents## 850-4·221A
Comparative Pathologic Studies of Vascular Tissue Responses 
to Sirolimus-Eluting and Bare Metal Stent Implantation in 
Human Coronary Arteries##910-184·293A
Comparison between Culprit and Nonculprit Lesions in 
Patients with Multiple Plaque Ruptures and Acute 
Coronary Syndrome##951-231·183A
Comparison of Atherosclerotic Plaque Characteristics by IVUS 
and Multislice CT## 970-42·131A
Comparison of Computed Tomography Coronary Angiography 
with Conventional Coronary Angiography for the 
Detection of Signiﬁcant Coronary Lesions in the Pre-
Operative Valve Surgery Patient## 970-8·126A
Comparison of Continuous Infusion Versus Bolus Injection 
of Intravenous Microbubbles in Detecting Myocardial 
Perfusion Defects During Dobutamine Stress 
Echocardiography## 1016-38·150A
Comparison of Myocardial Contrast Echocardiography 
Versus Sestamibi Myocardial Perfusion Imaging in Early 
Diagnosis of Acute Coronary Syndrome## 827-5·132A
Comparison of Predictive Value Between 16-Slice And 64-
Slice Multidetector Computed Tomography to Detect 
Signiﬁcant Obstructive Coronary Artery Disease## 970-
38·130A
Complex Plaques and Coronary Plaque Progression in Patients 
With Acute Myocardial Infarction##977-163·329A
Contrast Stress Echocardiography for Improved Accuracy in 
Evaluation of Myocardial Ischemia in Women## 948-
33·121A
Contributions of Endogenous Androgens Versus Age and Waist 
Circumference to Coronary Plaque and Remodeling in 
Women: A Report From the NHLBI-Sponsored Women’s 
Ischemia Syndrome Evaluation (WISE) Study##957-
178·321A
Coronary Angiography Is a Strong Predictor of Cardiovascular 
Events in Patients With End-Stage Renal Disease##905-
237·163A
Coronary Imaging With Multi-detector Computed 
Tomography: A Meta-analysis## 970-12·126A
Coronary Remodeling Is the Main Contributor to Lumen 
Narrowing in Diabetic Patients##978-174·331A
Correlation Between 16-Slice Multidectector Computed 
Tomography and Intravscular Ultrasound in Patients 
With Ambiguous Left Main Coronary Artery Stenosis## 
970-34·129A
Cost Beneﬁt Analysis of Treatment of Symptomatic 
Multivessel Coronary Disease With Preserved 
Left Ventricular Function. The Five-Year MASS II 
Report##999-254·218A
Diabetes and Coronary Artery Disease Impose Similar 
Cardiovascular Morbidity and Mortality to Patients With 
End-Stage Renal Disease: A Seven-Year Follow-Up 
Study##905-234·162A
Diagnostic Accuracy of Multislice CT Coronary Angiography 
in Patients Presenting With Non Diagnostic Chest Pain## 
970-14·127A
Diagnostic Performance of Combined Rubidium-82 Cardiac 
Positron Emission Tomography and X-Ray Computed 
Tomography (PET-CT) in the Detection of Coronary 
Artery Disease## 926-2·105A
Differences in Improvement in Reliability of Care by Patient 
Age, Race, and Gender in Get With the Guidelines 
Coronary Artery Disease##946-148·254A
Do CT-low-dense Coronary Artery Plaques Represent Plaque 
Vulnerability? Study by Intravascular Ultrasound and 
Coronary Angioscopy## 970-2·125A
Do Omega-3 Fatty Acids/Fish Oil Reduce Mortality in Patient 
without Coronary Artery Disease?##914-206·298A
Does Real Time Three-Dimensional Dobutamine Stress 
Echocardiography Is the Method of Choice in Patients 
Qualiﬁcation Towards Severe Ischemic Mitral 
Regurgitation to Cardiosurgical Treatment?## 991-
43·140A
Does Revascularization of Chronic Total Occlusion(CTO) 
Contribute to Improve the Long-Term Prognosis?##976-
252·202A
Does the Presence of a Depressive State Contribute to 
Endothelial Dysfunction in Patients With Coronary Artery 
Disease?##1000-161·344A
Down-regulation of ζ-chain in CD4+ T-cells and in Natural 
Killer Cells in Patients With Acute Coronary Syndrome 
(ACS)##977-159·328A
Drug-Eluting Stent Supported Percutaneous Coronary 
Intervention for Unprotected Left Main Disease##928-
224·171A
Dual-frequency Intravascular Ultrasound Imaging: A Novel 
Approach to Plaque Vulnerability## 948-30·120A
Early and Subtle Neointimal Growth Detection Following 
Stent Implantation Using Optical Coherence Tomography 
and Intravascular Ultrasound and Histology##910-
181·293A
Early Results of a Nurse-Based Outpatient Telemedicine 
Project for Patients After Acute Coronary 
Syndrome##1036-151·270A
Effect of Amlodipine and Enalapril on Cardiovascular Events 
in Normotensive Coronary Artery Disease Patients with 
Concomitant Statin Use in the CAMELOT Trial##938-
202·310A
Effect of Amlodipine and Enalapril on Cardiovascular Events 
in Patients With Insulin Resistance and Diabetes in the 
CAMELOT Trial##938-199·309A
Effect of Post Fat Loading Remnant Like Particles-Cholesterol 
on Prognosis in Patients With Coronary Artery 
Disease##1014-214·355A
Effects of Insulin Dependence in Patients With Type 2 Diabetes 
Mellitus and Advanced Atherosclerosis, on Inﬂammatory 
Process, Thrombotic Mechanisms and Endothelial 
Function##961-202·326A
Effects of Optimal Versus High Normal Blood Pressure on 
Progression of Coronary Atherosclerosis: Insight From the 
CAMELOT Study## 835-7·343A
Effects of Perindopril on Long-Term Clinical Outcome 
of Patients With Coronary Artery Disease and Left 
Ventricular Function##999-257·219A
Evaluation of Cardiac Arrest During Severe Chronic 
Obstructive Pulmonary Disease (COPD) 
Exacerbations##931-252·177A
Evaluation of Neointimal Hyperplasia by Optical Coherence 
Tomography at Six-Month After Sirolimus-Eluting Stent 
Deployment##956-162·318A
Feasibility of Transthoracic Doppler-determined Coronary 
Flow Reserve for the Assessment of Left Main Trunk 
Stenosis## 902-14·97A
First Human Experience with Intracoronary Red Light 
Irradiation for the Treatment of High Risk Non-Culprit 
Atheromatic Plaques##952-233·184A
Five-Year Follow-Up of the Medicine, Angioplasty or Surgery 
Study (mass-ii): A Randomized Controlled Clinical Trial 
of 3 Therapeutic Strategies for Multivessel Coronary 
Artery Disease##976-254·202A
Gene Sequence Variations of the CD14 Receptor Inﬂuences C-
Reactive Protein Levels in Patients With Stable Coronary 
Artery Disease##930-249·176A
Geometric Determinants of Chronic Ischemic Mitral 
Regurgitation in Patients With Inferior Myocardial 
Infarction: Three-Dimensional Magnetic Resonance 
Imaging Study##962-22·278A
GRACE 6-Month Post-discharge Prediction Model (GRACE 
Score) Predicts 4-Year Mortality in Survivors With Acute-
Coronary Syndromes##974-243·200A
HMG-CoA Reductase Inhibitors Are Effective for Prevention 
of Acute Coronary Artery Injury in a Rabbit Model of 
Kawasaki disease##1011-110·244A
Identiﬁcation of Plaque Composition in Multislice Computed 
Tomography## 970-35·129A
Identiﬁcation of Plaque Types and Distribution Patterns 
by Multi-detector Computed Tomography Enhances 
Prediction of Clinically Signiﬁcant Coronary Artery 
Disease## 970-30·128A
Impact of Novel Critical Care Pathway for Management of 
Acute Coronary Syndrome Leads to Markedly Improved 
Compliance With Guidelines and Decreased Angina 
Symptoms at 12-Month Follow-Up## 847-5·268A
Impact of Renal Insufﬁciency on the Long-Term Outcomes 
Following Percutaneous Coronary Intervention With 
Sirolimus-Eluting Stents##954-251·188A
Impact of Triglyceride Lowering on HDL-c: Is There a 
Continuum of HDL-c Increase Beyond Fasting TG < 150 
mg/dl?## 849-5·362A
Implications of Passive Cigarette Smoking on the Severity and 
Prognosis of Patients With Acute Coronary Syndromes: 
The Greek Study of ACS (The GREECS)##928-222·171A
Improved Prescription of Evidence-Based Medications and 
Maintenance of High Adherence to These Medications in 
Acute Coronary Syndrome Patients After Implementation 
of Guidelines Applied in Practice##946-146·254A
Increased Pulse Pressure is Strongly Associated with Adverse 
Cardiovascular Outcomes in both Diabetics and Non 
Diabetics: The International Verapamil SR-Trandolapril 
Study (INVEST)## 835-6·343A
Incremental Diagnostic Value of High-Frequency QRS 
Analysis for Identifying Stress-Induced Ischemia## 
828-3·132A
Incremental Prognostic Value of Transient Ischemic Left 
Ventricular Cavity Dilatation on Stress Echocardiography 
Over Historical, Clinical, Resting and Stress 
Echocardiographic Variables## 948-43·123A
Index of Microcirculatory Resistance: A Novel Measure for 
Predicting Myocardial Damage in Patients with Acute 
Myocardial Infarction##951-224·182A
Inﬂuence of Hemodialysis on the Blood Flow of AV Shunt 
and Contralateral Sides of Internal Thoracic Artery## 
902-42·101A
Inﬂuence of Mitral Valve Morphology and Functional 
Disorder on the Repair of Functional Ischemic Mitral 
Insufﬁciency##917-22·272A
Inﬂuence of Number of Vessels Disease in Prognosis and 
Therapeutic Results in Chronic Coronary Artery Disease 
After Medical, Bypass Surgery or Angioplasty: 3-Years 
Follow-Up of the Mass I I Study##955-256·189A
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Inhalation of Combustion-derived Air Pollution Impairs 
Endogenous Fibrinolysis in Patients With Ischemic Heart 
Disease##908-160·288A
Integrated SPECT/CT for the Assessment of Hemodinamically 
Signiﬁcant Coronary Artery Lesions## 812-6·115A
Intraperitoneal Administration of Anti-Angio-Associated 
Migratory Cell Protein-Antibody Inhibits Neointima 
Formation After Vascular Injury in Apolipoprotein E 
Knockout Mice##933-172·303A
Isolated Elevation in Troponin-T Following Percutaneous 
Coronary Intervention Is Associated With Higher Long-
Term Mortality## 850-5·221A
Isolated Potentials During Sinus Rhythm and Pace-Mapping 
Within Scars as Guides for Ablation of Post-Infarction 
Ventricular Tachycardia## 924-136·8A
Lack of Correlation Between Coronary Artery Calcium and 
Myocardial Perfusion Imaging## 926-12·107A
LDL Control in Patients Undergoing Peripheral Arterial 
Revascularization Procedures Compared to Coronary 
Arterial Revascularization Procedures##968-151·259A
Left Coronary Artery Flow Reserve Measured 
Transthoracically Improves the Diagnostic Value of 
Routine Dipirydamole-Atropine Stress Echocardiogram## 
948-41·123A
Less Revascularization in Diabetic Patients With Silent 
Myocardial Ischemia Results Poor Survival Compared 
to Diabetic Patients With Symptomatic Coronary Artery 
Disease##905-236·163A
Limitation of Angiography to Identify the Culprit Lesion 
in Acute Myocardial Infarction With Total Occlusion: 
Utility of Thermal Wire to Identify Culprit Lesion by 
Intravascular Ultrasound##951-228·183A
Lipoprotein-Associated Phospholipase A2 (LpPLA2) Measured 
30 Days Post-Acute Coronary Syndrome Independently 
Predicts Risk of Long-Term Cardiovascular Outcomes: A 
PROVE-IT TIMI-22 Substudy## 830-7·208A
Local Stress Concentration Around Calciﬁed Apoptotic 
Macrophages in the Fibrous Cap: A New Hypothesis 
for the Rupture of Coronary Thin-cap Atheroma 
Lesions##977-162·328A
Long-Term Result of Metabolic Syndrome with Patients 
Undergoing Coronary Artery Bypass Grafting##939-
207·311A
Long-Term Safety of Intramyocardial Injection of Autologous 
Bone Marrow Cells for Severe Ischemic Heart 
Disease##907-246·165A
Lower Plasma High-Density Lipoprotein Remains an 
Important Independent Predictor of Death or Non-Fatal 
Myocardial Infarction Among Statin Treated Patients 
Following Cardiac Catheterisation##1003-188·350A
Manganese Superoxide Dismutase Polymorphism Affects the 
Oxidized LDL-Induced Apoptosis of Macrophages and 
Coronary Artery Disease## 822-6·340A
Micro-Computed Tomographic Scanning of Stented Coronary 
Arteries Is Feasible, and Image Analysis Reliably 
Quantiﬁes the Coronary Vasa Vasorum Density##956-
172·320A
Mitral Annular Calciﬁcation Predicts Mortality and Coronary 
Artery Disease in Patients With End Stage Renal 
Disease## 902-39·100A
Monitoring Platelet Inhibition After Clopidogrel With 
VerifyNow-P2Y12® Rapid Analyzer: The VERIfy 
Thrombosis risk ASsessment (VERITAS) Study##908-
165·289A
Multislice Computed Tomography in Detection of Coronary 
Artery Disease in Heart Transplant Patients## 970-7·126A
Myocardial Infarction Presenting With Atypical Symptoms: 
Does the Absence of Chest Pain Predict Poor 
Outcomes?## 830-8·208A
Natural History of Patients With Refractory Angina##1021-
255·231A
Noninvasive Coronary Angiography Performed With 4-Slice, 
12-Slice, 16-Slice and 64-Slice CT: Comparison of 
Diagnostic Accuracy## 970-39·130A
Noninvasive Detection of Coronary Artery Disease in Patients 
With Left Bundle Branch Block Using 64-Slice Computed 
Tomography## 832-8·136A
Novel Intra-Operative Fluorescence Imaging System for On-
Site Assessment of Off-Pump Coronary Artery Bypass 
Graft##932-256·178A
Osteoprotegerin as a Novel Biomarker of Atherosclerosis: 
Independent Association With Coronary Artery Calcium 
in the Dallas Heart Study## 801-4·313A
Outcome of Medical Management of Patients With Severe 
Multi Vesssel Coronary Artery Disease Unsuitable for 
Revascularization##999-258·219A
Overall Myocardial Perfusion Changes by Positron Emission 
Tomography Throughout the Entire Coronary Vascular 
Tree but Not Changes Limited to the Region With the 
Most Severe Baseline Defect Predict Coronary Events## 
926-15·108A
Patients With Coronary Artery Disease that Suffer Sudden 
Cardiac Death Have Exaggerated Prolongation of 
Ventricular Repolarization: A Three-Year Community-
Wide Study## 924-126·6A
Percent Plaque Area at the Edge of Sirolimus-Eluting 
Stent Predicts Restenosis in Small Vessel Coronary 
Arteries##956-163·318A
Percutaneous Coronary Intervention Increases Endothelial 
Progenitor Cell Mobilisation in Patients With Ischemic 
Heart Disease##910-179·292A
Physical Functioning at Baseline Is a Strong Independent 
Predictor of Long-Term Mortality After Myocardial 
Infarction##916-257·168A
Pioglitazone Is Superior to Metformin or Glibenclamide in 
Recducing Markers of Cardiovascular Risk in Patients 
With Type-2-diabetes Mellitus##905-238·163A
Plaque Characterization by Intravascular Ultrasound Virtual 
Histology Analysis in Diabetic Patients##1019-239·226A
Platelet Aspirin Resistance in an ED Population With 
Suspected Acute Coronary Syndromes##995-227·212A
Polymer Based Paclitaxel-eluting Stents Are Superior to 
Non-polymer Based Paclitaxel-eluting Stents in the 
Treatment of De-novo Coronary Lesions: An Intravascular 
Ultrasound Study##956-165·318A
Prediction for Stent Underexpansion by Pre-procedural 
Multidetector Computed Tomography## 832-3·135A
Predictors of Target Lesion Revascularization and Target 
Vessel Revascularization After Implantation of Sirolimus- 
Eluting Stent: Pooled Analysis From 6 Randomized Trials 
and Registries##954-248·187A
Pregnancy Complications as Risk Factors for Cardiac-and All-
Cause Mortality##968-153·259A
Pregnancy Complications as Risk Factors for Coronary Artery 
Disease##1029-214·375A
Preprocedual Statin Administration Can Reduce Thrombosis 
Reaction in Both Acute Myocardial Infarction and Stable 
Angina - Histologic Evaluation## 855-4·379A
Prevalence of Metabolic Syndrome in Patients < 45 Years Old 
With Acute Coronary Syndrome Presenting for Emergent 
Primary Percutaneous Intervention##997-244·216A
Prevalence of Obstructive Lesions Detected by CT Coronary 
Angiography in Patients with Absent to Minimal 
Coronary Artery Calciﬁcation##1021-252·230A
Primary Thrombosuction With Export Aspiration Catheter 
During Percutaneous Coronary Intervention in Acute 
Coronary Syndrome: Acute Results and In-Hospital 
Outcomes##998-248·217A
Prognostic Value of Regional Left Ventricular Functional 
Assessment From Stress Tc-99m Sestamibi Gated 
SPECT## 926-34·110A
Prognostic Value of Regional Left Ventricular Functional 
Assessment in Patients Undergoing Exercise or 
Pharmacologic Gated SPECT## 926-29·109A
Progression of Coronary Artery Stenosis during 6 Months Was 
Associated With the Number of Yellow Plaques Detected 
by Baseline Angioscopy##930-244·175A
Prolongation of Time to Peak Strain During Adenosine 
Triphosphate Stress Is a Marker of Impaired Coronary 
Flow Velocity Reserve## 948-7·117A
QRS Duration and Microvolt T Wave Alternans Testing in 
Patients With Ischemic Cardiomyopathy## 924-123·5A
Randomized Comparison of Sirolimus Versus Bare Metal Stent 
Implantation in Bifurcation Lesions##1022-217·232A
Randomized Comparison of Triple Versus Dual Antiplatelet 
Therapy After Drug Eluting Stent Implantation## 843-
7·220A
Reappraisal of Conventional Coronary Heart Disease Risk 
Factors using Novel Statistical Approaches: A Critical Re-
analysis of Framingham Data##916-255·167A
Reduced Septal Wall Thickness not Hypoperfusion is 
the Cause of Perfusion Defects on Single Photon 
Emission Computed Tomography in Patients With 
Left Bundle Branch Block Without Coronary Artery 
Disease: Comparison With Myocardial Contrast 
Echocardiography## 827-3·131A
Regression of Coronary Atherosclerotic Plaques Induced by 
Pioglitazone in Patients With Type 2 Diabetes Mellitus or 
Impaired Glucose Tolerance: Results From a Randomized 
Prospective Study Using Intravascular Ultrasound##914-
207·298A
Relationship Between Late Loss, Diameter Stenosis and Target 
Lesion Revascularization After Stent Implantation: An 
Examination of Surrogate Endpoints From a Pooled 
Analysis of Eight Large Randomized DES Trials##954-
250·188A
Renal Function Predicts Presence and Severity of Abnormal 
SPECT Myocardial Perfusion Imaging (MPI)##905-
239·163A
Rescue Angioplasty versus Conservative Management for 
Failed Thrombolysis in Acute Myocardial Infarction: A 
Meta-Analysis##929-235·173A
Rescue Angioplasty Versus Conservative Treatment in 
Patients with Failed Fibrinolysis- No Late Survival 
Beneﬁt. The Final Analysis of the Middlesbrough 
Early Revascularisation to Limit Infarction (MERLIN) 
Randomised Trial##929-232·173A
Risk Assessment and Risk Reduction by Perindopril in Patients 
With Normal Left Ventricular Function or Previous 
Revascularization in the EUROPA study##1014-211·355A
Risk Assessment and Stratiﬁcation for Future Cardiac Events 
in Patients Admitted With Acute Coronary Syndrome 
Using a Novel Critical Pathway and Its Validation by 
Framingham Risk Score##916-253·167A
Risk Factors for Coronary Artery Involvement in Children 
After Kawasaki Disease## 840-9·247A
Risk Score for Prediction of Major Bleeding After 
Percutaneous Coronary Intervention##1021-257·231A
Self-reported Medication Adherence Predicts Cardiovascular 
Outcomes in Patients With Stable Coronary Disease: The 
Heart and Soul Study## 836-4·209A
Signiﬁcance of Calciﬁed and Non Calciﬁed Plaques of 
Coronary Arteries for Presence of Myocardial Infarction 
Evaluated by Multislice Computed Tomography## 970-
43·131A
Signiﬁcance of Lipid-content in Determining the Pattern 
of Coronary Arterial Remodeling: An Intravascular 
Ultrasound Study With Tissue Characterization by use of 
Wavelet Analysis##1024-177·367A
Skin Autoﬂuorescence Is Increased in Patients With Stable 
Coronary Artery Disease and Is Positively Associated 
With Serum Levels of Soluble Receptor for Advanced 
Glycation Endproducts## 850-3·221A
Statin Cools Down Temperature of Atherosclerotic Plaque 
in Patient With Coronary Artery Disease: Temperature 
Measurement and Intravasular Ultrasound Study##957-
173·320A
Statins in Acute Coronary Syndrome: A Meta-analysis##995-
224·212A
Statins in the Primary Prevention of Cardiovascular Diseases: 
Meta-analysis of Randomized Controlled Trials##981-
190·334A
Statins, Saphenous Vein Endothelial Function, and C-Reactive 
Protein in Patients With Coronary Artery Disease##907-
249·166A
Stem Cell Therapy Increases Myocardial Perfusion in Patients 
Undergoing Incomplete Coronary Artery Bypass 
Surgery##907-248·166A
Stress Echocardiography is More Cost-effective Than Stress 
Electrocardiography for Risk Stratiﬁcation of Troponin 
Negative Acute Chest Pain Patients: A Prospective 
Randomised Controlled Trial## 806-4·112A
Subendocardial LV Strain Measurements During ATP 
Infusion## 846-5·148A
Sudden Cardiac Arrest with Normal Ejection Fraction: How 
Often Is Coronary Ischemia the Trigger?## 924-130·7A
Sudden Cardiac Death Risk Prediction is Enhanced When 
Clinical Characteristics and Left Ventricular Ejection 
Fraction Are Evaluated Together Rather Than Relying on 
Left Ventricular Ejection Fraction Alone##983-209·339A
Suppression of Osteoprotegerin as a Potential Mechanism of 
Healing After Coronary Intervention##1000-172·346A
Survival in Ischemic Cardiomyopathy: Medical Therapy is 
Superior to Revascularization in Patients With Limited 
Viability##1008-95·79A
Symptomatic Obese Patients Undergoing 64-Slice Multi 
Detector Computed Tomography Are Younger and Have 
Lower Prevalence of Signiﬁcant Coronary Stenosis## 
970-9·126A
T Cell Receptor Signaling and Synapse Formation in T Cells 
From Patients With Acute Coronary Syndrome##977-
160·328A
Tako-tsubo -like Apical Ballooning Shape: What it Depends 
on?##1009-101·81A
The Applicability of the Asian Modiﬁed Criteria of the 
Metabolic Syndrome in the Asian Population##939-
205·311A
The Efﬁcacy and Safety of Fondaparinux Versus Enoxaparin 
in Non-ST Elevation ACS: Impact of Renal Dysfunction 
(OASIS 5)##972-222·195A
The Impact of the Deep Echo Attenuation on Coronary Flow 
After Percutaneous Coronary Intervention## 843-3·219A
The Long-Term Outcomes of Patients With Severe Left 
Ventricular Dysfunction Following Coronary Artery 
Bypass Graft (CABG) Surgery##940-27·276A
The Metabolic Syndrome but Not Estimated Insulin Resistance 
Is Associated With Higher-Risk of Adverse Clinical 
Outcomes Among Medically Managed Patients Following 
Cardiac Catheterisation##939-206·311A
The OPTIMIZE Trial: A Randomized Cross-Over Trial of 
Dobutamine Echocardiography, With and Without 
Deﬁnity™ Evaluating the Effect of Contrast on the Accuracy 
of Diagnosing Coronary Artery Disease## 806-6·112A
The Safety and Outcome of the Multiple, Very Long Sirolimus-
Eluting Stent Implantation in the the Real World Clinical 
Practice##976-260·203A
Three Optimally Placed Electrodes Versus 12-Lead ECG for 
Detecting Myocardial Occlusion Ischemia by Bayesian 
Classiﬁcation## 813-6·13A
Transient ST-Segment Depression Only During Paroxysms of 
Atrial Fibrillation in Patients Without History of Coronary 
Artery Disease. What Non-invasive Test to Unmask 
Severe Underlying Coronary Artery Disease?## 1016-
40·150A
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Transmyocardial Laser Revascularization Combined With 
Stem Cell Therapy Increases Myocardial Perfusion 
and Functional Capacity in Patients With Refractory 
Angina##907-250·166A
Unprotected Left Main Bifurcation Lesion: Impact of Drug-
Eluting Stents (Cypher)##952-239·185A
Use of Beta-Blockers and Progression of Coronary 
Atherosclerosis: An Intravascular Ultrasound Analysis 
from the CAMELOT Study##957-175·320A
Use of Percutaneous Coronary Intervention Versus Coronary 
Artery Bypass Surgery for Patients With Acute Coronary 
Syndromes and Multivessel Coronary Disease in the 
Drug-Eluting Stent Era: Data From the CRUSADE 
Quality Improvement Initiative## 821-6·205A
Usefulness of 64-slice Multi Detector Computed Tomography 
to Improve Diagnostic Yield in Patients With Chest Pain 
and Negative or Equivocal Exercise Treadmill Tests## 
807-6·114A
Wall Motion Score by Stress Echocardiography Is Superior to 
Angiographic Jeopardy Score for Risk Stratiﬁcation and 
Prognosis## 948-46·124A
Which Patients Develop New Lesions Post Percutaneous 
Coronary Intervention? The Impact of Initial Clinical 
Syndrome and the Smokers ‘Paradox’##910-180·292A
Which Patients With Previous Bypass Surgery Beneﬁt Most 
From Repeat Revascularization?##976-256·203A
Yellow Color Plaques Were Still Observed Among the 
Sirolimus Eluting Stent Struts at 3 and 6-Month Follow-
Up Via Coronary Angioscope##910-183·293A
Coronary circulation
Arachidonic Acid and Docosahexaenoic Acid Supplementation 
Increases Coronary Flow Velocity Reserve in Healthy 
Japanese Elderly Individuals##1024-175·367A
Dobutamine Stress Echocardiographic Assessment of Left 
Ventricular Function Long After Intervention for 
Coronary Artery Fistula##989-116·243A
Effect Of Coronary Stenosis On Adjacent Bed Microvascular 
Flow Reserve: Assessment Using Myocardial Contrast 
Echocardiography ## 827-4·132A
Is There an Impaired Coronary Collateral Function in Patients 
With Diabetes Mellitus? Invasive Assessment in Chronic 
Total Coronary Occlusions##978-175·331A
Left Coronary Artery Flow Reserve Measured 
Transthoracically Improves the Diagnostic Value of 
Routine Dipirydamole-Atropine Stress Echocardiogram## 
948-41·123A
Noninvasive Assessment of Coronary Vasodilating Capacity 
Using Freehand 3D Echocardiography With Rotational 
Scanning## 991-40·140A
Oxidative Stress Within the Coronary Circulation Is 
Associated With Reduction in Endothelium-Dependent 
Coronary Vasodilation in Patients With Acute Coronary 
Syndromes.##972-225·196A
Rapamycin Therapy Improves Coronary Physiology After 
Cardiac Transplantation##944-105·51A
Regional Myocardial Perfusion Reserve Determined by 
Quantitative Analysis of Myocardial Perfusion MRI 
Showed a Good Correlation With Coronary Flow Velocity 
Reserve by Doppler Flow Wire## 993-14·144A
Reversible Impairment of Coronary Blood Flow and 




 type IIA Levels Are Increased in 
the Coronary Circulation of Patients With Acute Coronary 
Syndromes##1019-232·225A
Coronary heart disease
Anemia Predicts Long-Term Mortality and Cardiovascular 
Events in Japanese Patients Undergoing Elective 
Revascularization: From the Coronary Revascularization 
Demonstrating Outcome Study in Kyoto (CREDO-
kyoto)##954-247·187A
Cardiovascular Events in Clinical Trials Involving Over 41,000 
Patients Evaluating the Cyclooxygenase-2 Inhibitor 
Celecoxib##1029-209·374A
Clinical Signiﬁcance of Large and Small Low-Density 
Lipoprotein-Cholesterol Concentrations in Patients 
With Various Types of Coronary Heart Diseases##1014-
212·355A
Colour-coded Tissue Tracking Is an Accurate, Fast, and Simple 
Tool for Identiﬁcation of Non-ischemic Patients in the 
Hand of Inexperienced Stress Echocardiography Reader## 
948-44·124A
Coronary Disease Prevalence on Stress Imaging in Patients 
With NCEP Deﬁned Metabolic Syndrome versus 
Traditional Risk Factors##961-200·326A
Effect of CT Beathing Protocol on Attenuation Corrected 
SPECT Distribution in Normal Myocardium## 926-
16·108A
Effect of Non-critical Coronary Stenosis, Adenosine, and 
Dobutamine on Phasic Changes in Myocardial Blood 
Volume## 1016-43·151A
Effects of Ezetimibe/Simvastatin Compared to Simvastatin 
Monotherapy in Reducing C-Reactive Protein and Low 
Density Lipoprotein-Cholesterol## 808-5·316A
Even Mild Reductions in Baseline Hemoglobin Concentration 
Increase the Risk of Death Among Cardiovascular 
Patients With Normal Ejection Fraction and no History of 
Myocardial Infarction##935-180·305A
Ezetimibe/Simvastatin Versus Atorvastatin for Attainment of 
Apolipoprotein B and C-Reactive Protein Goals: A VYVA 
Substudy##981-194·335A
Favorable Effects of Additional Mitral Valve Repair on 
Ischemic Mitral Regurgitation and Left Ventricular 
Remodeling##917-21·272A
How Should Dobutamine Stress Echocardiography and 
Multislice Computed Tomography be Used to Assess 
Coronary Heart Disease in the Clinical Settings?## 948-
39·122A
Human Umbilical Cord Blood Cells Improve Cardiac Function 
After Myocardial Infarction##1020-241·227A
Impact of Gender on the Clinical Beneﬁt of Anti-hypertensive 
Therapy in Patients With Coronary Artery Disease and 
Normal Blood Pressure##1028-199·372A
Inﬂuence of Severity and Extent of Coronary Artery 
Disease on Long-Term Survival of Patients With and 
Without Diabetes Mellitus: Analysis from the CASS 
Registry##905-235·162A
Intensive Lipid Lowering With Atorvastatin Is Associated 
With a Signiﬁcant Improvement in Renal Function: The 
Treating to New Targets (TNT) Study## 808-3·316A
Intracoronary Mesenchymal Stem Cell or Endothelial 
Progenitor Cell Transfer Post Myocardial Infarction 
Prevents Negative Remodeling but Fails to Enhance 
Global Functional Recovery##949-221·180A
Intraindividual Comparison of Radiation Dose Exposure 
between Multislice Computed Tomography and 
Conventional Coronary Angiography## 970-31·128A
Intravenous Nicorandil Immediately Before Percutaneous 
Coronary Intervention can Prevent Slow/no-reﬂow 
Phenomenon##995-222·212A
Investigation of the Relation Between the New AHA/CDC C-
Reactive Protein Cutpoints and Cardiovascular Outcomes 
and Incident Diabetes in Patients With Stable Coronary 
Disease: A PEACE Substudy## 850-8·222A
Lipoprotein-associated Phospholipase A2 (Lp-PLA2) in 
Chronic Kidney Disease: Results From the RRI-CKD 
Study## 854-7·378A
Long-Term Adherence to the ACC/AHA Class I Post-
Discharge Medications and Recommendations Using 
Multifaceted Medical Therapy in 2287 Patients With 
Established Coronary Heart Disease: Interim Data From 
the Clinical Outcomes Utilizing Revascularization and 
Aggressive Drug Evaluation (COURAGE) Trial## 836-
7·209A
Long-Term Prognostic Value of Negative Exercise 
Echocardiogram: Do Stress Electrocardiographic Changes 
Really Matter?## 806-5·112A
Long-Term Safety of Cholesterol Lowering Wth Pravastatin on 
Cancer Incidence in Patients With Coronary Heart Disease 
(CHD): The LIPID Trial Extension##975-251·201A
Malondialdehyde-modiﬁed LDL(MDA-LDL) Is a Novel 
Marker as Instability of Coronary Plaque: Angioscopic 
Analysis##951-227·183A
Microalbuminuria Is Associated With Severe Angiographic 
Coronary Artery Disease in Diabetics and Non-
Diabetics## 842-5·358A
Minimal Coronary Artery Calcium Score Alone Fails to 
Reliably Detect Signiﬁcant Lesions in Acute Chest Pain 
Patients## 807-5·114A
Modiﬁcation of a Simple Scoring System for Prediction of 
In-Hospital Mortality in Acute Coronary Syndromes: 
The Incremental Value of Cardiac Biomarkers in Risk 
Stratiﬁcation##1018-227·224A
Modulation of NK Receptors on NK (CD3-/CD56+), T (CD3+/
CD56-) and NKT-like (CD3+/CD56+) Cells in Coronary 
Artery Disease##977-170·330A
Older Patients Receive the Greatest Beneﬁt From the Initiation 
of Anti-hypertensive Agents in the Setting of Coronary 
Artery Disease and Normal Blood Pressure## 836-6·209A
Patterns of Brain Natriuretic Peptide Utilization for Risk 
Stratiﬁcation of Patients With Non-ST-Segment Elevation 
Acute Coronary Syndromes##1019-240·227A
Persistence of Depression at Four Months After Myocardial 
Infarction Is Not Associated With Increased Long-Term 
Mortality##1005-206·354A
Prevalence of Tako-Tsubo Syndrome and Description of Partial 
and Circular Patterns##975-249·201A
Prognostic Value of Rubidium-82 Perfusion Positron Emission 
Tomography in Patients with Obesity## 812-7·115A
Reduced Platelet Sensitivity to Aspirin in Type 2 Diabetic 
Subjects Compared to Non-Diabetics##1023-165·364A
Signiﬁcance of Small Dense Low-Density Lipoprotein-
Cholesterol Concentrations in Relation to the Coronary 
Events in Stable Ischemic Heart Disease##930-246·176A
Tako-tsubo -like Apical Ballooning Shape: What it Depends 
on?##1009-101·81A
The Impact of Metabolic Syndrome and Coronary Artery 
Disease on Health Care Costs of Acute Cardiovascular 
Events##939-211·312A
Use of Anti-Inﬂammatory Medications in Patients at Risk for 
Cardiovascular Diseases##1029-210·375A
Usefulness of Membrane Type 1-matrix Metalloproteinase 
Measurement In Vivo as a Novel Indicator of 
Atherogenesis##933-166·302A
Using Telemedicine to Decrease Cardiovascular Risk in 
Underserved Populations##968-148·258A
Coronary microcirculation
Augmented Nitric Oxide Release in the Coronary Circulation 
Parallels Myocardial Metabolic Stress in Patients with 
Dilated Cardiomyopathy##1033-104·91A
Clinical Signiﬁcance of Penetrating Intra-myocardial 
Coronary Arteries in Patients With Apical Hypertrophic 
Cardiomyopathy##920-104·43A
Coronary Blood Flow and Coronary Flow Reserve by Contrast-
Enhanced Transthoracic Echocardiography Predict Long-
Term Outcome in Heart Transplantation##1010-105·82A
Coronary Flow Reserve Is a Poor Marker of Coronary 
Microvascular Response## 853-7·376A
Early Electromechanical Changes Following Acute Coronary 
Artery Microembolization##950-216·180A
Effect Of Coronary Stenosis On Adjacent Bed Microvascular 
Flow Reserve: Assessment Using Myocardial Contrast 
Echocardiography ## 827-4·132A
Effect of Non-critical Coronary Stenosis, Adenosine, and 
Dobutamine on Phasic Changes in Myocardial Blood 
Volume## 1016-43·151A
Impaired Atrial Coronary Flow Reserve in Patients With Lone 
Paroxysmal Atrial Fibrillation##1024-174·366A
Index of Microcirculatory Resistance: A Novel Measure for 
Predicting Myocardial Damage in Patients with Acute 
Myocardial Infarction##951-224·182A
Intracoronary Streptokinase Infusion Just Following 
Primary Percutaneous Coronary Intervention Improves 
Microvascular Perfusion and Integrity in Patients With 
Acute Myocardial Infacrtion##929-237·174A
Micro-Computed Tomographic Scanning of Stented Coronary 
Arteries Is Feasible, and Image Analysis Reliably 
Quantiﬁes the Coronary Vasa Vasorum Density##956-
172·320A
Rapamycin Therapy Improves Coronary Physiology After 
Cardiac Transplantation##944-105·51A
Relationship Between Microvascular Injury and Degree of 
ST-Segment Elevation Before Percutaneous Coronary 
Intervention##973-241·199A
Transient Coronary Occlusion Stimulates Platelet Deposition 
and Microvascular Dysfunction in Remote Regions of 
the Heart: Relation to Platelet Activation Status##908-
166·289A
Coronary sinus
A Strategy of Retrograde Injection of Bone Marrow 
Mononuclear Cells Into the Myocardium for the 
Treatment of Ischemic Heart Disease##934-175·304A
Coronary Sinus Lead Extraction Is Safe Even With Prolonged 
Lead Inplant Duration## 969-133·22A
Coronary Sinus Stent Implantation Improves Ischemic Mitral 
Valve Regurgitation: An Experimental Study##1006-
23·283A
Exercise Training in Addition to Cardiac Resynchronisation 
Therapy to Maximise Patient Beneﬁt## 1017-18·156A
Feasibility and Short-Term Efﬁcacy of Percutaneous 
Mitral Annular Reduction for the Therapy of Mitral 
Regurgitation in Patients with Heart Failure##1008-
54·77A
Sinus of Valsalva Aneurysms-47 Years of Experience##922-
112·237A
Coronary vasospasm
Noninvasive Diagnosis of Coronary Vasospasm by Detection 
of Regional Left Ventricular Delayed Relaxation 
Following Hyperventilation With Color Kinesis## 806-
3·112A
Coronary venous
Assessment of Anatomical Relationship Between Papillary 
Muscle and Coronary Veins by Multi-detector Computed 
Tomography## 970-40·130A
Coronary vessels
64-Slice Computed Tomography Angiography Detects Graft 
and Coronary Artery Stenosis in Patients With Previous 
Coronary Artery Bypass Graft Surgery## 970-1·124A
A New Technique for Coronary Digital Subtraction 
Angiography##1012-150·265A
Assessment of Coronary Red and White Thrombus by Optical 
Coherence Tomography##908-163·289A
Coronary Hypersensitivity to Serotonin in Cardiac Transplant 
Recipients. Relation to Vessel Wall Morphology and 
Effect of Vitamin C##1010-107·82A
Fluvastatin Reduces Coronary Plaque and Increases Lumen 
Volume: Assessment by Multislice CT## 970-11·126A
Image Quality of 64-Slice Multi-Detector Computed 
Tomography Coronary Angiography in Heart Transplant 
Recipients## 970-37·130A
Inﬂammatory Activation During Coronary By-pass Surgery 
and the Effect of High Dose Statin Plus ACE-inhibitor 
Treatment## 845-3·359A
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Inﬂuence of Number of Vessels Disease in Prognosis and 
Therapeutic Results in Chronic Coronary Artery Disease 
After Medical, Bypass Surgery or Angioplasty: 3-Years 
Follow-Up of the Mass I I Study##955-256·189A
Lipopolysaccharide Induces CXCR6 Expression in Human 
Coronary Artery Smooth Muscle Cells in TLR4 
Dependent Myd88-TIRAP-TRIF-TRAF6 Mediated 
ERK1/2 Activation##933-160·301A
Multislice Computed Tomographic Findings of the Anomalous 
Origin of the Right Coronary Artery: Evaluation of 
Possible Causes of Myocardial Ischemia## 970-5·125A
Noninvasive Coronary Angiography Performed With 4-Slice, 
12-Slice, 16-Slice and 64-Slice CT: Comparison of 
Diagnostic Accuracy## 970-39·130A
The Effect of One-Year of Chelation Therapy on Coronary 
Volume Score## 970-10·126A
Variant Coronary Artery Pattern and Ventricular Septal Defect 
Are Associated With Chronotropic Impairment Late After 
the Arterial Switch Operation##1035-115·248A
Cost-effectiveness
64-Slice CT Angiography Is a Cost-saving Strategy for 
Patients With Mildly Abnormal Nuclear Stress Tests## 
807-4·113A
Atrial Versus Dual Chamber Pacing in Sinus Node Disease## 
969-140·24A
Cost Beneﬁt Analysis of Treatment of Symptomatic 
Multivessel Coronary Disease With Preserved 
Left Ventricular Function. The Five-Year MASS II 
Report##999-254·218A
Cost-Effectiveness of Chlorthalidone, Amlodipine, and 
Lisinopril as First-line Treatment for Patients With 
Hypertension: An ALLHAT Analysis##1028-198·372A
Echocardiographic Risk-stratiﬁcation for Early Surgery in 
Patients With Endocarditis Is a Cost-Attractive Alternative 
to Standard Care##984-22·280A
Exercise Testing Is Feasible, Efﬁcacious and Cost-Effective 
in the Prediction of Cardiovascular Events in the Very 
Elderly as Compared With Dipyridamole Tc-99m 
Sestamibi Spect## 1017-13·155A
Hospitalization Costs of Tenecteplase-Facilitated Angioplasty 
Versus Thrombolysis-Alone in Acute Myocardial 
Infarction##929-239·174A
Immediate Coronary Artery Computed Tomographic 
Angiography Rapidly and Deﬁnitively Excludes Coronary 
Artery Disease in Low-Risk Acute Chest Pain## 807-
8·114A
Percutaneous Pulmonary Valve Implantation: A Cost-Effective 
Strategy for Management of Right Ventricular Outﬂow 
Tract Dysfunction##945-114·239A
Stress Echocardiography is More Cost-effective Than Stress 
Electrocardiography for Risk Stratiﬁcation of Troponin 
Negative Acute Chest Pain Patients: A Prospective 
Randomised Controlled Trial## 806-4·112A
Taking the Doctor Out of the Loop: The Impact of a Technician 
Led Follow-Up Clinic for Heart Valve Disease##1036-
150·270A
The Cost-Effectiveness of Perindopril in Reducing 
Cardiovascular Events in Patients With Stable Coronary 
Artery Disease Using Data From the EUROPA 
Study##968-155·260A
The Long-Term Cost-Effectiveness of Cardiac 
Resynchronization Therapy With or Without an 
Implantable Cardioverter-Deﬁbrillator: Model 
Based Analyses Based on Results From the CArdiac 
REsynchronization In Heart Failure Trial## 851-6·92A
Creatine kinase
Delta Protein Kinase C Antagonist Given Systemically at 
Reperfusion is Cardioprotective##994-220·211A
Effect of CKMB Elevation After Successful PCI on One-Year 
Mortality##971-220·194A
Field Triage Directly to the Catheter Laboratory Safely Reduce 
Time to Reperfusion and Infarct Size in Patients With ST-
Elevation Myocardial Infarction## 815-5·192A
Link of Serum CK Activities to Vascular Smooth Muscle 
Revealed by Physiological-genomic Analyses of Statin-
treated Patients##956-168·319A
Cytokines
Adiposity and Atherogenic Inﬂammatory Response to 
Endotoxin in Humans##937-193·308A
C-Reactive Protein and Pro-Inﬂammatory Cytokines Are 
Elevated in Men With Erectile Dysfunction of Vascular 
Origin## 854-8·378A
Cardiac Expression of Placental Growth Factor Stimulates 
Peripheral Mobilization of CD34+ Progenitor Cells in 
Patients with Myocardial Infarction##972-228·196A
CD44 Critically Regulates Healing of Myocardial 
Infarcts##949-215·179A
Chronic Therapy with Selective Electric Vagus Nerve 
Stimulation Normalizes Plasma Concentration of Tissue 
Necrosis Factor-�, Interleukin-6 and B-Type Natriuretic 
Peptide in Dogs with Heart Failure##1008-57·77A
Comparative Evaluation of Postangioplasty Systemic 
Inﬂammatory and Oxidative Stress Response of 
Sirolimus-eluting and Bare Metal Stents## 850-4·221A
Deletion of Tumor Necrosis Factor α Receptor 1 Is Protective 
in A Mouse Model of Hindlimb Ischemia##933-168·302A
Early Initiation Of Low-Dose Atorvastatin Treatment After 
An Acute ST-Elevated Myocardial Infarction, Decreases 
Inﬂammatory Response And Stimulates Antithrombotic 
Mechanisms##996-234·214A
Effects of Insulin Dependence in Patients With Type 2 Diabetes 
Mellitus and Advanced Atherosclerosis, on Inﬂammatory 
Process, Thrombotic Mechanisms and Endothelial 
Function##961-202·326A
Effects of Irbesartan and Perindopril on Endothelial Function 
and Inﬂammatory Process in Patients With Coronary 
Artery Disease and Stable Angina Pectoris##1019-
236·226A
Enhanced Expression of Leptin, Leptin Receptor, and Leptin 
Signaling in the Failing Human Heart##913-200·297A
Fish Intake Is Associated With Decreased Levels of 
Inﬂammatory Markers Among People With Metabolic 
Syndrome: The ATTICA Study##1005-201·353A
Genetically Modifying Marrow Stromal Stem Cells to Secrete 
Erythropoietin Enhances the Protective Effect of Cellular 
Therapy in the Infarcted Myocardium## 829-4·206A
Importance and Signiﬁcance of Baroreﬂex Sensitivity(BRS) 
to Predict Prognosis of Chronic Heart Failure With 
Preserved Systolic Function##919-92·40A
Increased In-Stent Neo-Intimal Hyperplasia after Stem Cell 
Mobilization by Granulocyte-Colony Stimulating Factor 
in Bare Stent, but Not in Drug-Eluting Stent in a Porcine 
Myocardial Infarct Model##1020-250·229A
Paracrine Effects of Endothelial Progenitor Cells on Acutely 
Infarcted Myocardium## 814-3·190A
Prognostic Signiﬁcance of Interleukin-2 for the 
Pharmacological Cardioversion of Recent Onset Atrial 
Fibrillation## 1015-136·34A
RANTES Is an Independent Determinant of Outcome in 
Patients With Unstable Angina Pectoris##1019-235·225A
Sex Differences in the Inﬂammatory Response to Leptin: 
Results From the Dallas Heart Study##959-188·323A
Soluble Tumour Necrosis Factor-related Apoptosis Inducing 
Ligand is Low Early in the Presentation of Acute 
Coronary Syndromes and Is Inversely Correlated With 
C-Reactive Protein and Troponin T##971-217·194A
Study of Coronary Calcium Score by Multislice Computed 
Tomography in Relation to Endothelial Function, C-
Reactive Protein, and Interleukin-6 in Asymptomatic 
Individuals## 970-36·129A
TGF-β1 Enhances Cardiomyogenic Differentiation Potential of 
Adult Primitive Cells##903-217·158A
The Association Between Coffee Consumption and 
Inﬂammatory Markers, in Healthy Individuals: The 
ATTICA Study##935-182·306A
The Functional Interaction Between CREB and C/EBPb 
Mediate beta AR Stimulation Induced IL-18 Binding 
Protein Expression in Cardiomyocytes##1031-49·84A
The PPAR-α Activator, Fenoﬁbrate, Fails to Provide 
Myocardial Protection in Ischemia-reperfusion Injury in 
Pigs##994-215·210A
Death, sudden
Does Revascularization of Chronic Total Occlusion(CTO) 
Contribute to Improve the Long-Term Prognosis?##976-
252·202A
Natural History of Hemodialysis Patients Receiving an 
Implantable Cardioverter Deﬁbrillator for Secondary 
Prevention## 947-127·15A
Sudden Cardiac Death Risk Prediction is Enhanced When 
Clinical Characteristics and Left Ventricular Ejection 
Fraction Are Evaluated Together Rather Than Relying on 
Left Ventricular Ejection Fraction Alone##983-209·339A
Decision making, computer-assisted
An On-Line, Evidence-Based Calculator of Mortality 
in Congestive Heart Failure Based on Clinical 
Variables##1012-152·266A
Computer Alert Increases Use of Prophylaxis for Patients at 
High Venous Thromboembolism Risk##958-185·322A
Decision Support for Coronary Revascularization##1013-
146·266A
Electrogram Features Are Superior to Clinical Characteristics 
for Predicting Atrial Fibrillation After Coronary Artery 
Bypass Graft Surgery## 813-3·12A
Patient Safety Suffers at Nursing Shift Changes: Error 
Rate Peaks for Intravenous Unfractionated Heparin 
Administration##946-153·255A
Deﬁbrillation, atrial
Irbesartan Reduces Left Atrial Stunning After Electrical 
Cardioversion of Atrial Fibrillation## 924-141·9A
Deﬁbrillation, ventricular
Deﬁbrillation Thresholds in Patients with Hypertrophic 
Cardiomyopathy## 947-133·16A
Impact of Left Ventricular Mass and Diameter on Deﬁbrillation 
Thresholds in Patients with Implantable Cardioverter 
Deﬁbrillators## 947-128·15A
Intracellular Calcium Transient Dynamics and the Mechanism 
of Shock-Induced Ventricular Fibrillation and 
Deﬁbrillation in Rabbit Hearts## 901-133·3A
Stepped Deﬁbrillation Waveform Is Substantially More 
Efﬁcient Than the 50% Tilt Biphasic## 947-126·14A
Sudden Cardiac Death in Athletes: Rates of 
Deﬁbrillation##906-243·165A
Deﬁbrillators, implantable
Cardiac Resynchronization Therapy Reduces the Need 
for Shocks in Patients With Automated Implantable 
Cardioverter Deﬁbrillators## 947-135·17A
Circadian, Daily, and Seasonal Distributions of Ventricular 
Tachyarrhythmias in Patients With Implantable 
Cardioverter-Deﬁbrillator## 901-137·4A
Correlates of Arrhythmic Risk in MADIT II Patients: Signal 
Averaged EKG and Cardiac MRI## 993-29·146A
Deﬁbrillation Thresholds in Patients with Hypertrophic 
Cardiomyopathy## 947-133·16A
Do Implantable Cardioverter-Deﬁbrillator Patients Have 
Adequate Rate Control During Atrial Tachyarrhythmias? 
Results From a New Continuous Long-Term Monitoring 
System## 1015-135·34A
Do Ventricular Tachyarrhythmias From a Failing Heart Need 
More Energy to Convert?## 947-123·14A
Does Gender Alter the Efﬁcacy of Implantable Cardioverter 
Deﬁbrillators?## 947-129·15A
Impact of Left Ventricular Mass and Diameter on Deﬁbrillation 
Thresholds in Patients with Implantable Cardioverter 
Deﬁbrillators## 947-128·15A
Implantable Cardioverter-Deﬁbrillator FDA Recalls and Safety 
Alerts: Prevalence and Impact on Patient Mortality## 
818-8·20A
Internal Cardiac Deﬁbrillators With Right Ventricular Outﬂow 
Tract Lead Do Not Require Deﬁbrillation Threshold 
Testing At Routine Device Replacement## 947-136·17A
Is There a Role for Implantable Cardioverter-Deﬁbrillator 
Therapy for the Primary Prevention of Sudden Death in 
Patients With Chronic Kidney Disease?## 818-5·19A
Multicenter Experience with 1,355 Failed and Recalled 
Implantable Cardioverter Deﬁbrillators## 818-7·20A
Natural History of Hemodialysis Patients Receiving an 
Implantable Cardioverter Deﬁbrillator for Secondary 
Prevention## 947-127·15A
Physical and Mental Functioning and Health Outcome 
in Patients Enrolled in the Multicenter Automatic 
Deﬁbrillator Implantation Trial-II##919-54·38A
Polynomial Modeling of Ventricular Shock Electrogram for 
Rhythm Discrimination in Implantable Devices## 947-
130·15A
Predicting Cardiac Event Risk by Combined Assessment of 
Cardiac Sympathetic Nerve Activity and Myocardial 
Perfusion in Patients With Implantable Cardioverter 
Deﬁbrillators## 926-3·105A
Predictors of Mortality in Patients Receiving Implantable 
Deﬁbrillators## 947-132·16A
Relationship Between Renal Function, Risk of Sudden Cardiac 
Death, and Beneﬁt of the Implanted Cardiac Deﬁbrillator 
in Post Myocardial Infarction Patients With Left 
Ventricular Dysfunction## 818-4·19A
Stepped Deﬁbrillation Waveform Is Substantially More 
Efﬁcient Than the 50% Tilt Biphasic## 947-126·14A
Sustained Polymorphic Arrhythmias Induced by Programmed 
Ventricular Stimulation Have Prognostic Value in Patients 
Receiving Deﬁbrillators for Primary Prevention of Sudden 
Cardiac Death## 924-128·6A
The Long-Term Cost-Effectiveness of Cardiac 
Resynchronization Therapy With or Without an 
Implantable Cardioverter-Deﬁbrillator: Model 
Based Analyses Based on Results From the CArdiac 
REsynchronization In Heart Failure Trial## 851-6·92A
Utility of Electronic Reprogrammable Vectors in Biventricular 
Devices## 947-134·16A
Utility of Real-Time 3-D Echocardiography for Predicting 
Adverse Events in the MADIT-II Post-Myocardial 
Infarction Patient Population## 839-8·147A
Diabetes mellitus
Absence of Correlation Between Lipid-Lowering Effects 
and Impacts on Progressive Insulin Resistance in Statin 
Treatment of a Type-2 Diabetes Model##937-194·308A
Aldose Reductase Inhibitor Improves the Deterioration 
of Shear Induced Nitric Oxide Production by High 
Glucose##977-168·330A
Angiographic Severity of Coronary Artery Disease Is Not 
Related to the Duration of Type-2 Diabetes##905-
233·162A
Anti-thrombotic Effect of Bivalirudin Compared With 
Eptiﬁbatide and Heparin in Diabetic Patients Undergoing 
Angioplasty: An Ex-vivo Human Study##1023-171·366A
Apoptosis Is Increased in Diabetes Atherosclerosis Independent 
of Plaque Lipid Content##977-167·329A
Atorvastatin but Not Vitamin C, Affects Endothelial Function, 
Asymmetric-Dimethyl-Arginine Levels and Inﬂammatory 
Process, in Patients With Diabetes Mellitus Type 2, and 
Low Cholesterol Level##1003-189·350A
ACC_2006_12_SubjectIndex.indd   437 1/4/06   5:26:55 PM
438A  SUBJECT INDEX JACC February 21, 2006
KEY: Abstract Title, Session-abstract number•page number KEY: Abstract Title, Session-abstract number•page number
Beneﬁcial Effects of Dual Angiotensin-II Suppression With 
ACE-inhibitor and Angiotensin Receptor Blocker on 
BNP, CRP and Glucose Regulation in Patients With 
Symptomatic Heart Failure##959-189·323A
Blockade of RAGE With a New Fusion Protein Suppresses 
Neointimal Formation in Both Diabetic and Non-Diabetic 
Rats After Vascular Injury##956-171·320A
Clopidogrel Withdrawal Is Associated With Pro-Inﬂammatory 
Effects in Patients With Diabetes Mellitus##937-
196·308A
Combination Statin and Fibrate Therapy Improves Lipoprotein 
Subparticle Proﬁles in Diabetic Patients With Mixed 
Dyslipidemia: The DIACOR Study##1014-210·355A
Comparative Metabolic Effects of Ramipril and Candesartan in 
the Treatment of Hypertensive Patients##942-96·49A
Contribution of Obesity to Elevated Blood Pressure in 
Uncomplicated Diabetics: 26-Year of Follow-Up 
Study##1004-197·352A
Coronary Remodeling Is the Main Contributor to Lumen 
Narrowing in Diabetic Patients##978-174·331A
Despite Greater Co-Morbidities, Diabetes Does not Increase 
60-Day or 1-Year Post Stroke Mortality##961-208·327A
Diabetes and Coronary Artery Disease Impose Similar 
Cardiovascular Morbidity and Mortality to Patients With 
End-Stage Renal Disease: A Seven-Year Follow-Up 
Study##905-234·162A
Diabetes Mellitus Subjects Have Immune System Alterations 
Similar to That of Patients With Unstable Angina: A 
Clue to Explain Their High Cardiovascular Risk?##972-
231·197A
Diabetes Mellitus Type 2 Predisposes to Increased Culprit 
Plaque Inﬂammatory Activation in Patients With 
Coronary Artery Disease.## 854-4·377A
Diabetes, Insulin, and the Prevalence of Atrial Fibrillation and 
Flutter in a Large Heart Failure Population## 804-7·10A
Diabetes, Renal Function, and Cardiovascular Risk Following 
Myocardial Infarction: Lessons From The VALsartan In 
Acute myocardial iNfarcTion Trial (VALIANT)##998-
249·217A
Diabetes-Related Increased Mortality in Women With 
Heart Failure Is Modiﬁed by Non-Potassium-Sparing 
Diuretics##964-52·54A
Diabetic Plaque Inﬂammation and Neovascularization 
Are Associated With Increased Reparative Collagen 
Content: Implication for Plaque Progression in Diabetic 
Atherosclerosis##912-193·295A
Does Impaired Fasting Glucose Inﬂuence Long Term Mortality 
After an Acute Myocardial Infarction? Data From the 
Rico Survey##996-237·214A
Does Tight Glycemic Control Improve Survival in Diabetic 
Patients With Chronic Heart Failure Started on Insulin 
Therapy?##964-55·55A
Effect of Amlodipine and Enalapril on Cardiovascular Events 
in Patients With Insulin Resistance and Diabetes in the 
CAMELOT Trial##938-199·309A
Effect of Physician Financial Incentives and Clinical 
Information Systems on Medication Use and Congestive 
Heart Failure Admissions## 834-8·264A
Effects of Insulin Dependence in Patients With Type 2 Diabetes 
Mellitus and Advanced Atherosclerosis, on Inﬂammatory 
Process, Thrombotic Mechanisms and Endothelial 
Function##961-202·326A
Endovascular Therapy as First Revascularization Procedure in 
Ischemic Diabetic Foot##979-184·333A
Fasting Glucose Is a Powerful Independent Risk Factor for 
Long-Term Mortality in Patients With Acute Myocardial 
Infarction. A Prospective Study## 830-5·207A
Features of the Metabolic Syndrome and Diabetes Mellitus 
as Predictors of Aortic Valve Calciﬁcation as Detected 
by Electron Beam Computed Tomography in the Multi-
Ethnic Study of Atherosclerosis##1030-27·287A
Fragmented QRS on 12-lead ECG Represents Increased 
Cardiac Events and Mortality in Diabetic Patients With 
Abnormal Myocardial Perfusion Scan##1029-208·374A
Frequency of Angina Pectoris in Patients With Diabetes 
Mellitus Compared to Non-Diabetic Patients: Clarifying 
an Old Myth##927-215·169A
Identiﬁcation of Diabetics at High Risk of Mortality: A 10-
Year Follow-Up Analysis After Myocardial Perfusion 
SPECT## 926-10·106A
Impact of Renal Dysfunction and Glucometabolic Status 
on One Year Mortality After Acute Myocardial 
Infarction##904-226·160A
Increased Aortic Characteristic Impedance Contributes to 
Increased Central Aortic Pulse Pressure in Young Women 
With Type 1 Diabetes##1025-181·368A
Increased Plaque Heat Generation in Patients With Diabetes 
Mellitus and Acute Coronary Syndromes. An Increased 
Local Inﬂamamtory Actiation##1019-234·225A
Increased Pulse Pressure is Strongly Associated with Adverse 
Cardiovascular Outcomes in both Diabetics and Non 
Diabetics: The International Verapamil SR-Trandolapril 
Study (INVEST)## 835-6·343A
Infectious Endocaritis Is Independently Associated With Type 
II Diabetes Mellitus##984-25·281A
Inﬂuence of Severity and Extent of Coronary Artery 
Disease on Long-Term Survival of Patients With and 
Without Diabetes Mellitus: Analysis from the CASS 
Registry##905-235·162A
Investigation of the Relation Between the New AHA/CDC C-
Reactive Protein Cutpoints and Cardiovascular Outcomes 
and Incident Diabetes in Patients With Stable Coronary 
Disease: A PEACE Substudy## 850-8·222A
Is There an Impaired Coronary Collateral Function in Patients 
With Diabetes Mellitus? Invasive Assessment in Chronic 
Total Coronary Occlusions##978-175·331A
Lectin-like Oxidized LDL Receptor-1 (LOX-1) as a Novel 
Receptor for Remnant-like Lipoprotein Particles (RLPs) 
in Vascular Smooth Muscle Cells## 822-4·340A
Left Atrial Mechanics in Type 2 Diabetics## 948-17·120A
Less Revascularization in Diabetic Patients With Silent 
Myocardial Ischemia Results Poor Survival Compared 
to Diabetic Patients With Symptomatic Coronary Artery 
Disease##905-236·163A
Lipid Parameters and Risk of Ischemic Stroke in Type 2 
Diabetes Mellitus: The Strong Heart Study##1003-
190·350A
Long-Term Administration of Pioglitazone Reverses 
Arteriosclerotic Processes in Type-2 Diabetics##957-
176·321A
Low Dose Pioglitazone Does Not Adversely Affect Left 
Ventricular Remodeling After Primary PCI in Patients 
With Acute Myocardial Infarction and With Type 2 
Diabetes Mellitus or Impaired Glucose Tolerance##964-
56·56A
Magnetic Resonance-Based Evaluation of Cardiac 
Hypertrophy in the db/db Mouse## 993-10·144A
Masked Hypertension Is Associated With Impaired Glucose 
Tolerance and Larger Left Atrium in the Elderly##1004-
193·351A
Microalbuminuria Is Associated With Severe Angiographic 
Coronary Artery Disease in Diabetics and Non-
Diabetics## 842-5·358A
Myocardial Thickness and Pulmonary Vein Flow Impedance: 
Correlation During Fetal Life##989-112·242A
Pioglitazone Is Superior to Metformin or Glibenclamide in 
Recducing Markers of Cardiovascular Risk in Patients 
With Type-2-diabetes Mellitus##905-238·163A
Plaque Characterization by Intravascular Ultrasound Virtual 
Histology Analysis in Diabetic Patients##1019-239·226A
Predictive Value on Mortality of Stress Hyperglycaemia 
in Patients With Acute Myocardial Infarction##996-
238·215A
Predictors of Sudden Cardiac Death in a Population With High 
Prevalences of Obesity and Diabetes: The Strong Heart 
Study##961-207·327A
Prevalence and Platelet Function Proﬁles of Clopidogrel Hypo-
responders Identiﬁed Following Drug Withdrawal##1023-
160·363A
Prevalence of Concomitant Suboptimal Responsiveness 
to Aspirin and Clopidogrel Treatment in Diabetic 
Patients##1023-162·364A
Reduced Platelet Sensitivity to Aspirin in Type 2 Diabetic 
Subjects Compared to Non-Diabetics##1023-165·364A
Regression of Coronary Atherosclerotic Plaques Induced by 
Pioglitazone in Patients With Type 2 Diabetes Mellitus or 
Impaired Glucose Tolerance: Results From a Randomized 
Prospective Study Using Intravascular Ultrasound##914-
207·298A
Relationship Between White Cell Count, Blood Sugar Level 
and Mortality in Acute Coronary Syndromes. The Global 
Registry of Acute Coronary Events##990-148·261A
Risk Factors for Cardiovascular Disease in Patients with 
Prediabetes## 842-3·357A
Similar Hospital Mortality for Diabetics With NSTEMI as 
for Non-diabetics With STEMI: Results of the Acos 
Registry##1019-237·226A
The Effects of the Frequency of Exercise-Based Cardiac 
Rehabilitation on Glucose Tolerance and Lipid Levels in 
Patients With Acute Coronary Syndrome##916-254·167A
The Impact of Medication Non-adherence on Hospitalization 
and Mortality Among Patients With Diabetes## 834-
7·264A
The Impact of Metabolic Syndrome and Diabetes on Long-
Term Outcomes Following Percutaneous Coronary 
Intervention##961-201·326A
The Impact of Reduced Left Ventricular Function on Long-
Term Outcomes in Diabetes Mellitus Patients With 
Coronary Artery Disease Undergoing Percutaneous 
Coronary Intervention##905-240·164A
The Independent and Combined Risks of Diabetes and Non-
Endstage Renal Impairment in Non ST-Segment Elevation 
Acute Coronary Syndromes## 830-3·207A
The Reduction of Inﬂammatory Biomarkers by Statin, Fibrate, 
and Combination Therapy Among Diabetic Patients With 
Mixed Dyslipidemia: The DIACOR Study## 854-5·377A
Triple-Therapy with a Statin, Fibrate and Ezetimibe Safely 
Allows More Diabetic Patients with Mixed Dyslipidemias 
to Reach NCEP Guidelines: An Analysis of The DIACOR 
Study## 808-6·316A
Diagnosis, computer-assisted
Detecting Depression in Cardiac Patients: Description of an 
Innovative System and Preliminary Findings Related to 
Gender and Age##1005-205·353A
Determination of Atrial Flutter Type Using Interactive ECG 
Analysis## 992-130·27A
ECG-Based Method for Identifying KvLQT1/KCNE1 
or HERG Mutation in Patients With The Long QT 
Syndrome## 813-7·13A
Polynomial Modeling of Ventricular Shock Electrogram for 
Rhythm Discrimination in Implantable Devices## 947-
130·15A
Diagnostic techniques
64-Slice Computed Tomography Angiography Detects Graft 
and Coronary Artery Stenosis in Patients With Previous 
Coronary Artery Bypass Graft Surgery## 970-1·124A
64-Slice Peripheral Computed Tomography Angiography: A 
Clinical Accuracy Evaluation## 970-18·128A
A Novel Echo-Doppler Method to Predict Diastolic and Mean 
Pulmonary Artery Pressures: Derivation and Validation by 
Catheterization## 852-6·249A
A Prehospital Diagnostic Strategy Reduces Time to Treatment 
and Mortality in Real Life Patients With ST-Elevation 
Myocardial Infarction Treated With Primary Percutaneous 
Coronary Intervention## 815-3·192A
A Study of Platelet Function Following Selective and 






B-Natriuretic Peptide Levels Are Elevated in Single Ventricle 
Patients With Systemic Ventricular Failure but not With 
Cavopulmonary Failure##967-109·240A
C-reactive Protein Concentrations at Emergency Department 
Presentation Strongly Predict One Year Mortality in 
Dyspneic Patients##986-89·67A
Comparison of Resting Magnetocardiography With Stress 
Single Photon Emission Computed Tomography in 
Patients With Stable and Unstable Angina##930-
247·176A
Discrimination of Human Coronary Thrombus Types by 
Optical Coherence Tomography in Vitro## 843-6·220A
Does African American or Caucasian Race Impact Use of 
B-Type Natriuretic Peptide and N-Terminal proBNP for 
Diagnosis of Decompensated Heart Failure and Predicting 
Mortality?##1032-92·88A
Evaluation of Neointimal Hyperplasia by Optical Coherence 
Tomography at Six-Month After Sirolimus-Eluting Stent 
Deployment##956-162·318A
Feasibility of Transthoracic Doppler-determined Coronary 
Flow Reserve for the Assessment of Left Main Trunk 
Stenosis## 902-14·97A
Haemodilution Is the Primary Cause of Mild Anaemia in Heart 
Failure##986-52·65A
How Much Reduction is Needed in BNP Levels to Reduce 
Future Clinical Events with Treatment During 
Hospitalization for Heart Failure?## 819-7·72A
Immediate Coronary Artery Computed Tomographic 
Angiography Rapidly and Deﬁnitively Excludes Coronary 
Artery Disease in Low-Risk Acute Chest Pain## 807-
8·114A
Monitoring Platelet Inhibition After Clopidogrel With 
VerifyNow-P2Y12® Rapid Analyzer: The VERIfy 
Thrombosis risk ASsessment (VERITAS) Study##908-
165·289A
Multislice Computed Tomography in the Detection of 
Coronary In-Stent Restenosis## 970-32·129A
Noninvasive Coronary Angiography Performed With 4-Slice, 
12-Slice, 16-Slice and 64-Slice CT: Comparison of 
Diagnostic Accuracy## 970-39·130A
Noninvasive Coronary Angiography: Agreement of 64-Slice 
Cardiovascular Computed Tomography and Selective 
Catheter Angiography## 970-13·127A
Noninvasive Diagnosis of Coronary Vasospasm by Detection 
of Regional Left Ventricular Delayed Relaxation 
Following Hyperventilation With Color Kinesis## 806-
3·112A
Novel Intra-Operative Fluorescence Imaging System for On-
Site Assessment of Off-Pump Coronary Artery Bypass 
Graft##932-256·178A
Perfusion Defects in the Absence of Abnormal Wall Motion 
and Thickening Are Not Clinically Signiﬁcant in Chest 
Pain Patients Undergoing Acute Rest Myocardial 
Perfusion Imaging## 926-17·108A
Resting Magnetocardiography Detects Ischemia With 
High Accuracy in Patients With Acute Coronary 
Syndrome##951-223·182A
ST-Elevation in Lead aVR During Exercise Testing Should Not 
Be Ignored## 992-131·27A
Successful Direct Left Atrial Pressure Monitoring and Fossal 
Pacing via an Implantable HEARTPOD Device in Animal 
Models##1008-60·78A
The Role of Contrast-Enhanced Real-Time 3D Stress 
Echocardiography in Diagnosing Coronary Artery 
Disease## 991-42·140A
The Utility of Aminoterminal Pro-B-type Natriuretic Peptide 
for the Detection of Preclinical Systolic and Diastolic 
Dysfunction in the Community##942-89·47A
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There Is No Objective Evidence That “Self-Referral” Is 
Responsible for Growth of Imaging Services Billed to the 
Medicare System.## 834-3·263A
There is Nothing Grey About It: Dyspnea with Intermediate 
Aminoterminal Pro-B Type Natriuretic Peptide 
Concentrations##986-91·67A
Time Resolved Sequence of Left Ventricular Flow Redirection 
during Isovolumic Intervals of the Cardiac Cycle## 
805-3·110A
Use of N-Terminal-pro-Brain Natriuretic Peptide as a 
Diagnostic and Prognostic Marker for Ischemic Heart 
Disease in Patients Presenting to a Rapid Access Chest 
Pain Clinic##1005-199·352A
Value of Electrocardiographic Findings in Predicting Rest Left 
Ventricular Diastolic and Systolic Function in Community 
Dwelling Adults##942-97·49A
Diastole
A Controlled Exercise Training Trial in Patients With Diastolic 
Dysfunction## 1017-14·155A
Alternate BNP Forms in Preclinical Ventricular Dysfunction or 
Overt Heart Failure##986-56·66A
Angiotensin II Acutely Increases Diastolic Distensibility: 
A Protein Kinase C and Na+/H+ Exchanger-mediated 
Effect##1031-47·84A
Brain Natriuretic Peptide and Systolic or Isolated Diastolic 
Heart Failure in the Community##942-92·48A
Coexistence and Post-Exercise Exacerbation of Intra-Left 
Ventricular Contractile Dyssynchrony in Medically 
Controlled Hypertensive Patients with Diastolic 
Dysfunction: A Tissue Doppler Echocardiography 
Study## 925-40·103A
Echocardiographic Evaluation of Left Ventricular Filling 
Pressure During Exercise Validated With Hemodynamic 
Measurement## 831-3·133A
Effects of Lifestyle Modiﬁcation on Left Ventricular Diastolic 
Filling and Endothelial Function in Those at Risk for 
Cardiovascular Diseases##1028-202·373A
Hypertensive Heart Failure with a Normal Ejection Fraction: 
Abnormal Load or Abnormal Ventricular Function?##942-
57·46A
Impact of Obstructive Sleep Apnea for the Impairment of Left 
Ventricular Diastolic Function##964-93·57A
Improved LV Relaxation Measured by Tissue Doppler 2 Years 
After Gastric Bypass Surgery##942-91·48A
Improvement of Diastolic Function Is related to Left 
Ventricular Reverse Remodeling After Mid-Term Cardiac 
Resynchronization Therapy##942-58·46A
Increased Plasma Concentrations of N-terminal Pro Brain 
Natriuretic Peptide is a More Sensitive Marker 
of Subclinical Diastolic Dysfunction and Arterial 
Remodeling in Hypertension: Analytical Performance 
Comparison With BNP##1028-200·372A
Intra-Left Ventricular Contractile Dyssynchrony Is 
Independently Associated with Diastolic Heart Failure in 
Medically Controlled Hypertensive Patients## 851-5·92A
Left Atrial Mechanics in Type 2 Diabetics## 948-17·120A
Left Atrial Volume Mirrors Diastolic Dysfunction Caused by 
Hypertension Alone##942-60·47A
Left Ventricular Untwisting Was Delayed and Reduced in 
Patients With Hypertensive Left Ventricular Hypertrophy: 
Demonstration by 2-Dimensional Speckle Tracking 
Imaging## 902-30·98A
Metoprolol Prevents Progression of Diastolic Dysfunction 
in Patients With Asymptomatic Left Ventricular 
Systolic Dysfunction: Observations From the REVERT 
Trial##942-95·49A
Myocardial Strain During Early Diastole Is Useful in Assessing 
Left Ventricular Early Diastolic Function: Comparison 
With Invasive Parameters## 846-4·148A
Nesiritide Improves Left Ventricular Compliance in Diastolic 
Heart Failure##942-55·46A
Noninvasive Diagnosis of Coronary Vasospasm by Detection 
of Regional Left Ventricular Delayed Relaxation 
Following Hyperventilation With Color Kinesis## 806-
3·112A
Sex Determines Differences in Left Ventricular Diastolic 
Properties in the Model of Chronic Estrogen 
Deﬁciency##985-50·64A
Unrecognized Myocardial Infarction: The Association With 
Cardiopulmonary Symptoms and Mortality is Mediated 
Via Echocardiographic Abnormalities of Global 
Dysfunction Instead of Regional Dysfunction. The 
Olmsted County Heart Function Study##950-215·180A
Value of Electrocardiographic Findings in Predicting Rest Left 
Ventricular Diastolic and Systolic Function in Community 
Dwelling Adults##942-97·49A
Value of Measuring the Time Difference Between Onset of 
Mitral Inﬂow and Onset of Early Diastolic Mitral Annulus 
Velocity for the Evaluation of Left Ventricular Diastolic 
Pressures in Patients With Normal Systolic Function and 
Indeterminate E/E’## 902-12·96A
Ventricular Structure and Function in Hypertensive Patients 
with Heart Failure and a Normal Ejection Fraction: The 
Cardiovascular Health Study (CHS)##942-52·45A
Diet
Effects of Lifestyle Modiﬁcation on Left Ventricular Diastolic 
Filling and Endothelial Function in Those at Risk for 
Cardiovascular Diseases##1028-202·373A
Fish Intake Is Associated With Decreased Levels of 
Inﬂammatory Markers Among People With Metabolic 
Syndrome: The ATTICA Study##1005-201·353A
Sodium: An Old Enemy or a New Friend for Advanced 
Failured Patients?## 819-6·72A
The Association Between Coffee Consumption and 
Inﬂammatory Markers, in Healthy Individuals: The 
ATTICA Study##935-182·306A
Very Low-Fat Japanese Diet and Daily Exercise Reduce 
Plasma Lipid Levels With Small Dose of Statins 
and is Effective for Regression of Coronary 
Atherosclerosis##1014-209·354A
Diuretics
Coadministration of the V2 Receptor Antagonist Tolvaptan and 
B-Type Natriuretic Peptide Enhances Water and Sodium 
Excretion Without Adversely Affecting Renal Function: A 
Physiologic Approach to Sodium and Water Retention in 
Experimental Heart Failure##913-199·297A
Cost-Effectiveness of Chlorthalidone, Amlodipine, and 
Lisinopril as First-line Treatment for Patients With 
Hypertension: An ALLHAT Analysis##1028-198·372A
Diabetes-Related Increased Mortality in Women With 
Heart Failure Is Modiﬁed by Non-Potassium-Sparing 
Diuretics##964-52·54A
Loop Diuretic Dose Is Independently Associated With 
Increased Mortality in Advanced Heart Failure##919-
93·41A
Sodium: An Old Enemy or a New Friend for Advanced 
Failured Patients?## 819-6·72A
The Effect of Intensity of Intravenous Diuretic Dosing on 
Occurrence of Worsening Renal Function in Patients 
Hospitalized With Acute Decompensated Heart 
Failure##1032-90·87A
Doppler ultrasound
A Novel Echo-Doppler Method to Predict Diastolic and Mean 
Pulmonary Artery Pressures: Derivation and Validation by 
Catheterization## 852-6·249A
Aviodance of Left Ventricular Dyssynchrony Detected by 
Tissue Doppler Echocardiogrphy by Permanent Right 
Ventricular Septal Pacing in Patients With High-Grade 
Avtrioventricular Block## 969-139·23A
Brain Natriuretic Peptide and Systolic or Isolated Diastolic 
Heart Failure in the Community##942-92·48A
Can Displacement or Strain Imaging Predict a Favorable 
Response to Cardiac Resynchronization Therapy?## 
948-4·117A
Can Stress Echocardiography With Tissue Characterization 
Evaluate Non-Critical Coronary Stenosis? A Validation 
Study Against Simultaneous Measurement of Fractional 
Flow Reserve## 925-39·102A
Changes in Doppler Tissue Indices Are More Related With 
Improvement of Functional Status in Diastolic Heart 
Failure Than BNP Levels##942-99·49A
Colour-coded Tissue Tracking Is an Accurate, Fast, and Simple 
Tool for Identiﬁcation of Non-ischemic Patients in the 
Hand of Inexperienced Stress Echocardiography Reader## 
948-44·124A
Combined ANG-1 and VEGF Gene Transfer Enhances 
Perfusion and Improves Segmental Systolic Velocity in 
a Swine Chronic Myocardial Ischemic Model## 856-
5·234A
Comparison of Autonomic Control Between Atrial Septal 
Defect and Ventricular Septal Defect Based on Heart Rate 
Variability and Respiration##1011-113·244A
Delayed Diastolic Untwisting in Chronic Mitral 
Regurgitation## 846-7·148A
Determinants of Left Atrial Function by Strain Rate Imaging in 
Healthy Subjects## 925-42·103A
Direct Ultrasound Measurement of the 3 Principal Components 
of Left Ventricular Regional Systolic Strain## 948-2·116A
Do Changes in Systolic Myocardial Velocities Precede 
Changes in Ejection Phase Indices of Ventricular Systolic 
Performance in Duchenne Muscular Dystrophy?##967-
113·241A
Echocardiographic Evaluation of Left Ventricular Filling 
Pressure During Exercise Validated With Hemodynamic 
Measurement## 831-3·133A
End Diastolic Pulmonary Regurgitation Gradient Predicts 
Adverse Cardiovascular Outcomes: Data from the Heart 
and Soul Study## 902-18·98A
Feasibility of Using Spatiotemporal Image Correlation to 
Allow 3D Assessment of Right and Left Ventricular 
Volumes and Function in the Human Fetus## 991-
34·138A
Improvement of Diastolic Function Is related to Left 
Ventricular Reverse Remodeling After Mid-Term Cardiac 
Resynchronization Therapy##942-58·46A
Inﬂuence of Hemodialysis on the Blood Flow of AV Shunt 
and Contralateral Sides of Internal Thoracic Artery## 
902-42·101A
Is Echocardiographic Atrio-Ventricular Optimization in 
Patients With Biventricular Pacemakers Needed? An 
Acute Hemodynamic Study## 805-6·111A
Lack of Association Between QRS Duration and Cardiac 
Asynchrony in Candidates for Cardiac Resynchronization 
Therapy## 969-143·24A
Myocardial Contractile Reserve Is Depressed in Patients With 
Obstructive Sleep Apnea##964-60·56A
Peak Systolic Strain and Strain Rate in Children With 
Pulmonary Hypertension: A Tissue Doppler Study and 
Correlation With Cardiac Catheterization Data##936-
186·306A
Prolongation of Time to Peak Strain During Adenosine 
Triphosphate Stress Is a Marker of Impaired Coronary 
Flow Velocity Reserve## 948-7·117A
Should We Measure Both Electrical and Mechanical 
Dyssynchrony in Patients With Advanced Heart Failure? 
Learning From Long-Term Clinical Follow-Up##1008-
59·78A
Subendocardial LV Strain Measurements During ATP 
Infusion## 846-5·148A
The Accuracy of Real-Time Three-Dimensional Doppler 
Echocardiography for Computing LV Stroke Volume 
Compared to Phase Contrast Magnetic Resonance 
Imaging in Patients## 991-41·140A
The Haemodynamic, and Humoral Mediators of Left 
Ventricular Diastolic Dysfunction in Essential 
Hypertension: A Tissue Doppler Imaging Study##1028-
204·373A
The Incidence of Intraventricular Dyssynchrony in Patients 
With Dilated Cardiomyopathy With Narrow QRS 
Duration: Studied by Tissue Doppler and Strain 
Image##1008-96·80A
Three-Dimensional Evaluation of Dobutamine-Induced 
Changes in Regional Myocardial Deformation in Ischemic 
Myocardium Using Tissue Strain Measurements: The 
Role of Circumferential Myocardial Shortening## 948-
34·121A
Time Resolved Sequence of Left Ventricular Flow Redirection 
during Isovolumic Intervals of the Cardiac Cycle## 
805-3·110A
Time to End Systolic Velocity, a Novel Tissue Doppler 
Measurement, Correlates Best With Maximal 
Longitudinal Contraction## 948-8·118A
Tissue Doppler Imaging Predicts NYHA Functional Class 
and Plasma BNP Levels in Patients With Hypertrophic 
Cardiomyopathy## 948-1·116A
Tricuspid Annular and Septal Doppler Tissue Velocities are 
Reduced in Pediatric Heart Transplant Recipients##967-
114·241A
Usefulness of 2-dimensional Longitudinal Strain of Apical 
Septum to Predict Functional Recovery After Successful 
Primary Revascularization Procedure in Anterior Wall 
Myocardial Infarction## 948-5·117A
Vasoreactive Response to Maternal Hyperoxygenation in the 
Fetus with Hypoplastic Left Heart Syndrome##1011-
109·244A
Dose-response relationship, drug
Paradoxical Decrease in Plasma N-Terminal-proBNP (NT-
proBNP) Levels in Patients Receiving Doxorubicin 
Chemotherapy and Declining Left Ventricular Ejection 
Fraction##986-57·66A
Drug administration
A New Concept of Local Paclitaxel Delivery for Prevention 
of Restenosis: Intracoronary Paclitaxel Delivery With the 
New Genie®-application Device##956-166·319A
Effect of Amlodipine on the Restenosis and Clinical Outcome 
in Patients With Coronary Artery Disease After 
Angioplasty : Results From the Cardiovascular Events 
Follow-Up Trial in Kokura (CAVEFT-Kokura)##999-
255·218A
Exogenous Adenosine Triphosphate Disodium During 
Primary Percutaneous Coronary Intervention Preserves 
Microvascular Integrity and Left Ventricular Function in 
Patients with Acute Myocardial Infarction Regardless of 
Antecedent Angina## 1016-39·150A
Patient Safety Suffers at Nursing Shift Changes: Error 
Rate Peaks for Intravenous Unfractionated Heparin 
Administration##946-153·255A
Drug interactions
High Dose Atorvastatin Does Not Impact the Efﬁcacy of 
Clopidogrel - A PROVE IT TIMI-22 Analysis## 855-
8·380A
Link of Serum CK Activities to Vascular Smooth Muscle 
Revealed by Physiological-genomic Analyses of Statin-
treated Patients##956-168·319A
Drug therapy
5-Fluorouracil Improves Postinfarct Left Ventricular 
Dysfunction due to Upregulated SDF-1, Mobilized CD34 
Positive Cells and Attenuated Fibrosis##927-219·170A
Combination Therapy With Motexaﬁn Gadolinium and 
Ascorbate Stabilizes Plaques in Fat-Fed Apolipoprotein E 
Knockout Mice##937-192·308A
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CYP2C19*2 Polymorphism Contributes to a Diminished 
Pharmacodynamic Response to Clopidogrel## 855-
7·380A
Effect of Angiotension Receptor Blockade Alone or in 
Combination with Spironolactone on Left Ventricular 
Systolic and Diastolic Function in Chronic Heart 
Failure##942-53·45A
Effects of Ezetimibe/Simvastatin Compared to Simvastatin 
Monotherapy in Reducing C-Reactive Protein and Low 
Density Lipoprotein-Cholesterol## 808-5·316A
Efﬁcacy and Safety of Extra Class IC Doses for Pharmacologic 
Cardioversion in Patients Maintained on Class IC Drugs 
for Atrial Fibrillation##938-200·309A
Enoxaparin Dosing and Bleeding in Real World Practice: 





 Receptor Selectivity of Endothelin-1 Receptor 
Antagonists in Human Myocardial Membranes##936-
191·307A
Fluvastatin Reduces Coronary Plaque and Increases Lumen 
Volume: Assessment by Multislice CT## 970-11·126A
Haemodilution Is the Primary Cause of Mild Anaemia in Heart 
Failure##986-52·65A
HMG-CoA Reductase Inhibitors Are Effective for Prevention 
of Acute Coronary Artery Injury in a Rabbit Model of 
Kawasaki disease##1011-110·244A
Home Uptitration of Beta-blockers by Heart Failure 
Clinic Patients With Telephone Advice: A British 
experience##1036-152·270A
Improved Prescription of Evidence-Based Medications and 
Maintenance of High Adherence to These Medications in 
Acute Coronary Syndrome Patients After Implementation 
of Guidelines Applied in Practice##946-146·254A
Improved Visualization of Thrombus Using tPA-Encapsulated 
Echogenic Liposomes## 1016-35·149A
Improvement of Metabolic Parameters with Rimonabant 
Beyond the Effect Attributable to Weight Loss Alone: 
Pooled 1-Year Data from the RIO (Rimonabant In Obesity 
and Related Metabolic Disorders) Program## 849-3·362A
Inﬂammatory Activation During Coronary By-pass Surgery 
and the Effect of High Dose Statin Plus ACE-inhibitor 
Treatment## 845-3·359A
Long- Term Sildenaﬁl Administration Improves Aortic 
Stiffness and Wave Reﬂections in Patients With Erectile 
Dysfunction of Vascular Origin##1026-188·370A
Outcome of Medical Management of Patients With Severe 
Multi Vesssel Coronary Artery Disease Unsuitable for 
Revascularization##999-258·219A
Paclitaxel-Eluting Stents Implanted in De-Endothelialized 
Coronary Arteries for 180 Days Did Not Cause Luminal 
Thrombi Using Standard Antiplatelet Therapy##956-
167·319A
Patients’ Pill Burden Predicts Adherence to Antihypertensive 
and Lipid-lowering Therapy## 834-6·263A
Platelet Reactivity in Coronary Artery Disease Patients with 
Depression: Are All Anti-Depressants Equal?##1005-
204·353A
Selective Cyclooxygenase-2 Inhibition by Celecoxib Abrogates 
the Acute Smoking-Induced Vascular Dysfunction## 
841-3·356A
Socioeconomic Differences in Use of Secondary Preventive 
Medication After Myocardial Infarction: A National 
Population-Based Study##1020-249·229A
Speciﬁc Effects of Statins on Gene- Proﬁling in Human End- 
Stage Stenotic Calciﬁed Aortic Valves##1030-23·286A
The Impact of Medication Non-adherence on Hospitalization 
and Mortality Among Patients With Diabetes## 834-
7·264A
The Inﬂuence of Baseline Platelet Aggregation Response on 
Subsequent Inhibition of Aggregation Achieved With 
Clopidogrel or Prasugrel## 855-3·378A
The Rosuvastatin Impact on Ventricular Remodeling Cytokines 
and Neurohormones (UNIVERSE) Study## 816-6·61A
Triple-Therapy with a Statin, Fibrate and Ezetimibe Safely 
Allows More Diabetic Patients with Mixed Dyslipidemias 
to Reach NCEP Guidelines: An Analysis of The DIACOR 
Study## 808-6·316A
Echocardiography, contrast
A Novel Double-Shelled Microsphere Targeted to 
Leukocyte Adhesion Molecules Adheres to Inﬂamed 
Microcirculation in Vivo## 1016-34·149A
Adenosine Stress Myocardial Contrast Perfusion Imaging: 
Comparison With Radionuclide SPECT## 1016-44·151A
Can Nornal Myocardial Perfusion During Dobutamine Stress 
Echocardiography Predict a Good Long Term Prognosis 
in Women?## 1016-45·152A
Comparison of Continuous Infusion Versus Bolus Injection 
of Intravenous Microbubbles in Detecting Myocardial 
Perfusion Defects During Dobutamine Stress 
Echocardiography## 1016-38·150A
Comparison of Myocardial Contrast Echocardiography 
Versus Sestamibi Myocardial Perfusion Imaging in Early 
Diagnosis of Acute Coronary Syndrome## 827-5·132A
Contrast Stress Echocardiography for Improved Accuracy in 
Evaluation of Myocardial Ischemia in Women## 948-
33·121A
Coronary Blood Flow and Coronary Flow Reserve by Contrast-
Enhanced Transthoracic Echocardiography Predict Long-
Term Outcome in Heart Transplantation##1010-105·82A
Do Simple Clinical and Echocardiographic Parameters Predict 
Long Term Responsiveness to Cardiac Resynchronization 
Therapy? Results From the CARE-HF Trial##1008-
52·76A
Effect Of Coronary Stenosis On Adjacent Bed Microvascular 
Flow Reserve: Assessment Using Myocardial Contrast 
Echocardiography ## 827-4·132A
Effect of Non-critical Coronary Stenosis, Adenosine, and 
Dobutamine on Phasic Changes in Myocardial Blood 
Volume## 1016-43·151A
Effects of Transcranial Ultrasound and Intravenous 
Microbubbles on Blood Brain Barrier Permeability## 
1016-33·149A
Electrocardiographic Unrecognized Myocardial Infarction 
Is Associated With Increased Mortality Independent 
of Regional Wall Motion Abnormalities on 
Echocardiogram##971-218·194A
Exogenous Adenosine Triphosphate Disodium During 
Primary Percutaneous Coronary Intervention Preserves 
Microvascular Integrity and Left Ventricular Function in 
Patients with Acute Myocardial Infarction Regardless of 
Antecedent Angina## 1016-39·150A
High Resolution Myocardial Perfusion Imaging in Mice by 
Microbubble Depot and Delayed Opaciﬁcation## 1016-
41·151A
Improved Visualization of Thrombus Using tPA-Encapsulated 
Echogenic Liposomes## 1016-35·149A
Incremental Value of Quantitative Analysis of Myocardial 
Perfusion in Dobutamine and Adenosine Stress Real-Time 
Perfusion Echocardiography## 1016-37·150A
Interactive Computer Detection of Nonperfused Myocardial 
Area in Attenuated Harmonic Contrast Images## 1016-
42·151A
Novel Transthoracic Triplane-Echocardiography With Contrast 
Agent Improves the Accuracy of Left Ventricular Volume 
Measurements: A Comparison With Magnetic Resonance 
Imaging## 1016-36·150A
Quantitative Assessment of Regional Left Ventricular Wall 
Motion From Real-Time 3D Echocardiography: Effects 
of Dual-Triggered Contrast Enhancement Tested Against 
Magnetic Resonance## 1016-46·152A
Reduced Septal Wall Thickness not Hypoperfusion is 
the Cause of Perfusion Defects on Single Photon 
Emission Computed Tomography in Patients With 
Left Bundle Branch Block Without Coronary Artery 
Disease: Comparison With Myocardial Contrast 
Echocardiography## 827-3·131A
The Effect of Atherosclerotic Plaque and Complement Levels 
on Microbubble Adherence to the Vascular Wall##977-
161·328A
The OPTIMIZE Trial: A Randomized Cross-Over Trial of 
Dobutamine Echocardiography, With and Without 
Deﬁnity™ Evaluating the Effect of Contrast on the 
Accuracy of Diagnosing Coronary Artery Disease## 
806-6·112A
The Role of Contrast-Enhanced Real-Time 3D Stress 
Echocardiography in Diagnosing Coronary Artery 
Disease## 991-42·140A
The Use of Contrast Improves Positive Predictive Value and 
Result Determinability in Routine Dobutamine Stress 
Echocardiography## 827-6·132A
Transient ST-Segment Depression Only During Paroxysms of 
Atrial Fibrillation in Patients Without History of Coronary 
Artery Disease. What Non-invasive Test to Unmask 
Severe Underlying Coronary Artery Disease?## 1016-
40·150A
Unrecognized Myocardial Infarction: The Association With 
Cardiopulmonary Symptoms and Mortality is Mediated 
Via Echocardiographic Abnormalities of Global 
Dysfunction Instead of Regional Dysfunction. The 
Olmsted County Heart Function Study##950-215·180A
Value of Electrocardiographic Findings in Predicting Rest Left 
Ventricular Diastolic and Systolic Function in Community 
Dwelling Adults##942-97·49A
Echocardiography, stress
3D Contraction Front Mapping: Initial Experience With a 
Novel 3D Echo Technique to Visualise Left Ventricular 
Mechanical Contraction## 991-37·139A
Acute Changes in N-terminal pro-Brain Natriuretic Peptide 
Induced by Dobutamine Stress Echocardiography## 
948-45·124A
Adenosine Stress Myocardial Contrast Perfusion Imaging: 
Comparison With Radionuclide SPECT## 1016-44·151A
Adenosine Triphosphate Stress Strain Measurements Before 
and After Percutaneous Coronary Interventions## 948-
14·119A
Appearance of Right Ventricular Activation Delay by 
Pilsicainide Challenge Impaired Myocardial Performance 
Index in Brugada Syndrome## 948-42·123A
Association of Chronotropic Incompetence With Exercise 
Induced Echocardiographic Ischemia and Prognosis## 
948-38·122A
Can Nornal Myocardial Perfusion During Dobutamine Stress 
Echocardiography Predict a Good Long Term Prognosis 
in Women?## 1016-45·152A
Can Stress Echocardiography With Tissue Characterization 
Evaluate Non-Critical Coronary Stenosis? A Validation 
Study Against Simultaneous Measurement of Fractional 
Flow Reserve## 925-39·102A
Color M-mode Strain Rate Stress Echocardiography Predicts 
Prognosis in Patients Evaluated for Coronary Disease## 
948-40·123A
Combined ANG-1 and VEGF Gene Transfer Enhances 
Perfusion and Improves Segmental Systolic Velocity in 
a Swine Chronic Myocardial Ischemic Model## 856-
5·234A
Contrast Stress Echocardiography for Improved Accuracy in 
Evaluation of Myocardial Ischemia in Women## 948-
33·121A
Does Real Time Three-Dimensional Dobutamine Stress 
Echocardiography Is the Method of Choice in Patients 
Qualiﬁcation Towards Severe Ischemic Mitral 
Regurgitation to Cardiosurgical Treatment?## 991-
43·140A
Effect of Non-critical Coronary Stenosis, Adenosine, and 
Dobutamine on Phasic Changes in Myocardial Blood 
Volume## 1016-43·151A
Enhancement of Cardiac Rotation as a Possible Mechanism 
of During Dobutamine Stress Echocardiography: A 
Compensatory Mechanism for Decreased Myocardial 
Strain Under Tachycardia?## 948-29·120A
Flow-Function Relationship in Left Anterior Descending 
Artery Territory: Correlation of Adenosine Induced 
Strain Rate Changes and Simultaneously Estimated Fow 
Reserve## 948-36·122A
Greater Reduction in Mitral Regurgitation During Therapy 
Guided by Measured Filling Pressures##1008-94·79A
How Should Dobutamine Stress Echocardiography and 
Multislice Computed Tomography be Used to Assess 
Coronary Heart Disease in the Clinical Settings?## 948-
39·122A
Impact of the Change of Myocardial Velocity on Exercise-
Induced Functional Mitral Regurgitation in Patients with 
Non-Ischemic Cardiomyopathy## 806-8·113A
Incremental Prognostic Value of Transient Ischemic Left 
Ventricular Cavity Dilatation on Stress Echocardiography 
Over Historical, Clinical, Resting and Stress 
Echocardiographic Variables## 948-43·123A
Incremental Value of Quantitative Analysis of Myocardial 
Perfusion in Dobutamine and Adenosine Stress Real-Time 
Perfusion Echocardiography## 1016-37·150A
Inotropic Stimulation Enhanced Left Ventricular Endocardial 
Apical Twisting in Normal Subjects: Evaluation by a 
Novel Automated Tracking Technique## 948-35·122A
Long-Term Prognostic Value of Negative Exercise 
Echocardiogram: Do Stress Electrocardiographic Changes 
Really Matter?## 806-5·112A
Myocardial Contractile Reserve Is Depressed in Patients With 
Obstructive Sleep Apnea##964-60·56A
Noninvasive Diagnosis of Coronary Vasospasm by Detection 
of Regional Left Ventricular Delayed Relaxation 
Following Hyperventilation With Color Kinesis## 806-
3·112A
Prolongation of Time to Peak Strain During Adenosine 
Triphosphate Stress Is a Marker of Impaired Coronary 
Flow Velocity Reserve## 948-7·117A
Survival in Ischemic Cardiomyopathy: Medical Therapy is 
Superior to Revascularization in Patients With Limited 
Viability##1008-95·79A
Sustained Improvement in Right Ventricular Function 
After Therapy to Reduce Congestion in the ESCAPE 
Trial##1032-91·88A
The OPTIMIZE Trial: A Randomized Cross-Over Trial of 
Dobutamine Echocardiography, With and Without 
Deﬁnity™ Evaluating the Effect of Contrast on the 
Accuracy of Diagnosing Coronary Artery Disease## 
806-6·112A
The Role of Contrast-Enhanced Real-Time 3D Stress 
Echocardiography in Diagnosing Coronary Artery 
Disease## 991-42·140A
The Use of Contrast Improves Positive Predictive Value and 
Result Determinability in Routine Dobutamine Stress 
Echocardiography## 827-6·132A
Three-Dimensional Evaluation of Dobutamine-Induced 
Changes in Regional Myocardial Deformation in Ischemic 
Myocardium Using Tissue Strain Measurements: The 
Role of Circumferential Myocardial Shortening## 948-
34·121A
Three-Dimensional Stress Echocardiography Shortens Imaging 
Time With Excellent Concordance With Conventional 
Dobutamine Stress Echocardiography## 806-7·112A
Usefulness and Cost Effectiveness of Squatting Stress 
Echocardiography in the Diagnosis of Coronary Artery 
Disease## 948-37·122A
Wireless Transmission of Images Obtained During Ambulatory 
Echocardiography With a Novel Low Proﬁle Ultrasound 
Transducer.## 902-29·98A
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Echocardiography, transesophageal
Association Between Carotid Intima-Media Thickness and 
Aortic Arch Plaque Thickness in the Elderly##980-
188·334A
Atherosclerosis of the Aorta Is Strongly Associated With 
Calciﬁc Aortic Valve Stenosis Independently of Classical 
Atherosclerosis Risk Factors##1030-25·287A
Atrial septal Aneurysm Predicts Persistent Residual Shunt 
Following PFO Closure With CardioSEAL/STARFlex 
Occluder Device## 1017-3·152A
Effect of Pitavastatin Therapy on the Thoracic Aorta in 
Hypercholesterolemic Patients Evaluated With Integrated 
Backscatter and Wall Thickness by Transesophageal 
Echocardiography## 1017-7·153A
Incidence and Prognosis of Pacemaker Lead Associated 
Masses: A Study of 1569 Transesophageal 
Echocardiograms## 1017-6·153A
Is Myxomatous Mitral Valve Disease the Leading Cause 
of Partially Flail Mitral Valve Leaﬂet and Ruptured 
Chordae?##962-20·278A
Left Atrial Functional Reserve Can Predict the Long 
Term Prognosis of the Cardioverted Chronic Atrial 
Fibrillation?## 1017-4·153A
Long-Term Follow-Up in Patients With Percutaneous Left 
Atrial Appendage Transcatheter Occlusion System 
(PLAATO): Risk of Thrombus Formation and 
Development of Pulmonary Venous Obstruction After 
Percutaneous Left Atrial Appendage Occlusion## 1015-
142·36A
Multidetector Row Computed Tomography and Magnetic 
Resonance Imaging Can Accurately Estimate Aortic Valve 
Area as Compared to Transthoracic and Transesophageal 
Echocardiography## 970-17·128A
PFO Closure With the Amplatzer, CardioSEAL-STARﬂex and 
Helex Occluder: A Randomized Trial##945-109·238A
Pulmonary Vein Size Greater Than 1.7cm Measured on 
Transesophageal Echocardiography Predicts Recurrence 
of Atrial Fibrillation After Cardioversion## 1017-5·153A
Success of Surgical Left Atrial Appendage Occlusion 
Techniques Assessed by Transesophageal 
Echocardiography## 1017-1·152A
Three-Dimensional Imaging Surpasses Conventional 
Transesophageal Echocardiography for Preoperative 
Conceptualization in Mitral Valve Prolapse## 991-
32·138A
Warfarin Therapy Initiated Before Transesophageal 
Echocardiography Detected Left Atrial Thrombus Is More 
Beniﬁcial Than When Started After## 1017-2·152A
Echocardiography, transthoracic
3D Real Time-Echocardiography: A Novel Tool in the 
Assessment of Intraventricular Mechanical Asynchrony in 
Heart Failure Patients## 839-6·147A
A Novel Method Using Real-Time 3D Echo in Assessment of 
Ventricular Dyssynchrony: Virtual Resynchronization## 
991-35·139A
A Novel Two-Dimensional Echocardiographic Image 
Analysis System Using Artiﬁcial Intelligence Shape 
and Pattern Recognition for Rapid Automated Ejection 
Fraction##1012-147·264A
A Novel, Simpliﬁed Two-Dimensional Echocardiographic 
Measure of Left Ventricular Dyssynergy Predicts Patient 
Response to Cardiac Resynchronization Therapy##1008-
98·80A
A Small Pericardial Effusion is a Marker of Shortened 
Survival## 902-13·96A
Abnormal Radial Strain in Both Infarcted and Remote 
Myocardial Regions Following Ischemia and Reperfusion 
in Rats Assessed by 2D Strain Echocardiography##971-
221·195A
Acute Left Atrial Reverse Remodeling After Pulmonary 
Venous Ablation: Evaluation With Tissue Doppler 
Myocardial Velocities## 805-7·111A
Acute Volume Loading Inﬂuences Left Ventricular Apical 
Twist: Studies in an Animal Model## 948-6·117A
Aging Modiﬁes Cardiac Phenotype of Mice Expressing 
Familial Hypertrophic Cardiomyopathy Linked Troponin 
T Mutants##965-100·59A
An Evaluation of Optimal AV Delays During Exercise in Heart 
Failure Patients Receiving Cardiac Resynchronization 
Therapy## 1015-124·31A
Analysis of Myocardial Deformation Based on Ultrasonic 
Pixel Tracking for Deﬁnition of Transmurality in Chronic 
Myocardial Infarction## 831-6·134A
Aortic Valve Replacement in Patients With Moderate to 
Severe Aortic Stenosis Does Not Prevent Bleeding From 
Gastrointestinal Arteriovenous Malformations##1030-
22·286A
Arachidonic Acid and Docosahexaenoic Acid Supplementation 
Increases Coronary Flow Velocity Reserve in Healthy 
Japanese Elderly Individuals##1024-175·367A
Are the American Heart Association Bacterial Endocarditis 
Prophylaxis Guidelines Obsolete?## 902-35·99A
Assessement of Intraventricular Asynchrony in Patients 
With Atrial Fibrillation Using Tri-plane Tissue Doppler 
Imaging## 846-3·147A
Assessment of Left Ventricular Function in Patients with 
Ischemic Heart Disease and Heart Failure by Three-
Dimensional Echocardiography and Cardiac Magnetic 
Resonance Imaging## 839-7·147A
Assessment of Longitudinal, Radial and Circumferential 
Dyssynchrony Using Speckle Tracking and Tissue 
Doppler in Patients With Systolic Heart Failure and 
Narrow QRS## 831-5·134A
Assessment of Mitral Regurgitation by CMR Derived 
Regurgitant Volume and Fraction: Is It Superior to 
Echocardiographic ERO?## 844-8·285A
Assessment of the Severity of Outﬂow Obstruction in Patients 
With Hypertrohyphic Cardiomyopathy: A Real-Time 
Three-Dimensional Echocardiographic Study## 839-
3·146A
Association of Left Bundle Branch Block with New Onset 
Abnormal Left Ventricular Wall Motion in Hypertensive 
Patients with Left Ventricular Hypertrophy: The LIFE 
study## 902-40·100A
Aviodance of Left Ventricular Dyssynchrony Detected by 
Tissue Doppler Echocardiogrphy by Permanent Right 
Ventricular Septal Pacing in Patients With High-Grade 
Avtrioventricular Block## 969-139·23A
Baseline Dyssynchrony Derived by Strain Imaging Correlates 
With the Effect of Cardiac Resynchronization Therapy at 
1-Month Follow-Up## 925-36·102A
Bicuspid Aortic Valve Phenotype Predicts Aortic Elastic 
Properties## 803-6·276A
Biochemical Markers of Collagen Turnover in Asymptomatic 
Aortic Regurgitation With Normal EF and LV 
Dimension## 844-5·285A
Biochemical Markers of Collagen Turnover in Atrial 
Fibrillation## 1015-137·34A
Brain Natriuretic Peptide Plasma Levels Combined to Diastolic 
Filling Pattern Predict Ventilatory Response to Exercise in 
Patients With Chronic Heart Failure## 902-11·96A
Calculation of Pulmonary Vascular Resistance Reclassiﬁes 
Patients Identiﬁed as Having Pulmonary Hypertension in 
Routine Echocardiography## 831-4·134A
Cardiac Hypertrophy and Renal Disease in GLUT1-
Overexpressing Mice##918-51·38A
Cardiac Remodeling in Professional Tennis Players 
Participating in Roland-Garros Grand Slam## 902-4·94A
Cardiac Resynchronization Therapy (CRT) In Patients With 
Left Ventricular Dysfunction and Narrow QRS Complex: 
Sequential Echocardiographic Dyssynchrony Analysis 
and Correlation with Improvements in Heart Failure 
Symptoms## 1015-123·31A
Cause of Death and Serum Cardiac Troponin Levels Predict 
Cardiac Function in Heart Transplant Donors##966-
106·60A
Characteristics, Treatments and Outcomes of Patients 
Hospitalized for Heart Failure with Preserved Systolic 
Function: A Report from OPTIMIZE-HF##942-90·47A
Coexistence and Post-Exercise Exacerbation of Intra-Left 
Ventricular Contractile Dyssynchrony in Medically 
Controlled Hypertensive Patients with Diastolic 
Dysfunction: A Tissue Doppler Echocardiography 
Study## 925-40·103A
Comparison and Co-Relation of Invasive and Noninvasive 
Methods of Ejection Fraction Measurement##919-53·38A
Comparison of 64-Slice Computed Tomography and 
Transthoracic Echocardiography in Quantiﬁcation of 
Native Aortic Valve Stenosis## 832-5·135A
Comparison of Reverse Ventricular Remodeling Between 
Surgical Direct Epicardial and Tranvenous Coronary 
Sinus Lead Placement for Cardiac Resynchronization 
Therapy## 1015-125·32A
Comparison of Usefulness of Newer Echo-Doppler Variables 
to Left Ventricular End-Diastolic Pressure in Predicting 
Heart Failure## 902-37·100A
Comparison of Various Dyssynchrony Parameters of 
Echocardiography in the Canine Model of Heart Failure 
With Dyssynchrony## 948-9·118A
Congenitally Corrected Transposition of the Great Ateries: 
Intermediate Results of the Anatomic Repair## 852-
7·249A
Coronary Calciﬁcation and Left Atrial Size Are of Additive 
Incremental Value to the Framingham Risk Score for the 
Prediction of Cardiovascular Events##983-204·337A
Correlates of Arrhythmic Risk in MADIT II Patients: Signal 
Averaged EKG and Cardiac MRI## 993-29·146A
Correlation Between Acute Effect of Cardiac 
Resynchronization Therapy and Mechanical 
Dyssynchrony Measured by Tissue Velocity and Strain 
Parameters## 902-7·95A
Deﬁnition of Optimal Left Ventricular Lead Position in 
Cardiac Resynchronisation Therapy Using Myocardial 
Deformation Imaging## 810-4·11A
Delayed Diastolic Untwisting in Chronic Mitral 
Regurgitation## 846-7·148A
Determinants of Left Atrial Function by Strain Rate Imaging in 
Healthy Subjects## 925-42·103A
Determinants of the Severity of Functional Tricuspid 
Regurgitation: The Emerging Role of the Right 
Ventricular Geometry## 844-7·285A
Diastolic Dysfunction in Hypertrophic Cardiomyopathy 
Is Related to Myocardial Fibrosis as Determined by 
Cardiovascular Magnetic Resonance##943-101·50A
Diastolic Dysfunction Predicts Enhanced Ventilatory Response 
to Exercise in Patients With Chronic Heart Failure## 
902-44·101A
Difference in the Left Atrial Function Between Patients 
With Hypertensive Hypertrophy and Hypertrophic 
Cardiomyopathy Evaluated by Tissue Strain Imaging## 
948-18·120A
Direct Ultrasound Measurement of the 3 Principal Components 
of Left Ventricular Regional Systolic Strain## 948-2·116A
Discrimination of Left Ventricular Radial Wall Motion 
Dyssynchrony From Contractile Synchronicity on 
the Basis of Displacement and Strain Imaging by 
Two-Dimensional Echocardiography in Patients With 
Pulmonary Hypertension## 948-12·119A
Does Left Bundle Branch Block Indicate a Better Response 
to Cardiac Resynchronization Therapy in Heart Failure 
Patients with Echocardiographic Evidence of Mechanical 
Asynchrony?## 969-127·21A
Does Normalization for Body Size Variables Actually Work in 
a Pediatric Population?##989-114·243A
Does Standard Normalization for Body Size Variables Actually 
Work?## 805-4·110A
Doppler Derived Strain Measurements for Evaluation of 
Effects of Biventricular Pacing: Comparison With Right 
Ventricular Pacing Using Oxygen-15 Positron Emission 
Tomography## 948-3·117A
Dyssynchrony in Heart Failure Patients With Narrow QRS 
Versus Wide QRS: Insights From Radial Strain by 
Echocardiographic Speckle Tracking## 831-7·134A
Echocardiographic Epicardial Adipose Tissue as an Another 
Imaging Indicator of Visceral Adipose Tissue## 902-
10·96A
Echocardiographic Parameters of Right Heart Function in 
Patients With Symptoms of Heart Failure## 902-41·101A
Echocardiographic-Determined Septal Morphology in Z-Disc 
Hypertrophic Cardiomyopathy## 817-4·63A
Effect of Postero-lateral Scar Tissue on Clinical and 
Echocardiographic Improvement Following Cardiac 
Resynchronization Therapy## 810-6·12A
Effects of Differents Pacing Modes on Right Ventricular 
Function in Cardiac Resynchronization Patients## 1015-
128·32A
Effects of Isolated Obesity on Cardiac Functions: A Tissue 
Doppler and Strain Rate Imaging Study## 902-9·95A
Exaggerated Alterations in Left ventricular Relaxation and 
Chamber Compliance With Pressure Loading in a Model 
of Left Ventricular Dysfunction With Preserved Ejection 
Fraction##942-54·46A
Feasibility of Transthoracic Doppler-determined Coronary 
Flow Reserve for the Assessment of Left Main Trunk 
Stenosis## 902-14·97A
Impact of Antiphospholipid Antibodies on Cardiovascular 
Disease in Systemic Lupus Erythematosus## 803-7·277A
Inappropriate Left Ventricular Mass Identiﬁes Hypertensive 
Patients With High-Risk Cardiac Phenotype## 835-
8·343A
Inferior Myocardial Infarction is Associated with Greater 
Left Ventricular Dyssynchrony and Mitral Regurgitation 
Compared to Anterior Myocardial Infarction## 902-
43·101A
Inﬂuence of Location of Scar Tissue in Cardiac 
Resynchronization Therapy## 969-129·21A
Initial Experience of New Three-Dimensional Annuloplasty 
Ring for Functional Tricuspid Regurgitation##917-
27·273A
Inotropic Stimulation Enhanced Left Ventricular Endocardial 
Apical Twisting in Normal Subjects: Evaluation by a 
Novel Automated Tracking Technique## 948-35·122A
Insulin Resistance is a Determinant of Myocardial Dysfunction 
in Apparently Healthy Obese Subjects##964-54·55A
Intra-Left Ventricular Contractile Dyssynchrony Is 
Independently Associated with Diastolic Heart Failure in 
Medically Controlled Hypertensive Patients## 851-5·92A
Intraventricular Dyssynchrony Measured by Tissue Velocity 
Does Not Change Acutely After CRT## 925-41·103A
Is Echocardiographic Atrio-Ventricular Optimization in 
Patients With Biventricular Pacemakers Needed? An 
Acute Hemodynamic Study## 805-6·111A
Is Myxomatous Mitral Valve Disease the Leading Cause 
of Partially Flail Mitral Valve Leaﬂet and Ruptured 
Chordae?##962-20·278A
Left Atrial Emptying Rate: A Marker of Hypertrophy and 
Diastolic Dysfunction in Patients With Hypertrophic 
Cardiomyopathy##943-104·51A
Left Atrial Mechanics in Type 2 Diabetics## 948-17·120A
Left Atrial Size Can Identify the Highest Risk Multicenter 
Automatic Deﬁbrillator Implantation Trial-II Patients for 
Ventricular Arrhythmic Events## 805-8·111A
Left Atrial Volume is a Predictor of Atrial Fibrillation 
Recurrence After Catheter Ablation## 902-6·95A
Left Atrial Volume Mirrors Diastolic Dysfunction Caused by 
Hypertension Alone##942-60·47A
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Left Ventricular Apical Rotation is Impaired in Patients with 
Dilated Cardiomyopathy: Quantitative Analysis by Two-
Dimensional Tissue Tracking System## 902-15·97A
Left Ventricular Dysfunction and Mortality in Patients with 
Eisenmenger Syndrome## 852-8·249A
Left Ventricular Myocardial Performance Index is Abnormal 
in Patients With Repaired Tetralogy of Fallot##1035-
116·248A
Left Ventricular Remodeling Index Assessed by Real-Time 
Three-Dimensional Echocardiography in Various 
Pathophysiologic Conditions## 839-4·146A
Left Ventricular Torsion Is not Inﬂuenced by Acute Preload 
Change## 846-6·148A
Left Ventricular Untwisting Was Delayed and Reduced in 
Patients With Hypertensive Left Ventricular Hypertrophy: 
Demonstration by 2-Dimensional Speckle Tracking 
Imaging## 902-30·98A
Longitudinal Systolic Motion Assessed by Doppler Myocardial 
Imaging Is Impaired in Children With Acute Kawasaki 
Disease## 948-10·118A
Measurement of Cardiac Output by Real-Time 3-D 
Echocardiography in Patients Undergoing Assessment for 
Cardiac Transplantation## 991-45·141A
Metoprolol Prevents Progression of Diastolic Dysfunction 
in Patients With Asymptomatic Left Ventricular 
Systolic Dysfunction: Observations From the REVERT 
Trial##942-95·49A
Mitral Valve Repair with a Novel Etiology-Speciﬁc 
Annuloplasty Ring for Ischemic Mitral Regurgitation: 
Early Echocardiographic Results from a Multi-center 
Study##917-23·272A
Morphologic Ventricular Adaptations to Training in Young 
Soccer Players and Swimmers: An Echocardiographic 
Study## 902-5·95A
Multidetector Row Computed Tomography and Magnetic 
Resonance Imaging Can Accurately Estimate Aortic Valve 
Area as Compared to Transthoracic and Transesophageal 
Echocardiography## 970-17·128A
Myocardial Adaptation to Short-Term High-Intensity 
Exercise## 902-45·101A
Myocardial Fibrosis in Patients with Hypertrophic 
Cardiomyopathy: Correlation with Echocardiographic 
Measurements of Diastolic Dysfunction and Genetic 
Perturbations##942-59·47A
Myocardial Strain During Early Diastole Is Useful in Assessing 
Left Ventricular Early Diastolic Function: Comparison 
With Invasive Parameters## 846-4·148A
Myocardial Strain Predicts Left Ventricular Responses 
to Valve Surgery in Asymptomatic Severe Mitral 
Regurgitation##962-23·278A
New Concepts of Myocardial Mechanics in Hypertrophic 
Cardiomyopathy## 948-13·119A
Noninvasive Assessment of Coronary Vasodilating Capacity 
Using Freehand 3D Echocardiography With Rotational 
Scanning## 991-40·140A
Noninvasive Monitoring of Pulmonary Vascular Resistance 
Changes in Patients With Pulmonary Hypertension##936-
190·307A
Normalization of Nonuniform Contraction of the Left Ventricle 
Early After Aortic Valve Replacement in Patients With 
Severe Aortic Stenosis## 925-43·103A
Novel Velocity Vector Imaging Ultrasound Technique 
Demonstrates Asymmetric Deformation in the Normal 
Aortic Root## 925-38·102A
Obesity Has No Effect on the Sensitivity Of NT-ProBNP 
for Detection of Systolic and Diastolic Dysfunction: 
Results From the ProBNP Investigation of Dyspnea in 
the Emergency Department (PRIDE) Echocardiography 
Substudy## 902-2·94A
Outcome in Heart Failure and Narrow QRS Patients With and 
Without Left Ventricular Dyssynchrony## 902-36·99A
Outcome Of Prenatally Diagnosed Tricuspid Atresia: A 
Multicenter Experience##1035-114·248A
PAMM (Parametric Analysis of Main Motion): First Evaluation 
of a New Parametric Imaging Method for Segmental Wall 
Motion Analysis## 902-38·100A
Parameters of Cardiac Dyssynchrony Can Predict Chronic 
Phase Cardiac Function After Acute Myocardial 
Infarction: A Real-Time 3D Echocardiography Study## 
991-36·139A
Patients With Different Degrees of Left Ventricular Systolic 
Dysfunction Have Similar Prevalence of Intraventricular 
Asynchrony: Results From AVE (Ventricular Asyncrony) 
Register by SIEC (Italian Society of Cardiovascular 
Echography)## 902-16·97A
Permanent His Bundle Pacing Does Not Induce Dyssynchrony. 
An Intrapatient Comparison## 969-138·23A
Predictors of Death in Patients With Atrial Fibrillation: The 
Role of Echocardiography## 902-1·94A
Prevalence of Tako-Tsubo Syndrome and Description of Partial 
and Circular Patterns##975-249·201A
Quantitative Assessment of Left Ventricular Size and Function: 
Side-by-Side Comparison of Three-Dimensional 
Echocardiography and Computed Tomography Against 
Magnetic Resonance Reference## 991-38·139A
Radial Artery Pulse Wave Analysis Corresponds to Echo 
Doppler Measures of Cardiac Function in Patients 
Undergoing Atrioventricular and Ventriculo-Ventricular 
Optimization of Biventricular Pacemaker## 969-124·20A
Real-Time Three-Dimensional Echocardiography for 
Visualization and Quantiﬁcation of Atrial Septal Defect: 
Compared with Transcatheter Balloon Measurements## 
991-39·139A
Reduced Ventricular Volumes and Improved Systolic 
Performance with Cardiac Resynchronization Therapy: 
A Comparison of Simultaneous Biventricular Pacing vs. 
Sequential Biventricular Pacing vs. Left Univentricular 
Pacing## 969-123·20A
Reduction in Left Atrial Volume and Improvement in Left 
Atrial Ejection Fraction Does Not Predict Decline in 
Recurrence of Atrial Fibrillation Following Pulmonary 
Vein Ablation as Assessed by Echocardiography## 902-
8·95A
Regional Left Ventricular Myocardial Contraction by 
Quantitative Automated 2D Strain Echocardiography 
and Thallium-201 Single-Photon Emission Computed 
Tomographic Perfusion Imaging## 948-15·119A
Relation of Components of the Metabolic Syndrome to Left 
Ventricular Mass##982-202·337A
Relationship Between Left Atrial and Left Ventricular Function 
in Hypertrophic Cardiomyopathy: A Real Time 3D 
Echocardiographic Study##943-103·50A
Relationship of Tissue Doppler Dyssynchrony and Acute 
Hemodynamic Response to Later Reverse Remodeling 
After Resynchronization Therapy## 810-5·11A
Reproducibility of Echocardiographic Assessments of Mitral 
Regurgitation for Percutaneous Endovascular Edge to 
Edge Repair## 902-31·98A
Right Ventricular Injury and Dysfunction During Endurance 
Sports## 1017-32·157A
Role of Inducible NO in Sepsis Related Hemodynamic 
Impairment Assessed by High-frequency 
Echocardiography in a Murine Model##1031-51·85A
Role of Volume Load in Heritability of Left Ventricular Mass: 
The Hypergen Offspring Study## 835-3·342A
Serial Echocardiograms in Patients With Cardiogenic Shock: 
Analysis of the Shock Trial## 805-5·111A
Strain Imaging Can Differentiate Constriction From 
Restriction##1033-100·90A
Stratiﬁcation of Coronary Risk Beyond the Framingham Risk 
Classiﬁcation: Ultrasound Assessment of Subclinical 
Disease in a Multiethnic Population##983-208·338A
Subclinical Left Ventricular Abnormalities Predict Outcome in 
Chronic Kidney Disease and Are Reversible With Renal 
Transplantation## 925-44·104A
Temporal Trends in the Evaluation of Ejection Fraction in 
Patients Hospitalized With Acute Myocardial Infarction: 
Insights From the Worcester Heart Attack Study##973-
240·199A
Test-Retest Variability of Three-Dimensional 
Echocardiography for Serial Evaluation of Patients With 
Ischemic Heart Disease and Congestive Heart Failure## 
991-30·137A
The Accuracy of Real-Time Three-Dimensional Doppler 
Echocardiography for Computing LV Stroke Volume 
Compared to Phase Contrast Magnetic Resonance 
Imaging in Patients## 991-41·140A
The Accuracy of Real-Time Three-Dimensional 
Echocardiographic Derived Flow Volumes With 
Increasing Depth: An in Vitro Study## 991-46·141A
The Relationship Between Regional Left Ventricular 
Wall Motion and Troponin-I Levels in Patients With 
Subarachnoid Hemorrhage: Results of the SAHMII 
study##1025-183·368A
Three-Dimensional Echocardiographic Indices of Left 
Ventricular Dysynchrony: Normal Values## 991-31·138A
Time Resolved Sequence of Left Ventricular Flow Redirection 
during Isovolumic Intervals of the Cardiac Cycle## 
805-3·110A
Tissue Doppler and 2-D-derived Measurements of Peak 
Endocardial Systolic Velocity, Strain and Strain Rate in 
Senior Athletes## 902-32·98A
Tissue Doppler Imaging for Cardiac Resynchronization 
Therapy Are the Current Guidelines Sufﬁcient## 902-
33·99A
Tissue Doppler Imaging Predicts NYHA Functional Class 
and Plasma BNP Levels in Patients With Hypertrophic 
Cardiomyopathy## 948-1·116A
Tissue Doppler Is Superior to Conventional Echocardiography 
in the Diagnosis of Arrhythmogenic Right Ventricular 
Dysplasia/Cardiomyopathy## 846-8·149A
Tissue Strain Imaging Versus Velocity Imaging in Identifying 
Right Ventricular Dysfunction in Pulmonary Arterial 
Hypertension## 948-11·118A
Torsion Deﬁned by Strain Imaging Facilitates Deﬁnition of 
LV Segmental Dysfunction in Experimental Myocardial 
Infarction## 925-46·104A
Usefulness and Cost Effectiveness of Squatting Stress 
Echocardiography in the Diagnosis of Coronary Artery 
Disease## 948-37·122A
Usefulness of Three-Dimensional Echocardiographic 
Quantiﬁcation During Percutaneous Alcohol Septal 
Ablation for Hypertrophic Obstructive Cardiomyopathy## 
991-33·138A
Utility of Real-Time 3-D Echocardiography for Predicting 
Adverse Events in the MADIT-II Post-Myocardial 
Infarction Patient Population## 839-8·147A
Value of Measuring the Time Difference Between Onset of 
Mitral Inﬂow and Onset of Early Diastolic Mitral Annulus 
Velocity for the Evaluation of Left Ventricular Diastolic 
Pressures in Patients With Normal Systolic Function and 
Indeterminate E/E’## 902-12·96A
Wireless Transmission of Images Obtained During Ambulatory 
Echocardiography With a Novel Low Proﬁle Ultrasound 
Transducer.## 902-29·98A
Ejection fraction
A Novel Two-Dimensional Echocardiographic Image 
Analysis System Using Artiﬁcial Intelligence Shape 
and Pattern Recognition for Rapid Automated Ejection 
Fraction##1012-147·264A
Assessment of Left Ventricular Function in Patients with 
Ischemic Heart Disease and Heart Failure by Three-
Dimensional Echocardiography and Cardiac Magnetic 
Resonance Imaging## 839-7·147A
Brain Natriuretic Peptide and Systolic or Isolated Diastolic 
Heart Failure in the Community##942-92·48A
Changes in the 1-Year Survival After Hospital Discharge in 
Heart Failure Patients With Depressed Systolic Function 
in the Last Years. Had We Reached the Same in Men and 
Women?## 837-4·83A
Characteristics, Treatments and Outcomes of Patients 
Hospitalized for Heart Failure with Preserved Systolic 
Function: A Report from OPTIMIZE-HF##942-90·47A
Clinical Outcomes by Baseline Left Ventricular Ejection 
Fraction in the African-American Heart Failure Trial## 
837-7·83A
Comparative Value of Resting Left Ventricular Dysfunction 
and Left Ventricular Response to Stress as Predictors 
of Cardiac Mortality in Patients Undergoing Gated 
Myocardial Perfusion SPECT## 812-8·116A
Comparison and Co-Relation of Invasive and Noninvasive 
Methods of Ejection Fraction Measurement##919-53·38A
Death Causes in Hospitalized Heart Failure Patients With 
Preserved and Depressed Left Ventricular Systolic 
Function##1032-89·87A
Delayed Enhanced Magnetic Resonance Imaging Is a Predictor 
of Resistance to Medical Treatment in Non-Ischemic 
Dilated Cardiomyopathy## 993-18·145A
Does Revascularization of Chronic Total Occlusion(CTO) 
Contribute to Improve the Long-Term Prognosis?##976-
252·202A
Effects of Perindopril on Long-Term Clinical Outcome 
of Patients With Coronary Artery Disease and Left 
Ventricular Function##999-257·219A
Evolution of the Prognosis of Hospitalized Heart Failure 
Patients With Depressed and Normal Systolic Function 
Between 1991 and 2001.##1032-59·87A
Hypertensive Heart Failure with a Normal Ejection Fraction: 
Abnormal Load or Abnormal Ventricular Function?##942-
57·46A
Impaired Left Ventricular Systolic Function Predicts Increased 
One-Year Mortality Following Normal Positron Emission 
Tomography Stress Myocardial Perfusion Imaging## 
926-1·104A
Kidney Transplantation Leads to Improved Left Ventricular 
Ejection Fraction in Patients with Systolic Dysfunction 
and End Stage Renal Failure Compared to Medical 
Management Alone##1008-99·80A
Novel Transthoracic Triplane-Echocardiography With Contrast 
Agent Improves the Accuracy of Left Ventricular Volume 
Measurements: A Comparison With Magnetic Resonance 
Imaging## 1016-36·150A
Paradoxical Decrease in Plasma N-Terminal-proBNP (NT-
proBNP) Levels in Patients Receiving Doxorubicin 
Chemotherapy and Declining Left Ventricular Ejection 
Fraction##986-57·66A
Predictors of Sudden Cardiac Death in a Population With High 
Prevalences of Obesity and Diabetes: The Strong Heart 
Study##961-207·327A
Quantitative Assessment of Regional Left Ventricular Wall 
Motion From Real-Time 3D Echocardiography: Effects 
of Dual-Triggered Contrast Enhancement Tested Against 
Magnetic Resonance## 1016-46·152A
Regression of Left Ventricular Mass and Improvement in 
Left Ventricular Ejection Fraction Following Long-Term 
Aldosterone Receptor Antagonist Therapy in Patients with 
Chronic Systolic Heart Failure## 809-7·53A
Sudden Cardiac Arrest with Normal Ejection Fraction: How 
Often Is Coronary Ischemia the Trigger?## 924-130·7A
Temporal Trends in the Evaluation of Ejection Fraction in 
Patients Hospitalized With Acute Myocardial Infarction: 
Insights From the Worcester Heart Attack Study##973-
240·199A
Test-Retest Variability of Three-Dimensional 
Echocardiography for Serial Evaluation of Patients With 
Ischemic Heart Disease and Congestive Heart Failure## 
991-30·137A
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The Impact of Reduced Left Ventricular Function on Long-
Term Outcomes in Diabetes Mellitus Patients With 
Coronary Artery Disease Undergoing Percutaneous 
Coronary Intervention##905-240·164A
Utility of Real-Time 3-D Echocardiography for Predicting 
Adverse Events in the MADIT-II Post-Myocardial 
Infarction Patient Population## 839-8·147A
Ventricular Structure and Function in Hypertensive Patients 
with Heart Failure and a Normal Ejection Fraction: The 
Cardiovascular Health Study (CHS)##942-52·45A
Electrocardiography
Can the Electrocardiogram Distinguish Stress (Tako-Tsubo) 
Cardiomyopathy from Acute Anterior Myocardial 
Infarction?##1009-100·81A
Characteristics of Cavotricuspid Isthmus-Dependent Flutter 
Following Left Atrial Ablation of Atrial Fibrillation## 
947-141·18A
Determination of Atrial Flutter Type Using Interactive ECG 
Analysis## 992-130·27A
Do ECG Abnormalities Pose the Same Risk for Women and 
Men?## 992-123·26A
Does Left Bundle Branch Block Indicate a Better Response 
to Cardiac Resynchronization Therapy in Heart Failure 
Patients with Echocardiographic Evidence of Mechanical 
Asynchrony?## 969-127·21A
ECG-Based Method for Identifying KvLQT1/KCNE1 
or HERG Mutation in Patients With The Long QT 
Syndrome## 813-7·13A
Electrocardiographic Unrecognized Myocardial Infarction 
Is Associated With Increased Mortality Independent 
of Regional Wall Motion Abnormalities on 
Echocardiogram##971-218·194A
Fragmented QRS on 12-lead ECG Represents Increased 
Cardiac Events and Mortality in Diabetic Patients With 
Abnormal Myocardial Perfusion Scan##1029-208·374A
Impact of Plaque Rupture on Myocardial Infarct Size in ST-
Elevation Anterior Acute Myocardial Infarction##995-
226·212A
Increasing QRS Duration During Antihypertensive Therapy is 
Associated With an Increased Incidence of New-Onset 
Congestive Heart Failure: The LIFE Study## 851-4·92A
Lack of Association Between QRS Duration and Cardiac 
Asynchrony in Candidates for Cardiac Resynchronization 
Therapy## 969-143·24A
Long-Term Prognostic Value of Negative Exercise 
Echocardiogram: Do Stress Electrocardiographic Changes 
Really Matter?## 806-5·112A
Lower Mortality With Paramedics Interpreting the 
Electrocardiogram Coupled to Primary Percutaneous 
Angioplasty for ST-Segment Elevation Myocardial 
Infarction## 815-7·193A
Methodological Issues of QRS Duration Measurements in 
Candidates for Cardiac Resynchronization Therapy## 
992-138·29A
Novel Computer Assisted Measurement of 
Electrocardiographic P Terminal Force to Predict Elevated 
Left Ventricular End Diastolic Pressure## 813-8·13A
Pediatric EKG: A Computer Aided Approach Reducing 
Common but Important Errors##1013-147·266A
Polynomial Modeling of Ventricular Shock Electrogram for 
Rhythm Discrimination in Implantable Devices## 947-
130·15A
Prevalence of Recognized and Unrecognized Myocardial 
Infarction: The ICELAND MI Substudy to the AGES-
Reykjavik Study## 833-6·137A
Prognostic Signiﬁcance of Inverted T Waves in Patients With 
Acute Pulmonary Embolism##958-182·322A
QTc Variability in Patients With Long QT Syndrome: The 
Importance of the Maximum QTc Value From Follow-
Up Electrocardiograms in Predicting Cardiac Events## 
992-124·26A
Recurrent Ischemia Detected by Continuous Electrocardiogram 
Recording After Percutaneous Coronary Intervention for 
Non-ST-Elevation Acute Coronary Syndromes##951-
222·182A
Regression of Electrocardiographic Left Ventricular 
Hypertrophy by Both Cornell Voltage-Duration Product 
and Sokolow-Lyon Voltage During Antihypertensive 
Therapy is Associated With Decreased Incidence of 
Sudden Cardiac Death: The LIFE Study## 848-4·360A
Repolarization Complexity is Increased in Left Ventricular 
Hypertrophy: The Strong Heart Study## 992-125·26A
Signiﬁcant Low-Voltage ECG and Impaired Systolic Cardiac 
Function in Neonatal Mice Expressing Connexin 31 
Instead of 43## 901-126·1A
Stress Echocardiography is More Cost-effective Than Stress 
Electrocardiography for Risk Stratiﬁcation of Troponin 
Negative Acute Chest Pain Patients: A Prospective 
Randomised Controlled Trial## 806-4·112A
Three Optimally Placed Electrodes Versus 12-Lead ECG for 
Detecting Myocardial Occlusion Ischemia by Bayesian 
Classiﬁcation## 813-6·13A
Validation of an Electrocardiographic Predictive Regression 
Model for the Differential Diagnosis of Paroxysmal 
Junctional Tachycardias in Patients Without 
Preexcitation## 992-137·29A
Which ECG Criteria for Left Ventricular Hypertrophy Best 
Predict Mortality?## 813-4·13A
Electron beam CT
A Coronary Artery Calciﬁcation Score ≥ 400 Is Signiﬁcantly 
Associated With Myocardial Ischemia Independently of 
Framingham Risk Score##983-206·338A
Aortic Pulse Wave Velocity Is Associated With Presence and 
Quantity of Coronary Artery Calcium: A Community-
Based Study## 801-5·313A
Atherosclerosis Regression With Selective Estrogen Receptor 
Modulator Therapy: An In Vivo Study of Raloxifene 
by Magnetic Resonance Imaging and Micro-Computed 
Tomography##913-196·296A
Coronary Calciﬁcation and Left Atrial Size Are of Additive 
Incremental Value to the Framingham Risk Score for the 
Prediction of Cardiovascular Events##983-204·337A
Ethnic Differences in the Prognostic Value of Coronary Artery 
Calciﬁcation: Data from an Observational Cohort of 
14,812 Patients## 970-33·129A
Minimal Coronary Artery Calcium Score Alone Fails to 
Reliably Detect Signiﬁcant Lesions in Acute Chest Pain 
Patients## 807-5·114A
Multislice Computed Tomographic Findings of the Anomalous 
Origin of the Right Coronary Artery: Evaluation of 
Possible Causes of Myocardial Ischemia## 970-5·125A
Prevalence of Obstructive Lesions Detected by CT Coronary 
Angiography in Patients with Absent to Minimal 
Coronary Artery Calciﬁcation##1021-252·230A
Subclinical Coronary Atherosclerotic Burden and High-
Sensitive CRP Levels Frequently Do Not Match 
Framingham Risk Scores in a General Population##983-
207·338A
The Effect of One-Year of Chelation Therapy on Coronary 
Volume Score## 970-10·126A
Electropharmacology
Eplerenone Attenuates Ventricular Electrical Remodeling in 
Experimental Heart Failure: Mechanism of Reduced Risk 
of Sudden Cardiac Death with Aldosterone Blockade?## 
924-131·7A
Hydrogen Peroxide-Induced Arrhythmogenic Activity and 
Contractile Dysfunction of Ventricular Myocytes is Reduced 
by a Blocker of Late Sodium Current## 901-130·2A
Electrophysiology
Atrial Arrhythmias Post Atricure Radiofrequency Ablation for 
Atrial Fibrillation: Findings During Catheter Ablation## 
901-140·4A
Biventricular Pacing Reduces Incidence of Microvolt T Wave 




 Receptors: A Physiologic Role in Mediating 
ATP-evoked Current and Regulation in Human Atrial 
Fibrillation## 901-135·3A
Cardiac Pacemaker Precursor Cells Can Be Obtained From 
Human Endometrial Mesenchymal Stem Cells for 
Biological Pacemaker Cell Transplantation.## 901-
131·2A
Conditional Expression of a Gain of Function Alpha-5 
Integrin in Adult Mouse Heart Increases Ventricular 
Automaticity## 901-127·1A
Connexin30.2 Containing Gap Junction Channels Decelerate 
AV-nodal Conduction## 901-123·1A
Early Electromechanical Changes Following Acute Coronary 
Artery Microembolization##950-216·180A
Early Experience Of Pulmonary Vein Antral Isolation Using 
an Open Irrigation Ablation Catheter for the Treatment 
of Atrial Fibrillation: Immediate Short Term Results of a 
Randomized Study## 992-142·30A
Effect of Left Atrial Decompression by Percutaneous 
Mitral Commissurotomy on Atrial Electrophysiologic 
Properties## 1015-139·35A
Effects of Verapamil on the Short-Term Electrophysiological 
Remodeling of Superior Vena Cava in Human## 924-
137·8A
Evaluation of Left Ventricle Pressure Derivative Enhanced 
by Multi Site Pacing in Patients With Heart Failure## 
969-132·22A
Forced Expression of Human Myocardin Increases Electrical 
Conduction Velocity Across Human Adult Mesenchymal 
Stem Cells to Levels Comparable to Cardiomyocytes.## 
901-124·1A
Heart Rate Turbulence Onset After Atrial Premature 
Complexes Does Not Reﬂect Cardiac Autonomic 
Regulations in Postinfarction Patients## 992-126·26A
Heat Shock Proteins Prevent Atrial Tachycardia Remodeling 
and Atrial Fibrillation Promotion## 826-4·25A
Hydrogen Peroxide-Induced Arrhythmogenic Activity and 
Contractile Dysfunction of Ventricular Myocytes is 
Reduced by a Blocker of Late Sodium Current## 901-
130·2A
Long-Term Electrical Conduction Across Human Adult 
Mesenchymal Stem Cells Connecting Two Fields 
of Cultured Cardiomyocytes and the Effect of Cx43 
Knockdown by RNA Interference## 901-125·1A
Magnetic Resonance Imaging Based Characterization of 
Mechanical Dyssynchrony and Cardiac Resynchronization 
Therapy in Right Bundle Branch Block## 810-3·11A
Noninvasive Electrophysiological Study of Ivabradine (NESI) 
in Patients With Dual Chamber Pacemakers: Effects on 
Ventricular Repolarization## 992-129·27A
Permanent His Bundle Pacing Does Not Induce Dyssynchrony. 
An Intrapatient Comparison## 969-138·23A
Possibility of Electrical Bridging over AV Groove by the 
Artiﬁcial Epicardiac Accessory Pathway in a Rat Model 
of Atrio-Ventricular Block## 826-5 ·25A
Signiﬁcant Low-Voltage ECG and Impaired Systolic Cardiac 
Function in Neonatal Mice Expressing Connexin 31 
Instead of 43## 901-126·1A
Sudden Cardiac Death Risk Prediction is Enhanced When 
Clinical Characteristics and Left Ventricular Ejection 
Fraction Are Evaluated Together Rather Than Relying on 
Left Ventricular Ejection Fraction Alone##983-209·339A
Validation of an Electrocardiographic Predictive Regression 
Model for the Differential Diagnosis of Paroxysmal 
Junctional Tachycardias in Patients Without 
Preexcitation## 992-137·29A
Emergency care
Immediate Coronary Artery Computed Tomographic 
Angiography Rapidly and Deﬁnitively Excludes Coronary 
Artery Disease in Low-Risk Acute Chest Pain## 807-
8·114A
Mild Therapeutic Hypothermia After Cardic Arrest: A 
Nationwide Survey on the Implementation of the ILCOR 
Guidelines in Intensive Care Units##906-242·164A
Use of Semiautomatic Deﬁbrillators by Minimally Trained 
Lay Persons in Cardiac Emergencies: Is It Safe?##906-
244·165A
Endocarditis
Adverse Clinical Outcomes in Left-sided Infective 
Endocarditis Complicated Intravenous Drug Addict##984-
27·281A
Antibiotic Proﬁlaxis is Essential in Surgical Procedures of 
Cardiac Implantable Devices## 969-135·23A
Are the American Heart Association Bacterial Endocarditis 
Prophylaxis Guidelines Obsolete?## 902-35·99A
Baseline Characteristics Associated With Embolism in 
Infective Endocarditis##984-26·281A
Echocardiographic Risk-stratiﬁcation for Early Surgery in 
Patients With Endocarditis Is a Cost-Attractive Alternative 
to Standard Care##984-22·280A
Elevation of Cardiac Troponin T in Infective Endocarditis 
Predicts an Adverse Outcome##984-20·280A
Impact of Chronic, Daily Antiplatelet Therapy on Embolic 
Events in Infective Endocarditis##984-19·279A
Incidence and Prognosis of Pacemaker Lead Associated 
Masses: A Study of 1569 Transesophageal 
Echocardiograms## 1017-6·153A
Infectious Endocaritis Is Independently Associated With Type 
II Diabetes Mellitus##984-25·281A
Intravenous Heroin Increases the Risk of Right-sided Infective 
Endocarditis Compared to Other Intravenous Drugs of 
Abuse##984-23·280A
Prospective Determination of the Prevalence of Clinically 
Unapparent Cerebral Embolization in Patients With Left-
Sided Infective Endocarditis##984-21·280A
Temporal Trend of Infective Endocarditis in Chinese: A 
Population Based Study Over 10 Years Period##984-
24·281A
Endothelial function
A Novel Double-Shelled Microsphere Targeted to 
Leukocyte Adhesion Molecules Adheres to Inﬂamed 
Microcirculation in Vivo## 1016-34·149A
Association of High Molecular Weight Form of Adiponectin 
With Endothelial Function in Healthy Young Men##933-
161·301A
Atorvastatin but Not Vitamin C, Affects Endothelial Function, 
Asymmetric-Dimethyl-Arginine Levels and Inﬂammatory 
Process, in Patients With Diabetes Mellitus Type 2, and 
Low Cholesterol Level##1003-189·350A
Atrial Fibrillation Is Associated With Reversible Impairment of 
Endothelial Function## 853-5·376A
Coronary Flow Reserve Is a Poor Marker of Coronary 
Microvascular Response## 853-7·376A
Does the Presence of a Depressive State Contribute to 
Endothelial Dysfunction in Patients With Coronary Artery 
Disease?##1000-161·344A
Early Comprehensive Characterisation of the Vascular 
Response to Statin Treatment Using MRI## 845-7·359A
Effects of Lifestyle Modiﬁcation on Left Ventricular Diastolic 
Filling and Endothelial Function in Those at Risk for 
Cardiovascular Diseases##1028-202·373A
Effects of Nitric Oxide Donor, Molsidomine, on 
Blood Pressure in Patients With Isolated Systolic 
Hypertension##1027-192·371A
Endothelial Dysfunction Accelerates Future Hypertensive 
Evolution and Causes Excess of Fatal Events## 853-
6·376A
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Endothelial Dysfunction and Increased Carotid Intima-Media 
Thickness in Primary Antiphospholipid Syndrome##1001-
179·348A
Endothelial Dysfunction and Therapeutic Strategy in Adult 
Cyanotic Congenital Heart Disease Patients: Assessment 
of Noninvasive Study##1011-114·244A
Endothelial Function Is Increasingly More Impaired in the 
Leg Compared to the Arm in Groups With Increasing 
Risk: Assessment Using Magnetic Resonance Imaging## 
841-8·357A
Erythropoietin Therapy Improves Vascular Dysfunction in Pre-
dialysis Chronic Renal Failure Patients: A Novel Strategy 
for Atherosclerosis Prevention## 853-8·377A
Flow Mediated Dilation Predicts Improved Cardiovascular 
Outcomes with Atorvastatin Therapy in Patients with 
Nonischemic Heart Failure##964-96·58A
High Level of Fibrinogen is Associated with Occlusive 
Coronary Artery Spasm##935-185·306A
High-dose Folic Acid Supplementation Improves Atherogenic 
Process in Predialysing Chronic Renal Failure 
Independent of Homocysteine-lowering##1000-164·345A
Increased Dilator Response to Nitrate in Contrast to 
Decreased Flow Mediated Dilatation in Migraineurs: 
An Ultrasonographic Evaluation of Brachial Artery## 
841-7·357A
Inhalation of Combustion-derived Air Pollution Impairs 
Endogenous Fibrinolysis in Patients With Ischemic Heart 
Disease##908-160·288A
Investigation of Genetic and Biochemical Determinants 
of Depressed L-Arginine Transport in Human 
Hypertension##960-194·324A
Long-Term Association of Brachial Artery Flow-mediated 
Vasodilation and Cardiovascular Events in Middle-Aged 
Subjects With no Apparent Heart Disease## 801-6·313A
Losartan Combined With Simvastatin Shows Additive 
Beneﬁcial Effects on Inﬂammation in the Treatment of 
Hypercholesterolemic, Hypertensive Patients## 845-
5·359A
Mortality, Cause of Death, and Coronary Endothelial Function 
During Long-Term Follow-Up Among Hypertensive 
African and Caucasian Americans## 841-5·356A
Oxidative Stress Within the Coronary Circulation Is 
Associated With Reduction in Endothelium-Dependent 
Coronary Vasodilation in Patients With Acute Coronary 
Syndromes.##972-225·196A
Periodontal Disease and Endothelial Function## 853-4·376A
PPAR-γ Agonist Improves Endothelial Function in Patients 
With Metabolic Syndrome: Pivotal Role of NOx and 
Inﬂammation## 841-6·356A
Preserved Epicardial Coronary Endothelial Function by 
Inhibition of δ Protein Kinase C in a Porcine Acute 
Myocardial Infarction Model##1020-245·228A
Proteasome Inhibition: A New Road to Coronary 
Atherogenesis?##977-166·329A
Regulation of Endothelial Progenitor Cell (EPC) Survival and 
Vasculogenesis by Peroxisome Proliferator-activated 
Receptor-Delta (PPAR-δ) Activation## 823-6·342A
Selective Cyclooxygenase-2 Inhibition by Celecoxib Abrogates 
the Acute Smoking-Induced Vascular Dysfunction## 
841-3·356A
Study of Coronary Calcium Score by Multislice Computed 
Tomography in Relation to Endothelial Function, C-
Reactive Protein, and Interleukin-6 in Asymptomatic 
Individuals## 970-36·129A
Subclinical Target Organ Damage in Masked and White-Coat 
Hypertension##982-198·336A
Tetrahydrobiopterin: A Novel Anti-hypertensive 
Therapy##1027-194·371A
The Efﬁcacy and Safety of EECP in Patients with Peripheral 
Arterial Disease##1002-182·348A
The Incidence of Provoked Spasm Using Acetylcholine 
Predicts Adverse Outcomes After Acute Myocardial 
Infarction## 830-6·208A
Vascular and Biochemical Markers of Cardiovascular Risk 
in Healthy Subjects With the Metabolic Syndrome## 
801-7·314A
Endothelin
Bosentan Improves Hemodynamics and Exercise Capacity in 
Eisenmenger Physiology## 840-6·246A






 Receptor Selectivity of Endothelin-1 Receptor 
Antagonists in Human Myocardial Membranes##936-
191·307A
Myocardial Dysfunction and Neurohumoral Activation Without 
Remodeling in the Left Ventricle of Monocrotaline-
Induced Pulmonary Hypertensive Rats##963-49·54A
Sitaxsentan Improves Time to Clinical Worsening (TCW) 
in Patients With Pulmonary Arterial Hypertension 
(PAH)##936-189·307A
Endothelium
A Novel Method for Enumerating Circulating Endothelial 
Progenitor Cells Based on ALDH Activity##933-
165·302A
Amiodarone and its Metabolite, N-desethylamiodarone, 
Enhance Endothelial Nitric Oxide Production in Human 
Endothelial Cells##937-197·309A
Curcumin Protects TNF-α-Induced Inﬂammatory Responses 
via NF-κB Inhibition in Endothelial Cells##933-163·301A
Effect of Chronic Sildenaﬁl Therapy on Endothelial Function 
in Diabetic Patients##957-177·321A
Effects of Mediterranean Diet or Supplements on Circulating 
Endothelial Progenitor Cells in Obesity##1000-165·345A
Endothelial-dependent vasodilation and Prognosis in 
Postmenopausal Women## 853-3·376A
Erythropoietin Receptor and Anti-Apoptotic Effect of 
Erythropoietin on Anoxia/Reoxygenation Injury in 
Endothelial Cells##949-217·179A
Genetic Polymorphism C242T on the NADPH Subunit p22-
phox, Is Associated With Increased Risk for Myocardial 
Infarction and Endothelial Activation##1019-238·226A
Gentic Polymorphism G894T Modiﬁes the Smoking-
Associated Risk for Myocardial Infarction in Young 
Individuals##983-210·339A
Increased Dilator Response to Nitrate in Contrast to 
Decreased Flow Mediated Dilatation in Migraineurs: 
An Ultrasonographic Evaluation of Brachial Artery## 
841-7·357A
Inhibition of Serine Protease Activity at Reperfusion Reduces 









 is an Independent 
Marker for Coronary Endothelial Dysfunction in 
Humans##1000-160·344A
Long-Term Association of Brachial Artery Flow-mediated 
Vasodilation and Cardiovascular Events in Middle-Aged 
Subjects With no Apparent Heart Disease## 801-6·313A
Non-Dipping Status Is Accompanied by a State of 
Hypoadiponectinemia, and Arterial Stiffening in 
Essential Hypertensive Subjects: A Link to Subclinical 
Atherosclerotic Processes##1004-194·351A
Parathyroid Hormone, Endothelial Dysfunction and Arterial 
Stiffness in Chronic Renal Disease##912-192·295A
Percutaneous Coronary Intervention Increases Endothelial 
Progenitor Cell Mobilisation in Patients With Ischemic 
Heart Disease##910-179·292A
Protease Activated Receptor-1 Activation Causes Platelet 
Independent Venoconstriction in Vivo in Man##908-
167·289A
Rapid Effects of 5-Methyl-Tetrahydrofolic Acid on Endothelial 
Function and Vascular Superoxide Production in Human 
Coronary Artery Disease##933-171·303A
Role of Platelets in Homing of Endothelial Progenitor Cells to 
the Site of Vascular Injury##909-174·291A
Small HDL Particles Exert Potent Protection of Human 
Endothelial Cells Against Apoptosis: Relevance to 
Metabolic Syndrome##1000-162·344A
Statins, Saphenous Vein Endothelial Function, and C-Reactive 
Protein in Patients With Coronary Artery Disease##907-
249·166A
Systemic Hypoxia Without Ischemic Organ Damage can 
Mobilize Endothelial Progenitor Cells in Human 
Peripheral Blood by Increased Levels of VEGF, 
MCP-1 and SDF-1: A Novel Insight of Hypoxic 
Preconditioning##933-164·302A
The Effect of Estrogens on Vascular Reactivity in Women Is 
Dependent on Aging and Previous Hormone Use##957-
179·321A
Energy metabolism
Cardiac Hypertrophy and Renal Disease in GLUT1-
Overexpressing Mice##918-51·38A
Epidemiologic methods
Current Trends in the Prevalence of Metabolic Syndrome Risk 
Factors##939-213·312A
Gender Differences in Pressure Wave Reﬂection Changes With 
Healthy Aging: A Population-Based Study in Hispanic 
Mestizos## 835-4·342A
Global Risk Assessment of U.S. Persons With the Metabolic 
Syndrome##939-204·310A
Impact of Age on the Outcome of Fibrinolytic Therapy for 
ST-Segment Elevation Myocardial Infarction: A Meta-
analysis of a Decade of Trials##904-223·159A
Is the Non-inferiority Claim for Bivalirudin in Percutaneous 
Coronary Intervention Warranted? REPLACE-2 
Revisited##923-145·251A
Job-Strain Induced Workplace Hypertension Is Associated 
With Obesity and High Normal Blood Pressures at the 
Physical Checkup##1004-191·350A
Prevalence of Recognized and Unrecognized Myocardial 
Infarction: The ICELAND MI Substudy to the AGES-
Reykjavik Study## 833-6·137A
Prevalence, Treatment, and Control of Hypertension in U.S. 
Adults 2001-2002 Overall and With Metabolic Syndrome, 
Diabetes, Kidney Disease, Stroke or Coronary Artery 
Disease## 848-6·361A
Reappraisal of Conventional Coronary Heart Disease Risk 
Factors using Novel Statistical Approaches: A Critical Re-
analysis of Framingham Data##916-255·167A
The Fate of Randomized Trials Presented at the American 
College of Cardiology Meeting 1999-2002: What Follows 
the 15 Minute Presentation?##923-147·251A
The Utility of Aminoterminal Pro-B-type Natriuretic Peptide 
for the Detection of Preclinical Systolic and Diastolic 
Dysfunction in the Community##942-89·47A
Trends in Survival Following a Diagnosis of Heart Failure## 
837-3·82A
Waist Circumference and Body Mass Index Are Both 
Independently Associated With Cardiovascular Disease. 
The International Day for the Evaluation of Abdominal 
Obesity (IDEA) Survey## 842-6·358A
Which ECG Criteria for Left Ventricular Hypertrophy Best 
Predict Mortality?## 813-4·13A
Estrogen
Atherosclerosis Regression With Selective Estrogen Receptor 
Modulator Therapy: An In Vivo Study of Raloxifene 
by Magnetic Resonance Imaging and Micro-Computed 
Tomography##913-196·296A
Sex Determines Differences in Left Ventricular Diastolic 
Properties in the Model of Chronic Estrogen 
Deﬁciency##985-50·64A
The Effect of Estrogens on Vascular Reactivity in Women Is 
Dependent on Aging and Previous Hormone Use##957-
179·321A
Ethics
Attitudes Toward Management of the Hypoplastic Left Heart 
Syndrome Among Pediatric Nurses and Residents##1035-
113·248A
Pediatric EKG: A Computer Aided Approach Reducing 
Common but Important Errors##1013-147·266A
Practices and Opinions of Morticians Regarding Postmortem 
Implantable Device Analysis and Retrieval## 947-
124·14A
Prevalence and Predictors of Advance Directives in Patients in 
the Cardiac Care Unit##1036-155·271A
Exercise
A Controlled Exercise Training Trial in Patients With Diastolic 
Dysfunction## 1017-14·155A
Blunted Hemodynamic Response and Reduced Oxygen 
Delivery With Exercise in Anemic Heart Failure 
Patients##986-53·65A
Brain Natriuretic Peptide Plasma Levels Combined to Diastolic 
Filling Pattern Predict Ventilatory Response to Exercise in 
Patients With Chronic Heart Failure## 902-11·96A
Cardiac Remodeling in Professional Tennis Players 
Participating in Roland-Garros Grand Slam## 902-4·94A
Cardiospeciﬁcity of the 3rd Generation Cardiac Troponin T 
Assay After a 216 km Ultra-Endurance Marathon Run in 
the Death Valley##950-219·181A
Changes in Parasympathetic Tone Result in QT-RR Interval 
Hysteresis during Exercise and Recovery## 813-5·13A
Coexistence and Post-Exercise Exacerbation of Intra-Left 
Ventricular Contractile Dyssynchrony in Medically 
Controlled Hypertensive Patients with Diastolic 
Dysfunction: A Tissue Doppler Echocardiography 
Study## 925-40·103A
Cyclooxygenase Products Sensitize Muscle Mechanoreceptors 
in Heart Failure Patients##986-99·69A
Dipyridamole-Exercise Tc-99m Sestamibi Gated Single-Photon 
Emission Computed Tomography Provides Effective Risk 
Stratiﬁcation of Elderly Patients## 926-6·106A
Effects of Lifestyle Modiﬁcation on Left Ventricular Diastolic 
Filling and Endothelial Function in Those at Risk for 
Cardiovascular Diseases##1028-202·373A
Exercise Capacity but Not BMI Is Associated With Mortality 
in Patients Referred for Exercise Myocardial Perfusion 
Imaging## 1017-31·156A
Exercise Training in Addition to Cardiac Resynchronisation 
Therapy to Maximise Patient Beneﬁt## 1017-18·156A
Heart Rate Variability Response to Dynamic Exercise Testing: 
Implications for Interpretation of Spectral Analysis 
Parameters During Periods of Less Oscillatory Autonomic 
Function## 992-133·28A
Improved Risk Stratiﬁcation in Primary Prevention by 
Utilizing the Impact of Life Style Factors for the 
Calculation of Cardiovascular Risk in Three Different 
Scoring Systems##1036-148·269A
Improvement in Exercise Capacity After Inspiratory 
Muscle Training Is Associated With Reduced Dyspnea 
and Enhanced Limb Blood Flow in Chronic Heart 
Failure##1005-207·354A
Morphologic Ventricular Adaptations to Training in Young 
Soccer Players and Swimmers: An Echocardiographic 
Study## 902-5·95A
Myocardial Adaptation to Short-Term High-Intensity 
Exercise## 902-45·101A
Randomized, Double-Blind, Placebo-controlled Study 
to Evaluate the Effect of two Dosing Regimens of 
Darbepoetin Alfa on Hemoglobin Response and 
Symptoms in Patients With Heart Failure and Anemia## 
816-5·61A
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Right Ventricular Injury and Dysfunction During Endurance 
Sports## 1017-32·157A
The Effect of Exercise on Pulmonary Artery Systolic Pressure 
and Pulmonary Vascular Resistance## 902-17·97A
Tissue Doppler and 2-D-derived Measurements of Peak 
Endocardial Systolic Velocity, Strain and Strain Rate in 
Senior Athletes## 902-32·98A
Exercise tests
A Biphasic Improvement Following Cardiac Resynchronisation 
Therapy## 1017-17·155A
Abnormal Blood Pressure Response to Exercise and 
Oxygen Consumption in Patients With Hypertrophic 
Cardiomyopathy##920-103·43A
Abnormal Ventilatory Response to Exercise Predicts Mortality 
in Adult Congenital Heart Disease Patients## 840-5·246A
Beta-blockers, Chronotropic Incompetence, and Functional 
Capacity in Severe Congestive Heart Failure## 1017-
8·153A
Can Exercise Induced Heart Rate Variability Spectral 
Slopes Provide Insights Into Autonomic Activity and 
Prognosis?## 1017-10·154A
Can Exercise Myocardial Perfusion SPECT Continue to 
Predict Patient Outcomes Long After Testing? Results of a 
10-Year Follow-Up Analysis## 926-32·109A
Comparison of a New Submaximal Prognostic Marker to the 
Duke Treadmill Score## 828-4·133A
Delayed Heart Rate Recovery After Adenosine Stress Testing 
With Supplemental Exercise Predicts Mortality## 926-
13·107A
Diastolic Dysfunction Predicts Enhanced Ventilatory Response 
to Exercise in Patients With Chronic Heart Failure## 
902-44·101A
Echocardiographic Evaluation of Left Ventricular Filling 
Pressure During Exercise Validated With Hemodynamic 
Measurement## 831-3·133A
Endothelial Nitric Oxide Synthase Glu298asp Gene 
Polymorphism Is Associated With Hypertensive 
Response to Exercise in Well-controlled Hypertensive 
Patients##960-196·325A
Exercise Testing Is Feasible, Efﬁcacious and Cost-Effective 
in the Prediction of Cardiovascular Events in the Very 
Elderly as Compared With Dipyridamole Tc-99m 
Sestamibi Spect## 1017-13·155A
Heart Rate Recovery is a Stronger Predictor of Mortality Than 
Chronotropic Index## 1017-9·154A
Hypertensive Response to Exercise Is Related to Insulin 
Resistance in Non-diabetic Patients With Well Controlled 
Hypertension##1004-196·351A
Impact of Age on the Prognostic Value of Cardiopulmonary 
Exercise Testing in Subjects with Heart Failure## 1017-
12·154A
Incremental Diagnostic Value of High-Frequency QRS 
Analysis for Identifying Stress-Induced Ischemia## 
828-3·132A
Oxygen Uptake Efﬁciency Slope and Survival in Patients With 
Systolic Heart Failure## 1017-15·155A
Preoperative Exercise Capacity Predicts Survival and Persistent 
Symptoms After Surgery for Chronic Nonischemic Mitral 
Regurgitation##962-26·279A
Prognosis Value of Brain Natriuretic Peptide Kinetics During 
Cardiopulmonary Exercise Test in Chronic Heart Failure 
Patients##986-92·68A
Prognostic Signiﬁcance of Systolic Blood Pressure Increase 
in Patients Referred for Exercise Stress Testing## 1017-
11·154A
Relation Between Plasma Brain Natriuretic Peptide, Right 
Ventricular Function and Exercise Capacity in Patients 
After Surgical Repair of Tetralogy of Fallot##967-
111·240A
Relationship Between Cardiopulmonary Exercise Testing and 
Pulmonary Pressures in Hypertrophic Cardiomyopathy## 
1017-30·156A
Relationship of Cardiac Hemodynamics and Ventilatory 
Inefﬁciency, and Their Mortality Prediction in Patients 
With Heart Failure## 1017-16·155A
The Prognostic Value of Peak Oxygen Consumption in Men 
and Women with Severe Systolic Heart Failure## 828-
5·133A
Usefulness of 64-slice Multi Detector Computed Tomography 
to Improve Diagnostic Yield in Patients With Chest Pain 
and Negative or Equivocal Exercise Treadmill Tests## 
807-6·114A
Using Reference Equations, Percent Predicted Value (PPV), for 
the Six-Minute Walk Test: A Better Indicator of Severity 
of Heart Failure Condition
.
##964-92·57A
Variant Coronary Artery Pattern and Ventricular Septal Defect 
Are Associated With Chronotropic Impairment Late After 
the Arterial Switch Operation##1035-115·248A
Ventilation Efﬁciency for Monitoring CHF Therapy: A Need 
for Method Standardization## 1017-29·156A
Extracellular matrix
Conditional Expression of a Gain of Function Alpha-5 
Integrin in Adult Mouse Heart Increases Ventricular 
Automaticity## 901-127·1A
Gadoﬂourine M Enhances Atherosclerotic Plaque Lesions in 
Apolipoprotein E Knockout Mice Through tnteraction 
With Extracellular Matrix Proteins## 993-13·144A
Non-invasive Evaluation of Regional Myocardial Strain and 
Activation of Matrix Metalloproteinases## 812-3·114A
Novel Injectable Alginate Biomaterial Attenuates Progressive 
Infarct Expansion and Preserves Left Ventricular Systolic 
and Diastolic Function Late after Myocardial Infarction## 
820-5·73A
Selective Secretion of MMP-8 and -9 in the Coronary 
Circulation in Parallel with BNP in Human Heart Failure 
## 819-4·72A
Usefulness of Membrane Type 1-matrix Metalloproteinase 
Measurement In Vivo as a Novel Indicator of 
Atherogenesis##933-166·302A
Extracorporeal circulation
Antiplatelet Treatment with P2Y
12
 Receptor Antagonist 
Decreases Blood Loss in a Canine CABG Model with 
Cardiopulmonary Bypass##955-258·190A
Fatty acids
Arachidonic Acid and Docosahexaenoic Acid Supplementation 
Increases Coronary Flow Velocity Reserve in Healthy 
Japanese Elderly Individuals##1024-175·367A
Do Omega-3 Fatty Acids/Fish Oil Reduce Mortality in Patient 
without Coronary Artery Disease?##914-206·298A
The PPAR-α Activator, Fenoﬁbrate, Fails to Provide 
Myocardial Protection in Ischemia-reperfusion Injury in 
Pigs##994-215·210A
Fetal cardiology
Assessment of Fetal Ventricular Volume by Dynamic 3D/4D 
Echocardiography in Normal Fetuses##989-113·243A
Feasibility of Using Spatiotemporal Image Correlation to 
Allow 3D Assessment of Right and Left Ventricular 
Volumes and Function in the Human Fetus## 991-
34·138A
Myocardial Thickness and Pulmonary Vein Flow Impedance: 
Correlation During Fetal Life##989-112·242A
Outcome Of Prenatally Diagnosed Tricuspid Atresia: A 
Multicenter Experience##1035-114·248A
Vasoreactive Response to Maternal Hyperoxygenation in the 
Fetus with Hypoplastic Left Heart Syndrome##1011-
109·244A
Fibrinolytic agents
Impact of Age on the Outcome of Fibrinolytic Therapy for 
ST-Segment Elevation Myocardial Infarction: A Meta-
analysis of a Decade of Trials##904-223·159A
Increased Bleeding Risk in Fibrinolytic Treatment of STEMI-
Register of Information and Knowledge About Swedish 
Heart Intensive Care Admissions (RIKS-HIA) 2002-
2004##904-225·160A
Intracoronary Streptokinase Infusion Just Following 
Primary Percutaneous Coronary Intervention Improves 
Microvascular Perfusion and Integrity in Patients With 
Acute Myocardial Infacrtion##929-237·174A
Long Distance Transfer for Direct Percutaneous Coronary 
Intervention: A Facilitated Approach##929-238·174A
Rescue Angioplasty versus Conservative Management for 
Failed Thrombolysis in Acute Myocardial Infarction: A 
Meta-Analysis##929-235·173A
Similar Mortality After Prehospital Thrombolysis or 
Primary PCI in Patients With ST-Elevation Myocardial 
Infarction Diagnosed in the Prehospital Phase. Results of 
PREMIR##952-234·184A
The Efﬁcacy and Safety of Combination Therapy Facilitated 
Angioplasty for ST-Elevation Myocardial Infarction: 
A Meta-analysis of Randomized Clinical Trials##929-
233·173A
The TIMI Risk Index for Myocardial Infarction Predicts 
Post-MI LV Ejection Fraction: A CLARITY - TIMI 28 
Substudy##1018-228·224A
Fish oils
Do Omega-3 Fatty Acids/Fish Oil Reduce Mortality in Patient 
without Coronary Artery Disease?##914-206·298A
Follow-up studies
Association of Chronotropic Incompetence With Exercise 
Induced Echocardiographic Ischemia and Prognosis## 
948-38·122A
Congenitally Corrected Transposition of the Great Ateries: 
Intermediate Results of the Anatomic Repair## 852-
7·249A
Contribution of Obesity to Elevated Blood Pressure in 
Uncomplicated Diabetics: 26-Year of Follow-Up 
Study##1004-197·352A
Coronary Blood Flow and Coronary Flow Reserve by Contrast-
Enhanced Transthoracic Echocardiography Predict Long-
Term Outcome in Heart Transplantation##1010-105·82A
Do Omega-3 Fatty Acids/Fish Oil Reduce Mortality in Patient 
without Coronary Artery Disease?##914-206·298A
Does Impaired Fasting Glucose Inﬂuence Long Term Mortality 
After an Acute Myocardial Infarction? Data From the 
Rico Survey##996-237·214A
Endothelial Dysfunction Accelerates Future Hypertensive 
Evolution and Causes Excess of Fatal Events## 853-
6·376A
Living Alone and Atypical Clinical Presentation Are 
Associated With Higher Mortality in Patients With all 
Components of the Acute Coronary Syndrome##953-
244·186A
Predictors of In-Hospital and Late (More Than Three Years) 
Death of Acute Myocardial Infarction Complicated by 
Cardiogenic Shock##931-250·176A
Self-reported Medication Adherence Predicts Cardiovascular 
Outcomes in Patients With Stable Coronary Disease: The 
Heart and Soul Study## 836-4·209A
The Impact of Complete Revascularization on Long-
Term Outcomes in Elderly Patients With Coronary 
Artery Disease Undergoing Percutaneous Coronary 
Intervention##976-253·202A
Free radicals/scavengers
Acute Vincristine Pretreatment Protects Adult Cardiac 
Myocytes From Oxidative Stress## 820-6·74A
Alteration in Iron Kinetics May Contribute to Doxorubicin 
Cardiotoxicity##987-100·70A
Asymmetrical Dimethylarginine (ADMA) Is Elevated In 
Heart Failure, Independently From Oxidative Stress And 
Inﬂammatory Status##985-47·64A
Pyrroloquinoline Quinone (PQQ) and/or Metoprolol Decrease 
Infarct Size and Improve Mitochondrial Function in a Rat 
Model of Ischemia/Reperfusion##994-216·210A
Signiﬁcance of 8-hydroxy-2’-deoxyguanosine Levels in 
Patients With Idiopathic Dilated Cardiomyopathy##987-
103·70A
Skin Autoﬂuorescence Is Increased in Patients With Stable 
Coronary Artery Disease and Is Positively Associated 
With Serum Levels of Soluble Receptor for Advanced 
Glycation Endproducts## 850-3·221A
The Betareceptor Blocker Nebivolol Inhibits Angiotensin 
II-Induced Aortic and Cardiac Superoxide Formation 
and Expression and Activity of the Vascular NADPH 
Oxidase##1027-196·371A
G proteins
A Comparison of Upstream Versus Downstream 
Administration of Glycoprotein 2b/3a Blockers in Patients 
With Non ST-Elevation Acs Who Are All Scheduled for 
Early Invasive Therapy## 843-5·220A
Description and Functional Characterization of two Novel 
SNPs in the Promoter of the Human Gene GNAQ 
Encoding the G Protein Gαq Subunit and Their Potential 
Role for Cardiac Hypertrophy##918-49·37A
Gap junctions
Connexin30.2 Containing Gap Junction Channels Decelerate 
AV-nodal Conduction## 901-123·1A
Forced Expression of Human Myocardin Increases Electrical 
Conduction Velocity Across Human Adult Mesenchymal 
Stem Cells to Levels Comparable to Cardiomyocytes.## 
901-124·1A
Long-Term Electrical Conduction Across Human Adult 
Mesenchymal Stem Cells Connecting Two Fields 
of Cultured Cardiomyocytes and the Effect of Cx43 
Knockdown by RNA Interference## 901-125·1A
Gender
Are There Gender Differences in Risk of Ischemic Stroke in 
Patients with Atrial Fibrillation Who Are Anticoagulated? 
Results from the AFFIRM Trial## 804-6·10A
Are There Gender-Related Differences in Presentation 
and Management of Patients with Severe Aortic 
Stenosis?##1030-21·286A
CABG and PCI Rates Differ Between Genders Even With 
Similar Coronary Anatomy: A Computer Based Patient 
Simulation Explores the Gender Gap##1013-145·266A
Can Nornal Myocardial Perfusion During Dobutamine Stress 
Echocardiography Predict a Good Long Term Prognosis 
in Women?## 1016-45·152A
Changes in the 1-Year Survival After Hospital Discharge in 
Heart Failure Patients With Depressed Systolic Function 
in the Last Years. Had We Reached the Same in Men and 
Women?## 837-4·83A
Characterisation of the Vasodilatory Action of Testosterone in 
the Human Pulmonary Circulation##936-187·306A
Clinical Presentation and Management of Patients With Severe 
Mitral Regurgitation: Are There Differences Between 
Men and Women?##962-24·279A
Contrast Stress Echocardiography for Improved Accuracy in 
Evaluation of Myocardial Ischemia in Women## 948-
33·121A
Detecting Depression in Cardiac Patients: Description of an 
Innovative System and Preliminary Findings Related to 
Gender and Age##1005-205·353A
Diabetes-Related Increased Mortality in Women With 
Heart Failure Is Modiﬁed by Non-Potassium-Sparing 
Diuretics##964-52·54A
Do ECG Abnormalities Pose the Same Risk for Women and 
Men?## 992-123·26A
Does Gender Alter the Efﬁcacy of Implantable Cardioverter 
Deﬁbrillators?## 947-129·15A
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Does Hormone Therapy Impact Stroke Risk Among Women 
With Atrial Fibrillation?Results from the AFFRIM trial## 
1015-131·33A
Gender and Racial Differences in Invasive Diagnostic and 
Interventional Cardiac Procedures in the Management 
of Acute Myocardial Infarction: 15-Year Trends in a 
Statewide Database##904-230·161A
Gender Difference in the QT Interval and Ventricular 
Tachycardia or Fibrillation in MADIT II## 924-135·8A
Gender Difference of Small and Large Artery Elasticity in 
Relation to Pulse Pressure##1001-174·347A
Gender Differences in Hospital Survival Rates for Medicare 
Beneﬁciaries Undergoing CABG: Hospital Performance 
Rankings Matter##990-152·262A
Gender Differences in Non-ST-Elevation Acute Coronary 
Syndromes##953-243·186A
Impact of Gender on Left Atrial and Ventricular Response 
to Asymptomatic Aortic Valve Stenosis. The SEAS 
Study##1030-19·285A
Impact of Gender on the Clinical Beneﬁt of Anti-hypertensive 
Therapy in Patients With Coronary Artery Disease and 
Normal Blood Pressure##1028-199·372A
Inﬂuence of Blood Pressure Versus Overweight/Obesity 
on Biomarkers of Vascular Health in Postmenopausal 
Women##915-214·300A
Outcomes by Gender in the African-American Heart Failure 
Trial (A-HeFT)## 837-8·84A
Sex Determines Differences in Left Ventricular Diastolic 
Properties in the Model of Chronic Estrogen 
Deﬁciency##985-50·64A
Sex Differences in the Efﬁcacy of Statins in Patients After 
Acute Myocardial Infarction##996-236·214A
Sex Differences in the Inﬂammatory Response to Leptin: 
Results From the Dallas Heart Study##959-188·323A
Sex-Related Differences in Non-Obstructive Coronary Artery 
Disease Among Patients With Non-ST-Segment Elevation 
Acute Coronary Syndromes: Results From the CRUSADE 
Quality Improvement Initiative##928-228·172A
Short- and Long-Term Prognosis of First Acute ST-Segment 
Elevation Myocardial Infarction in Older Women. The 
PPRIMM75 Registry##928-230·172A
Testosterone, Estrogen, and Coronary Function in Women: A 
Report From the NHLBI-Sponsored Women’s Ischemia 
Syndrome Evaluation (WISE) Study##1024-173·366A
The Effect of Estrogens on Vascular Reactivity in Women Is 
Dependent on Aging and Previous Hormone Use##957-
179·321A
The Prognostic Value of Peak Oxygen Consumption in Men 
and Women with Severe Systolic Heart Failure## 828-
5·133A
Gene expression
A Novel Plasmid Vector for Quantitative and Noninvasive 
Positron-Emission Tomography Imaging of the 
Therapeutic Cardiac Transgene Expression ## 812-4·115A




-Adrenergic cAMP Signaling Is Uncoupled After Acute 
Treatment of Anthrax Lethal Toxin in Cardiomyocytes in 
Normal Rats##1032-99·89A
Cardiac SP Cells Have Different Characteristics Distinct From 
Bone Marrow SP Cells##903-219·159A
Chronic Therapy with Cardiac Contractility Modulation 
Electrical Signals Normalizes mRNA Expression of the 
Sodium-Calcium Exchanger and its Modulators GATA-4 
and FOG-2 in Dogs With Chronic Heart Failure##1007-
49·76A
Chronic Therapy with the Acorn Cardiac Support Device 
Normalizes mRNA Gene Expression of Fatty Acid 
Oxidation Regulatory Enzymes in Dogs with Heart 
Failure##963-48·54A
Gene Expression Proﬁling in Fabry Cardiomyopathy##987-
101·70A
Gene Expression Proﬁling of Left Ventricular Tissue in 
Mdx Mice Showing Echocardiographic Evidence of 
Cardiomyopathy##918-48·37A
Hypoxia-Induced Differential Expression of Angiogenesis 
Genes by Umbilical Cord Blood-derived CD34+/CD133+ 
Progenitor Cells## 814-5·191A
Increased Expression of Phospholemman in Left Ventricular 
Myocardium of Explanted Failed Human Hearts and in 
Dogs with Experimentally-Induced Heart Failure##963-
50·54A
Induction of Heart and Smooth Muscle-Speciﬁc Genes in 
Human Mesenchymal Stem Cells and Epicardium-
Derived Cells After Forced Myocardin Expression## 
823-4·341A
Lipopolysaccharide Induces CXCR6 Expression in Human 
Coronary Artery Smooth Muscle Cells in TLR4 
Dependent Myd88-TIRAP-TRIF-TRAF6 Mediated 
ERK1/2 Activation##933-160·301A
Manganese Superoxide Dismutase Polymorphism Affects the 
Oxidized LDL-Induced Apoptosis of Macrophages and 
Coronary Artery Disease## 822-6·340A
mRNA Expression and Protein Levels for Granulocyte Colony 
Stimulating Factor are Increased in Left Ventricular 
Myocardium of Patients With Heart Failure## 819-8·73A
Post-transplant Ischemic Injury Is Associated With Increased 
AlloMap Gene Expression Score##1034-107·91A
Speciﬁc Effects of Statins on Gene- Proﬁling in Human End- 
Stage Stenotic Calciﬁed Aortic Valves##1030-23·286A
Structural, Functional and Molecular Recovery of the Failing 
Canine Left Ventricle Following Short-Term Therapy with 
the Orqis Medical Cardiac Recovery System## 825-6·75A
The Functional Interaction Between CREB and C/EBPb 
Mediate beta AR Stimulation Induced IL-18 Binding 
Protein Expression in Cardiomyocytes##1031-49·84A
Up-Regulation of Pro-Platelet Basic Protein in Older Men 
with Obstructive Coronary Disease as Determined by 
Positron Emission Tomographic Perfusion Imaging: A 
New Noninvasive Marker for Coronary Artery Disease?## 
926-31·109A
Xanthine Oxidase Inhibition Causes Reverse Remodeling in 
Rats with Dilated Cardiomyopathy##963-47·53A
Gene-based therapy
Prolonged Adenovirus and Adeno-associated Virus-mediated 
Gene Delivery to Rabbit Iliac Arteries Using Gene-
Eluting Stents: A Direct Comparison##934-177·304A
A New Strategy for Atherosclerosis Using Sendai Virus 
Mediated Delivery of Paraoxonase##909-177·292A
A Novel Plasmid Vector for Quantitative and Noninvasive 
Positron-Emission Tomography Imaging of the 
Therapeutic Cardiac Transgene Expression ## 812-4·115A
Adenoviral Fibroblast Growth Factor-4 Gene Therapy in 
patients With Stable Angina. 12-Month Results of a 
Double Blind Randomized Multicenter Trial##934-
178·305A
Beneﬁcial Impact of Cardiac-Isolated Recirculating Delivery 
of AAV-SERCA2a Gene Therapy in a Large Animal 
Model of Heart Failure## 820-4·73A
Forced Expression of Human Myocardin Increases Electrical 
Conduction Velocity Across Human Adult Mesenchymal 
Stem Cells to Levels Comparable to Cardiomyocytes.## 
901-124·1A
Hypoxia-Induced Differential Expression of Angiogenesis 
Genes by Umbilical Cord Blood-derived CD34+/CD133+ 
Progenitor Cells## 814-5·191A
Improvement of Left Ventricular Function With 
Intramyocardial Injections of Hepatocyte Growth Factor 
Naked DNA Plasmid in Dogs With Heart Failure Is 
Associated With Normalization of Cardiac Sarcoplasmic 
Reticulum Calcium Cycling Proteins## 823-3·341A
Induction of Heart and Smooth Muscle-Speciﬁc Genes in 
Human Mesenchymal Stem Cells and Epicardium-
Derived Cells After Forced Myocardin Expression## 
823-4·341A
Skeletal Myoblast Delivery of Angiopoietin-1 Versus Direct 
Adenoviral Angiopoietin-1 Injection## 856-7·234A
Therapeutic Angiogenesis Using Novel Vascular Endothelial 
Growth Factor-E / Human Placental Growth Factor 
Chimera Genes##933-169·303A
Vascular Endothelium Growth Factor-165 Gene Therapy 
Increases Left Ventricular Mass and Decreases Wall 
Thinning in Reperfused Myocardial Infarction## 856-
3·233A
Genetic techniques
Genetically Modifying Marrow Stromal Stem Cells to Secrete 
Erythropoietin Enhances the Protective Effect of Cellular 
Therapy in the Infarcted Myocardium## 829-4·206A
Long-Term Electrical Conduction Across Human Adult 
Mesenchymal Stem Cells Connecting Two Fields 
of Cultured Cardiomyocytes and the Effect of Cx43 
Knockdown by RNA Interference## 901-125·1A
Up-Regulation of Pro-Platelet Basic Protein in Older Men 
with Obstructive Coronary Disease as Determined by 
Positron Emission Tomographic Perfusion Imaging: A 
New Noninvasive Marker for Coronary Artery Disease?## 
926-31·109A
Genetics
ACTN2-Encoded Alpha-Actinin 2: A Novel Hypertrophic 
Cardiomyopathy Susceptibility Gene## 817-5·63A
A Common Polymorphism H558R in SCN5A is Associated 
with Lone Atrial Fibrillation## 826-6·25A
A Novel Locus for Familial Atrial Fibrillation on Chromosome 
10p11-q21## 804-8·11A
Ace Gene Copies Number Impairs Hemodynamic Responses 
to Hypertension in Mice##960-193·324A
Aldosterone Synthase Promoter Polymorphism Modulates 
Outcome In Black Patients With Heart Failure: Results 
From the A-HeFT Trial## 819-5·72A
Angiotensin Converting Enzyme (ACE) Polymorphism, 
Albuminuria, and Systemic Capillary Permeability in 
Hypertensive Men##960-192·324A
Association Between Refractory Hypertension and Endothelial 
Nitric Oxide Synthase -786C allele##960-197·325A
Association of the Deletion/Insertion Polymorphism of 
the Angiotensin-Converting Enzyme With Cardiac 
Conduction, Repolarization, and Function in A 
Population-based Study##918-50·37A
Association of Transforming Growth Factor-β1 Gene 
Polymorphisms With Myocardial Infarction## 856-
4·233A
Association of Variant Alleles of Paraoxonase and Endothelial 
Nitric Oxide Synthase Genes With Early Onset of First 
Myocardial Infarction##1021-253·230A
Beta 1 Adrenergic Receptor Gly389Arg Polymorphism and 
the Impact of Fixed-Dose Combination of Isosorbide 
Dinitrate/Hydralazine in Heart Failure: Results From the 
A-HeFT trial##986-60·67A
Brain Natriuretic Peptide Gene Polymorphism (C+171A) 
Is Associated With the Presence of Left Ventricular 
Hypertrophy## 835-5·342A
CYP2C19*2 Polymorphism Contributes to a Diminished 
Pharmacodynamic Response to Clopidogrel## 855-
7·380A
Description and Functional Characterization of two Novel 
SNPs in the Promoter of the Human Gene GNAQ 
Encoding the G Protein Gαq Subunit and Their Potential 
Role for Cardiac Hypertrophy##918-49·37A
Differences in Protein-Protein Interactions as a Basis for the 
Contrasting Phenotypes of Hypertrophic and Dilated 
Cardiomyopathies Resulting From Different Mutations in 
the Same Sarcomeric Protein## 817-3·62A
Different Genetic Make-up of the Anti-inﬂammatory Il10-
gene Contributes to the Development of Restenosis After 
PCI##956-159·317A
Do Loss-of-Function Mutations in Alpha 2 Adrenergic 
Receptor Subtypes Predispose to Hypertension in 
Blacks? Population-Level Data From the Dallas Heart 
Study##960-195·325A
Early Initiation of Perindopril Preserves Left Ventricular 
Ejection Fraction and Decreases Mortality in Duchenne 
Muscular Dystrophy: Results After Ten-Years Follow-
Up## 840-7·246A
Echocardiographic-Determined Septal Morphology in Z-Disc 
Hypertrophic Cardiomyopathy## 817-4·63A
Endothelial Nitric Oxide Synthase Glu298asp Gene 
Polymorphism Is Associated With Hypertensive 
Response to Exercise in Well-controlled Hypertensive 
Patients##960-196·325A
Ethnic Differences in the Effect of Polymorphisms in the 
Renin-Angiotensin System on Recurrent Cardiac Events 
in Post-Myocardial Infarction Patients##953-242·186A
Gene Sequence Variations of the CD14 Receptor Inﬂuences C-
Reactive Protein Levels in Patients With Stable Coronary 
Artery Disease##930-249·176A
Genetic Analysis of Hyperpolarization-activated and Cyclic 
Nucleotide-gated Cation Channels 4 (HCN4) in Patients 
With Bradyarrhythmia## 901-134·3A
Genetic Polymorphism C242T on the NADPH Subunit p22-
phox, Is Associated With Increased Risk for Myocardial 
Infarction and Endothelial Activation##1019-238·226A
Genetic Polymorphisms on Platelet Glycoprotein Ia, Increase 
the Risk for Myocardial Infarction by Modifying Platelet 
Activation##908-164·289A
Genomic Association of Graft Failure of the Left Internal 
Thoracic Artery for Myocardial Revascularization##907-
247·165A
Genotype of the Beta-Adrenergic Receptor Polymorphism 
Was a Strong Risk Factors for Neurally Mediated 
Syncope##913-201·297A
Gentic Polymorphism G894T Modiﬁes the Smoking-
Associated Risk for Myocardial Infarction in Young 
Individuals##983-210·339A
Investigation of Genetic and Biochemical Determinants 
of Depressed L-Arginine Transport in Human 
Hypertension##960-194·324A
Left Ventricular Size and Function and the Common Sodium 
Channel Polymorphism, H558R-SCN5A: A Population-
Based Association Study##918-47·37A
Linkage Analyses of Markers of Inﬂammation: The Genetic 





Polymorphism Is Associated With Coronary Endothelial 
Dysfunction##933-162·301A
Mutations in the Genes for Sarcomeric Proteins in Japanese 
Patients With Elderly-Onset Sporadic Hypertrophic 
Cardiomyopathy##965-101·59A
Myocardial Fibrosis in Patients with Hypertrophic 
Cardiomyopathy: Correlation with Echocardiographic 
Measurements of Diastolic Dysfunction and Genetic 
Perturbations##942-59·47A
Pharmacogenetic Warfarin-Dosing Algorithm Is Substantially 
Improved When Both VKORC1 and CYP2C9 Gene 
Variants Are Considered##908-159·288A
Phenotypic Comparison Between Myoﬁlament Positive and 
Myoﬁlament Negative Hypertrophic Cardiomyopathy 
Among Italians##965-102·59A
Synergistic Effect of Cytochrome P450 Epoxygenase CYP2J2 
G-50T Polymorphism With Smoking on the Onset of 
Premature Myocardial Infarction## 822-8·341A
Synergistic Effects of the Cholesteryl Ester Transfer Protein 
TaqIB, the Apolipoprotein E E2/E3/E4, and the 
Apolipoprotein C3 -482 C>T Polymorphisms on the Risk 
of Coronary Artery Disease## 850-6·221A
The CYBA Genotype Is Associated With Altered NADPH 
Oxidase Activity in Patients With Cardiovascular 
Disease## 822-7·340A
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Thrombospondin-4 A387p Polymorphism Is not Associated 
With Markers of Vascular Function and Incidence of 
Myocardial Infarction##933-159·300A
Glucose
Admission White Blood Cell Count and Plasma Glucose: A 
Simple and Useful Combination for Predicting In-Hospital 
Outcome After Acute Myocardial Infarction##1018-
230·224A
Cardiac Hypertrophy and Renal Disease in GLUT1-
Overexpressing Mice##918-51·38A
Does Impaired Fasting Glucose Inﬂuence Long Term Mortality 
After an Acute Myocardial Infarction? Data From the 
Rico Survey##996-237·214A
Fasting Glucose Is a Powerful Independent Risk Factor for 
Long-Term Mortality in Patients With Acute Myocardial 
Infarction. A Prospective Study## 830-5·207A
GLP-1 Depresses Myocardial Contractility, but Increases 
Myocardial Glucose Uptake in Isolated Rat Hearts 
Independent of cAMP or Akt-1 Activation##963-51·54A
Impact of Admission Serum Glucose Level on In-Hospital 
Outcomes Following Coronary Artery Bypass Grafting 
Surgery##955-257·190A
Inﬂuence of Severity and Extent of Coronary Artery 
Disease on Long-Term Survival of Patients With and 
Without Diabetes Mellitus: Analysis from the CASS 
Registry##905-235·162A
Pioglitazone Is Superior to Metformin or Glibenclamide in 
Recducing Markers of Cardiovascular Risk in Patients 
With Type-2-diabetes Mellitus##905-238·163A
The Effects of the Frequency of Exercise-Based Cardiac 
Rehabilitation on Glucose Tolerance and Lipid Levels in 
Patients With Acute Coronary Syndrome##916-254·167A
The Heterogeneous Inﬂuence of Metabolic Risk Factors on 
Arterial Elasticity##1001-173·346A
Growth factors
Bone Marrow-derived Stem Cell Interactions With Adult 
Cardiomyocytes and Skeletal Myoblasts in Culture##941-
48·44A
Growth Factors Inﬂuence Collagen Metabolism and 
Hypertrophy in Hypertrophic Cardiomyopathy##965-
104·60A
Improvement of Left Ventricular Function With 
Intramyocardial Injections of Hepatocyte Growth Factor 
Naked DNA Plasmid in Dogs With Heart Failure Is 
Associated With Normalization of Cardiac Sarcoplasmic 
Reticulum Calcium Cycling Proteins## 823-3·341A
Relation of Insulin-like Growth Factor-1 and Insulin-like 
Growth Factor Binding Protein-3 to Carotid Intima-media 
Thickness and Elasticity in Younger Adults: The Bogalusa 
Heart Study##961-203·326A
TGF-β1 Enhances Cardiomyogenic Differentiation Potential of 
Adult Primitive Cells##903-217·158A
Guidelines
ACC/AHA Performance Measures for Patients 
Hospitalized With HF: Are They Predictive of Clinical 
Outcomes?##946-152·255A
Are the American Heart Association Bacterial Endocarditis 
Prophylaxis Guidelines Obsolete?## 902-35·99A
Cardiovascular Risk Classiﬁcation in Hypertensive Patients 
With or Without Metabolic Syndrome: Results From the 
ICEBERG Study##939-209·311A
Catholic Healthcare Partners’ Closing the Gap for Heart Failure 
Initiative: A Large Multistate Health System Takes on the 
Challenge to Inprove Quality of Care## 847-3·267A
Compliance With Contemporary Guidelines for Non-ST-
Elevation Acute Coronary Syndromes: Inﬂuence on 
Outcome and Interaction With Risk Stratiﬁcation## 
811-6·257A
Do Hospitals That Provide Heart Failure Patient Education 
Prior to Discharge Also Promote Continuity of Care? A 
Report from OPTIMIZE-HF## 847-4·267A
Early Results of a Nurse-Based Outpatient Telemedicine 
Project for Patients After Acute Coronary 
Syndrome##1036-151·270A
Impact of Early Beta-Blocker Therapy for Acute Myocardial 
Infarction on In-Hospital Mortality## 857-7·235A
Improving Compliance With Heart Failure Core Measures: 
Michigan Heart Failure Discharge Document 
Initiative##990-145·260A
Mayo Clinic Fast Track Protocol for ST-Elevation Myocardial 
Infarction: Process Improvements to Minimize Treatment 
Delays## 847-7·268A
Mild Therapeutic Hypothermia After Cardic Arrest: A 
Nationwide Survey on the Implementation of the ILCOR 
Guidelines in Intensive Care Units##906-242·164A
National Improvements in the Recognition and Treatment of 
Patients at Increased Coronary Risk: The National Health 
and Nutrition Examination Survey, 1999 - 2002##916-
260·169A
Practice Makes Perfect: ACC/AHA Guideline Adherence 
Is Higher in Hospitals With High Acute Myocardial 
Infarction Volume##946-150·255A
Predictive Value on Mortality of Stress Hyperglycaemia 
in Patients With Acute Myocardial Infarction##996-
238·215A
Statin Use and Low-Density Lipoprotein Cholesterol Goals in 
2004: How Are We Doing Applying National Cholesterol 
Education Program III Guidelines?## 836-5·209A
Taking the Doctor Out of the Loop: The Impact of a Technician 
Led Follow-Up Clinic for Heart Valve Disease##1036-
150·270A
Health education
A Virtual Classroom is Superior to Traditional Training in 
Teaching Cardiac Auscultation##1013-148·267A
Do Hospitals That Provide Heart Failure Patient Education 
Prior to Discharge Also Promote Continuity of Care? A 
Report from OPTIMIZE-HF## 847-4·267A
Enhanced Self-Efﬁcacy but not Knowledge Predicts Increased 
Physical Activity##1036-154·270A
The Impact of an Electronic Stethoscope as a Patient Simulator 
in Cardiac Auscultation##1013-150·267A
Virtual Cardiac Symposia: World Wide Internet Based, 
Educational Forums for Cardiologists##1013-149·267A
Health policy
Clusters of Cardiovascular Risk Factors: A Health Economics 
Perspective for the Metabolic Syndrome## 842-7·358A
Driving Times and Distances to Hospitals With Percutaneous 
Coronary Intervention in the U.S.: Implications for Pre-
Hospital Triage of Patients With ST-Elevation Myocardial 
Infarction## 811-3·256A
Effects of Amlodipine or Enalapril Versus Placebo on Rates 
of Cardiovascular Hospitalization and Costs Among 
Coronary Artery Disease Patients With Normal Blood 
Pressure: Findings From the CAMELOT Economic 
Substudy## 848-8·361A
Financial Barriers to Health Care and Recovery After Acute 
Myocardial Infarction: A Prospective Registry Evaluating 
Myocardial Infarction: Event and Recovery (PREMIER) 
Study##923-153·253A
Mortality, Cause of Death, and Coronary Endothelial Function 
During Long-Term Follow-Up Among Hypertensive 
African and Caucasian Americans## 841-5·356A
The Cost-Effectiveness of Perindopril in Reducing 
Cardiovascular Events in Patients With Stable Coronary 
Artery Disease Using Data From the EUROPA 
Study##968-155·260A
The Effects of Statin Copayments and Statin Adherence on 
Medical Care Utilization and Expenditures## 834-5·263A
The Impact of Inpatient Quality of Care on Socioeconomic 
Disparities in Outcomes from Acute Myocardial 
Infarction## 811-7·257A
The Impact of Over-the-Counter Simvastatin on the Number of 
Statin Prescriptions in the United Kingdom: A View from 
the General Practice Research Database## 808-7·316A
There Is No Objective Evidence That “Self-Referral” Is 
Responsible for Growth of Imaging Services Billed to the 
Medicare System.## 834-3·263A
Health services
Catholic Healthcare Partners’ Closing the Gap for Heart Failure 
Initiative: A Large Multistate Health System Takes on the 
Challenge to Inprove Quality of Care## 847-3·267A
Effect of Physician Financial Incentives and Clinical 
Information Systems on Medication Use and Congestive 
Heart Failure Admissions## 834-8·264A
Health Status and Clinical Outcomes After Myocardial 
Infarction at One-Year: A Comparison Between Patients 
Hospitalized With ST-Elevation Versus Non-ST-Elevation 
Myocardial Infarction##946-155·256A
Healthcare Resource Utilization in Adults with Congenital 
Heart Disease: A Population-Based Study## 840-4·245A
Primary Percutaneous Coronary Intervention for Acute 
Myocardial Infarction in Women Versus Men 1995-
2004##952-235·184A
The Effects of Statin Copayments and Statin Adherence on 
Medical Care Utilization and Expenditures## 834-5·263A
There Is No Objective Evidence That “Self-Referral” Is 
Responsible for Growth of Imaging Services Billed to the 
Medicare System.## 834-3·263A
Heart block
Atrial Versus Dual Chamber Pacing in Sinus Node Disease## 
969-140·24A
Evolution of Left Ventricular Function in Pediatric Patients 
With Permanent Right Ventricular Pacing for Isolated 
Congenital Heart Block: A Medium Term Follow-Up## 
969-141·24A
Noninvasive Detection of Coronary Artery Disease in Patients 
With Left Bundle Branch Block Using 64-Slice Computed 
Tomography## 832-8·136A
Heart catheterization
A Novel Echo-Doppler Method to Predict Diastolic and Mean 
Pulmonary Artery Pressures: Derivation and Validation by 
Catheterization## 852-6·249A
A Routine Intervention Strategy in Patients With Non-ST 
Segment Elevation Acute Coronary Syndromes Is Not 
Superior to a Selective Intervention Strategy: A Meta-
Analysis of Randomized Controlled Trials## 811-4·257A
Alcohol Septal Ablation Is Safe and Effective in Patients 
With Left Ventricular Hypertrophy and Outﬂow Tract 
Obstruction##920-100·42A
Beneﬁcial Impact of Cardiac-Isolated Recirculating Delivery 
of AAV-SERCA2a Gene Therapy in a Large Animal 
Model of Heart Failure## 820-4·73A
Blood Type and the Age of the Red Cells Transfused 
Affects Mortality After Percutaneous Coronary 
Intervention##997-245·216A
Coronary Imaging With Multi-detector Computed 
Tomography: A Meta-analysis## 970-12·126A
Distal Protection Devices During Percutaneous Coronary 
Intervention Are Effective in Reducing Death or 
Recurrent Myocardial Infarction in Saphenous Vein 
Grafts but Not in Acute Myocardial Infarction: A Meta-
analysis##923-148·251A
Evaluation of Robotic Coronary Surgery by Intraoperative 
Angiography in Combination With Postoperative 
Multislice Computer Tomography##932-254·177A
Mononuclear Bone Marrow Stem Cells Implant as an 
Alternative Treatment in Non-isquemic Dilated 
Cardiomyopathy##1008-97·80A
Prospective, Randomized Controlled Trial Comparing 
the Effectiveness and Safety of a Vascular Closure 
Device and a Topically Applied Hemostatic System 
With Manual Compression in Patients Undergoing 
Cardiac Catheterization and Percutaneous Coronary 
Intervention##990-149·261A
Radial Artery Patency in CABG and Factors Affecting Long 
Term Outcome##932-255·178A
Usefulness of a New Risk Score to Identify Patients With Non-
ST-Segment Elevation Acute Coronary Syndromes Who 
Beneﬁt From an Invasive Treatment Strategy##1018-
224·223A
Heart conduction system
Biventricular Pacing Mode is Associated With a Higher 
Mortality Rate in Cardiac Resynchronization 
Therapy##1008-55·77A
Connexin30.2 Containing Gap Junction Channels Decelerate 
AV-nodal Conduction## 901-123·1A
Dyssynchrony in Heart Failure Patients With Narrow QRS 
Versus Wide QRS: Insights From Radial Strain by 
Echocardiographic Speckle Tracking## 831-7·134A
High-Septal Pacing Reduces Electrical Remodeling and 
Arrhythmogeneity in the Chronic Atrioventricular Block 
Dog## 826-3·25A
Relationship of Tissue Doppler Dyssynchrony and Acute 
Hemodynamic Response to Later Reverse Remodeling 
After Resynchronization Therapy## 810-5·11A
Heart defects, congenital
A Novel Microaxial Venous Assist Device for Enhancing 
Pulmonary Flow and Reducing Venous Pressure Within 
the Total Cavopulmonary Connection: Computational 
Fluid Dynamics Studies##922-115·238A
Atrial Septostomy Improves Survival in Primary Pulmonary 
Hypertension and Pulmonary Hypertension with 
Associated Congenital Heart Disease##945-113·239A
B-Natriuretic Peptide Levels Are Elevated in Single Ventricle 
Patients With Systemic Ventricular Failure but not With 
Cavopulmonary Failure##967-109·240A
Bosentan Improves Hemodynamics and Exercise Capacity in 
Eisenmenger Physiology## 840-6·246A
Comparison of Autonomic Control Between Atrial Septal 
Defect and Ventricular Septal Defect Based on Heart Rate 
Variability and Respiration##1011-113·244A
Congenital Heart Disease and Late Mortality Following 
Pediatric Heart Transplantation##967-115·241A
Congenitally Corrected Transposition of the Great Ateries: 
Intermediate Results of the Anatomic Repair## 852-
7·249A
Epidemiologic Features of the Presentation of Critical 
Congenital Heart Disease: Implications for 
Screening##1035-109·247A
Evolution of the Paced and Nonpaced QRS Duration With 
Chronic Right Ventricular Pacing in Pediatric Patients 
With and Without Structural Heart Disease## 992-
128·27A
Flow Proﬁles Across the Right Ventricle to Pulmonary Artery 
Shunt and Ventricular Mechanics in Hypoplastic Left 
Heart Syndrome##1011-112·244A
Healthcare Resource Utilization in Adults with Congenital 
Heart Disease: A Population-Based Study## 840-4·245A
Left Ventricular Dysfunction and Mortality in Patients with 
Eisenmenger Syndrome## 852-8·249A
Left Ventricular Myocardial Performance Index is Abnormal 
in Patients With Repaired Tetralogy of Fallot##1035-
116·248A
Near Infra-red Spectroscopy is a Reliable Indicator of Systemic 
Perfusion for Unsedated Infants with Single Ventricle 
Physiology##989-109·242A
Obesity is Prevalent, and is a Signiﬁcant Additional 
Comorbidity in Children With Congenital and Acquired 
Heart Disease## 840-8·246A
Outcomes of Stent Implantation for Native and Recurrent 
Coarctation of the Aorta (COA): Classiﬁcation and 
Implications of Aortic Wall Injury##945-111·239A
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Pulmonary Autograft Dilatation After Ross Procedure: 
Incidence of and Risk Factors##922-109·237A
Real-Time Three-Dimensional Echocardiography-guided 
Beating-heart Atrial Septal Defect Closure: The Next Step 
Toward Hybrid Procedures##922-111·237A
Right Ventricle to Pulmonary Artery Shunt Versus Modiﬁed 
Blalock-Taussig Shunt in Hypoplastic Left Heart 
Syndrome: Assessment and Outcome Through Stage 2 
Palliation##922-114·238A
Systemic Oxygen Saturation and Coagulation Factor 
Abnormalities Before and After the Fontan 
Procedure##1011-111·244A
The Changing Age Distribution of Severe Congenital Heart 
Disease in the General Population##1035-110·247A
The RV to PA Conduit in the Modiﬁed Norwood Procedure: A 
Caveat##922-116·238A
Who Needs Gadolinium? Three-Dimensional Reconstruction 
Utilizing Steady State Free Precession Cardiac Magnetic 
Resonance in Congenital Heart Disease##989-115·243A
Heart defects, echocardiography
Flow Proﬁles Across the Right Ventricle to Pulmonary Artery 
Shunt and Ventricular Mechanics in Hypoplastic Left 
Heart Syndrome##1011-112·244A
Real-Time Three-Dimensional Echocardiography-guided 
Beating-heart Atrial Septal Defect Closure: The Next Step 
Toward Hybrid Procedures##922-111·237A
Right Ventricle to Pulmonary Artery Shunt Versus Modiﬁed 
Blalock-Taussig Shunt in Hypoplastic Left Heart 
Syndrome: Assessment and Outcome Through Stage 2 
Palliation##922-114·238A
Heart defects, interventional
Atrial Septostomy Improves Survival in Primary Pulmonary 
Hypertension and Pulmonary Hypertension with 
Associated Congenital Heart Disease##945-113·239A
Real-Time 3-Dimensional Echocardiography for the 
Calculation of Left Ventricular Volumes in Fetuses 
With Aortic Stenosis Being Considered for In-Utero 
Intervention: An In-Vivo, and In-Vitro Validation Study## 
852-5·249A
Real-Time Three-Dimensional Echocardiography for 
Visualization and Quantiﬁcation of Atrial Septal Defect: 
Compared with Transcatheter Balloon Measurements## 
991-39·139A
Heart disease
Assessment of Mitral Regurgitation by CMR Derived 
Regurgitant Volume and Fraction: Is It Superior to 
Echocardiographic ERO?## 844-8·285A
Depression Is Not Associated With Long-Term Mortality in 
a Representative Patient Population With Myocardial 
Infarction##974-244·200A
Do Loss-of-Function Mutations in Alpha 2 Adrenergic 
Receptor Subtypes Predispose to Hypertension in 
Blacks? Population-Level Data From the Dallas Heart 
Study##960-195·325A
Enhanced Self-Efﬁcacy but not Knowledge Predicts Increased 
Physical Activity##1036-154·270A
Outcomes in Cardiac Transplant Recipients Using Donor 
Allografts With Left Ventricular Hypertrophy##966-
105·60A
Persistence of Depression at Four Months After Myocardial 
Infarction Is Not Associated With Increased Long-Term 
Mortality##1005-206·354A
Using Telemedicine to Decrease Cardiovascular Risk in 
Underserved Populations##968-148·258A
Heart failure
3D Contraction Front Mapping: Initial Experience With a 
Novel 3D Echo Technique to Visualise Left Ventricular 
Mechanical Contraction## 991-37·139A
3D Real Time-Echocardiography: A Novel Tool in the 
Assessment of Intraventricular Mechanical Asynchrony in 
Heart Failure Patients## 839-6·147A
A Biphasic Improvement Following Cardiac Resynchronisation 
Therapy## 1017-17·155A
A Novel Method Using Real-Time 3D Echo in Assessment of 
Ventricular Dyssynchrony: Virtual Resynchronization## 
991-35·139A
A Novel Two-Dimensional Echocardiographic Image 
Analysis System Using Artiﬁcial Intelligence Shape 
and Pattern Recognition for Rapid Automated Ejection 
Fraction##1012-147·264A
A Novel, Simpliﬁed Two-Dimensional Echocardiographic 
Measure of Left Ventricular Dyssynergy Predicts Patient 
Response to Cardiac Resynchronization Therapy##1008-
98·80A
A Simple Multi-biomarker Model Does Not Predict Outcomes 
Better Than Single Biomarkers in Heart Failure##1032-
95·89A
Absence of Clinical Hypotension with Eplerenone in Post-
acute Myocardial Infarction Patients With Heart Failure 
and Left Ventricular Systolic Dysfunction: Results from 
EPHESUS##1020-242·227A
ACC/AHA Performance Measures for Patients 
Hospitalized With HF: Are They Predictive of Clinical 
Outcomes?##946-152·255A
ACE Inhibitor Associated Cough: Difference Between 
Hypertension and Congestive Heart Failure##915-
209·299A
Activation of Focal Adhesion Kinase and Neuronal Nitric 
Oxide Synthase in Right Ventricular Myocardium of Rats 
With Right-sided Congestive Heart Failure##985-49·64A
Acute Effect of Continuous Positive Airway Pressure on 
Nocturnal Variation of Atrial Natriuretic Peptide 
Levels in Heart Failure Patients with Obstructive Sleep 
Apnea##964-91·57A
Acute Heart Failure Asociated With Atrial Fibrillation: A 
Distinct Disorder and Not Just a Fast Pulse Rate?##1032-
54·86A
Aldosterone Synthase Promoter Polymorphism Modulates 
Outcome In Black Patients With Heart Failure: Results 
From the A-HeFT Trial## 819-5·72A
Alternate BNP Forms in Preclinical Ventricular Dysfunction or 
Overt Heart Failure##986-56·66A
An Evaluation of Optimal AV Delays During Exercise in Heart 
Failure Patients Receiving Cardiac Resynchronization 
Therapy## 1015-124·31A
An On-Line, Evidence-Based Calculator of Mortality 
in Congestive Heart Failure Based on Clinical 
Variables##1012-152·266A
Anemia Is Related to Blunted Erythropoietin Production 
and Impaired Renal Function in Chronic Heart Failure 
Patients##964-98·58A
Assessment of Left Ventricular Function in Patients with 
Ischemic Heart Disease and Heart Failure by Three-
Dimensional Echocardiography and Cardiac Magnetic 
Resonance Imaging## 839-7·147A
Assessment of Longitudinal, Radial and Circumferential 
Dyssynchrony Using Speckle Tracking and Tissue 
Doppler in Patients With Systolic Heart Failure and 
Narrow QRS## 831-5·134A
Audioelectric Parameters are Superior to BNP for Detecting 
Hemodynamic Evidence of Heart Failure##986-90·67A
B-Natriuretic Peptide Levels Are Elevated in Single Ventricle 
Patients With Systemic Ventricular Failure but not With 
Cavopulmonary Failure##967-109·240A
Baseline Dyssynchrony Derived by Strain Imaging Correlates 
With the Effect of Cardiac Resynchronization Therapy at 
1-Month Follow-Up## 925-36·102A
Beta-blockers, Chronotropic Incompetence, and Functional 
Capacity in Severe Congestive Heart Failure## 1017-
8·153A
Blunted Hemodynamic Response and Reduced Oxygen 
Delivery With Exercise in Anemic Heart Failure 
Patients##986-53·65A
Brain Natriuretic Peptide Plasma Levels Combined to Diastolic 
Filling Pattern Predict Ventilatory Response to Exercise in 
Patients With Chronic Heart Failure## 902-11·96A
Can Displacement or Strain Imaging Predict a Favorable 
Response to Cardiac Resynchronization Therapy?## 
948-4·117A
Can the Electrocardiogram Distinguish Stress (Tako-Tsubo) 
Cardiomyopathy from Acute Anterior Myocardial 
Infarction?##1009-100·81A
Cardiac Resynchronization Device Placement During 
Hospitalization for Heart Failure is Associated With a 
Signiﬁcant Improvement in Early Clinical Outcomes## 
818-6·19A
Cardiac Resynchronization Therapy (CRT) In Patients With 
Left Ventricular Dysfunction and Narrow QRS Complex: 
Sequential Echocardiographic Dyssynchrony Analysis 
and Correlation with Improvements in Heart Failure 
Symptoms## 1015-123·31A
Cardiac Troponin T and Brain Natriuretic Peptide in Patients 
with Heart Failure and Preserved Versus Depressed Left 
Ventricular Systolic Function##942-93·48A
Cardiac Troponin T in Heart Failure: Results from Val-
HeFT##986-58·66A
Cardiology Specialty Care is Associated With Higher 
Quality Performance for Patients Admitted With Heart 
Failure##946-147·254A
Catholic Healthcare Partners’ Closing the Gap for Heart Failure 
Initiative: A Large Multistate Health System Takes on the 
Challenge to Inprove Quality of Care## 847-3·267A
Changes in Doppler Tissue Indices Are More Related With 
Improvement of Functional Status in Diastolic Heart 
Failure Than BNP Levels##942-99·49A
Changes in Renal Function During Hospitalization for 
Worsening Heart Failure Predict Postdischarge Survival: 
An OPTIME-CHF Analysis##1032-60·87A
Changes in the 1-Year Survival After Hospital Discharge in 
Heart Failure Patients With Depressed Systolic Function 
in the Last Years. Had We Reached the Same in Men and 
Women?## 837-4·83A
Characteristics, Treatments and Outcomes of Patients 
Hospitalized for Heart Failure with Preserved Systolic 
Function: A Report from OPTIMIZE-HF##942-90·47A
Chronic Therapy with Cardiac Contractility Modulation 
Electrical Signals Normalizes mRNA Expression of the 
Sodium-Calcium Exchanger and its Modulators GATA-4 
and FOG-2 in Dogs With Chronic Heart Failure##1007-
49·76A
Chronic Therapy with Selective Electric Vagus Nerve 
Stimulation Normalizes Plasma Concentration of Tissue 
Necrosis Factor-α, Interleukin-6 and B-Type Natriuretic 
Peptide in Dogs with Heart Failure##1008-57·77A
Chymase Inhibitor Improves Left Ventricular Dysfunction 
Under Long-Term Angiotensin-Converting Enzyme 
Inhibition in Heart Failure##919-99·42A
Clinical Impact of Collateral Circulation on 30-Day Mortality 
for Acute Myocardial Infarction Complicating Heart 
Failure##951-226·182A
Collagen Turnover is Initiated in the Early Phase of Congestive 
Heart Failure##986-55·66A
Comparison of Factors Identiﬁed as Precipitating Heart Failure 
Hospital Admissions and Clinical Outcomes: A Report 
From OPTIMIZE-HF##990-153·262A
Comparison of Heart Failure Adverse Event Rates Between 
Alternative Cardiac Resynchronization Therapy Pacing 
Modalities## 818-3·19A
Comparison of Ultraﬁltration to Nesiritide Therapy as 
a Treatment Modality for Decompensated Heart 
Failure##1032-52·85A
Comparison of Usefulness of Newer Echo-Doppler Variables 
to Left Ventricular End-Diastolic Pressure in Predicting 
Heart Failure## 902-37·100A
Comparison of Various Dyssynchrony Parameters of 
Echocardiography in the Canine Model of Heart Failure 
With Dyssynchrony## 948-9·118A
Conivaptan, a Novel Arginine Vasopressin Antagonist, 
Increased Serum Sodium Concentration in Patients 
With Heart Failure and Euvolemic or Hypervolemic 
Hyponatremia## 816-7·62A
Correlates of Arrhythmic Risk in MADIT II Patients: Signal 
Averaged EKG and Cardiac MRI## 993-29·146A
Correlation Between Acute Effect of Cardiac 
Resynchronization Therapy and Mechanical 
Dyssynchrony Measured by Tissue Velocity and Strain 
Parameters## 902-7·95A
Cyclooxygenase Products Sensitize Muscle Mechanoreceptors 
in Heart Failure Patients##986-99·69A
Death Causes in Hospitalized Heart Failure Patients With 
Preserved and Depressed Left Ventricular Systolic 
Function##1032-89·87A
Deﬁnition of Optimal Left Ventricular Lead Position in 
Cardiac Resynchronisation Therapy Using Myocardial 
Deformation Imaging## 810-4·11A
Delayed Enhanced Magnetic Resonance Imaging Is a Predictor 
of Resistance to Medical Treatment in Non-Ischemic 
Dilated Cardiomyopathy## 993-18·145A
Development and In Vivo Testing of a Simple Subcutaneous 
Circulatory Support Device##988-107·71A
Diabetes-Related Increased Mortality in Women With 
Heart Failure Is Modiﬁed by Non-Potassium-Sparing 
Diuretics##964-52·54A
Diastolic Dysfunction Predicts Enhanced Ventilatory Response 
to Exercise in Patients With Chronic Heart Failure## 
902-44·101A
Direct and Acute Cardiotoxicity of Ultraﬁne Air 
Pollutants##1031-48·84A
Direct Comparison of the Prognostic Value of Brain Natriuretic 
Peptide (BNP) and N-terminal ProBNP in a Large 
Population of Patients With Chronic and Symptomatic 
Heart Failure. The Valsartan In Heart Failure (Val-HeFT) 
Data## 819-3·71A
Do Biomarkers Add Prognostic Information to Routine 
Measures of the Severity of Heart Failure?##986-59·66A
Do Hospitals That Provide Heart Failure Patient Education 
Prior to Discharge Also Promote Continuity of Care? A 
Report from OPTIMIZE-HF## 847-4·267A
Do Simple Clinical and Echocardiographic Parameters Predict 
Long Term Responsiveness to Cardiac Resynchronization 
Therapy? Results From the CARE-HF Trial##1008-
52·76A
Do Ventricular Tachyarrhythmias From a Failing Heart Need 
More Energy to Convert?## 947-123·14A
Does African American or Caucasian Race Impact Use of 
B-Type Natriuretic Peptide and N-Terminal proBNP for 
Diagnosis of Decompensated Heart Failure and Predicting 
Mortality?##1032-92·88A
Does Tight Glycemic Control Improve Survival in Diabetic 
Patients With Chronic Heart Failure Started on Insulin 
Therapy?##964-55·55A
Down-regulation of Myocardial Fatty Acid Metabolism in 
Heart Failure Patients Is Dependent on Left Ventricular 
Chamber Size##1031-50·85A
Dyssynchrony in Heart Failure Patients With Narrow QRS 
Versus Wide QRS: Insights From Radial Strain by 
Echocardiographic Speckle Tracking## 831-7·134A
Echocardiographic Parameters of Right Heart Function in 
Patients With Symptoms of Heart Failure## 902-41·101A
Effect of Cardiac Resynchronization on the Incidence of Atrial 
Fibrillation in Patients with Severe Heart Failure##1008-
53·77A
Effect of Different Cardiac Resynchronization Therapy 
Pacing Modalities on Ventricular Tachycardia/Ventricular 
Fibrillation Events in Heart Failure Patients## 947-
125·14A
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Effect of False Tendons on Mitral Regurgitation in Patients 
with Severe Left Ventricular Dysfunction##919-90·40A
Effect of Metoprolol CR/XL on Diurnal Variation in 
Pulmonary Artery Pressure Measured Noninvasively 
Using First in Human Implant Responding to Ultrasonic 
Signals##1026-190·370A
Effect of Metoprolol CR/XL on Pulmonary Artery Pressure 
in Patients With Heart Failure Measured Using First in 
Human Implantable Device Responding to Ultrasonic 
Signal##938-201·310A
Effect of Nadir Hemoglobin During Hospital Course on the 
Long-Term Risk of Heart Failure and Death in Survivors 
of Acute Myocardial Infarction##953-245·187A
Effect of Physician Financial Incentives and Clinical 
Information Systems on Medication Use and Congestive 
Heart Failure Admissions## 834-8·264A
Effects of Differents Pacing Modes on Right Ventricular 
Function in Cardiac Resynchronization Patients## 1015-
128·32A
Effects of Isolated Obesity on Cardiac Functions: A Tissue 
Doppler and Strain Rate Imaging Study## 902-9·95A
Elevated Blood Urea Nitrogen Level Predicts Cardiovascular 
Death in Patients Admitted for Decompensated Heart 
Failure Irrespective of the Presence of Left Ventricular 
Systolic Dysfunction##986-98·69A
End Diastolic Pulmonary Regurgitation Gradient Predicts 
Adverse Cardiovascular Outcomes: Data from the Heart 
and Soul Study## 902-18·98A
Endogenous Stem Cell Circulation in Patients Suffering from 
Idiopathic Dilated Cardiomyopathy##941-47·44A
Enhanced Expression of Leptin, Leptin Receptor, and Leptin 
Signaling in the Failing Human Heart##913-200·297A
Eplerenone Attenuates Ventricular Electrical Remodeling in 
Experimental Heart Failure: Mechanism of Reduced Risk 
of Sudden Cardiac Death with Aldosterone Blockade?## 
924-131·7A
Evaluation of the Patient Global Assessment Questionnaire as a 
Health Status Measure for Heart Failure##990-146·260A
Evidence Refuting the Obesity Paradox: Weight Loss 
Regardless of Obesity and Independent of Volume Status 
Predicts Outcome in Heart Failure Patients##964-95·58A
Evolution of Left Ventricular Function in Pediatric Patients 
With Permanent Right Ventricular Pacing for Isolated 
Congenital Heart Block: A Medium Term Follow-Up## 
969-141·24A
Evolution of the Prognosis of Hospitalized Heart Failure 
Patients With Depressed and Normal Systolic Function 
Between 1991 and 2001.##1032-59·87A
Exaggerated Alterations in Left ventricular Relaxation and 
Chamber Compliance With Pressure Loading in a Model 
of Left Ventricular Dysfunction With Preserved Ejection 
Fraction##942-54·46A
Failure to Use Percutaneous Coronary Intervention in Patients 
With an Acute Coronary Syndrome and Congestive 
Heart Failure. The Global Registry of Acute Coronary 
Events##1032-56·86A
Fate of Patients With Reversibile, Non-ischemic Left 
Ventricular Systolic Dysfunction: Is IT Reasonable to 
Continue Anti-Heart Failure Medications?##919-97·42A
First Human Experience With a New Left Atrial Pressure 
Monitoring Device: Validation with Simultaneous 
Pulmonary Artery Occlusion Pressure in Subjects With 
Heart Failure##1008-93·79A
Flow Mediated Dilation Predicts Improved Cardiovascular 
Outcomes with Atorvastatin Therapy in Patients with 
Nonischemic Heart Failure##964-96·58A
Haemodilution Is the Primary Cause of Mild Anaemia in Heart 
Failure##986-52·65A
Heart Rate Turbulence as a Marker of Severity of Congestive 
Heart Failure## 992-127·26A
Hemoglobin and N-Terminal Pro-brain Natriuretic Peptide: 
Independent and Synergistic Predictors of Mortality in 
Patients With Acute Heart Failure##1032-97·89A
Home Uptitration of Beta-blockers by Heart Failure 
Clinic Patients With Telephone Advice: A British 
experience##1036-152·270A
How Much Reduction is Needed in BNP Levels to Reduce 
Future Clinical Events with Treatment During 
Hospitalization for Heart Failure?## 819-7·72A
Hypertensive Heart Failure with a Normal Ejection Fraction: 
Abnormal Load or Abnormal Ventricular Function?##942-
57·46A
Impact of Age on the Prognostic Value of Cardiopulmonary 
Exercise Testing in Subjects with Heart Failure## 1017-
12·154A
Impact of Increased Body Mass Index on Use of B-Type 
Natriuretic Peptide and N-Terminal proBNP for Diagnosis 
of Decompensated Heart Failure and Prediction of All-
Cause Mortality##1032-93·88A
Impact of Obstructive Sleep Apnea for the Impairment of Left 
Ventricular Diastolic Function##964-93·57A
Impact of the Change of Myocardial Velocity on Exercise-
Induced Functional Mitral Regurgitation in Patients with 
Non-Ischemic Cardiomyopathy## 806-8·113A
Impedance Cardiography as a Predictor of Clinical Outcome in 
Heart Failure Patients##1008-91·79A
Importance and Signiﬁcance of Baroreﬂex Sensitivity(BRS) 
to Predict Prognosis of Chronic Heart Failure With 
Preserved Systolic Function##919-92·40A
Improvement in Exercise Capacity After Inspiratory 
Muscle Training Is Associated With Reduced Dyspnea 
and Enhanced Limb Blood Flow in Chronic Heart 
Failure##1005-207·354A
Improvement of Diastolic Function Is related to Left 
Ventricular Reverse Remodeling After Mid-Term Cardiac 
Resynchronization Therapy##942-58·46A
Improvement of Left Ventricular Function With 
Intramyocardial Injections of Hepatocyte Growth Factor 
Naked DNA Plasmid in Dogs With Heart Failure Is 
Associated With Normalization of Cardiac Sarcoplasmic 
Reticulum Calcium Cycling Proteins## 823-3·341A
Improving Compliance With Heart Failure Core Measures: 
Michigan Heart Failure Discharge Document 
Initiative##990-145·260A
Incidence of Left Ventricular Dysfunction After Pacemaker 
Implantation for Complete Heart Block## 969-126·21A
Increased Expression of Phospholemman in Left Ventricular 
Myocardium of Explanted Failed Human Hearts and in 
Dogs with Experimentally-Induced Heart Failure##963-
50·54A
Increased Left Ventricular Myocardial Stiffness Is the Major 
Cause of Recurrent Decompensation in Patients With 
Diastolic Heart Failure##942-56·46A
Increasing QRS Duration During Antihypertensive Therapy is 
Associated With an Increased Incidence of New-Onset 
Congestive Heart Failure: The LIFE Study## 851-4·92A
Inﬂuence of Location of Scar Tissue in Cardiac 
Resynchronization Therapy## 969-129·21A
Inhibition of Protein Synthesis via mTOR Dependent Pathway 
Prevents Adverse Left Ventricular Remodeling and 
Reduces Infarct Size After Experimental Myocardial 
Infarction## 820-7·74A
Intra-Renal Infusion of BNP: A Novel Strategy to Overcome 
the Renal Resistance to BNP in Severe Experimental 
Heart Failure## 820-3·73A
Intraventricular Dyssynchrony Measured by Tissue Velocity 
Does Not Change Acutely After CRT## 925-41·103A
Investigation of the Relation Between the New AHA/CDC C-
Reactive Protein Cutpoints and Cardiovascular Outcomes 
and Incident Diabetes in Patients With Stable Coronary 
Disease: A PEACE Substudy## 850-8·222A
Is Echocardiographic Atrio-Ventricular Optimization in 
Patients With Biventricular Pacemakers Needed? An 
Acute Hemodynamic Study## 805-6·111A
Kidney Transplantation Leads to Improved Left Ventricular 
Ejection Fraction in Patients with Systolic Dysfunction 
and End Stage Renal Failure Compared to Medical 
Management Alone##1008-99·80A
Long-Term Monotherapy with Rosuvastatin Prevents 
Progressive Left Ventricular Dysfunction and Remodeling 
in Dogs with Heart Failure##964-94·58A
Low Body Temperature at Hospital Discharge is a Marker 
of Poor Prognosis in Patients with Congestive Heart 
Failure##1032-94·88A
Low Serum Total Cholesterol Is Associated With Increased 
Mortality in Non-Ischemic Heart Failure##964-99·59A
Magnetic Resonance Imaging Based Characterization of 
Mechanical Dyssynchrony and Cardiac Resynchronization 
Therapy in Right Bundle Branch Block## 810-3·11A
Mechanisms of Chronotropic Incompetence in Patients With 
Congestive Heart Failure Taking Beta-blockers##919-
57·39A
Metoprolol Prevents Progression of Diastolic Dysfunction 
in Patients With Asymptomatic Left Ventricular 
Systolic Dysfunction: Observations From the REVERT 
Trial##942-95·49A
Mid-regional Pro-atrial Natriuretic Peptide (MR-proANP) as 
a Novel and More Stable Prognostic Marker in Chronic 
Heart Failure (CHF)##986-54·65A
Modulation of BNP Release in Relation to Myocardial 
Scarring, Ischemia and Hibernation on PET in Patients 
With Chronic Heart Failure##919-52·38A
Mortality by Race in Patients With Congestive Heart 
Failure##919-60·40A
mRNA Expression and Protein Levels for Granulocyte Colony 
Stimulating Factor are Increased in Left Ventricular 
Myocardium of Patients With Heart Failure## 819-8·73A
N-terminal ProBNP is not Only Related to the Severity of 
Heart Failure##986-93·68A
Nitroxyl Increases Contractility in Failing (Gαq 
Overexpressing) Cardiomyocytes That Display Altered 
Cellular Redox Conditions##985-48·64A
Novel Computer Assisted Measurement of 
Electrocardiographic P Terminal Force to Predict Elevated 
Left Ventricular End Diastolic Pressure## 813-8·13A
Novel Injectable Alginate Biomaterial Attenuates Progressive 
Infarct Expansion and Preserves Left Ventricular Systolic 
and Diastolic Function Late after Myocardial Infarction## 
820-5·73A
NT-proBNP Predicts Perioperative Cardiac Events in Patients 
Undergoing Noncardiac Surgery##1005-200·352A
Obesity and the Metabolic Syndrome are Associated With 
Improved Survival in the Heart Failure Population##964-
57·56A
Obesity Has No Effect on the Sensitivity Of NT-ProBNP 
for Detection of Systolic and Diastolic Dysfunction: 
Results From the ProBNP Investigation of Dyspnea in 
the Emergency Department (PRIDE) Echocardiography 
Substudy## 902-2·94A
Obesity is Independently Associated With Increased 
Ventricular Systolic Tension: A Population-Based 
Study##982-199·336A
One Day Kinetics of Bone Marrow Mononuclear Cells in 
Acute and Chronic Myocardial Infarction: Transient 
Myocardial Homing or Persistent Engraftment After 
Intracoronary Injections in Human?## 829-6·206A
Outcome in Heart Failure and Narrow QRS Patients With and 
Without Left Ventricular Dyssynchrony## 902-36·99A
Patient Satisfaction With a Home Based Program Designed to 
Treat Elderly Heart Failure Patients##1036-153·270A
Patients With Different Degrees of Left Ventricular Systolic 
Dysfunction Have Similar Prevalence of Intraventricular 
Asynchrony: Results From AVE (Ventricular Asyncrony) 
Register by SIEC (Italian Society of Cardiovascular 
Echography)## 902-16·97A
Patients With Severely Reduced Ejection Fractions and Atrial 
Fibrillation Have No Beneﬁt from Rhythm Control: An 
Analysis of the AFFIRM Study## 851-7·93A
Physical and Mental Functioning and Health Outcome 
in Patients Enrolled in the Multicenter Automatic 
Deﬁbrillator Implantation Trial-II##919-54·38A
Predictors of Mortality After Discharge in Patients 
Hospitalized with Heart Failure: An Analysis from the 
Organized Program to Initiate Lifesaving Treatment in 
Hospitalized Patients with Heart Failure (OPTIMIZE-
HF)## 837-5·83A
Preservation of Diastolic Kinetic Energy: A Marker of 
Ventricular Efﬁciency?##942-98·49A
Prevalence of Atrial Fibrillation and Flutter by Different HMG-
CoA Reductase Inhibitors and Doses in Heart Failure## 
816-4·61A
Prevalence of Sleep Disordered Breathing in 700 State of 
the Art Treated Patients With Symptomatic Chronic 
Heart Failure: Implications for Cardiopulmonary 
Function##964-58·56A
Prognosis Value of Brain Natriuretic Peptide Kinetics During 
Cardiopulmonary Exercise Test in Chronic Heart Failure 
Patients##986-92·68A
Prognostic Role of Chronic Obstructive Pulmonary Disease 
in Congestive Heart Failure. Data From The IN-CHF 
Registry##964-89·57A
Prognostic Value of Cardiac Sympathetic Activity Evaluated 
by Scintigraphics 123I-MIBG Imaging Pre and Post 
Resynchronization Therapy## 926-30·109A
Prognostic Value of Regional Versus Global Measures of Left 
Ventricular Function Following Myocardial Infarction: 
The VALIANT Echo Study## 902-3·94A
Relationship of Cardiac Hemodynamics and Ventilatory 
Inefﬁciency, and Their Mortality Prediction in Patients 
With Heart Failure## 1017-16·155A
Rhythm Versus Rate Control for Atrial Fibrillation in Post-MI 
Patients With Heart Failure: Results from the VALIANT 
Trial##919-95·41A
Risk for Early Heart Failure Hospitalization or Death After 
Cardiac Resynchronization Therapy## 947-137·17A
Risk Prediction With Cardiac Troponin T Versus Biochemical 
Markers Associated With Cardiac Remodeling##959-
191·324A
Serial Studies of Cardiac I-123 Metaiodobenzylguanidine 
Imaging Improve the Prediction of Cardiac Death in 
Patients With Chronic Heart Failure After Carvedilol 
Therapy: A Prospective Study## 926-9·106A
Should We Measure Both Electrical and Mechanical 
Dyssynchrony in Patients With Advanced Heart Failure? 
Learning From Long-Term Clinical Follow-Up##1008-
59·78A
Single Center Experience With the HeartMate II Left 
Ventricular Assist System## 825-5·75A
Strain Related Alterations of the Phosphoinositide 3-Kinase/
Akt/BAD Survival Pathway##1007-50·76A
Structural, Functional and Molecular Recovery of the Failing 
Canine Left Ventricle Following Short-Term Therapy with 
the Orqis Medical Cardiac Recovery System## 825-6·75A
Survival in Ischemic Cardiomyopathy: Medical Therapy is 
Superior to Revascularization in Patients With Limited 
Viability##1008-95·79A
Test-Retest Variability of Three-Dimensional 
Echocardiography for Serial Evaluation of Patients With 
Ischemic Heart Disease and Congestive Heart Failure## 
991-30·137A
The Association of Insulin Resistance with Global and 
Regional Left Ventricular Dysfunction in Four 
Racioethnic Groups: The Multi-Ethnic Study of 
Atherosclerosis (MESA)##964-53·55A
The Effect of Intensity of Intravenous Diuretic Dosing on 
Occurrence of Worsening Renal Function in Patients 
Hospitalized With Acute Decompensated Heart 
Failure##1032-90·87A
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The Effects of Antidepressant Therapy on Depression 
and Quality of Life in Patients with Chronic Heart 
Failure##919-96·41A
The Incidence of Thromboembolism in Patients With NYHA 
Class II and III Heart Failure: An Analysis From the 
Sudden Cardiac Death in Heart FailureTrial (SCD-
HeFT)##919-58·39A
The Long-Term Outcomes of Patients With Severe Left 
Ventricular Dysfunction Following Coronary Artery 
Bypass Graft (CABG) Surgery##940-27·276A
The Prognostic Value of Peak Oxygen Consumption in Men 
and Women with Severe Systolic Heart Failure## 828-
5·133A
The Rosuvastatin Impact on Ventricular Remodeling Cytokines 
and Neurohormones (UNIVERSE) Study## 816-6·61A
The Safe Use of Aldosterone Antagonists in Patients With 
Chronic Heart Failure and Associated Chronic Kidney 
Disease Facilitated by a Protocol in an Outpatient 
Clinic##990-147·261A
The Variable Natural History of Idiopathic Dilated 
Cardiomyopathy##1009-103·81A
There is Nothing Grey About It: Dyspnea with Intermediate 
Aminoterminal Pro-B Type Natriuretic Peptide 
Concentrations##986-91·67A
Thyroid Dysfunction is More Prevalent in Cardiomyopathy 
Patients Than in the General Population##986-95·68A
Trends in Survival Following a Diagnosis of Heart Failure## 
837-3·82A
Tumoral Marker Carbohydrate Antigen 125: An Emerging 
Prognostic Risk Factor in Heart Failure?##986-96·69A
Upregulation of Functional Cardiac Beta
3
-Adrenergic 
Receptors and Chronic Anthrax Lethal Toxin-Induced 
Progressive Cardiac Depression: Insights Into the 
Underlying Molecular Mechanism##1007-51·76A
Using Reference Equations, Percent Predicted Value (PPV), for 
the Six-Minute Walk Test: A Better Indicator of Severity 
of Heart Failure Condition
.
##964-92·57A
Ventilation Efﬁciency for Monitoring CHF Therapy: A Need 
for Method Standardization## 1017-29·156A
Ventricular Dyssynchrony Assessment With Equilibrium 
Radionuclide Angiography Phase Analysis Predicts 
Outcome After Cardiac Resynchronization Therapy## 
969-128·21A
Ventricular Structure and Function in Hypertensive Patients 
with Heart Failure and a Normal Ejection Fraction: The 
Cardiovascular Health Study (CHS)##942-52·45A
Which Parameter Is Best to Quantify Electromechanical 
Dyssynchrony for Predicting Cardiac Events in Patients 
With Advanced Heart Failure?##1008-58·78A
Heart failure, treatment
A Controlled Exercise Training Trial in Patients With Diastolic 
Dysfunction## 1017-14·155A
Acute Effect of Continuous Positive Airway Pressure on 
Nocturnal Variation of Atrial Natriuretic Peptide 
Levels in Heart Failure Patients with Obstructive Sleep 
Apnea##964-91·57A
Allogeneic and Syngenic Multipotent Adult Progenitor Cell 
Delivery Improves Cardiac Function After Myocardial 
Infarct##941-49·44A
Allogeneic Mesenchymal Stem Cells Restore Early Tissue 
Perfusion in Regions of Ischemically Damaged 
Myocardium## 993-3·142A
Association Between Study Drug Dose and Survival/
Hospitalization in Relation to Initiation of Treatment 
for Chronic Heart Failure With Bisoprolol Followed by 
Additional Enalapril Compared to the Opposite Sequence: 
Results of the Randomized CIBIS-III Trial##919-91·40A
Atorvastatin Might Improve Cardiac Function in Patients With 
Chronic Heart Failure by the Antioxidative Effect: A 
Prospective Randomized Placebo-Controlled Study##964-
97·58A
Attenuation of Cardiac Remodeling After Recent Myocardial 
Infarction Through Biventricular Pacing## 1015-127·32A
Attenuation of LV Dysfunction by A PPAR-alpha Agonist in 
Hypertensive Rats is Associated With Down-regulation of 
Redox-regulated Transcription Factors##1007-47·75A
Baseline Systolic Blood Pressure Predicts Response to Cardiac 
Resynchronization Therapy in Heart Failure Patients## 
969-142·24A
Beneﬁcial Effects of Dual Angiotensin-II Suppression With 
ACE-inhibitor and Angiotensin Receptor Blocker on 
BNP, CRP and Glucose Regulation in Patients With 
Symptomatic Heart Failure##959-189·323A
Beneﬁcial Impact of Cardiac-Isolated Recirculating Delivery 
of AAV-SERCA2a Gene Therapy in a Large Animal 
Model of Heart Failure## 820-4·73A
Beta 1 Adrenergic Receptor Gly389Arg Polymorphism and 
the Impact of Fixed-Dose Combination of Isosorbide 
Dinitrate/Hydralazine in Heart Failure: Results From the 
A-HeFT trial##986-60·67A
Beta Adrenergic Blockers Reduce the Risk of Mortality 
Associated with Elevated Troponin T in Patients with 
Acutely Decompensated Congestive Heart Failure##1032-
53·85A
Biventricular Pacing Mode is Associated With a Higher 
Mortality Rate in Cardiac Resynchronization 
Therapy##1008-55·77A
BNP Guided Care by a Heart Failure Specialist in Addition 
to Home-Based Nurse Care in Patients With Chronic 
Heart Failure: A Three-Arm, Prospective, Randomized 
Study##1032-96·89A
Candesartan Improves Outcome in Patients With Low Ejection 
Fraction Heart Failure, Irrespective of Background Dose 
of ACE Inhibitor: An Analysis of the CHARM-Added 
Trial## 809-5·52A
Carvedilol Use at Discharge in Patients Hospitalized for Heart 
Failure is Associated with Markedly Improved Survival## 
809-8·53A
Changes in Renal Function During Hospitalization for 
Worsening Heart Failure Predict Postdischarge Survival: 
An OPTIME-CHF Analysis##1032-60·87A
Chronic Therapy with Selective Electric Vagus Nerve 
Stimulation Normalizes Plasma Concentration of Tissue 
Necrosis Factor-α, Interleukin-6 and B-Type Natriuretic 
Peptide in Dogs with Heart Failure##1008-57·77A
Chronic Therapy with the Acorn Cardiac Support Device 
Normalizes mRNA Gene Expression of Fatty Acid 
Oxidation Regulatory Enzymes in Dogs with Heart 
Failure##963-48·54A
Closed-loop Automated Drug Delivery to Optimize Systemic 
Arterial Pressure, Cardiac Output, and Left Heart Filling 
Pressure in Discompensated Heart Failure##1012-
148·265A
Coadministration of the V2 Receptor Antagonist Tolvaptan and 
B-Type Natriuretic Peptide Enhances Water and Sodium 
Excretion Without Adversely Affecting Renal Function: A 
Physiologic Approach to Sodium and Water Retention in 
Experimental Heart Failure##913-199·297A
Comparison of Ultraﬁltration to Nesiritide Therapy as 
a Treatment Modality for Decompensated Heart 
Failure##1032-52·85A
Difference in Left Ventricular Reverse Remodeling in 
Response to Angiotensin Receptor Blockade Alone or 
in Combination With Spironolactone in Patients With 
Systolic Dsyfunction: Insight From Serial Prospective 
CMR Study##919-59·39A
Effect of Angiotension Receptor Blockade Alone or in 
Combination with Spironolactone on Left Ventricular 
Systolic and Diastolic Function in Chronic Heart 
Failure##942-53·45A
Effect of Metoprolol CR/XL on Pulmonary Artery Pressure 
in Patients With Heart Failure Measured Using First in 
Human Implantable Device Responding to Ultrasonic 
Signal##938-201·310A
Effect on New York Heart Association Class and Signs/
Symptoms of Heart Failure of Initiation of Treatment 
for Chronic Heart Failure With Bisoprolol Followed by 
Additional Enalapril Compared to the Opposite Sequence: 
Results of the Randomized CIBIS-III Trial## 809-6·53A
Evaluation of Left Ventricle Pressure Derivative Enhanced 
by Multi Site Pacing in Patients With Heart Failure## 
969-132·22A
Fate of Patients With Reversibile, Non-ischemic Left 
Ventricular Systolic Dysfunction: Is IT Reasonable to 
Continue Anti-Heart Failure Medications?##919-97·42A
Feasibility and Short-Term Efﬁcacy of Percutaneous Mitral 
Annular Reduction for the Therapy of Mitral Regurgitation 
in Patients with Heart Failure##1008-54·77A
Haemodilution Is the Primary Cause of Mild Anaemia in Heart 
Failure##986-52·65A
Impact of Pulmonary Hypertension on Left Ventricular Reverse 
Remodeling and Long-term Outcome in Patients with 
Cardiac Resynchronization Therapy## 1015-129·33A
Improvement of Obstructive Sleep Apnea in Heart Failure 
Patients After Cardiac Resynchronization##964-90·57A
Incidence and Predictors of Hyperkalemia in Patients With 
Heart Failure - An Analysis of the Candesartan in Heart 
failure - Assessment of Reduction in Mortality and 
morbidity (CHARM) Program## 809-4·52A
Is Cardiac Resynchronisation Therapy Effective in Patients 
With Less Severe Symptoms?## 851-8·93A
Isosorbide Dinitrate-Hydralazine Decreased Blood Pressure 
in Patients with High But Not Low Blood Pressure 
and Improved Survival Independent of Baseline Blood 
Pressure in African American Heart Failure Trial## 
809-3·52A
Lack of Association Between QRS Duration and Cardiac 
Asynchrony in Candidates for Cardiac Resynchronization 
Therapy## 969-143·24A
Left Ventricular Lead Positioning Over Infarcted Myocardium 
Results in Less Improvement in Ejection Fraction in 
Patients With Ischemic Cardiomyopathy Following 
Cardiac Resynchronization Therapy## 810-7·12A
Long-Term Effect of Repeated Sequential VV Optimization in 
Patients with CRT-Therapy?##1008-89·78A
Long-Term Monotherapy with Rosuvastatin Prevents 
Progressive Left Ventricular Dysfunction and Remodeling 
in Dogs with Heart Failure##964-94·58A
Loop Diuretic Dose Is Independently Associated With 
Increased Mortality in Advanced Heart Failure##919-
93·41A
Low-dose Erythropoietin Treatment Preserves Cardiac 
Function and Mobilizes Endothelial Progenitor Cells in 
Rats With Ischemic Heart Failure## 820-8·74A
Methodological Issues of QRS Duration Measurements in 
Candidates for Cardiac Resynchronization Therapy## 
992-138·29A
Mononuclear Bone Marrow Stem Cells Implant as an 
Alternative Treatment in Non-isquemic Dilated 
Cardiomyopathy##1008-97·80A
Nesiritide Improves Left Ventricular Compliance in Diastolic 
Heart Failure##942-55·46A
No Evidence of Detrimental Effects of Doxazosin as an 
Additional Antihypertensive Therapy in Mild/Moderate 
Heart Failure Patients on Full Medical Therapy##919-
89·40A
Outcomes by Gender in the African-American Heart Failure 
Trial (A-HeFT)## 837-8·84A
Randomized, Double-Blind, Placebo-controlled Study 
to Evaluate the Effect of two Dosing Regimens of 
Darbepoetin Alfa on Hemoglobin Response and 
Symptoms in Patients With Heart Failure and Anemia## 
816-5·61A
Rapid and Sustained Reductions of Plasma B-Type 
Natriuretic Peptide Concentrations in Patients with 
Acutely Decompensated Heart Failure Treated with 
Levosimendan: The REVIVE II Study##1032-57·86A
Reduced Ventricular Volumes and Improved Systolic 
Performance with Cardiac Resynchronization Therapy: 
A Comparison of Simultaneous Biventricular Pacing vs. 
Sequential Biventricular Pacing vs. Left Univentricular 
Pacing## 969-123·20A
Regression of Left Ventricular Mass and Improvement in 
Left Ventricular Ejection Fraction Following Long-Term 
Aldosterone Receptor Antagonist Therapy in Patients with 
Chronic Systolic Heart Failure## 809-7·53A
Relationship of Tissue Doppler Dyssynchrony and Acute 
Hemodynamic Response to Later Reverse Remodeling 
After Resynchronization Therapy## 810-5·11A
Renal and Neurohormonal Effects of Intravenous and Intra-
Renal Nesiritide in Patients with Renal Insufﬁciency: A 
Multicenter, Randomized, Placebo-Controlled Trial## 
816-3·61A
Repeated Thermal Therapy Improves the Abnormality of 
Sympathetic Nervous System in Patients With Chronic 
Heart Failure##1008-90·78A
Right Ventricular Dysfunction and Adverse Outcome in 
Patients Receiving Cardiac Resynchronization Therapy## 
851-3·92A
Risk Factors for Ventricular Arrhythmias in Heart Failure 
Patients## 947-131·15A
Short-Term and Long-Term Mortality With Nesiritide for 
Decompensated Heart Failure: A Meta-Analysis of 
Randomized Controlled Trials## 837-6·83A
Sodium: An Old Enemy or a New Friend for Advanced 
Failured Patients?## 819-6·72A
Structural, Functional and Molecular Recovery of the Failing 
Canine Left Ventricle Following Short-Term Therapy with 
the Orqis Medical Cardiac Recovery System## 825-6·75A
Superior Renin-Angiotensin-Aldosterone System (RAAS) 
Inhibiting Properties of a Novel Long-Acting ANP 
Designer Peptide Compared to Native ANP in Normal 
Dogs##919-94·41A
The Effect of Pre-Admission Use of Angiotensin Converting 
Enzyme Inhibitor/Angiotensin II Receptor Blocker and/or 
Beta-Blocker Therapy on Hospital Acute Decompensated 
Heart Failure Hospital Mortality##1032-55·86A
The Efﬁcacy of Continuous Positive Airway Pressure in Non-
Obese Patients With Obstructive Sleep Apnea and Heart 
Failure##964-59·56A
The Haemodynamic Response to Changes in Atrioventricular 
and Interventricular Delay of Cardiac Resynchronization 
Therapy Closely Fits a Parabola, Which May Allow More 
Efﬁcient Optimization## 969-130·22A
The Impact of Patient Selection on Long-Term Outcomes of 
Left-ventricular Assist Device Implantation as Destination 
Therapy for End-Stage Heart Failure## 825-4·75A
The Long-Term Cost-Effectiveness of Cardiac 
Resynchronization Therapy With or Without an 
Implantable Cardioverter-Deﬁbrillator: Model 
Based Analyses Based on Results From the CArdiac 
REsynchronization In Heart Failure Trial## 851-6·92A
The Safe Use of Aldosterone Antagonists in Patients With 
Chronic Heart Failure and Associated Chronic Kidney 
Disease Facilitated by a Protocol in an Outpatient 
Clinic##990-147·261A
Underuse of ACE Inhibitors, Beta-blockers and Spironolactone 
in Patients With Heart Failure Is Primarily Due to Lack of 
Initiation of Treatment##919-98·42A
Utility of Electronic Reprogrammable Vectors in Biventricular 
Devices## 947-134·16A
Venous Thromboembolic Prophylaxis in Hospitalized Heart 
Failure Patients: Missing in Action?##1032-58·86A
Xanthine Oxidase Inhibition Causes Reverse Remodeling in 
Rats with Dilated Cardiomyopathy##963-47·53A
Heart function tests
Acute Volume Loading Inﬂuences Left Ventricular Apical 
Twist: Studies in an Animal Model## 948-6·117A
Impedance Cardiography as a Predictor of Clinical Outcome in 
Heart Failure Patients##1008-91·79A
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Insulin Resistance is a Determinant of Myocardial Dysfunction 
in Apparently Healthy Obese Subjects##964-54·55A
Pediatric Impedance Cardiography: Is it reliable?##989-
111·242A
Pulmonary Surfactant Protein B for Detection of Preclinical 
Ventricular Dysfunction##986-94·68A
Radial Artery Pulse Wave Analysis Corresponds to Echo 
Doppler Measures of Cardiac Function in Patients 
Undergoing Atrioventricular and Ventriculo-Ventricular 
Optimization of Biventricular Pacemaker## 969-124·20A
Subclinical Target Organ Damage in Masked and White-Coat 
Hypertension##982-198·336A
The Prognostic Value of Pharmacologic Nuclear Stress Testing 
in Elderly Patients Undergoing Moderate to High-Risk 
Surgery## 926-14·107A
Time Resolved Sequence of Left Ventricular Flow Redirection 
during Isovolumic Intervals of the Cardiac Cycle## 
805-3·110A
Torsion Deﬁned by Strain Imaging Facilitates Deﬁnition of 
LV Segmental Dysfunction in Experimental Myocardial 
Infarction## 925-46·104A
Using Reference Equations, Percent Predicted Value (PPV), for 
the Six-Minute Walk Test: A Better Indicator of Severity 




Association of Chronotropic Incompetence With Exercise 
Induced Echocardiographic Ischemia and Prognosis## 
948-38·122A
Beta-blockers, Chronotropic Incompetence, and Functional 
Capacity in Severe Congestive Heart Failure## 1017-
8·153A
Can Exercise Induced Heart Rate Variability Spectral 
Slopes Provide Insights Into Autonomic Activity and 
Prognosis?## 1017-10·154A
Changes in Parasympathetic Tone Result in QT-RR Interval 
Hysteresis during Exercise and Recovery## 813-5·13A
Characteristics of Heart Rate Changes in Response to Sleep-
Disordered Breathing among Cardiac Patients## 992-
132·27A
Chronotropic Incompetence in Patients on Beta Blocker 
Referred for Stress Echocardiography: Superiority of 
Heart Rate Reserve Over 85% Maximum Predicted Heart 
Rate## 828-6·133A
Delayed Heart Rate Recovery After Adenosine Stress Testing 
With Supplemental Exercise Predicts Mortality## 926-
13·107A
Do Implantable Cardioverter-Deﬁbrillator Patients Have 
Adequate Rate Control During Atrial Tachyarrhythmias? 
Results From a New Continuous Long-Term Monitoring 
System## 1015-135·34A
Heart Rate Recovery is a Stronger Predictor of Mortality Than 
Chronotropic Index## 1017-9·154A
Heart Rate Turbulence Onset After Atrial Premature 
Complexes Does Not Reﬂect Cardiac Autonomic 
Regulations in Postinfarction Patients## 992-126·26A
Heart Rate Variability Response to Dynamic Exercise Testing: 
Implications for Interpretation of Spectral Analysis 
Parameters During Periods of Less Oscillatory Autonomic 
Function## 992-133·28A
Increased Heart Rate is Associated with Reduced Regional 
Myocardial Function in Cardiovascular Asymptomatic 
Population: The Multi-Ethnic Study of Atherosclerosis## 
993-4·142A
Mechanisms of Chronotropic Incompetence in Patients With 
Congestive Heart Failure Taking Beta-blockers##919-57·39A
Moderate Weight Loss Decreases Heart Rate and Myocardial 
Oxygen Consumption and Cardiac Work in Obese Men 
and Women## 926-5·105A
Heart septal defects
Real-Time Three-Dimensional Echocardiography-guided 
Beating-heart Atrial Septal Defect Closure: The Next Step 
Toward Hybrid Procedures##922-111·237A
Heart surgery
Anomalous Papillary Muscles as the Predominant Cause 
of Left Ventricular Outﬂow Tract Obstruction in 
Hypertrophic Cardiomyopathy: A Novel Form of 
Disease?## 817-8·64A
Congenitally Corrected Transposition of the Great Ateries: 
Intermediate Results of the Anatomic Repair## 852-
7·249A
Electrogram Features Are Superior to Clinical Characteristics 
for Predicting Atrial Fibrillation After Coronary Artery 
Bypass Graft Surgery## 813-3·12A
Evidence for Differential Tissue Effects of Alcohol Septal 
Ablation and Surgical Septal Myectomy on Left 
Ventricular Myocardium## 817-7·63A
Impact of Perioperative Myocardial Infarction on Angiographic 
and Clinical Outcomes Following Coronary Artery 
Bypass Surgery: Findings From PREVENT IV##932-
258·178A
Minimally Invasive Direct Coronary Artery Bypass (midcab) 
Surgery Versus Bare-metal Stenting in Isolated Proximal 
LAD-Stenosis: 5-Year Follow-up##976-258·203A
Radial Artery Patency in CABG and Factors Affecting Long 
Term Outcome##932-255·178A
The RV to PA Conduit in the Modiﬁed Norwood Procedure: A 
Caveat##922-116·238A
Heart valve prosthesis
Aortic Valve Replacement in Patients With Moderate to 
Severe Aortic Stenosis Does Not Prevent Bleeding From 
Gastrointestinal Arteriovenous Malformations##1030-
22·286A
Normalization of Nonuniform Contraction of the Left Ventricle 
Early After Aortic Valve Replacement in Patients With 
Severe Aortic Stenosis## 925-43·103A
Prosthesis-Patient Mismatch Affects Long-Term Survival After 
Mechanical Aortic Valve Replacement## 824-5·282A
Valve Type and Long Term Outcomes After Aortic Valve 
Replacement in Older Patients## 824-4·281A
Heart valves
Elevation of Cardiac Troponin T in Infective Endocarditis 
Predicts an Adverse Outcome##984-20·280A
Prospective Determination of the Prevalence of Clinically 
Unapparent Cerebral Embolization in Patients With Left-
Sided Infective Endocarditis##984-21·280A
Taking the Doctor Out of the Loop: The Impact of a Technician 
Led Follow-Up Clinic for Heart Valve Disease##1036-
150·270A
Three-Dimensional Tricuspid Annular Function Provides 
Insight Into the Mechanisms of Valve Regurgitation in 
Classic Hypoplastic Left Heart Syndrome## 839-5·146A
Valvular Heart Disease Surveillance in the United States, 1980-
2000## 803-4·276A
Hemodynamics
Audioelectric Parameters are Superior to BNP for Detecting 
Hemodynamic Evidence of Heart Failure##986-90·67A
Blunted Hemodynamic Response and Reduced Oxygen 
Delivery With Exercise in Anemic Heart Failure 
Patients##986-53·65A
Closed-loop Automated Drug Delivery to Optimize Systemic 
Arterial Pressure, Cardiac Output, and Left Heart Filling 
Pressure in Discompensated Heart Failure##1012-
148·265A
Echocardiographic Evaluation of Left Ventricular Filling 
Pressure During Exercise Validated With Hemodynamic 
Measurement## 831-3·133A
Effect of Metoprolol CR/XL on Diurnal Variation in 
Pulmonary Artery Pressure Measured Noninvasively 
Using First in Human Implant Responding to Ultrasonic 
Signals##1026-190·370A
Enhancement of Cardiac Rotation as a Possible Mechanism 
of During Dobutamine Stress Echocardiography: A 
Compensatory Mechanism for Decreased Myocardial 
Strain Under Tachycardia?## 948-29·120A
First Human Experience With a New Left Atrial Pressure 
Monitoring Device: Validation with Simultaneous 
Pulmonary Artery Occlusion Pressure in Subjects With 
Heart Failure##1008-93·79A
Increased Left Ventricular Myocardial Stiffness Is the Major 
Cause of Recurrent Decompensation in Patients With 
Diastolic Heart Failure##942-56·46A
Myocardial Strain During Early Diastole Is Useful in Assessing 
Left Ventricular Early Diastolic Function: Comparison 
With Invasive Parameters## 846-4·148A
Novel Computer Assisted Measurement of 
Electrocardiographic P Terminal Force to Predict Elevated 
Left Ventricular End Diastolic Pressure## 813-8·13A
Relation of Left Atrial Enlargement to Various Haemodynamic, 
and Humoral Parameters in Patients With Essential 
Hypertension##1026-187·369A
Relationship of Shear Stress With In-Stent Restenosis: Bare 
Metal Stenting Versus Bare Metal Stenting and Adjunctive 
Brachytherapy##910-185·293A
Reliability of Cardiac Index Monitoring With an Analysis of 
Peripheral Arterial Waveform During Varing Loading 
Condition in Vivo##1012-149·265A
Successful Direct Left Atrial Pressure Monitoring and Fossal 
Pacing via an Implantable HEARTPOD Device in Animal 
Models##1008-60·78A
The Haemodynamic Response to Changes in Atrioventricular 
and Interventricular Delay of Cardiac Resynchronization 
Therapy Closely Fits a Parabola, Which May Allow More 
Efﬁcient Optimization## 969-130·22A
The Long Acting Phosphodiesterase-5 Inhibitor Tadalaﬁl 
Reduces Myocardial Infarct Size##927-217·170A
Value of Measuring the Time Difference Between Onset of 
Mitral Inﬂow and Onset of Early Diastolic Mitral Annulus 
Velocity for the Evaluation of Left Ventricular Diastolic 
Pressures in Patients With Normal Systolic Function and 
Indeterminate E/E’## 902-12·96A
Hemostasis
Added Ramipril to Simvastatin Shows Additive Effects on 
Tissue Factor Activity and Prothrombin Fragment 1+2 in 
Patients With Type 2 Diabetes##1023-172·366A
The Efﬁcacy and Safety of Fondaparinux Versus Enoxaparin 
in Non-ST Elevation ACS: Impact of Renal Dysfunction 
(OASIS 5)##972-222·195A
Hormones
Characterisation of the Vasodilatory Action of Testosterone in 
the Human Pulmonary Circulation##936-187·306A
Contributions of Endogenous Androgens Versus Age and Waist 
Circumference to Coronary Plaque and Remodeling in 
Women: A Report From the NHLBI-Sponsored Women’s 
Ischemia Syndrome Evaluation (WISE) Study##957-
178·321A
Direct Comparison of the Prognostic Value of Brain Natriuretic 
Peptide (BNP) and N-terminal ProBNP in a Large 
Population of Patients With Chronic and Symptomatic 
Heart Failure. The Valsartan In Heart Failure (Val-HeFT) 
Data## 819-3·71A
Does Hormone Therapy Impact Stroke Risk Among Women 
With Atrial Fibrillation?Results from the AFFRIM trial## 
1015-131·33A
Effect of Growth Hormone on Cardiac Contractility in Patients 
With Growth Hormone Deﬁciency## 925-45·104A
Impact of a Novel Hormone Therapy, Drospirenone and 17-
beta Estradiol, on Clinic and Ambulatory Blood Pressure 
in Postmenopausal Women with Hypertension##1027-
197·372A
Mid-regional Pro-atrial Natriuretic Peptide (MR-proANP) as 
a Novel and More Stable Prognostic Marker in Chronic 
Heart Failure (CHF)##986-54·65A
Parathyroid Hormone, Endothelial Dysfunction and Arterial 
Stiffness in Chronic Renal Disease##912-192·295A
Patterns of Brain Natriuretic Peptide Utilization for Risk 
Stratiﬁcation of Patients With Non-ST-Segment Elevation 
Acute Coronary Syndromes##1019-240·227A
Risk Prediction With Cardiac Troponin T Versus Biochemical 
Markers Associated With Cardiac Remodeling##959-
191·324A
Sex Differences in the Inﬂammatory Response to Leptin: 
Results From the Dallas Heart Study##959-188·323A
Testosterone, Estrogen, and Coronary Function in Women: A 
Report From the NHLBI-Sponsored Women’s Ischemia 
Syndrome Evaluation (WISE) Study##1024-173·366A
Thyroid Hormone Protects the Heart Against Ischaemia-
Reperfusion Injury Through a Redox Regulated Survival 
Signaling##949-219·180A
Urocortin 2 Infusion in Healthy Humans Induces 
Marked Hemodynamic, Neurohormonal, and Renal 
Responses##938-203·310A
Hyperlipoproteinemia
Coronary Heart Disease Events Preventable by Control 
of Blood Pressure and Lipids in U.S. Persons with 
Hypertension##915-210·299A
Evidence of Myocardial Adrenergic Innervation Abnormalities 
in Hyperlipidemic Subjects: The Effect of Statins## 
926-33·110A
Hypertension and Hypercholesterolemia: Achievement 
of Treatment Targets in a Primary Prevention 
Population##1014-213·355A
Lipoprotein Subclasses, Hydroxy Fatty Acids, and the 
Inﬂammatory Response in Metabolic Syndrome 
Patients##914-205·298A
Profound Increase of HDL-c Levels (>50%) With Long-Term 
Niacin Treatment##914-204·298A
Hypertension, pulmonary
A Novel Echo-Doppler Method to Predict Diastolic and Mean 
Pulmonary Artery Pressures: Derivation and Validation by 
Catheterization## 852-6·249A
A Novel Microaxial Venous Assist Device for Enhancing 
Pulmonary Flow and Reducing Venous Pressure Within 
the Total Cavopulmonary Connection: Computational 
Fluid Dynamics Studies##922-115·238A
Atrial Septostomy Improves Survival in Primary Pulmonary 
Hypertension and Pulmonary Hypertension with 
Associated Congenital Heart Disease##945-113·239A






 Receptor Selectivity of Endothelin-1 Receptor 
Antagonists in Human Myocardial Membranes##936-
191·307A
Linkage Analyses of Markers of Inﬂammation: The Genetic 
Epidemiology Network of Arteriopathy (GENOA) 
Study##971-216·193A
Myocardial Dysfunction and Neurohumoral Activation Without 
Remodeling in the Left Ventricle of Monocrotaline-
Induced Pulmonary Hypertensive Rats##963-49·54A
Peak Systolic Strain and Strain Rate in Children With 
Pulmonary Hypertension: A Tissue Doppler Study and 
Correlation With Cardiac Catheterization Data##936-
186·306A
Pulmonary Hypertension With Excessive Transpulmonary 
Gradients Among Mitral Stenotics: Prevalence and 
Clinical Outcome Following Percutaneous Balloon Mitral 
Commissurotomy##1006-21·283A
Resveratrol Induced Up-Regulation of Vascular Endothelial 
Growth Factor in Monocrotaline-Induced Pulmonary 
Hypertension##936-188·307A
Sitaxsentan Improves Time to Clinical Worsening (TCW) 
in Patients With Pulmonary Arterial Hypertension 
(PAH)##936-189·307A
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The Effect of Exercise on Pulmonary Artery Systolic Pressure 
and Pulmonary Vascular Resistance## 902-17·97A
Tissue Strain Imaging Versus Velocity Imaging in Identifying 
Right Ventricular Dysfunction in Pulmonary Arterial 
Hypertension## 948-11·118A
Hypertension, systemic
ACE Inhibitor Associated Cough: Difference Between 
Hypertension and Congestive Heart Failure##915-
209·299A
Additive Beneﬁcial Effects of Fenoﬁbrate Combined with 
Candesartan in the Treatment of Hypertriglyceridemic, 
Hypertensive Patients## 845-4·359A
Alcohol-Associated Hypertension and Risk of Cardiovascular 
Hospitalizations##915-213·300A
Amlodipine Modulates the MEK1 and ERK Pathway to 
Induce Vascular Smooth Muscle Cell Differentiation In 
Vivo##956-169·319A
Angiotensin Converting Enzyme (ACE) Polymorphism, 
Albuminuria, and Systemic Capillary Permeability in 
Hypertensive Men##960-192·324A
Antiplatelet Effects of Angiotensin-Converting Enzyme 
(ACE) Inhibitors and Angiotensin II Subtype 1 Receptor 
Blockers (ARBs): Modiﬁed Ex Vivo Platelet Aggregation 
of 374 Cardiovascular Patients##1023-166·365A
Association Between Refractory Hypertension and Endothelial 
Nitric Oxide Synthase -786C allele##960-197·325A
Association of Left Bundle Branch Block with New Onset 
Abnormal Left Ventricular Wall Motion in Hypertensive 
Patients with Left Ventricular Hypertrophy: The LIFE 
study## 902-40·100A
Brain Natriuretic Peptide Gene Polymorphism (C+171A) 
Is Associated With the Presence of Left Ventricular 
Hypertrophy## 835-5·342A
C-Reactive Protein Levels Is the Major Determinant 
of microalbuminuria in Essential Hypertensive 
Patients##982-200·336A
Coronary Heart Disease Events Preventable by Control 
of Blood Pressure and Lipids in U.S. Persons with 
Hypertension##915-210·299A
Cost-Effectiveness of Chlorthalidone, Amlodipine, and 
Lisinopril as First-line Treatment for Patients With 
Hypertension: An ALLHAT Analysis##1028-198·372A
Do Loss-of-Function Mutations in Alpha 2 Adrenergic 
Receptor Subtypes Predispose to Hypertension in 
Blacks? Population-Level Data From the Dallas Heart 
Study##960-195·325A
Does the Presence of Hypertension Affect Cardiovascular 
Beneﬁts of Statin Therapy? Results From a Meta-
regression Analysis of 69,984 Patients##1027-193·371A
Effect of Statin Therapy on Renal Function in Hypertensive 
African Americans##981-192·335A
Effects of Amlodipine or Enalapril Versus Placebo on Rates 
of Cardiovascular Hospitalization and Costs Among 
Coronary Artery Disease Patients With Normal Blood 
Pressure: Findings From the CAMELOT Economic 
Substudy## 848-8·361A
Effects of Angiotensin-Converting Enzyme Inhibitors on 
Interstitial Collagen and QTc Interval In Hypertensive 
Left Ventricular Hypertrophy##1028-203·373A
Effects of Nitric Oxide Donor, Molsidomine, on 
Blood Pressure in Patients With Isolated Systolic 
Hypertension##1027-192·371A
Endothelial Dysfunction Accelerates Future Hypertensive 
Evolution and Causes Excess of Fatal Events## 853-
6·376A
Endothelial Nitric Oxide Synthase Glu298asp Gene 
Polymorphism Is Associated With Hypertensive 






 Receptor Selectivity of Endothelin-1 Receptor 
Antagonists in Human Myocardial Membranes##936-
191·307A
Hypertension and Hypercholesterolemia: Achievement 
of Treatment Targets in a Primary Prevention 
Population##1014-213·355A
Hypertensive Heart Failure with a Normal Ejection Fraction: 
Abnormal Load or Abnormal Ventricular Function?##942-
57·46A
Hypertensive Response to Exercise Is Related to Insulin 
Resistance in Non-diabetic Patients With Well Controlled 
Hypertension##1004-196·351A
Impact of a Novel Hormone Therapy, Drospirenone and 17-
beta Estradiol, on Clinic and Ambulatory Blood Pressure 
in Postmenopausal Women with Hypertension##1027-
197·372A
Impact of Gender on the Clinical Beneﬁt of Anti-hypertensive 
Therapy in Patients With Coronary Artery Disease and 
Normal Blood Pressure##1028-199·372A
Increased Arterial Stiffness: A Major Determinant of the 
White-Coat Effect##982-197·336A
Increased Plasma Concentrations of N-terminal Pro Brain 
Natriuretic Peptide is a More Sensitive Marker 
of Subclinical Diastolic Dysfunction and Arterial 
Remodeling in Hypertension: Analytical Performance 
Comparison With BNP##1028-200·372A
Increased Pulse Pressure is Strongly Associated with Adverse 
Cardiovascular Outcomes in both Diabetics and Non 
Diabetics: The International Verapamil SR-Trandolapril 
Study (INVEST)## 835-6·343A
Increasing QRS Duration During Antihypertensive Therapy is 
Associated With an Increased Incidence of New-Onset 
Congestive Heart Failure: The LIFE Study## 851-4·92A
Inﬂuence of Blood Pressure Versus Overweight/Obesity 
on Biomarkers of Vascular Health in Postmenopausal 
Women##915-214·300A
Investigation of Genetic and Biochemical Determinants 
of Depressed L-Arginine Transport in Human 
Hypertension##960-194·324A
Job-Strain Induced Workplace Hypertension Is Associated 
With Obesity and High Normal Blood Pressures at the 
Physical Checkup##1004-191·350A
Left Atrial Volume Mirrors Diastolic Dysfunction Caused by 
Hypertension Alone##942-60·47A
Left Ventricle Concentric Remodeling: A First Step of 
Impaired Cardiac Performance in Middle Aged Subjects 
With Masked Hypertension##960-198·325A
Left Ventricle Diastolic Dysfunction, and Aortic Stiffening in 
Hypertension: The Web of Causative Interrelationships of 
Atrial Fibrillation##982-201·337A
Masked Hypertension Is Associated With Impaired Glucose 
Tolerance and Larger Left Atrium in the Elderly##1004-
193·351A
Mortality, Cause of Death, and Coronary Endothelial Function 
During Long-Term Follow-Up Among Hypertensive 
African and Caucasian Americans## 841-5·356A
Non-Dipping Status Is Accompanied by a State of 
Hypoadiponectinemia, and Arterial Stiffening in 
Essential Hypertensive Subjects: A Link to Subclinical 
Atherosclerotic Processes##1004-194·351A
Obstructive Sleep Apnea Impairs Arterial Stiffness in 
Hypertensive Patients: Potential Additive Effects to 
Atherosclerosis##915-211·299A
Older Patients Receive the Greatest Beneﬁt From the Initiation 
of Anti-hypertensive Agents in the Setting of Coronary 
Artery Disease and Normal Blood Pressure## 836-6·209A
Once-Daily Carvedilol Is Effective in Treating 
Hypertension##1027-195·371A
Prevalence, Treatment, and Control of Hypertension in U.S. 
Adults 2001-2002 Overall and With Metabolic Syndrome, 
Diabetes, Kidney Disease, Stroke or Coronary Artery 
Disease## 848-6·361A
Prognostic Signiﬁcance of Systolic Blood Pressure Increase 
in Patients Referred for Exercise Stress Testing## 1017-
11·154A
Regression of Electrocardiographic Left Ventricular 
Hypertrophy by Both Cornell Voltage-Duration Product 
and Sokolow-Lyon Voltage During Antihypertensive 
Therapy is Associated With Decreased Incidence of 
Sudden Cardiac Death: The LIFE Study## 848-4·360A
Tetrahydrobiopterin: A Novel Anti-hypertensive 
Therapy##1027-194·371A
Usefulness of Arterial Stiffness Evaluation for the Differential 
Diagnosis of Hypertrophic Cardiomyopathy From 
Hypertensive Heart Disease##920-102·43A
Hypertrophy
Ace Gene Copies Number Impairs Hemodynamic Responses 
to Hypertension in Mice##960-193·324A
Akt Overexpression Improves Cardiac Function and 
Ameliorates Heart Failure in Pressure Overload Animal 
Model Phosporilating Key Ca 2+ Handling Protein##1007-
48·76A
Assessment of the Severity of Outﬂow Obstruction in Patients 
With Hypertrohyphic Cardiomyopathy: A Real-Time 
Three-Dimensional Echocardiographic Study## 839-
3·146A
Association of Left Bundle Branch Block with New Onset 
Abnormal Left Ventricular Wall Motion in Hypertensive 
Patients with Left Ventricular Hypertrophy: The LIFE 
study## 902-40·100A
Attenuation of LV Dysfunction by A PPAR-alpha Agonist in 
Hypertensive Rats is Associated With Down-regulation of 
Redox-regulated Transcription Factors##1007-47·75A
Brain Natriuretic Peptide Gene Polymorphism (C+171A) 
Is Associated With the Presence of Left Ventricular 
Hypertrophy## 835-5·342A
Clinical Signiﬁcance of Penetrating Intra-myocardial 
Coronary Arteries in Patients With Apical Hypertrophic 
Cardiomyopathy##920-104·43A
Description and Functional Characterization of two Novel 
SNPs in the Promoter of the Human Gene GNAQ 
Encoding the G Protein Gαq Subunit and Their Potential 
Role for Cardiac Hypertrophy##918-49·37A
Diastolic Dysfunction and Systemic Sclerosis with Normal 
Left Ventricular Mass##942-94·48A
Difference in the Left Atrial Function Between Patients 
With Hypertensive Hypertrophy and Hypertrophic 
Cardiomyopathy Evaluated by Tissue Strain Imaging## 
948-18·120A
Does Reduction in Left Atrial Diameter During 
Antihypertensive Treatment Reduce New-Onset Atrial 
Fibrillation in Hypertensive Patients with Left Ventricular 
Hypertrophy: The LIFE Study## 924-139·9A
Effects of Angiotensin-Converting Enzyme Inhibitors on 
Interstitial Collagen and QTc Interval In Hypertensive 
Left Ventricular Hypertrophy##1028-203·373A
Impact of Gender on Left Atrial and Ventricular Response 
to Asymptomatic Aortic Valve Stenosis. The SEAS 
Study##1030-19·285A
Inappropriate Left Ventricular Mass Identiﬁes Hypertensive 
Patients With High-Risk Cardiac Phenotype## 835-
8·343A
Increased Sudden Death Risk Conferred by LVH is 
Independent of Age and Left Ventricular Dysfunction: 
A Three-Year Community-Wide Study in Patients with 
Established Signiﬁcant Coronary Artery Disease## 924-
134·8A
Left Atrial Emptying Rate: A Marker of Hypertrophy and 
Diastolic Dysfunction in Patients With Hypertrophic 
Cardiomyopathy##943-104·51A
Left Ventricle Concentric Remodeling: A First Step of 
Impaired Cardiac Performance in Middle Aged Subjects 
With Masked Hypertension##960-198·325A
Left Ventricular Untwisting Was Delayed and Reduced in 
Patients With Hypertensive Left Ventricular Hypertrophy: 
Demonstration by 2-Dimensional Speckle Tracking 
Imaging## 902-30·98A
Masked Hypertension Is Associated With Impaired Glucose 
Tolerance and Larger Left Atrium in the Elderly##1004-
193·351A
Mutations in the Genes for Sarcomeric Proteins in Japanese 
Patients With Elderly-Onset Sporadic Hypertrophic 
Cardiomyopathy##965-101·59A
Nitroxyl Increases Contractility in Failing (Gαq 
Overexpressing) Cardiomyocytes That Display Altered 
Cellular Redox Conditions##985-48·64A
Outcomes in Cardiac Transplant Recipients Using Donor 
Allografts With Left Ventricular Hypertrophy##966-
105·60A
Regression of Electrocardiographic Left Ventricular 
Hypertrophy by Both Cornell Voltage-Duration Product 
and Sokolow-Lyon Voltage During Antihypertensive 
Therapy is Associated With Decreased Incidence of 
Sudden Cardiac Death: The LIFE Study## 848-4·360A
Relation of Components of the Metabolic Syndrome to Left 
Ventricular Mass##982-202·337A
Relationship Between Low-grade Inﬂammation Indices 
and Target-organ Damage in Patients With Essential 
Hypertension##1028-201·373A
Repolarization Complexity is Increased in Left Ventricular 
Hypertrophy: The Strong Heart Study## 992-125·26A
Role of Volume Load in Heritability of Left Ventricular Mass: 
The Hypergen Offspring Study## 835-3·342A
Subclinical Target Organ Damage in Masked and White-Coat 
Hypertension##982-198·336A
Which ECG Criteria for Left Ventricular Hypertrophy Best 
Predict Mortality?## 813-4·13A
Hypoxia
Olmesartan Inhibits NF-κB Activity and Attenuates Hypoxia-
Induced Left Ventricular Remodeling in Apolipoprotein 
E-Knockout Mice##913-198·296A
Systemic Hypoxia Without Ischemic Organ Damage can 
Mobilize Endothelial Progenitor Cells in Human 
Peripheral Blood by Increased Levels of VEGF, 
MCP-1 and SDF-1: A Novel Insight of Hypoxic 
Preconditioning##933-164·302A
Image processing, computer-assisted
Anatomical Remodeling of Left Atria in Subjects with 
Chronic and Paroxysmal Atrial Fibrillation Evaluated by 
Multislice Computed Tomography## 1015-138·35A
Assessment of Coronary Red and White Thrombus by Optical 
Coherence Tomography##908-163·289A
Automated Pericardial Fat Quantiﬁcation in CT Data##1012-
145·264A
Collagen Content of Coronary Plaque Measured by 
Polarization Sensitive Optical Coherence Tomography 
(PS-OCT)## 948-32·121A
Does the Point of Closest Approach Between the Esophagus 
and the Posterior Left Atrium Move with the Cardiac 
Cycle?## 901-139·4A
Evaluation of Neointimal Hyperplasia by Optical Coherence 
Tomography at Six-Month After Sirolimus-Eluting Stent 
Deployment##956-162·318A
Extraction of Latent, Computed Tomographic Images of 
Coronary Artery Plaque Components by Isotropic, Three-
Dimensional Wavelet Analysis## 970-29·128A
Feasibility of Using Spatiotemporal Image Correlation to 
Allow 3D Assessment of Right and Left Ventricular 
Volumes and Function in the Human Fetus## 991-
34·138A
In Vivo Real-Time Vessel Imaging and Ex vivo 3D 
Reconstruction of Atherosclerotic Plaque in 
Apolipoprotein E-Knockout Mice Using Synchrotron 
Radiation Microscopy##977-172·330A
Interactive Computer Detection of Nonperfused Myocardial 
Area in Attenuated Harmonic Contrast Images## 1016-
42·151A
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Intravascular Ultrasound-Based Imaging of Vasa Vasorum 
for the Detection of Vulnerable Atherosclerotic 
Plaque##1012-146·264A
Noninvasive Assessment of Coronary Vasodilating Capacity 
Using Freehand 3D Echocardiography With Rotational 
Scanning## 991-40·140A
Novel Velocity Vector Imaging Ultrasound Technique 
Demonstrates Asymmetric Deformation in the Normal 
Aortic Root## 925-38·102A
PAMM (Parametric Analysis of Main Motion): First Evaluation 
of a New Parametric Imaging Method for Segmental Wall 
Motion Analysis## 902-38·100A
Synchrotron Radiation Coronary Microangiography for 
Morphometric and Physiological Evaluation of 
Myocardial Neovascularization Induced by Cell-Based 
Transplantation##909-178·292A
Three-Dimensional Electroanatomical Image Integration 
Versus Phased Array Intracardiac Echocardiography 
for Left Atrial Mapping Procedure: Operator Blinded 
Accuracy Study## 838-8·31A
Immune suppression
Renal Dysfunction and New Onset Proteinuria Predict 
Mortality in Heart Transplant Patients After Replacement 
of Calcineurin Inhibitors With Sirolimus##944-106·51A
Sirolimus as a Primary Immunosuppressant in Calcineurin-
Inhibitor induced Nephrotoxicity##944-107·51A
Immune system
Diabetes Mellitus Subjects Have Immune System Alterations 
Similar to That of Patients With Unstable Angina: A 
Clue to Explain Their High Cardiovascular Risk?##972-
231·197A
Down-regulation of ζ-chain in CD4+ T-cells and in Natural 
Killer Cells in Patients With Acute Coronary Syndrome 
(ACS)##977-159·328A
High Frequency of Anti-heart Autoantibodies in Acute 
Myocardial Infarction With Angiographically Normal 
Coronary Arteries: Evidence for Undiagnosed Immune-
mediated Myocarditis##987-104·71A
Prognostic Signiﬁcance of Interleukin-2 for the 
Pharmacological Cardioversion of Recent Onset Atrial 
Fibrillation## 1015-136·34A
Somatostatin Receptor Type 2 (SSTR2) Expression in Post-
Infarction Myocardial Inﬂammatory Inﬁltrate##1019-
231·225A
Toll-like Receptors in Giant Cell Arteritis: Differential Effects 
of TLR4 and TLR5 Ligation##933-167·302A
Immunologic factors
Carotid Stenting Induces Platelet Activation and a Pro-
inﬂammatory Response##1025-182·368A
Different Genetic Make-up of the Anti-inﬂammatory Il10-
gene Contributes to the Development of Restenosis After 
PCI##956-159·317A
High Frequency of Anti-heart Autoantibodies in Acute 
Myocardial Infarction With Angiographically Normal 
Coronary Arteries: Evidence for Undiagnosed Immune-
mediated Myocarditis##987-104·71A
Modulation of NK Receptors on NK (CD3-/CD56+), T (CD3+/
CD56-) and NKT-like (CD3+/CD56+) Cells in Coronary 
Artery Disease##977-170·330A
Somatostatin Receptor Type 2 (SSTR2) Expression in Post-
Infarction Myocardial Inﬂammatory Inﬁltrate##1019-
231·225A
Suppression of Osteoprotegerin as a Potential Mechanism of 
Healing After Coronary Intervention##1000-172·346A
Toll-like Receptors in Giant Cell Arteritis: Differential Effects 
of TLR4 and TLR5 Ligation##933-167·302A
Vascular Dendritic Cells as Gatekeepers in Vascular 
Inﬂammation##934-174·304A
Implants, artiﬁcial
Stroke Prevention Technology for Patients With Non-Valvular 
AF - Worldwide Experience with the New WATCHMAN 
LAA System## 1015-143·36A
Infarct size
A Comparison of Upstream Versus Downstream 
Administration of Glycoprotein 2b/3a Blockers in Patients 
With Non ST-Elevation Acs Who Are All Scheduled for 
Early Invasive Therapy## 843-5·220A
Analysis of Myocardial Deformation Based on Ultrasonic 
Pixel Tracking for Deﬁnition of Transmurality in Chronic 
Myocardial Infarction## 831-6·134A
Better Ventricular Function and Reduced Necrosis After 
Myocardial Ischemia/Reperfusion in Rabbits Treated 
With Ranolazine, an Inhibitor of the Late Sodium 
Current##927-216·169A
Bone Marrow-Derived Cells Do Not Transdifferentiate Into 
Cardiomyocytes After Myocardial Infarction##903-
216·158A
Chronic Therapy With Erythropoietin, Even Administrated 
Late After Reperfusion, Induces Endothelial Progenitor 
Cells Mobilization and Myocardial Salvage in Post-mi 
Rats## 829-5·206A
Chronic Therapy With Erythropoietin, Even Administrated 
Late After Reperfusion, Induces Endothelial Progenitor 
Cells Mobilization and Myocardial Salvage in Post-mi 
Rats## 829-5·206A
Delta Protein Kinase C Antagonist Given Systemically at 
Reperfusion is Cardioprotective##994-220·211A
Human Umbilical Cord Mononuclear Cells (HUCMC) 
Improve Left Ventricular Function and Reduce Infarct 
Size in a Mouse Model of Myocardial Infarction##941-
51·45A
Impact of Plaque Rupture on Myocardial Infarct Size in ST-
Elevation Anterior Acute Myocardial Infarction##995-
226·212A
Inhibition of Serine Protease Activity at Reperfusion Reduces 
Postischemic Injury in a Closed-Chest Model of Acute 
Myocardial Infarction##927-221·170A
Left Ventricular Lead Positioning Over Infarcted Myocardium 
Results in Less Improvement in Ejection Fraction in 
Patients With Ischemic Cardiomyopathy Following 
Cardiac Resynchronization Therapy## 810-7·12A
MSCT and MRI for the Assessment of Reperfused Acute 
Myocardial Infarction## 832-7·135A
Pyrroloquinoline Quinone (PQQ) and/or Metoprolol Decrease 
Infarct Size and Improve Mitochondrial Function in a Rat 
Model of Ischemia/Reperfusion##994-216·210A
The Changing Characteristics and In-Hospital Mortality 
of Acute Myocardial Infarction in New Jersey 1986-
2002##928-227·172A
The Long Acting Phosphodiesterase-5 Inhibitor Tadalaﬁl 
Reduces Myocardial Infarct Size##927-217·170A
The Protection Device Reduced Infarct Size Measured by 
Serial Contrast Enhancement MRIs in STEMI patients## 
993-2·142A
Time From Symptom Onset to Reperfusion and Inﬂuence on 
Infarct Size in Patients with ST-Elevation Myocardial 
Infarction Reperfused by Prehospital Fibrinolysis 
or Prehospital Initiated Facilitated Percutaneous 
Intervention##929-240·174A
Vascular Endothelium Growth Factor-165 Gene Therapy 
Increases Left Ventricular Mass and Decreases Wall 
Thinning in Reperfused Myocardial Infarction## 856-
3·233A
Inotropic agents
Rapid and Sustained Reductions of Plasma B-Type 
Natriuretic Peptide Concentrations in Patients with 
Acutely Decompensated Heart Failure Treated with 
Levosimendan: The REVIVE II Study##1032-57·86A
The Impact of Treatment With Levosimendan or Dobutamine 
on Brain Natriuretic Peptide Levels in Patients With 
Acutely Decompensated Chronic Heart Failure. Results 
From the Calcium Sensitizer or Other Inotrope or None 
in Acutely Decompensated CHF (CASINO) Study##959-
190·324A
Insulin
Comparative Metabolic Effects of Ramipril and Candesartan in 
the Treatment of Hypertensive Patients##942-96·49A
Diabetes, Insulin, and the Prevalence of Atrial Fibrillation and 
Flutter in a Large Heart Failure Population## 804-7·10A
Does Tight Glycemic Control Improve Survival in Diabetic 
Patients With Chronic Heart Failure Started on Insulin 
Therapy?##964-55·55A
Effect of Amlodipine and Enalapril on Cardiovascular Events 
in Patients With Insulin Resistance and Diabetes in the 
CAMELOT Trial##938-199·309A
Hypertensive Response to Exercise Is Related to Insulin 
Resistance in Non-diabetic Patients With Well Controlled 
Hypertension##1004-196·351A
Inﬂuence of Severity and Extent of Coronary Artery 
Disease on Long-Term Survival of Patients With and 
Without Diabetes Mellitus: Analysis from the CASS 
Registry##905-235·162A
The Applicability of the Asian Modiﬁed Criteria of the 
Metabolic Syndrome in the Asian Population##939-
205·311A
The Association of Insulin Resistance with Global and 
Regional Left Ventricular Dysfunction in Four 
Racioethnic Groups: The Multi-Ethnic Study of 
Atherosclerosis (MESA)##964-53·55A
The Effects of the Frequency of Exercise-Based Cardiac 
Rehabilitation on Glucose Tolerance and Lipid Levels in 
Patients With Acute Coronary Syndrome##916-254·167A
The Impact of Changes in Insulin Resistance After PCI on 
Lumen Narrowing##954-254·189A
The Metabolic Syndrome but Not Estimated Insulin Resistance 
Is Associated With Higher-Risk of Adverse Clinical 
Outcomes Among Medically Managed Patients Following 
Cardiac Catheterisation##939-206·311A
Integrated delivery systems
Clinical and Business Integration in a Pediatric/Congenital 
Heart Center##1036-145·269A
Intravascular ultrasound/doppler
Better Coronary Flow in Culprit Lesions With Deep 
Echo Attenuation Treated by Directional Coronary 
Atherectomy##995-225·212A
C-Reactive Protein and Plaque Composition in Patients with 
Stable Angina Pectoris (An Intravascular Ultrasound-
Virtual Histology Study)##1000-171·346A
Can Stress Echocardiography With Tissue Characterization 
Evaluate Non-Critical Coronary Stenosis? A Validation 
Study Against Simultaneous Measurement of Fractional 
Flow Reserve## 925-39·102A
Clinical Feasibility of Quantitative Color-mapping of Shear 
Stress for Predicting Coronary Plaque Rupture Site With 
Use of Three-Dimensional Intravascular Ultrasound 
Imaging##951-225·182A
Comparison of Atherosclerotic Plaque Characteristics by IVUS 
and Multislice CT## 970-42·131A
Contributions of Endogenous Androgens Versus Age and Waist 
Circumference to Coronary Plaque and Remodeling in 
Women: A Report From the NHLBI-Sponsored Women’s 
Ischemia Syndrome Evaluation (WISE) Study##957-
178·321A
Coronary Artery Lesions with Intra-plaque Enhancement in 
Multidetector Spiral Computed Tomography## 970-
6·125A
Coronary Atherosclerosis by Intravascular Ultrasound in 
Women With Suspected Myocardial Ischemia, but No 
or Minimal Angiographic Disease: A Report From 
the NHLBI-Sponsored Women’s Ischemia Syndrome 
Evaluation Study (WISE) Study##977-164·329A
Coronary Hypersensitivity to Serotonin in Cardiac Transplant 
Recipients. Relation to Vessel Wall Morphology and 
Effect of Vitamin C##1010-107·82A
Coronary Remodeling Is the Main Contributor to Lumen 
Narrowing in Diabetic Patients##978-174·331A
Correlation Between 16-Slice Multidectector Computed 
Tomography and Intravscular Ultrasound in Patients 
With Ambiguous Left Main Coronary Artery Stenosis## 
970-34·129A
Detection of Angiographically Silent In-Stent Restenosis in 
Multislice Computed Tomography## 970-3·125A
Determinants of Arterial Wall Remodeling During Lipid 
Lowering Therapy. Serial IVUS Observations from the 
REVERSAL Trial.##957-174·320A
Do CT-low-dense Coronary Artery Plaques Represent Plaque 
Vulnerability? Study by Intravascular Ultrasound and 
Coronary Angioscopy## 970-2·125A
Dual-frequency Intravascular Ultrasound Imaging: A Novel 
Approach to Plaque Vulnerability## 948-30·120A
Early and Subtle Neointimal Growth Detection Following 
Stent Implantation Using Optical Coherence Tomography 
and Intravascular Ultrasound and Histology##910-
181·293A
Echo-attenuation in the Target Lesion Before Perutaneous 
Coronary Intervention and Incidence of Angiographic 
Slow Flow##951-230·183A
Effects of Optimal Versus High Normal Blood Pressure on 
Progression of Coronary Atherosclerosis: Insight From the 
CAMELOT Study## 835-7·343A
Follow-Up LDL-cholesterol Level as an Independent Predictor 
of Changes of Coronary Atherosclerotic Plaque Size: A 
Serial Intravascular Ultrasound Analysis##1024-178·367A
Identiﬁcation of Plaque Composition in Multislice Computed 
Tomography## 970-35·129A
Impact of Elevated Troponin T level at Admission on the 
Non-Culprit Plaque Progression in Clinical Unstable 
Angina Pectoris: A Volumetric Intravascular Ultrasound 
Analysis##951-229·183A
Index of Microcirculatory Resistance: A Novel Measure for 
Predicting Myocardial Damage in Patients with Acute 
Myocardial Infarction##951-224·182A
Intravascular Ultrasound Predictors and Their Cut-off Values 
for Angiographic Restenosis After Sirolimus-Eluting Stent 
Implantation##954-253·189A
Late- Acquired Incomplete Apposition After Drug-eluting 
Stents: Frequency and Potencial for Late Stent 
Thrombosis##1023-168·365A
Plaque Characterization by Intravascular Ultrasound Virtual 
Histology Analysis in Diabetic Patients##1019-239·226A
Positive Coronary Artery Remodeling in Women With No or 
Minimal Angiographic Disease: Intravascular Ultrasound 
Findings From the NHLBI-Sponsored Women’s Ischemia 
Syndrome Evaluation (WISE) Study##978-173·331A
Preserved Epicardial Coronary Endothelial Function by 
Inhibition of δ Protein Kinase C in a Porcine Acute 
Myocardial Infarction Model##1020-245·228A
Regression of Coronary Atherosclerotic Plaques Induced by 
Pioglitazone in Patients With Type 2 Diabetes Mellitus or 
Impaired Glucose Tolerance: Results From a Randomized 
Prospective Study Using Intravascular Ultrasound##914-
207·298A
Relationship Between Microvascular Injury and Degree of 
ST-Segment Elevation Before Percutaneous Coronary 
Intervention##973-241·199A
Risk Factors for the Development of Coronary Artery 
Disease After Cardiac Transplantation. An Intravascular 
Ultrasound Study##1034-106·91A
Signiﬁcance of Lipid-content in Determining the Pattern 
of Coronary Arterial Remodeling: An Intravascular 
Ultrasound Study With Tissue Characterization by use of 
Wavelet Analysis##1024-177·367A
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The Impact of the Deep Echo Attenuation on Coronary Flow 
After Percutaneous Coronary Intervention## 843-3·219A
Two-Year Intravascular Ultrasound Follow-Up After 
Implantation of Non-Polymeric Paclitaxel-Coated Stents: 
A Serial Volumetric Intravascular Ultrasound Analysis 
From the Asian Paclitaxel-Eluting Stent Clinical Trial 
(ASPECT)##954-255·189A
Use of Beta-Blockers and Progression of Coronary 
Atherosclerosis: An Intravascular Ultrasound Analysis 
from the CAMELOT Study##957-175·320A
Investigational devices
Chronic Total Occlusion of Coroanry Artery Intervention 
Using the Novel Multidirectional Double Lumen 
Catheter##1022-219·232A
Cooling Blankets Are Effective for Achieving Therapeutic 
Hypothermia and Improving Survival-to-discharge 
Following Cardiac Arrest for Patients With All 
Arrhythmia Types##906-245·165A
Effect of Metoprolol CR/XL on Diurnal Variation in 
Pulmonary Artery Pressure Measured Noninvasively 
Using First in Human Implant Responding to Ultrasonic 
Signals##1026-190·370A
Effect of Metoprolol CR/XL on Pulmonary Artery Pressure 
in Patients With Heart Failure Measured Using First in 
Human Implantable Device Responding to Ultrasonic 
Signal##938-201·310A
Feasibility and Short-Term Efﬁcacy of Percutaneous 
Mitral Annular Reduction for the Therapy of Mitral 
Regurgitation in Patients with Heart Failure##1008-
54·77A
First Report of the CASES-PMS Study: Patient Demographics 
and 30-Day Major Adverse Events for the Cordis 
PRECISE™ Nitinol Stent and Angioguard™ XP Emboli 
Capture Guidewire Condition of Approval Surveillance 
Study## 802-8·315A
Novel Non-Implant Radiofrequency Energy Catheter Closure 
of Patent Foramen Ovale in Swine## 852-4·249A
Reproducibility of Echocardiographic Assessments of Mitral 
Regurgitation for Percutaneous Endovascular Edge to 
Edge Repair## 902-31·98A
Safety and Efﬁcacy of Remote Ablation by Magnetic Catheter 
in Patients With WPW Syndrome## 901-141·4A
Single Center Experience With the HeartMate II Left 
Ventricular Assist System## 825-5·75A
Statin Cools Down Temperature of Atherosclerotic Plaque 
in Patient With Coronary Artery Disease: Temperature 
Measurement and Intravasular Ultrasound Study##957-
173·320A
Investigational drugs
A Novel Caspase Inhibitor, VX-166, Reduces Myocardial 
Infarction in the Rat##927-218·170A
A Phase-I Study to Assess the Antithrombotic Properties 
of DU-176b: An Orally Active Direct Factor-Xa 
Inhibitor##908-161·288A
Anti-Thrombotic Properties of A Novel Nitric Oxide Donor 
(LA-419) in a Human Model of Thrombosis##908-
172·290A
Darusentan Antihypertensive Effect in Patients With Resistant 
Hypertension##915-208·299A
Increasing Concentrations of Prasugrel’s Active Metabolite 
Produce Increased Inhibition of Platelet Aggregation## 
855-6·379A
Noninvasive Electrophysiological Study of Ivabradine (NESI) 
in Patients With Dual Chamber Pacemakers: Effects on 
Ventricular Repolarization## 992-129·27A
Ranolazine Safety and Tolerability During Long Term 
Treatment of Stable Angina##999-253·218A
The Inﬂuence of Baseline Platelet Aggregation Response on 
Subsequent Inhibition of Aggregation Achieved With 
Clopidogrel or Prasugrel## 855-3·378A
Urocortin 2 Infusion in Healthy Humans Induces 
Marked Hemodynamic, Neurohormonal, and Renal 
Responses##938-203·310A
Ion channels
A Common Polymorphism H558R in SCN5A is Associated 
with Lone Atrial Fibrillation## 826-6·25A
Better Ventricular Function and Reduced Necrosis After 
Myocardial Ischemia/Reperfusion in Rabbits Treated 
With Ranolazine, an Inhibitor of the Late Sodium 
Current##927-216·169A
Cardiac Kir2.x Channels in Homomeric and Heteromeric 
Composition Are Markedly Activated by Adrenergic 




 Receptors: A Physiologic Role in Mediating 
ATP-evoked Current and Regulation in Human Atrial 
Fibrillation## 901-135·3A
Forced Expression of Human Myocardin Increases Electrical 
Conduction Velocity Across Human Adult Mesenchymal 
Stem Cells to Levels Comparable to Cardiomyocytes.## 
901-124·1A
Intracoronary Infusion of Gd3+ Into the Ischemic Region Does 
not Suppress Phase Ib Ventricular Arrhythmias After 
Coronary Occlusion in Swine##950-220·181A
Left Ventricular Size and Function and the Common Sodium 
Channel Polymorphism, H558R-SCN5A: A Population-
Based Association Study##918-47·37A
New in-vivo Canine Model of Drug-induced Long-QT
1
 
Syndrome: Beta-adrenergic Challenges Trigger Torsade 
De Pointes## 901-136·3A
ZnT-1, A Missing Link in the Regulation of Cardiac L-Type 
Calcium Channels## 901-129·2A
Ion currents
Hydrogen Peroxide-Induced Arrhythmogenic Activity and 
Contractile Dysfunction of Ventricular Myocytes is 
Reduced by a Blocker of Late Sodium Current## 901-
130·2A
Ischemia
A Strategy of Retrograde Injection of Bone Marrow 
Mononuclear Cells Into the Myocardium for the 
Treatment of Ischemic Heart Disease##934-175·304A
Acute Changes in N-terminal pro-Brain Natriuretic Peptide 
Induced by Dobutamine Stress Echocardiography## 
948-45·124A
Adult Mesenchymal Stem Cells From Patients With Ischemic 
Heart Disease Engraft in Ischemic Myocardium 
and Improve Left Ventricular Function in NOD/scid 
Mice##903-221·159A
Atrial Fibrillation Is a Long-Term Predictor of Poor Outcome 
in Acute Myocardial Infarction##975-250·201A
Better Ventricular Function and Reduced Necrosis After 
Myocardial Ischemia/Reperfusion in Rabbits Treated 
With Ranolazine, an Inhibitor of the Late Sodium 
Current##927-216·169A
Comparison of Resting Magnetocardiography With Stress 
Single Photon Emission Computed Tomography in 
Patients With Stable and Unstable Angina##930-
247·176A
Continuous Brain Natriuretic Peptide Infusion Preserves 
Systolic Function After Myocardial Ischemia and Prevents 
Ventricular Remodeling in Conscious Dogs##1032-
98·89A
Deletion of Tumor Necrosis Factor α Receptor 1 Is Protective 
in A Mouse Model of Hindlimb Ischemia##933-168·302A
Early Electromechanical Changes Following Acute Coronary 
Artery Microembolization##950-216·180A
Effect of Autologous Bone Marrow-derived Mononuclear 
Cell Injection on Myocardial Function and Perfusion in 
Patients With Refractory Angina Pectoris and Chronic 
Ischemia##1022-216·231A
Effect of Free Fatty Acid Inhibition on Silent and Symptomatic 
Myocardial Ischemia in Diabetic Patients with Coronary 
Artery Disease##999-252·218A
Five-Year Follow-Up in Patients With Endstage Coronary 
artery Disease After Treatment of Myocardial Ischemia 
With Cardiac Shock Wave##1022-258·233A
Frequency of Angina Pectoris in Patients With Diabetes 
Mellitus Compared to Non-Diabetic Patients: Clarifying 
an Old Myth##927-215·169A
Functional Ischemic Mitral Regurgitation: Impact of Left 
Ventricular Function on Outcome##917-20·272A
Homing of 111In-oxine Radiolabelled Endothelial Progenitor 
Cells in Ischemic or Inﬂammed Mice Hindlimbs: 
Differential Cytokine and Chemokine Proﬁle## 948-
31·121A
Incremental Diagnostic Value of High-Frequency QRS 
Analysis for Identifying Stress-Induced Ischemia## 
828-3·132A
Intracoronary Infusion of Gd3+ Into the Ischemic Region Does 
not Suppress Phase Ib Ventricular Arrhythmias After 
Coronary Occlusion in Swine##950-220·181A
Mitral Valve Repair with a Novel Etiology-Speciﬁc 
Annuloplasty Ring for Ischemic Mitral Regurgitation: 
Early Echocardiographic Results from a Multi-center 
Study##917-23·272A
Oral Nicorandil Improves Clinical Outcomes After Coronary 
Angioplasty in Patients With Renal Failure on 
Hemodialysis##959-187·323A
Overall Myocardial Perfusion Changes by Positron Emission 
Tomography Throughout the Entire Coronary Vascular 
Tree but Not Changes Limited to the Region With the 
Most Severe Baseline Defect Predict Coronary Events## 
926-15·108A
PAMM (Parametric Analysis of Main Motion): First Evaluation 
of a New Parametric Imaging Method for Segmental Wall 
Motion Analysis## 902-38·100A
Perfusion Defects in the Absence of Abnormal Wall Motion 
and Thickening Are Not Clinically Signiﬁcant in Chest 
Pain Patients Undergoing Acute Rest Myocardial 
Perfusion Imaging## 926-17·108A
Physical Functioning at Baseline Is a Strong Independent 
Predictor of Long-Term Mortality After Myocardial 
Infarction##916-257·168A
Post-transplant Ischemic Injury Is Associated With Increased 
AlloMap Gene Expression Score##1034-107·91A
Ranolazine Safety and Tolerability During Long Term 
Treatment of Stable Angina##999-253·218A
Reduced Renal Function is Associated With Increased 
Effectiveness of ACE Inhibitor Therapy in Patients With 
Chronic Stable Coronary Disease in the Prevention 
of Events With ACE inhibition (PEACE) Trial##905-
232·162A
Refractory Angina Is Associated With Excessive Chest Pain 
but Not Excessive Cardiac Mortality##1029-206·374A
Renin-Angiotensin System Inhibition Improves Outcomes in 
Acute Coronary Syndrome Patients With Chronic Kidney 
Disease and Preserved Left Ventricular Function##974-
246·200A
Resting Magnetocardiography Detects Ischemia With 
High Accuracy in Patients With Acute Coronary 
Syndrome##951-223·182A
Sildenaﬁl Enhances Angiogenesis After Mice Hindlimb 
Ischemia##909-175·291A
Somatostatin Receptor Type 2 (SSTR2) Expression in Post-
Infarction Myocardial Inﬂammatory Inﬁltrate##1019-
231·225A
Statins in Acute Coronary Syndrome: A Meta-analysis##995-
224·212A
Stem Cell Therapy Increases Myocardial Perfusion in Patients 
Undergoing Incomplete Coronary Artery Bypass 
Surgery##907-248·166A
Survival After Coronary Revascularization, With and Without 
Mitral Valve Repair, in Patients With Ischemic Mitral 
Regurgitation. Importance of Pre-operative Myocardial 
Viability##962-21·278A
The Incidence of Provoked Spasm Using Acetylcholine 
Predicts Adverse Outcomes After Acute Myocardial 
Infarction## 830-6·208A
Three Optimally Placed Electrodes Versus 12-Lead ECG for 
Detecting Myocardial Occlusion Ischemia by Bayesian 
Classiﬁcation## 813-6·13A
Ischemia, preconditioning
COMP-angiopoietin 1 Enhances the Engraftment of the 
Mobilized Peripheral Blood Stem Cells to Ischemic Tissue 
by Induction of Adhesion Molecules## 856-6·234A
Mobilization of Bone Marrow Mesenchymal Stem Cells 
in Response to Myocardial Ischemia Depends on the 
Duration of the Coronary Occlusion and Reperfusion in 
Pig Myocardial Infarction Model##994-218·210A
Systemic Hypoxia Without Ischemic Organ Damage can 
Mobilize Endothelial Progenitor Cells in Human 
Peripheral Blood by Increased Levels of VEGF, 
MCP-1 and SDF-1: A Novel Insight of Hypoxic 
Preconditioning##933-164·302A
Ischemia, reperfusion
A Novel Caspase Inhibitor, VX-166, Reduces Myocardial 
Infarction in the Rat##927-218·170A
Abnormal Radial Strain in Both Infarcted and Remote 
Myocardial Regions Following Ischemia and Reperfusion 
in Rats Assessed by 2D Strain Echocardiography##971-
221·195A
Bay 11-7082, an Inhibitor of NF-κB, Improves Post-Ischemic 
Ventricular Dysfunction in Rats##949-220·180A
CD44 Critically Regulates Healing of Myocardial 
Infarcts##949-215·179A
Ghrelin Protects Myocardium Against Ischemia/Reperfusion 
Injury via Inhibiting Myocardial Apoptosis##937-
195·308A
Increased Bleeding Risk in Fibrinolytic Treatment of STEMI-
Register of Information and Knowledge About Swedish 
Heart Intensive Care Admissions (RIKS-HIA) 2002-
2004##904-225·160A
Mobilization of Bone Marrow Mesenchymal Stem Cells 
in Response to Myocardial Ischemia Depends on the 
Duration of the Coronary Occlusion and Reperfusion in 
Pig Myocardial Infarction Model##994-218·210A
Myocyte Bag-1 Provides Endogenous Cardioprotection 
Following Relocation From the Cytoplasm to the Nuclei 
in the Rat Heart Exposed to in vivo Ischemia/Reperfusion 
Injury##994-219·211A
NECA at Reperfusion Limits Infarction and Inhibits Formation 
of the Mitochondrial Permeability Transition Pore by 
Activating PI3 Kinase, p70S6 Kinase, and GSK-3β##927-
220·170A
Persistent Reductions in Flow and Function After 
Revascularization of Swine With Hibernating 
Myocardium##949-216·179A
Relationship Between Microvascular Injury and Degree of 
ST-Segment Elevation Before Percutaneous Coronary 
Intervention##973-241·199A
Rescue Angioplasty versus Conservative Management for 
Failed Thrombolysis in Acute Myocardial Infarction: A 
Meta-Analysis##929-235·173A
Rescue Angioplasty Versus Conservative Treatment in 
Patients with Failed Fibrinolysis- No Late Survival 
Beneﬁt. The Final Analysis of the Middlesbrough 
Early Revascularisation to Limit Infarction (MERLIN) 
Randomised Trial##929-232·173A
ST-Elevation in Lead aVR During Exercise Testing Should Not 
Be Ignored## 992-131·27A
The Long Acting Phosphodiesterase-5 Inhibitor Tadalaﬁl 
Reduces Myocardial Infarct Size##927-217·170A
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Thyroid Hormone Protects the Heart Against Ischaemia-
Reperfusion Injury Through a Redox Regulated Survival 
Signaling##949-219·180A
Transient Coronary Occlusion Stimulates Platelet Deposition 
and Microvascular Dysfunction in Remote Regions of 
the Heart: Relation to Platelet Activation Status##908-
166·289A
Vascular Endothelium Growth Factor-165 Gene Therapy 
Increases Left Ventricular Mass and Decreases Wall 
Thinning in Reperfused Myocardial Infarction## 856-
3·233A
Kawasaki disease
HMG-CoA Reductase Inhibitors Are Effective for Prevention 
of Acute Coronary Artery Injury in a Rabbit Model of 
Kawasaki disease##1011-110·244A
Longitudinal Systolic Motion Assessed by Doppler Myocardial 
Imaging Is Impaired in Children With Acute Kawasaki 
Disease## 948-10·118A
Risk Factors for Coronary Artery Involvement in Children 
After Kawasaki Disease## 840-9·247A
Kidney
A Calculated Glomerular Filtration Rate or a Simple Serum 
Creatinine: Which is the Better Predictor of Mortality in 
Patients with Coronary Artery Disease?##983-203·337A
Anemia Is Related to Blunted Erythropoietin Production 
and Impaired Renal Function in Chronic Heart Failure 
Patients##964-98·58A
Cardiac Hypertrophy and Renal Disease in GLUT1-
Overexpressing Mice##918-51·38A
Effect of Statin Therapy on Renal Function in Hypertensive 
African Americans##981-192·335A
High-dose Folic Acid Supplementation Improves Atherogenic 
Process in Predialysing Chronic Renal Failure 
Independent of Homocysteine-lowering##1000-164·345A
Is There a Role for Implantable Cardioverter-Deﬁbrillator 
Therapy for the Primary Prevention of Sudden Death in 
Patients With Chronic Kidney Disease?## 818-5·19A
Meta-Analysis of the Association of Anemia, Chronic 
Kidney Disease (CKD), and Cardiovascular Disease 
(CVD)##968-154·260A
Oral Nicorandil Improves Clinical Outcomes After Coronary 
Angioplasty in Patients With Renal Failure on 
Hemodialysis##959-187·323A
Reduced Renal Function is Associated With Increased 
Effectiveness of ACE Inhibitor Therapy in Patients With 
Chronic Stable Coronary Disease in the Prevention 
of Events With ACE inhibition (PEACE) Trial##905-
232·162A
Subclinical Left Ventricular Abnormalities Predict Outcome in 
Chronic Kidney Disease and Are Reversible With Renal 
Transplantation## 925-44·104A
Laser
Transmyocardial Laser Revascularization Combined With 
Stem Cell Therapy Increases Myocardial Perfusion 
and Functional Capacity in Patients With Refractory 
Angina##907-250·166A
Leukocytes
Adenosine Regulation With Acadesine Improves Two-Year 
Survival After Reperfusion-Induced MI## 857-3·235A
Admission White Blood Cell Count and Plasma Glucose: A 
Simple and Useful Combination for Predicting In-Hospital 
Outcome After Acute Myocardial Infarction##1018-
230·224A
Beneﬁcial Effect of Combined Intramyocardial and 
Intracoronary Administration of Autologous Stem 
Cells on Global and Regional Left Ventricular Function 
and Myocardial Perfusion in Patients With Ischaemic 
Cardiomyopathy##934-173·304A
Down-regulation of ζ-chain in CD4+ T-cells and in Natural 
Killer Cells in Patients With Acute Coronary Syndrome 
(ACS)##977-159·328A
Increased Platelet-Leukocyte Aggregation in Indian Asian 
Men: A Mechanism Contributing to Greater Cardiovasular 
Risk?##1023-163·364A
Inﬂammatory Activation During Coronary By-pass Surgery 
and the Effect of High Dose Statin Plus ACE-inhibitor 
Treatment## 845-3·359A
Leucocyte Count Is a Marker of Arterial Wave Reﬂections in 
Apparently Healthy Individuals##1005-202·353A
Procollagen Type III Amino-terminal Peptide (PIIINP) and 
Surrogates of Ventricular/Vascular Stiffness in Chronic 
Kidney Disease##1001-177·347A
The CYBA Genotype Is Associated With Altered NADPH 
Oxidase Activity in Patients With Cardiovascular 
Disease## 822-7·340A
Toll-like Receptors in Giant Cell Arteritis: Differential Effects 
of TLR4 and TLR5 Ligation##933-167·302A
Vascular Dendritic Cells as Gatekeepers in Vascular 
Inﬂammation##934-174·304A
Lipid modifying agents
Absence of Correlation Between Lipid-Lowering Effects 
and Impacts on Progressive Insulin Resistance in Statin 
Treatment of a Type-2 Diabetes Model##937-194·308A
Added Ramipril to Simvastatin Shows Additive Effects on 
Tissue Factor Activity and Prothrombin Fragment 1+2 in 
Patients With Type 2 Diabetes##1023-172·366A
Additive Beneﬁcial Effects of Fenoﬁbrate Combined with 
Candesartan in the Treatment of Hypertriglyceridemic, 
Hypertensive Patients## 845-4·359A
After Adjustment for Confounding Variables, Treatment With 
Statin Therapy at Baseline but Not Low LDL-cholesterol 
Levels Results in Better Two-Year Outcome in Patients 
With Established Angiographic Coronary Disease##1026-
186·369A
Atorvastatin but Not Vitamin C, Affects Endothelial Function, 
Asymmetric-Dimethyl-Arginine Levels and Inﬂammatory 
Process, in Patients With Diabetes Mellitus Type 2, and 
Low Cholesterol Level##1003-189·350A
Atorvastatin Might Improve Cardiac Function in Patients With 
Chronic Heart Failure by the Antioxidative Effect: A 
Prospective Randomized Placebo-Controlled Study##964-
97·58A
Early Initiation Of Low-Dose Atorvastatin Treatment After 
An Acute ST-Elevated Myocardial Infarction, Decreases 
Inﬂammatory Response And Stimulates Antithrombotic 
Mechanisms##996-234·214A
Effect of Amlodipine and Enalapril on Cardiovascular Events 
in Normotensive Coronary Artery Disease Patients with 
Concomitant Statin Use in the CAMELOT Trial##938-
202·310A
Effects of Torcetrapib and/or Atorvastatin on HDL and LDL 
Particle Size and Composition: Results From a Phase 2 
Trial##981-195·335A
Evidence of Myocardial Adrenergic Innervation Abnormalities 
in Hyperlipidemic Subjects: The Effect of Statins## 
926-33·110A
Ezetimibe/Simvastatin Versus Atorvastatin for Attainment of 
Apolipoprotein B and C-Reactive Protein Goals: A VYVA 
Substudy##981-194·335A
Flow Mediated Dilation Predicts Improved Cardiovascular 
Outcomes with Atorvastatin Therapy in Patients with 
Nonischemic Heart Failure##964-96·58A
High Dose Atorvastatin Does Not Impact the Efﬁcacy of 
Clopidogrel - A PROVE IT TIMI-22 Analysis## 855-
8·380A
Lipid Effects of Torcetrapib With and Without Atorvastatin 
Are Optimized by Morning Dosing: Results From 
Pharmacokinetic/Pharmacodynamic Analyses##1003-
186·349A
Lipoprotein Subclasses, Hydroxy Fatty Acids, and the 
Inﬂammatory Response in Metabolic Syndrome 
Patients##914-205·298A
Lipoprotein-Associated Phospholipase A2 (LpPLA2) Measured 
30 Days Post-Acute Coronary Syndrome Independently 
Predicts Risk of Long-Term Cardiovascular Outcomes: A 
PROVE-IT TIMI-22 Substudy## 830-7·208A
Losartan Combined With Simvastatin Shows Additive 
Beneﬁcial Effects on Inﬂammation in the Treatment of 
Hypercholesterolemic, Hypertensive Patients## 845-
5·359A
Lower Plasma High-Density Lipoprotein Remains an 
Important Independent Predictor of Death or Non-Fatal 
Myocardial Infarction Among Statin Treated Patients 
Following Cardiac Catheterisation##1003-188·350A
Nicotinic Acid-Induced Vasodilation in Mice Is Predominantly 
Mediated via the Prostagladin D
2
 Receptor 1## 845-
8·360A




Prevalence of Atrial Fibrillation and Flutter by Different HMG-
CoA Reductase Inhibitors and Doses in Heart Failure## 
816-4·61A
Profound Increase of HDL-c Levels (>50%) With Long-Term 
Niacin Treatment##914-204·298A
Sex Differences in the Efﬁcacy of Statins in Patients After 
Acute Myocardial Infarction##996-236·214A
Specialized Lipid Clinic Management of Hyperlipidemia in 
Patients With Coronary Artery Disease: How Long Does 
the Effect Last?##968-152·259A
Statin Use and Low-Density Lipoprotein Cholesterol Goals in 
2004: How Are We Doing Applying National Cholesterol 
Education Program III Guidelines?## 836-5·209A
The Addition of Niacin to Statin Therapy Produces an 
Atheroprotective Shift in Lipoprotein Subclasses and 
Inﬂammatory Markers in Patients With Coronary Artery 
Disease and Well-Controlled LDL-Cholesterol##1026-
185·369A
Withdrawal Effect After 4-Year Statin Therapy on C-
reactive Protein Is Independent of LDL-cholesterol 
Change##1003-185·349A
Lipoproteins
Acute Coronary Syndromes Do Not Lower Lipid Levels##959-
186·323A
After Adjustment for Confounding Variables, Treatment With 
Statin Therapy at Baseline but Not Low LDL-cholesterol 
Levels Results in Better Two-Year Outcome in Patients 
With Established Angiographic Coronary Disease##1026-
186·369A
Apo A1-LDL Complex in Coronary Artery Disease - Oxidized 
Lipoprotein and Inﬂammation##930-248·176A
Effect of Post Fat Loading Remnant Like Particles-Cholesterol 
on Prognosis in Patients With Coronary Artery 
Disease##1014-214·355A
Lectin-like Oxidized LDL Receptor-1 (LOX-1) as a Novel 
Receptor for Remnant-like Lipoprotein Particles (RLPs) 
in Vascular Smooth Muscle Cells## 822-4·340A
Lipid Parameters and Risk of Ischemic Stroke in Type 2 
Diabetes Mellitus: The Strong Heart Study##1003-
190·350A
Lipid-Lowering Results From the First Large-Scale Trial 
of Statin Therapy in Hispanic-American Patients With 
Hypercholesterolemia: STARSHIP##1003-187·349A
Lipoprotein-associated Phospholipase A2 (Lp-PLA2) in 
Chronic Kidney Disease: Results From the RRI-CKD 
Study## 854-7·378A
Plasma Concentration of Lipoprotein(a) and the Risk of Future 
Cardiovascular Disease in Women## 801-8·314A
Quantitation and Distribution of Lipoprotein-Associated 
Phospholipase A
2 
and Oxidized Low Density Lipoprotein 
in Atherosclerotic Lesions of Carotid Endarterectomy 
Tissues##1000-170·346A
Synergistic Effects of the Cholesteryl Ester Transfer Protein 
TaqIB, the Apolipoprotein E E2/E3/E4, and the 
Apolipoprotein C3 -482 C>T Polymorphisms on the Risk 
of Coronary Artery Disease## 850-6·221A
The Addition of Niacin to Statin Therapy Produces an 
Atheroprotective Shift in Lipoprotein Subclasses and 
Inﬂammatory Markers in Patients With Coronary Artery 
Disease and Well-Controlled LDL-Cholesterol##1026-
185·369A
The Triglyceride/High Density Lipoprotein Ratio Predicts All-
Cause Mortality in Women## 808-8·317A
Lipoproteins, HDL
A New Strategy for Atherosclerosis Using Sendai Virus 
Mediated Delivery of Paraoxonase##909-177·292A
Association of High Density Lipoprotein Levels and Carotid 
Atherosclerotic Plaque Burden and Lipid Content by 
High-resolution Magnetic Resonance Imaging## 993-
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Effects of High-Dose Atorvastatin on HDL Anti-inﬂammatory/
Pro-inﬂammatory Function and Disease Activity in 
Patients With Rheumatoid Arthritis: Results of the Statin 
Anti-Rheumatic Activity (SARA) Pilot Study## 854-
6·378A
HDL Not Predictive of Longevity or Cardiovascular Events 
in Older Adults: Findings From the EPESE Study##968-
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Impact of High HDL Cholesterol on Hospital and 1-Year-
Mortality of Patients With Acute Myocardial Infarction: 
Results of the ACOS Registry##996-232·213A
Impact of Low High-density Lipoproteins on In-Hospital 
Events and Twelve-month Clinical Outcomes in Patients 
With Acute Coronary Syndrome Treated With Drug-
eluting Stent Implantation## 808-4·316A
Impact of Triglyceride Lowering on HDL-c: Is There a 
Continuum of HDL-c Increase Beyond Fasting TG < 150 
mg/dl?## 849-5·362A
Lack of Relationship Between Body Mass Index and 
Atherogenic Dyslipidemia in Asian Indians##1026-
189·370A
Lower Plasma High-Density Lipoprotein Remains an 
Important Independent Predictor of Death or Non-Fatal 
Myocardial Infarction Among Statin Treated Patients 
Following Cardiac Catheterisation##1003-188·350A
On-treatment Levels of HDL-C and the Ratio of LDL-C/HDL-
C as Predictors of Cardiovascular Events in the Treating 
to New Targets (TNT) Study##914-203·298A
Profound Increase of HDL-c Levels (>50%) With Long-Term 
Niacin Treatment##914-204·298A
Prospective Evaluation of New and Old Criteria for the 
Metabolic Syndrome## 850-7·222A
Small HDL Particles Exert Potent Protection of Human 
Endothelial Cells Against Apoptosis: Relevance to 
Metabolic Syndrome##1000-162·344A
Specialized Lipid Clinic Management of Hyperlipidemia in 
Patients With Coronary Artery Disease: How Long Does 
the Effect Last?##968-152·259A
The Triglyceride/High Density Lipoprotein Ratio Predicts All-
Cause Mortality in Women## 808-8·317A
Lipoproteins, LDL
Clinical Signiﬁcance of Large and Small Low-Density 
Lipoprotein-Cholesterol Concentrations in Patients 
With Various Types of Coronary Heart Diseases##1014-
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Combination of Aspirin and Pravastatin Dramatically Reduces 
Oxidative Stress and the Expression of LOX-1 and 
Adhesion Molecules: Novel Insight Into the Mechanism 
of Action of Aspirin and Statins## 822-5·340A
Effects of Ezetimibe/Simvastatin Compared to Simvastatin 
Monotherapy in Reducing C-Reactive Protein and Low 
Density Lipoprotein-Cholesterol## 808-5·316A
Follow-Up LDL-cholesterol Level as an Independent Predictor 
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Allogeneic Mesenchymal Stem Cells Restore Early Tissue 
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Assessment of Mitral Regurgitation by CMR Derived 
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Modulator Therapy: An In Vivo Study of Raloxifene 
by Magnetic Resonance Imaging and Micro-Computed 
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Intermedia Patients Confronted with Thalassemia Major 
Patients## 833-4·136A
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in Combination With Spironolactone in Patients With 
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Hypertension## 993-9·143A
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and Cardiac Regional Function##903-220·159A
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Therapy in Right Bundle Branch Block## 810-3·11A
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Multislice Multiecho T2* Cardiovascular Magnetic 
Resonance Approach for the Detection of Myocardial 
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Activation of Matrix Metalloproteinases## 812-3·114A
Novel Transthoracic Triplane-Echocardiography With Contrast 
Agent Improves the Accuracy of Left Ventricular Volume 
Measurements: A Comparison With Magnetic Resonance 
Imaging## 1016-36·150A
Preservation of Diastolic Kinetic Energy: A Marker of 
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Prevalence of Recognized and Unrecognized Myocardial 
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Side-by-Side Comparison of Three-Dimensional 
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Regression of Left Ventricular Hypertrophy in Morbidly Obese 
Women Who Undergo Rapid Weight Loss: A Prospective 
Cardiovascular Magnetic Resonance (CMR) Imaging 
Study## 993-11·144A
Spontaneous Evolution of Viability Indexes After Reperfused 
Myocardial Infarction. Implications on the Prediction of 
Late Systolic Function## 993-16·145A
The Association of Insulin Resistance with Global and 
Regional Left Ventricular Dysfunction in Four 
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MRI on Left Ventricular Diastolic Function in 
Hypertrophic Cardiomyopathy## 833-5·136A
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993-2·142A
The Relation Between Aortic Distensibility and Calciﬁed 
Aortic Atherosclerosis: Cardiovascular MRI and CT 
Correlations##1000-166·345A
The Utility of Cardiac Magnetic Resonance in Differentiating 
Hypertrophic Cardiomyopathy and Cardiac 
Amyloidosis## 993-5·143A
Time Course of Functional Recovery After Revascularization 
in Patients With Chronic Ischemic Left Ventricular 
Dysfunction: A Contrast Enhanced MRI Study## 833-
8·137A
Time Course of Microvascular Obstruction in Patients with 
Acute Myocardial Infarction## 993-15·145A
Time From Symptom Onset to Reperfusion and Inﬂuence on 
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Model of Myocardial Infarction##903-218·158A
Who Needs Gadolinium? Three-Dimensional Reconstruction 
Utilizing Steady State Free Precession Cardiac Magnetic 
Resonance in Congenital Heart Disease##989-115·243A
Magnetic resonance spectroscopy
Different Effects of Rosuvastatin and Simvastatin on 
Myocardial High-Energy Phosphate Metabolism## 
993-6·143A
Medical record systems, computerized
Reliability of Cardiac Index Monitoring With an Analysis of 
Peripheral Arterial Waveform During Varing Loading 
Condition in Vivo##1012-149·265A
Metabolic syndrome
Adiponectin in Patients With Hypertrophic 
Cardiomyopathy##965-103·60A
Cardiovascular Risk Assessment can Be Improved Using 
Components of the Metabolic Syndrome and Other Risk 
Markers: The European Concerted Action Project## 
842-4·357A
Cardiovascular Risk Classiﬁcation in Hypertensive Patients 
With or Without Metabolic Syndrome: Results From the 
ICEBERG Study##939-209·311A
Clinical Implication in Metabolic Syndrome and Ankle-
brachial Pressure Index as the Predictor of Cardiovascular 
Disease##983-211·339A
Clusters of Cardiovascular Risk Factors: A Health Economics 
Perspective for the Metabolic Syndrome## 842-7·358A
Coronary Disease Prevalence on Stress Imaging in Patients 
With NCEP Deﬁned Metabolic Syndrome versus 
Traditional Risk Factors##961-200·326A
Current Trends in the Prevalence of Metabolic Syndrome Risk 
Factors##939-213·312A
Dysmetabolic Status, and Not Obesity Per Se, Is Associated 
With Increased Cardiovascular Mortality in Patients With 
Stable Coronary Disease##939-208·311A
Echocardiographic Epicardial Adipose Tissue as an Another 
Imaging Indicator of Visceral Adipose Tissue## 902-
10·96A
Enhanced Expression of Leptin, Leptin Receptor, and Leptin 
Signaling in the Failing Human Heart##913-200·297A
Features of the Metabolic Syndrome and Diabetes Mellitus 
as Predictors of Aortic Valve Calciﬁcation as Detected 
by Electron Beam Computed Tomography in the Multi-
Ethnic Study of Atherosclerosis##1030-27·287A
Fish Intake Is Associated With Decreased Levels of 
Inﬂammatory Markers Among People With Metabolic 
Syndrome: The ATTICA Study##1005-201·353A
Global Risk Assessment of U.S. Persons With the Metabolic 
Syndrome##939-204·310A
Job-Strain Induced Workplace Hypertension Is Associated 
With Obesity and High Normal Blood Pressures at the 
Physical Checkup##1004-191·350A
Link of Serum CK Activities to Vascular Smooth Muscle 
Revealed by Physiological-genomic Analyses of Statin-
treated Patients##956-168·319A
Lipoprotein Subclasses, Hydroxy Fatty Acids, and the 
Inﬂammatory Response in Metabolic Syndrome 
Patients##914-205·298A
Long-Term Result of Metabolic Syndrome with Patients 
Undergoing Coronary Artery Bypass Grafting##939-
207·311A
Metabolic Syndrome Predicts Higher Cardiovascular Risk 
Independently of ECG Left Ventricular Hypertrophy: The 
LIFE Study## 848-3·360A
Microalbuminuria Is Associated With Severe Angiographic 
Coronary Artery Disease in Diabetics and Non-
Diabetics## 842-5·358A
Obesity and the Metabolic Syndrome are Associated With 
Improved Survival in the Heart Failure Population##964-
57·56A
PPAR-γ Agonist Improves Endothelial Function in Patients 
With Metabolic Syndrome: Pivotal Role of NOx and 
Inﬂammation## 841-6·356A
Prevalence of Metabolic Syndrome in Patients < 45 Years Old 
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Prospective Evaluation of New and Old Criteria for the 
Metabolic Syndrome## 850-7·222A
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Independent of cAMP or Akt-1 Activation##963-51·54A
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Kinase/Akt/PKB and Nuclear Factor kB in a Porcine 
Model of Coronary Atherosclerosis##977-169·330A
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Valve Regurgitation: An Experimental Study##1006-
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Does Real Time Three-Dimensional Dobutamine Stress 
Echocardiography Is the Method of Choice in Patients 
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Feasibility and Short-Term Efﬁcacy of Percutaneous 
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Functional Ischemic Mitral Regurgitation: Impact of Left 
Ventricular Function on Outcome##917-20·272A
Functional Mitral Stenosis Following Surgical Annuloplasty 
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Geometric Determinants of Chronic Ischemic Mitral 
Regurgitation in Patients With Inferior Myocardial 
Infarction: Three-Dimensional Magnetic Resonance 
Imaging Study##962-22·278A
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Impact of Mitral Valve Anuloplasty Combined with 
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Inferior Myocardial Infarction is Associated with Greater 
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Early Echocardiographic Results from a Multi-center 
Study##917-23·272A
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Percutaneous Edge-to-Edge Mitral Valve Repair Using the 
Evalve® MitraClip™: Initial Experience With Functional 
Mitral Regurgitation in the EVEREST I Trial##1006-
20·283A
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Ameliorates Functional Mitral Regurgitation##1006-
19·282A
Preoperative Exercise Capacity Predicts Survival and Persistent 
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Functional Mitral Stenosis Following Surgical Annuloplasty 
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Percutaneous Edge-to-Edge Mitral Valve Repair Using the 
Evalve® MitraClip™: Initial Experience With Functional 
Mitral Regurgitation in the EVEREST I Trial##1006-
20·283A
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Three-Dimensional Imaging Surpasses Conventional 
Transesophageal Echocardiography for Preoperative 
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Concurrent Percutaneous Balloon Valvuloplasties in Combined 
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Incidence of Atrial Fibrillation in Patients With Severe 
Mitral Stenosis##1006-24·283A
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Clinical Outcome Following Percutaneous Balloon Mitral 
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Molecular biology
Cardiac SP Cells Have Different Characteristics Distinct From 
Bone Marrow SP Cells##903-219·159A
Circulating Levels of Osteopontin Predicts Future Cardiac 
Events in Patients With Chronic Stable Angina## 801-
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Cardiomyopathies Resulting From Different Mutations in 
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Endogenous Stem Cell Circulation in Patients Suffering from 
Idiopathic Dilated Cardiomyopathy##941-47·44A
Intraperitoneal Administration of Anti-Angio-Associated 
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Formation After Vascular Injury in Apolipoprotein E 
Knockout Mice##933-172·303A
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in Response to Myocardial Ischemia Depends on the 
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Phosphoinositide 3-kinase γ Modulates Vascular Endothelial 
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Development Following Hindlimb Ischemia##909-
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Strain Related Alterations of the Phosphoinositide 3-Kinase/
Akt/BAD Survival Pathway##1007-50·76A
Stromal Cell-Derived Factor-1 Stimulates the Survival and 
Proliferation of Sca-1+ Mesenchymal Stem Cells Derived 
From Mouse Bone Marrow##994-217·210A
The Anti-Proliferative Effect on Vascular Smooth Muscle Cells 
by Rosiglitazone Is Mediated by Inhibition of the Akt-
mTOR-p70S6K Pathway## 845-6·359A
Monitoring, physiologic
Do Implantable Cardioverter-Deﬁbrillator Patients Have 
Adequate Rate Control During Atrial Tachyarrhythmias? 
Results From a New Continuous Long-Term Monitoring 
System## 1015-135·34A
Near Infra-red Spectroscopy is a Reliable Indicator of Systemic 
Perfusion for Unsedated Infants with Single Ventricle 
Physiology##989-109·242A
Muscle, skeletal
A Biphasic Improvement Following Cardiac Resynchronisation 
Therapy## 1017-17·155A
Bone Marrow-derived Stem Cell Interactions With Adult 
Cardiomyocytes and Skeletal Myoblasts in Culture##941-
48·44A
Improvement in Exercise Capacity After Inspiratory 
Muscle Training Is Associated With Reduced Dyspnea 
and Enhanced Limb Blood Flow in Chronic Heart 
Failure##1005-207·354A
Sildenaﬁl Enhances Angiogenesis After Mice Hindlimb 
Ischemia##909-175·291A
Skeletal Myoblast Delivery of Angiopoietin-1 Versus Direct 
Adenoviral Angiopoietin-1 Injection## 856-7·234A
TGF-β1 Enhances Cardiomyogenic Differentiation Potential of 
Adult Primitive Cells##903-217·158A
Muscle, smooth
Intraperitoneal Administration of Anti-Angio-Associated 
Migratory Cell Protein-Antibody Inhibits Neointima 
Formation After Vascular Injury in Apolipoprotein E 
Knockout Mice##933-172·303A
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Link of Serum CK Activities to Vascular Smooth Muscle 
Revealed by Physiological-genomic Analyses of Statin-
treated Patients##956-168·319A
The Anti-Proliferative Effect on Vascular Smooth Muscle Cells 
by Rosiglitazone Is Mediated by Inhibition of the Akt-
mTOR-p70S6K Pathway## 845-6·359A
Vascular Dendritic Cells as Gatekeepers in Vascular 
Inﬂammation##934-174·304A
Myocardial contraction
An Evaluation of Optimal AV Delays During Exercise in Heart 
Failure Patients Receiving Cardiac Resynchronization 
Therapy## 1015-124·31A
Angiotensin II Acutely Increases Diastolic Distensibility: 
A Protein Kinase C and Na+/H+ Exchanger-mediated 
Effect##1031-47·84A
Following Acute Myocardial Infarction, Myocardial 
Restraint With a Nitinol Wrap Reduces Left Ventricular 
Dyssynchrony##1008-56·77A
Insulin Resistance is a Determinant of Myocardial Dysfunction 
in Apparently Healthy Obese Subjects##964-54·55A
Intra-Left Ventricular Contractile Dyssynchrony Is 
Independently Associated with Diastolic Heart Failure in 
Medically Controlled Hypertensive Patients## 851-5·92A
Metoprolol Rescues Depressed Myocardial Contractility in 
Chronically Unloaded Hearts##1034-105·91A
Nitroxyl Increases Contractility in Failing (Gαq 
Overexpressing) Cardiomyocytes That Display Altered 
Cellular Redox Conditions##985-48·64A
Non-invasive Evaluation of Regional Myocardial Strain and 
Activation of Matrix Metalloproteinases## 812-3·114A
Normalization of Nonuniform Contraction of the Left Ventricle 
Early After Aortic Valve Replacement in Patients With 
Severe Aortic Stenosis## 925-43·103A
Parameters of Cardiac Dyssynchrony Can Predict Chronic 
Phase Cardiac Function After Acute Myocardial 
Infarction: A Real-Time 3D Echocardiography Study## 
991-36·139A
Torsion Deﬁned by Strain Imaging Facilitates Deﬁnition of 
LV Segmental Dysfunction in Experimental Myocardial 
Infarction## 925-46·104A
Myocardial hibernation
Persistent Reductions in Flow and Function After 
Revascularization of Swine With Hibernating 
Myocardium##949-216·179A
Myocardial infarction, pathophysiology
Abnormal Myocardial Transmural Shear Strains Persist During 
Evolution From Acute Ischemia to Infarction##950-
217·181A
Abnormal Radial Strain in Both Infarcted and Remote 
Myocardial Regions Following Ischemia and Reperfusion 
in Rats Assessed by 2D Strain Echocardiography##971-
221·195A
Acute Coronary Syndromes Do Not Lower Lipid Levels##959-
186·323A
Association of Transforming Growth Factor-β1 Gene 
Polymorphisms With Myocardial Infarction## 856-
4·233A
Bone Marrow-Derived Cells Do Not Transdifferentiate Into 
Cardiomyocytes After Myocardial Infarction##903-
216·158A
Cardiac Expression of Placental Growth Factor Stimulates 
Peripheral Mobilization of CD34+ Progenitor Cells in 
Patients with Myocardial Infarction##972-228·196A
CD44 Critically Regulates Healing of Myocardial 
Infarcts##949-215·179A
Clinical Impact of Collateral Circulation on 30-Day Mortality 
for Acute Myocardial Infarction Complicating Heart 
Failure##951-226·182A
Concurrent Evaluation of Novel Cardiac Biomarkers in ACS: 
Myelopyroxidase, sCD40L, C-reactive Protein and Risk 
of Death or Recurrent Ischemia in TACTICS-TIMI 
18##972-227·196A
Echo-attenuation in the Target Lesion Before Perutaneous 
Coronary Intervention and Incidence of Angiographic 
Slow Flow##951-230·183A
Effect of Nadir Hemoglobin During Hospital Course on the 
Long-Term Risk of Heart Failure and Death in Survivors 
of Acute Myocardial Infarction##953-245·187A
Effects of Irbesartan and Perindopril on Endothelial Function 
and Inﬂammatory Process in Patients With Coronary 
Artery Disease and Stable Angina Pectoris##1019-
236·226A
Electrocardiographic Unrecognized Myocardial Infarction 
Is Associated With Increased Mortality Independent 
of Regional Wall Motion Abnormalities on 
Echocardiogram##971-218·194A
Fasting Glucose Is a Powerful Independent Risk Factor for 
Long-Term Mortality in Patients With Acute Myocardial 
Infarction. A Prospective Study## 830-5·207A
Genetic Polymorphism C242T on the NADPH Subunit p22-
phox, Is Associated With Increased Risk for Myocardial 
Infarction and Endothelial Activation##1019-238·226A
Genetic Polymorphisms on Platelet Glycoprotein Ia, Increase 
the Risk for Myocardial Infarction by Modifying Platelet 
Activation##908-164·289A
Gentic Polymorphism G894T Modiﬁes the Smoking-
Associated Risk for Myocardial Infarction in Young 
Individuals##983-210·339A
Heart Rate Turbulence Onset After Atrial Premature 
Complexes Does Not Reﬂect Cardiac Autonomic 
Regulations in Postinfarction Patients## 992-126·26A
Human Umbilical Cord Blood Cells Improve Cardiac Function 
After Myocardial Infarction##1020-241·227A
Impact of Enhanced Platelet Reactivity on Microvascular 
Reperfusion and Left Ventricular Remodeling in 
ST-segment Elevation Myocardial Infarction.##908-
168·290A
Impact of Perioperative Myocardial Infarction on Angiographic 
and Clinical Outcomes Following Coronary Artery 
Bypass Surgery: Findings From PREVENT IV##932-
258·178A
Inferior Myocardial Infarction is Associated with Greater 
Left Ventricular Dyssynchrony and Mitral Regurgitation 
Compared to Anterior Myocardial Infarction## 902-
43·101A
Inhibition of Protein Synthesis via mTOR Dependent Pathway 
Prevents Adverse Left Ventricular Remodeling and 
Reduces Infarct Size After Experimental Myocardial 
Infarction## 820-7·74A
Insights Into the Change in Brain Natriuretic Peptide After ST-
Elevation Myocardial Infarction: Why Should it Be Better 
Than Baseline Brain Natriuretic Peptide?##973-236·198A
Ischemic Mitral Regurgitation Is an Independent Predictor 
of Heart Failure and Death in Survivors of Myocardial 
Infarction: A Prospective Study##962-19·277A
May an Acute Coronary Syndrome Occur in the Absence of 
Inﬂammation?## 854-3·377A
Microvascular Flow and Myocardial Perfusion After Acute MI 
Angioplasty in Anterior Versus Non-Anterior Infarcts: 
Results From the EMERALD Trial## 843-4·220A
Mitral Annular Dilatation; Is It Active or Passive? A Cardiac 
MRI Study##971-219·194A
Myocardial Infarction in Adolescents##1035-112·247A
Parameters of Cardiac Dyssynchrony Can Predict Chronic 
Phase Cardiac Function After Acute Myocardial 
Infarction: A Real-Time 3D Echocardiography Study## 
991-36·139A
Pregnancy-associated Plasma Protein A: An Instant Rising 
Biomarker in Patients With ST-Elevation Myocardial 
Infarction##971-215·193A
Prevalence of Recognized and Unrecognized Myocardial 
Infarction: The ICELAND MI Substudy to the AGES-
Reykjavik Study## 833-6·137A
Prognostic Value of Serum Gamma-Glutamyl Transferase 
Activity in Coronary Artery Disease##1029-213·375A
Reduction of Nitrite to Nitric Oxide in Ischemic Heart 
Is Catalyzed by Distinct Blood-Borne and Tissue 
Elements##994-221·211A
Serum Amyloid A Is a Better Predictor of Clinical Outcome 
Than C-reactive Protein in Non-ST-Segment Elevation 
Acute Coronary Syndrome##1019-233·225A
Somatostatin Receptor Type 2 (SSTR2) Expression in Post-
Infarction Myocardial Inﬂammatory Inﬁltrate##1019-
231·225A
Synchrotron Radiation Coronary Microangiography for 
Morphometric and Physiological Evaluation of 
Myocardial Neovascularization Induced by Cell-Based 
Transplantation##909-178·292A
Synergistic Effect of Cytochrome P450 Epoxygenase CYP2J2 
G-50T Polymorphism With Smoking on the Onset of 
Premature Myocardial Infarction## 822-8·341A
The TIMI Risk Index for Myocardial Infarction Predicts 
Post-MI LV Ejection Fraction: A CLARITY - TIMI 28 
Substudy##1018-228·224A
Thrombospondin-4 A387p Polymorphism Is not Associated 
With Markers of Vascular Function and Incidence of 
Myocardial Infarction##933-159·300A
Thyroid Hormone Receptors α1 and β1 Are Downregulated 
in the Post-infarcted Rat Heart: Consequences on the 
Response to Ischaemia-reperfusion##949-218·179A
Time Course of Microvascular Obstruction in Patients with 
Acute Myocardial Infarction## 993-15·145A
Transient Coronary Occlusion Stimulates Platelet Deposition 
and Microvascular Dysfunction in Remote Regions of 
the Heart: Relation to Platelet Activation Status##908-
166·289A
Unrecognized Myocardial Infarction: The Association With 
Cardiopulmonary Symptoms and Mortality is Mediated 
Via Echocardiographic Abnormalities of Global 
Dysfunction Instead of Regional Dysfunction. The 
Olmsted County Heart Function Study##950-215·180A
Usefulness of 2-dimensional Longitudinal Strain of Apical 
Septum to Predict Functional Recovery After Successful 
Primary Revascularization Procedure in Anterior Wall 
Myocardial Infarction## 948-5·117A
Myocardial infarction, treatment
5-Fluorouracil Improves Postinfarct Left Ventricular 
Dysfunction due to Upregulated SDF-1, Mobilized CD34 
Positive Cells and Attenuated Fibrosis##927-219·170A
A Novel Caspase Inhibitor, VX-166, Reduces Myocardial 
Infarction in the Rat##927-218·170A
A Novel Enoxaparin Regime for ST-Elevation Myocardial 
Infarction Patients Undergoing Primary Purcutaneous 
Coronary Intervention: Intravenous but Not Subcutaneous 
Enoxaparin Achieves Adequate Anti-Xa Levels##1020-
243·227A
A Phase 1/2 Trial of TG100-115, a Phosphatidylinositol-
3 Kinase Inhibitor, in Acute ST-Segment Elevation 
Myocardial Infarction Patients Treated by Percutaneous 
Coronary Intervention Indicates Acceptable Safety and 
Pharmacokinetics at the Initial Dose Level## 857-4·235A
A Prehospital Diagnostic Strategy Reduces Time to Treatment 
and Mortality in Real Life Patients With ST-Elevation 
Myocardial Infarction Treated With Primary Percutaneous 
Coronary Intervention## 815-3·192A
A Randomized Trial Comparing Primary PCI With or Without 
On-Site Surgery for Acute Myocardial Infarction in the 
Netherlands: From Randomization to Clinical Practice## 
815-6·193A
A Routine Intervention Strategy in Patients With Non-ST 
Segment Elevation Acute Coronary Syndromes Is Not 
Superior to a Selective Intervention Strategy: A Meta-
Analysis of Randomized Controlled Trials## 811-4·257A
Absence of Clinical Hypotension with Eplerenone in Post-
acute Myocardial Infarction Patients With Heart Failure 
and Left Ventricular Systolic Dysfunction: Results from 
EPHESUS##1020-242·227A
Achieving Rapid Myocardial Infarction Reperfusion 
With Percutaneous Coronary Intervention Remains a 
Challenge, Especially in Women, Elderly, and Minorities: 
Results From American Heart Association Get With the 
Guidelines## 815-8·193A
Adenosine Regulation With Acadesine Improves Two-Year 
Survival After Reperfusion-Induced MI## 857-3·235A
Adjunctive Use of the Rinspiration System for Fluidic 
Thrombectomy During Primary Angioplasty: The 
Rinspiration International Registy##952-237·185A
Admission White Blood Cell Count and Plasma Glucose: A 
Simple and Useful Combination for Predicting In-Hospital 
Outcome After Acute Myocardial Infarction##1018-
230·224A
Adult Mesenchymal Stem Cells From Patients With Ischemic 
Heart Disease Engraft in Ischemic Myocardium 
and Improve Left Ventricular Function in NOD/scid 
Mice##903-221·159A
Age Related Outcomes in Patients Undergoing Transfer for 
Direct Percutanous Coronary Intervention in ST-Elevation 
Myocardial Infarction##904-224·160A
Aging Impairs the Beneﬁcial Effects of Intravenous Infusion of 
Mesenchymal Stem Cells on Post- Myocardial Infarction 
Remodeling## 814-8·192A
Allogeneic and Syngenic Multipotent Adult Progenitor Cell 
Delivery Improves Cardiac Function After Myocardial 
Infarct##941-49·44A
Atrial Fibrillation Is a Long-Term Predictor of Poor Outcome 
in Acute Myocardial Infarction##975-250·201A
AZD6140 Yields Additional Suppression of Platelet 
Aggregation in Patients With Acute Coronary Syndromes 
Previously Treated With Clopidogrel## 821-4·204A
AZD6140 Yields Greater Inhibition of Platelet Aggregation 
Than Clopidogrel in Patients With Acute Coronary 
Syndromes Without Previous Clopidogrel Treatment## 
821-3·204A
Bleeding Complications Predict Major Cardiovascular 
Outcomes in Non ST-Elevation Acute Coronary 
Syndromes: Results From the OASIS - 5 Trial##972-
224·195A
Blood Transfusion in Patients Undergoing Primary 
Percutaneous Coronary Intervention for Acute Myocardial 
Infarction: Analysis From the CADILLAC Trial##996-
241·215A
Cardiac SP Cells Have Different Characteristics Distinct From 
Bone Marrow SP Cells##903-219·159A
Characteristics Predicting Successful Weight Reduction in 
Overweight and Obese Post Infarction Patients## 849-
4·362A
Chronic Obstructive Pulmonary Disease Is an Independent 
Predictor of Death in Patients With Myocardial Infarction: 
An Analysis of the VALsartan In Acute myocardial 
iNfarcTion Trial (VALIANT)##998-250·217A
Chronic Therapy With Erythropoietin, Even Administrated 
Late After Reperfusion, Induces Endothelial Progenitor 
Cells Mobilization and Myocardial Salvage in Post-mi 
Rats## 829-5·206A
Chronic Therapy With Erythropoietin, Even Administrated 
Late After Reperfusion, Induces Endothelial Progenitor 
Cells Mobilization and Myocardial Salvage in Post-mi 
Rats## 829-5·206A
Clinical Outcomes of Patients Undergoing Percutaneous 
Coronary Intervention on Weekends as Compared With 
Weekdays##946-149·254A
Clinical Pathway as a Strategy of Improving Care to Patients 
With an Acute Myocardial Infarction. From a Randomised 
Trial to Clinical Practice## 847-6·268A
Clopidogrel Attenuates the Complications Associated 
With Poor Early Reperfusion in Patients With STEMI 
Undergoing Lysis in the CLARITY-TIMI 28##995-
228·213A
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Cocaine-Related Chest Pain-Utility of TIMI Risk Stratiﬁcation 
and Effects of Beta Blockers on Outcome##1029-
205·373A
Collagen Implantation as an Internal Support to Prevent 
Eccentric Hypertrophy and Preserve Cardiac Function 
After Myocardial Infarction in Rats## 814-7·191A
Combining Warfarin and Antiplatelet Therapy After Coronary 
Stenting in the Global Registry of Acute Coronary Events: 
Is it Safe and Effective to Use Just One Antiplatelet 
Agent?##923-149·252A
Comparison of Reperfusion Times in Patients Transferred 
for Primary Angioplasty for ST Elevation Myocardial 
Infarction Prior to and After Instituting a Regional 
Myocardial Infarction Alert Protocol## 847-8·268A
Compliance With Contemporary Guidelines for Non-ST-
Elevation Acute Coronary Syndromes: Inﬂuence on 
Outcome and Interaction With Risk Stratiﬁcation## 
811-6·257A
Distal Protection Devices During Percutaneous Coronary 
Intervention Are Effective in Reducing Death or 
Recurrent Myocardial Infarction in Saphenous Vein 
Grafts but Not in Acute Myocardial Infarction: A Meta-
analysis##923-148·251A
Do All Patients With ST-Segment Elevation Myocardial 
Infarction Beneﬁt From Invasive Treatment? The Simple 
Risk-Score Derived From PL-ACS Registry##973-
235·198A
Does Hospital PTCA Volume Inﬂuence Mortality and 
Complication Rates in the Era of PTCA With Systematic 
Stenting? Results of the Greater Paris Area PTCA 
Registry## 815-4·192A
Does Rescue Angioplasty Improve Outcomes? A Quantitative 
Review of Randomized trials##929-236·174A
Driving Times and Distances to Hospitals With Percutaneous 
Coronary Intervention in the U.S.: Implications for Pre-
Hospital Triage of Patients With ST-Elevation Myocardial 
Infarction## 811-3·256A
Early Initiation Of Low-Dose Atorvastatin Treatment After 
An Acute ST-Elevated Myocardial Infarction, Decreases 
Inﬂammatory Response And Stimulates Antithrombotic 
Mechanisms##996-234·214A
Early Invasive Versus Conservative Management in Non ST 
Elevation Acute Coronary Syndromes: A Metanalysis## 
821-7·205A
Effect of Stem Cells on Left Ventricle Wall Thickness 
and Capillary Density in Pigs Following Myocardial 
Infarction## 829-3·206A
Effects of Single Nucletide Polymorphisms of Atherosclerosis 
Related Genes on Response to HMG-CoA Inhibitors After 
Acute Myocardial Infarction##914-202·297A
Erythropoietin Receptor and Anti-Apoptotic Effect of 
Erythropoietin on Anoxia/Reoxygenation Injury in 
Endothelial Cells##949-217·179A
Evaluation of the TIMI Risk Index in a Multi-continental 
Population of 19,103 Patients With STEMI in the 
ExTRACT-TIMI 25 Trial##1018-222·223A
Exogenous Adenosine Triphosphate Disodium During 
Primary Percutaneous Coronary Intervention Preserves 
Microvascular Integrity and Left Ventricular Function in 
Patients with Acute Myocardial Infarction Regardless of 
Antecedent Angina## 1016-39·150A
Failure to Use Percutaneous Coronary Intervention in Patients 
With an Acute Coronary Syndrome and Congestive 
Heart Failure. The Global Registry of Acute Coronary 
Events##1032-56·86A
Field Triage Directly to the Catheter Laboratory Safely Reduce 
Time to Reperfusion and Infarct Size in Patients With ST-
Elevation Myocardial Infarction## 815-5·192A
Final Results of the RECOVER G-CSF Randomized Trial in 
Patients With Large Myocardial Infarction## 829-7·207A
Financial Barriers to Health Care and Recovery After Acute 
Myocardial Infarction: A Prospective Registry Evaluating 
Myocardial Infarction: Event and Recovery (PREMIER) 
Study##923-153·253A
Following Acute Myocardial Infarction, Myocardial 
Restraint With a Nitinol Wrap Reduces Left Ventricular 
Dyssynchrony##1008-56·77A
Fondaparinux Is Associated With Substantially Less Major 
Bleeding and Vascular Access Site Complications 
Compared With Enoxaparin in Patients With Acute 
Coronary Syndrome Undergoing Percutaneous Coronary 
Intervention: Insights from the OASIS 5 Trial## 821-
5·205A
Fondaparinux Is Associated With Substantially Less Major 
Bleeding and Vascular Access Site Complications 
Compared With Enoxaparin in Patients With Acute 
Coronary Syndrome Undergoing Percutaneous Coronary 
Intervention: Insights from the OASIS 5 Trial## 821-
5·205A
Gender and Racial Differences in Invasive Diagnostic and 
Interventional Cardiac Procedures in the Management 
of Acute Myocardial Infarction: 15-Year Trends in a 
Statewide Database##904-230·161A
Gender Differences in Non-ST-Elevation Acute Coronary 
Syndromes##953-243·186A
Ghrelin Protects Myocardium Against Ischemia/Reperfusion 
Injury via Inhibiting Myocardial Apoptosis##937-
195·308A
Health Status and Clinical Outcomes After Myocardial 
Infarction at One-Year: A Comparison Between Patients 
Hospitalized With ST-Elevation Versus Non-ST-Elevation 
Myocardial Infarction##946-155·256A
Hospitalization Costs of Tenecteplase-Facilitated Angioplasty 
Versus Thrombolysis-Alone in Acute Myocardial 
Infarction##929-239·174A
Human Umbilical Cord Blood Cells Improve Cardiac Function 
After Myocardial Infarction##1020-241·227A
Human Umbilical Cord Mononuclear Cells (HUCMC) Improve 
Left Ventricular Function and Reduce Infarct Size in a 
Mouse Model of Myocardial Infarction##941-51·45A
Impact of Age on the Outcome of Fibrinolytic Therapy for 
ST-Segment Elevation Myocardial Infarction: A Meta-
analysis of a Decade of Trials##904-223·159A
Impact of Combination Evidence-based Medical Therapy on 
Mortality Following Myocardial Infarction in Patients 
With and Without Renal Dysfunction##904-228·161A
Impact of Early Beta-Blocker Therapy for Acute Myocardial 
Infarction on In-Hospital Mortality## 857-7·235A
Impact of High HDL Cholesterol on Hospital and 1-Year-
Mortality of Patients With Acute Myocardial Infarction: 
Results of the ACOS Registry##996-232·213A
Impact of Mesenchymal Stem Cell Therapy on Scar 
Composition and Cardiac Regional Function##903-
220·159A
Impact of Reduced Glomerular Filtration Rate on Outcomes 
in Patients With ST-Segment Elevation Myocardial 
Infarction Undergoing Fibrinolysis in CLARITY-TIMI 
28##904-222·159A
Impact of Renal Dysfunction and Glucometabolic Status 
on One Year Mortality After Acute Myocardial 
Infarction##904-226·160A
Impact of Secondary Prevention Treatment With Atorvastatin, 
Simvastatin and Pravastatin After Acute Myocardial 
Infarction on One-Year Outcome in Current Clinical 
Practice: Results of Mitraplus##995-231·213A
Impact of Time to Presentation and Reperfusion Modality on 
the Efﬁcacy of Adenosine During Reperfusion Therapy 
for Acute Myocardial Infarction: The AMISTAD-2 
Trial##929-241·175A
Improved Outcomes After In-Hospital Revascularization 
in the Elderly and Very Elderly with High-Risk Non-
ST-Elevation Acute Coronary Syndromes. The Global 
Registry of Acute Coronary Events##923-151·252A
Incidence of, Predictors of, and Outcomes Related to 
Discontinuation of Thienopyridine Therapy at 1-Month 
After Coronary Stenting in AMI## 857-8·236A
Increased Bleeding Risk in Fibrinolytic Treatment of STEMI-
Register of Information and Knowledge About Swedish 
Heart Intensive Care Admissions (RIKS-HIA) 2002-
2004##904-225·160A
Increased In-Stent Neo-Intimal Hyperplasia after Stem Cell 
Mobilization by Granulocyte-Colony Stimulating Factor 
in Bare Stent, but Not in Drug-Eluting Stent in a Porcine 
Myocardial Infarct Model##1020-250·229A
Increasing Occurrence of Multivessel Intervention and 
Multiple Stent Placement From 1999 to 2004. The Global 
Registry of Acute Coronary Events##990-150·261A
Index of Microcirculatory Resistance: A Novel Measure for 
Predicting Myocardial Damage in Patients with Acute 
Myocardial Infarction##951-224·182A
Inhibition of Serine Protease Activity at Reperfusion Reduces 
Postischemic Injury in a Closed-Chest Model of Acute 
Myocardial Infarction##927-221·170A
Initial Heart Rate and Systolic Blood Pressure Provides 
Important Insights in the Risk-Stratiﬁcation of Age-related 
Mortality Among Patients Presenting With Cardiogenic 
Shock and Acute ST-Elevation Myocardial Infarction 
Treated With Fibrinolysis##931-251·177A
Intracoronary Streptokinase Infusion Just Following 
Primary Percutaneous Coronary Intervention Improves 
Microvascular Perfusion and Integrity in Patients With 
Acute Myocardial Infacrtion##929-237·174A
Is There Additional Beneﬁt of Intracoronary Transplantation of 
Autologous Peripheral Blood Stem Cell in Patients With 
Acute Myocardial Infarction?##1020-248·229A
Isolation and Characterization Cardiac Progenitor Cells 
from Human Adipose Tissue Derived Stem Cells Using 
Lentiviral Cardiac Promoter/Marker Expression##941-
50·45A
Late Clinical Outcomes With Aspirin, Coumadin or Both 
After Acute Coronary Syndromes (Late Outcomes of the 
ASPECT-2 Trial)##999-259·219A
Living Alone and Atypical Clinical Presentation Are 
Associated With Higher Mortality in Patients With all 
Components of the Acute Coronary Syndrome##953-
244·186A
Long Distance Transfer for Direct Percutaneous Coronary 
Intervention: A Facilitated Approach##929-238·174A
Long-Term Follow-Up Patients with ST-Segment Elevation 
Acute Myocardial Infarction Treated with Sirolimus-
Eluting Stent and Paclitaxel-Eluting Stent##976-
255·202A
Long-Term Mortality and Changing Cause of Death in Patients 
With Acute Myocardial Infarction in New Jersey 1986-
1998##1021-254·230A
Long-term Mortality Reasons and Predictors in Primary 
Coronary Angioplasty Population##973-237·198A
Low Dose Pioglitazone Does Not Adversely Affect Left 
Ventricular Remodeling After Primary PCI in Patients 
With Acute Myocardial Infarction and With Type 2 
Diabetes Mellitus or Impaired Glucose Tolerance##964-
56·56A
Lower Mortality With Paramedics Interpreting the 
Electrocardiogram Coupled to Primary Percutaneous 
Angioplasty for ST-Segment Elevation Myocardial 
Infarction## 815-7·193A
Mayo Clinic Fast Track Protocol for ST-Elevation Myocardial 
Infarction: Process Improvements to Minimize Treatment 
Delays## 847-7·268A
Mesenchymal Stem Cells Improve Cardiac Function in a Rat 
Model of Myocardial Infarction Through a Mechanism 
Independent of Increasing Muscle Mass or Limiting 
Myocardial Infarct Size## 814-4·191A
Microvascular Flow and Myocardial Perfusion After Acute MI 
Angioplasty in Anterior Versus Non-Anterior Infarcts: 
Results From the EMERALD Trial## 843-4·220A
Minimising Door to Balloon Times and Day/Night Variation 
in Primary Percutaneous Coronary Angioplasty With 
Ambulance Triage, and Direct Transfer to the Cardiac 
Catheterisation Laboratory##973-238·198A
Natural Catastrophic Events Are Associated With 
Increased Incidence and Severity of Acute Coronary 
Syndromes##928-223·171A
Nicorandil Can Affect Left Ventricular Geometry at the 
Chronic Phase of Myocardial Infarction: Assessment With 
ECG-gated Myocardial Perfusion Imaging## 926-4·105A
On-site PCI Versus PCI After Transfer in Rural Germany: 
Network Logistics for Patients With ST-Elevation 
Myocardial Infarction (STEMI)##1021-256·231A
One Day Kinetics of Bone Marrow Mononuclear Cells in 
Acute and Chronic Myocardial Infarction: Transient 
Myocardial Homing or Persistent Engraftment After 
Intracoronary Injections in Human?## 829-6·206A
PET Imaging of Peripheral Stem Cell Homing After 
Intracoronary Transfer in Patients Following Acute 
Myocardial Infarction## 829-5·206A
PET Imaging of Peripheral Stem Cell Homing After 
Intracoronary Transfer in Patients Following Acute 
Myocardial Infarction## 829-5·206A
Practice Makes Perfect: ACC/AHA Guideline Adherence 
Is Higher in Hospitals With High Acute Myocardial 
Infarction Volume##946-150·255A
Predictive Value on Mortality of Stress Hyperglycaemia 
in Patients With Acute Myocardial Infarction##996-
238·215A
Primary Percutaneous Coronary Intervention for Acute 
Myocardial Infarction in Women Versus Men 1995-
2004##952-235·184A
Protection of Distal Embolization in High-Risk Patients 
With Acute ST-Segment Elevation Myocardial 
Infarction##952-241·186A
R Wave Frontal Plane Right Axis Deviation on the Admission 
Electrocardiogram in Patients With Acute Myocardial 
Infarction: A Strong Independent Predictor of Increased 
Mortality Both In-Hospital and in Early Follow-up##973-
233·197A
Randomized Trial of Sirolimus- Versus Paclitaxel-Eluting 
Stents for the Treatment of Acute ST-Elevation 
Myocardial Infarction##952-232·184A
Relationship Between Microvascular Injury and Degree of 
ST-Segment Elevation Before Percutaneous Coronary 
Intervention##973-241·199A
Relationship Between White Cell Count, Blood Sugar Level 
and Mortality in Acute Coronary Syndromes. The Global 
Registry of Acute Coronary Events##990-148·261A
Renal Dysfunction Negates the Beneﬁt of Primary 
Percutaneous Coronary Intervention Over Fibrinolytic 
Therapy in the Treatment of ST Segment Elevation 
Myocardial Infarction##904-227·160A
Renin-Angiotensin-Aldosterone System Antagonism Decreases 
the Incidence of Ventricular Dysrrhythmias Following 
Myocardial Infarction: Lessons From GUSTO-V##996-
240·215A
Rescue Percutaneous Coronary Intervention After Failed 
Fibrinolysis: A Meta-Analysis of Randomized Controlled 
Trials##929-234·173A
Routine Percutaneous Coronary Intervention in Elderly 
Patients With Cardiogenic Shock Complicating Acute 
Myocardial Infarction##952-236·185A
Sex Differences in the Efﬁcacy of Statins in Patients After 
Acute Myocardial Infarction##996-236·214A
Short- and Long-Term Prognosis of First Acute ST-Segment 
Elevation Myocardial Infarction in Older Women. The 
PPRIMM75 Registry##928-230·172A
Signiﬁcance of Calciﬁed and Non Calciﬁed Plaques of 
Coronary Arteries for Presence of Myocardial Infarction 
Evaluated by Multislice Computed Tomography## 970-
43·131A
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Similar Hospital Mortality for Diabetics With NSTEMI as 
for Non-diabetics With STEMI: Results of the Acos 
Registry##1019-237·226A
Similar Mortality After Prehospital Thrombolysis or 
Primary PCI in Patients With ST-Elevation Myocardial 
Infarction Diagnosed in the Prehospital Phase. Results of 
PREMIR##952-234·184A
Socioeconomic Differences in Use of Secondary Preventive 
Medication After Myocardial Infarction: A National 
Population-Based Study##1020-249·229A
Stromal Cell-Derived Factor-1 Stimulates the Survival and 
Proliferation of Sca-1+ Mesenchymal Stem Cells Derived 
From Mouse Bone Marrow##994-217·210A
Strong Impact of Mechanical Coronary Intervention on 
Cardiac Rupture After Acute Myocardial Infarction: The 
Kochi Acute Myocardial Infarction (KAMI) Study##952-
238·185A
Temporal Trends in the Evaluation of Ejection Fraction in 
Patients Hospitalized With Acute Myocardial Infarction: 
Insights From the Worcester Heart Attack Study##973-
240·199A
TGF-β1 Enhances Cardiomyogenic Differentiation Potential of 
Adult Primitive Cells##903-217·158A
The Changing Characteristics and In-Hospital Mortality 
of Acute Myocardial Infarction in New Jersey 1986-
2002##928-227·172A
The Deleterious Impact of Blood Transfusion on Mortality in 
Patients With ST-Elevation Myocardial Infarction##973-
234·198A
The Efﬁcacy and Safety of Combination Therapy Facilitated 
Angioplasty for ST-Elevation Myocardial Infarction: A Meta-
analysis of Randomized Clinical Trials##929-233·173A
The Impact of Inpatient Quality of Care on Socioeconomic 
Disparities in Outcomes from Acute Myocardial 
Infarction## 811-7·257A
The Impact of the Thrombus Aspiration on the Final TIMI 
Flow in Patients with ST-Elevation Myocardial Infarction 
(STEMI)##952-240·185A
The MITRA-Score: A New Score for the Quality of Care 
in Patients With Acute ST Elevation Myocardial 
Infarction##973-232·197A
The Relationship Between Health Insurance and Long-Term 
Health Status Among Acute Myocardial Infarction 
Survivors: Results From the PREMIER Registry##946-
154·256A
The SAMU Network Minimizes Treatment Delays for ST-
Elevation Myocardial Infarction: Insights From a Three-
Year Registry##973-239·199A
The TIMI Risk Index for Myocardial Infarction Predicts 
Post-MI LV Ejection Fraction: A CLARITY - TIMI 28 
Substudy##1018-228·224A
Therapeutic Potential of Human Unrestricted Somatic Stem 
Cells Isolated from Placental Cord Blood for Concurrent 
Cardiomyogenesis and Vasculogenesis With Functional 
Regenerative Recovery Post Myocardial Infarction## 
814-6·191A
Tracking of Intra-Coronary Delivered Mesenchymal Stem 
Cells Using Magnetic Resonance Imaging in a Porcine 
Model of Myocardial Infarction##903-218·158A
Unfractionated and Low-Molecular-Weight Heparin as 
Adjuncts to Thrombolysis in Aspirin-Treated Patients 
With ST-Elevation Acute Myocardial Infarction: A Meta-
Analysis of the Randomized Trials##1020-247·228A
Usefulness of a New Risk Score to Identify Patients With Non-
ST-Segment Elevation Acute Coronary Syndromes Who 
Beneﬁt From an Invasive Treatment Strategy##1018-
224·223A
Vascular Endothelium Growth Factor-165 Gene Therapy 
Increases Left Ventricular Mass and Decreases Wall 
Thinning in Reperfused Myocardial Infarction## 856-
3·233A
Myocardial stunning
Abnormal Radial Strain in Both Infarcted and Remote 
Myocardial Regions Following Ischemia and Reperfusion 
in Rats Assessed by 2D Strain Echocardiography##971-
221·195A
Can the Electrocardiogram Distinguish Stress (Tako-Tsubo) 
Cardiomyopathy from Acute Anterior Myocardial 
Infarction?##1009-100·81A
Parameters of Cardiac Dyssynchrony Can Predict Chronic 
Phase Cardiac Function After Acute Myocardial 
Infarction: A Real-Time 3D Echocardiography Study## 
991-36·139A
Spontaneous Evolution of Viability Indexes After Reperfused 
Myocardial Infarction. Implications on the Prediction of 
Late Systolic Function## 993-16·145A
Myocarditis
High Frequency of Anti-heart Autoantibodies in Acute 
Myocardial Infarction With Angiographically Normal 
Coronary Arteries: Evidence for Undiagnosed Immune-
mediated Myocarditis##987-104·71A
MRI for Diagnosis of Myocarditis by Global and Delayed 
Enhancement Techniques: Added Value to Diagnose 
Unsuspected Coronary Disease##1033-103·90A
Myocardium
Activation of Focal Adhesion Kinase and Neuronal Nitric 
Oxide Synthase in Right Ventricular Myocardium of Rats 
With Right-sided Congestive Heart Failure##985-49·64A
Enhancement of Cardiac Rotation as a Possible Mechanism 
of During Dobutamine Stress Echocardiography: A 
Compensatory Mechanism for Decreased Myocardial 
Strain Under Tachycardia?## 948-29·120A
Is There Additional Beneﬁt of Intracoronary Transplantation of 
Autologous Peripheral Blood Stem Cell in Patients With 
Acute Myocardial Infarction?##1020-248·229A
Novel Injectable Alginate Biomaterial Attenuates Progressive 
Infarct Expansion and Preserves Left Ventricular Systolic 
and Diastolic Function Late after Myocardial Infarction## 
820-5·73A
Torsion Deﬁned by Strain Imaging Facilitates Deﬁnition of 
LV Segmental Dysfunction in Experimental Myocardial 
Infarction## 925-46·104A
Myoglobin
Mobilization of Bone Marrow Mesenchymal Stem Cells 
in Response to Myocardial Ischemia Depends on the 
Duration of the Coronary Occlusion and Reperfusion in 
Pig Myocardial Infarction Model##994-218·210A
Myosin
Mutations in the Genes for Sarcomeric Proteins in Japanese 
Patients With Elderly-Onset Sporadic Hypertrophic 
Cardiomyopathy##965-101·59A
Natriuretic peptides, atrial
A Simple Multi-biomarker Model Does Not Predict Outcomes 
Better Than Single Biomarkers in Heart Failure##1032-
95·89A
Acute Changes in N-terminal pro-Brain Natriuretic Peptide 
Induced by Dobutamine Stress Echocardiography## 
948-45·124A
Acute Effect of Continuous Positive Airway Pressure on 
Nocturnal Variation of Atrial Natriuretic Peptide 
Levels in Heart Failure Patients with Obstructive Sleep 
Apnea##964-91·57A
Alternate BNP Forms in Preclinical Ventricular Dysfunction or 
Overt Heart Failure##986-56·66A
Audioelectric Parameters are Superior to BNP for Detecting 
Hemodynamic Evidence of Heart Failure##986-90·67A
Beta Adrenergic Blockers Reduce the Risk of Mortality 
Associated with Elevated Troponin T in Patients with 
Acutely Decompensated Congestive Heart Failure##1032-
53·85A
Brain Natriuretic Peptide Gene Polymorphism (C+171A) 
Is Associated With the Presence of Left Ventricular 
Hypertrophy## 835-5·342A
C-reactive Protein Concentrations at Emergency Department 
Presentation Strongly Predict One Year Mortality in 
Dyspneic Patients##986-89·67A
Changes in Doppler Tissue Indices Are More Related With 
Improvement of Functional Status in Diastolic Heart 
Failure Than BNP Levels##942-99·49A
Chronic Therapy with Selective Electric Vagus Nerve 
Stimulation Normalizes Plasma Concentration of Tissue 
Necrosis Factor-α, Interleukin-6 and B-Type Natriuretic 
Peptide in Dogs with Heart Failure##1008-57·77A
Coadministration of the V2 Receptor Antagonist Tolvaptan and 
B-Type Natriuretic Peptide Enhances Water and Sodium 
Excretion Without Adversely Affecting Renal Function: A 
Physiologic Approach to Sodium and Water Retention in 
Experimental Heart Failure##913-199·297A
Continuous Brain Natriuretic Peptide Infusion Preserves 
Systolic Function After Myocardial Ischemia and Prevents 
Ventricular Remodeling in Conscious Dogs##1032-
98·89A
Diagnostic Utility of NT-proBNP in the Evaluation of 
Congestive Heart Failure in the Emergency Department in 
Elderly Patients with Multiple Cardiac Morbidities##986-
97·69A
Does African American or Caucasian Race Impact Use of 
B-Type Natriuretic Peptide and N-Terminal proBNP for 
Diagnosis of Decompensated Heart Failure and Predicting 
Mortality?##1032-92·88A
Enhanced Expression of Natriuretic Peptide Receptors in 
Accumulated Neutrophils and Macrophages at the 
Sites of Coronary Unstable Plaques in Acute Coronary 
Syndromes##972-223·195A
How Much Reduction is Needed in BNP Levels to Reduce 
Future Clinical Events with Treatment During 
Hospitalization for Heart Failure?## 819-7·72A
Impact of Increased Body Mass Index on Use of B-Type 
Natriuretic Peptide and N-Terminal proBNP for Diagnosis 
of Decompensated Heart Failure and Prediction of All-
Cause Mortality##1032-93·88A
Insights Into the Change in Brain Natriuretic Peptide After ST-
Elevation Myocardial Infarction: Why Should it Be Better 
Than Baseline Brain Natriuretic Peptide?##973-236·198A
Intra-Renal Infusion of BNP: A Novel Strategy to Overcome 
the Renal Resistance to BNP in Severe Experimental 
Heart Failure## 820-3·73A
N-terminal ProBNP is not Only Related to the Severity of 
Heart Failure##986-93·68A
Obesity Has No Effect on the Sensitivity Of NT-ProBNP 
for Detection of Systolic and Diastolic Dysfunction: 
Results From the ProBNP Investigation of Dyspnea in 
the Emergency Department (PRIDE) Echocardiography 
Substudy## 902-2·94A
Paradoxical Decrease in Plasma N-Terminal-proBNP (NT-
proBNP) Levels in Patients Receiving Doxorubicin 
Chemotherapy and Declining Left Ventricular Ejection 
Fraction##986-57·66A
Patterns of Brain Natriuretic Peptide Utilization for Risk 
Stratiﬁcation of Patients With Non-ST-Segment Elevation 
Acute Coronary Syndromes##1019-240·227A
Prognosis Value of Brain Natriuretic Peptide Kinetics During 
Cardiopulmonary Exercise Test in Chronic Heart Failure 
Patients##986-92·68A
Prognostic Value of N-terminal Pro B-type Natriuretic Peptide 
(NT-proBNP) in Conservatively Treated Patients With 
Valvular Aortic Stenosis##1030-20·286A
Rapid and Sustained Reductions of Plasma B-Type 
Natriuretic Peptide Concentrations in Patients with 
Acutely Decompensated Heart Failure Treated with 
Levosimendan: The REVIVE II Study##1032-57·86A
Short-Term and Long-Term Mortality With Nesiritide for 
Decompensated Heart Failure: A Meta-Analysis of 
Randomized Controlled Trials## 837-6·83A
Superior Renin-Angiotensin-Aldosterone System (RAAS) 
Inhibiting Properties of a Novel Long-Acting ANP 
Designer Peptide Compared to Native ANP in Normal 
Dogs##919-94·41A
The Utility of Aminoterminal Pro-B-type Natriuretic Peptide 
for the Detection of Preclinical Systolic and Diastolic 
Dysfunction in the Community##942-89·47A
There is Nothing Grey About It: Dyspnea with Intermediate 
Aminoterminal Pro-B Type Natriuretic Peptide 
Concentrations##986-91·67A
Tissue Doppler Imaging Predicts NYHA Functional Class 
and Plasma BNP Levels in Patients With Hypertrophic 
Cardiomyopathy## 948-1·116A
Use of N-Terminal-pro-Brain Natriuretic Peptide as a 
Diagnostic and Prognostic Marker for Ischemic Heart 
Disease in Patients Presenting to a Rapid Access Chest 
Pain Clinic##1005-199·352A
Nitrates/nitroglycerin
Impaired Nitrate-Mediated Dilatation Could Reﬂect 
Nitrate Tolerance and Predicted Need of 
Revascularization##1000-159·343A
Reduction of Nitrite to Nitric Oxide in Ischemic Heart 
Is Catalyzed by Distinct Blood-Borne and Tissue 
Elements##994-221·211A
Nitric oxide
5-Methyl-Tetrahydrofolic Acid Rapidly Improves Endothelial 
Function and Superoxide Production in Human 
Atherosclerosis: Effects on Tetrahydrobiopterin-
Dependent eNOS Coupling## 841-4·356A
Absence of Correlation Between Lipid-Lowering Effects 
and Impacts on Progressive Insulin Resistance in Statin 
Treatment of a Type-2 Diabetes Model##937-194·308A
Activation of Focal Adhesion Kinase and Neuronal Nitric 
Oxide Synthase in Right Ventricular Myocardium of Rats 
With Right-sided Congestive Heart Failure##985-49·64A
Aldose Reductase Inhibitor Improves the Deterioration 
of Shear Induced Nitric Oxide Production by High 
Glucose##977-168·330A
Amiodarone and its Metabolite, N-desethylamiodarone, 
Enhance Endothelial Nitric Oxide Production in Human 
Endothelial Cells##937-197·309A
Anti-Thrombotic Properties of A Novel Nitric Oxide Donor 
(LA-419) in a Human Model of Thrombosis##908-
172·290A
Augmented Nitric Oxide Release in the Coronary Circulation 
Parallels Myocardial Metabolic Stress in Patients with 
Dilated Cardiomyopathy##1033-104·91A
Effects of Nitric Oxide Donor, Molsidomine, on 
Blood Pressure in Patients With Isolated Systolic 
Hypertension##1027-192·371A
Endothelial Nitric Oxide Synthase Glu298asp Gene 
Polymorphism Is Associated With Hypertensive 
Response to Exercise in Well-controlled Hypertensive 
Patients##960-196·325A
Impaired Nitric Oxide Mediated Vasodilation in Women With 
Chest Pain and Normal Angiograms##930-245·175A
Investigation of Genetic and Biochemical Determinants 
of Depressed L-Arginine Transport in Human 
Hypertension##960-194·324A
Nitroxyl Increases Contractility in Failing (Gαq 
Overexpressing) Cardiomyocytes That Display Altered 
Cellular Redox Conditions##985-48·64A
Outcomes by Gender in the African-American Heart Failure 
Trial (A-HeFT)## 837-8·84A
Oxidative Stress Within the Coronary Circulation Is 
Associated With Reduction in Endothelium-Dependent 
Coronary Vasodilation in Patients With Acute Coronary 
Syndromes.##972-225·196A
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PPAR-γ Agonist Improves Endothelial Function in Patients 
With Metabolic Syndrome: Pivotal Role of NOx and 
Inﬂammation## 841-6·356A
Reduction of Nitrite to Nitric Oxide in Ischemic Heart 
Is Catalyzed by Distinct Blood-Borne and Tissue 
Elements##994-221·211A
Role of Inducible NO in Sepsis Related Hemodynamic 
Impairment Assessed by High-frequency 
Echocardiography in a Murine Model##1031-51·85A
Sildenaﬁl Enhances Angiogenesis After Mice Hindlimb 
Ischemia##909-175·291A
Tetrahydrobiopterin: A Novel Anti-hypertensive 
Therapy##1027-194·371A
The Betareceptor Blocker Nebivolol Inhibits Angiotensin 
II-Induced Aortic and Cardiac Superoxide Formation 
and Expression and Activity of the Vascular NADPH 
Oxidase##1027-196·371A
Norepinephrine
Mechanisms of Chronotropic Incompetence in Patients With 
Congestive Heart Failure Taking Beta-blockers##919-
57·39A
The Efﬁcacy of Continuous Positive Airway Pressure in Non-
Obese Patients With Obstructive Sleep Apnea and Heart 
Failure##964-59·56A
Nutrition
Alimentary Lipemia Enhances Procoagulatory Effects 
of Inﬂammation in Patients With a History of Acute 
Myocardial Infarction Complicated by Ventricular 
Fibrillation##950-218·181A
Arachidonic Acid and Docosahexaenoic Acid Supplementation 
Increases Coronary Flow Velocity Reserve in Healthy 
Japanese Elderly Individuals##1024-175·367A
Effects of Mediterranean Diet or Supplements on Circulating 
Endothelial Progenitor Cells in Obesity##1000-165·345A
Obesity
Adiposity and Atherogenic Inﬂammatory Response to 
Endotoxin in Humans##937-193·308A
Can the Body Fat Composition Measurements Using Dual-
Energey X-ray Absorptiometry Predict Coronary Artery 
Disease in Both Sexes?##961-206·327A
Characteristics Predicting Successful Weight Reduction in 
Overweight and Obese Post Infarction Patients## 849-
4·362A
Contribution of Obesity to Elevated Blood Pressure in 
Uncomplicated Diabetics: 26-Year of Follow-Up 
Study##1004-197·352A
Differences in Health Awareness Knowledge, Environmental 
Tobacco Smoke Exposure (ETS), and Body-Shape 
Perception Among Adolescents Based Upon Body Mass 
Index (BMI)##1035-111·247A
Dysmetabolic Status, and Not Obesity Per Se, Is Associated 
With Increased Cardiovascular Mortality in Patients With 
Stable Coronary Disease##939-208·311A
Effect of Bariatric Surgery on Cardiovascular Risk Factors and 
Predicted Effect on Cardiovascular Events and Mortality 
in Class II-III Obesity## 842-8·358A
Effects of Isolated Obesity on Cardiac Functions: A Tissue 
Doppler and Strain Rate Imaging Study## 902-9·95A
Effects of Mediterranean Diet or Supplements on Circulating 
Endothelial Progenitor Cells in Obesity##1000-165·345A
Evidence Refuting the Obesity Paradox: Weight Loss 
Regardless of Obesity and Independent of Volume Status 
Predicts Outcome in Heart Failure Patients##964-95·58A
Exercise Capacity but Not BMI Is Associated With Mortality 
in Patients Referred for Exercise Myocardial Perfusion 
Imaging## 1017-31·156A
Impact of Increased Body Mass Index on Use of B-Type 
Natriuretic Peptide and N-Terminal proBNP for Diagnosis 
of Decompensated Heart Failure and Prediction of All-
Cause Mortality##1032-93·88A
Improved LV Relaxation Measured by Tissue Doppler 2 Years 
After Gastric Bypass Surgery##942-91·48A
Improved Risk Stratiﬁcation in Primary Prevention by 
Utilizing the Impact of Life Style Factors for the 
Calculation of Cardiovascular Risk in Three Different 
Scoring Systems##1036-148·269A
Inﬂuence of Blood Pressure Versus Overweight/Obesity 
on Biomarkers of Vascular Health in Postmenopausal 
Women##915-214·300A
Insulin Resistance is a Determinant of Myocardial Dysfunction 
in Apparently Healthy Obese Subjects##964-54·55A
Job-Strain Induced Workplace Hypertension Is Associated 
With Obesity and High Normal Blood Pressures at the 
Physical Checkup##1004-191·350A
Lipoprotein Subclasses, Hydroxy Fatty Acids, and the 
Inﬂammatory Response in Metabolic Syndrome 
Patients##914-205·298A
Moderate Weight Loss Decreases Heart Rate and Myocardial 
Oxygen Consumption and Cardiac Work in Obese Men 
and Women## 926-5·105A
N-terminal ProBNP is not Only Related to the Severity of 
Heart Failure##986-93·68A
Obesity and the Metabolic Syndrome are Associated With 
Improved Survival in the Heart Failure Population##964-
57·56A
Obesity Has No Effect on the Sensitivity Of NT-ProBNP 
for Detection of Systolic and Diastolic Dysfunction: 
Results From the ProBNP Investigation of Dyspnea in 
the Emergency Department (PRIDE) Echocardiography 
Substudy## 902-2·94A
Obesity Increases the Risk of Conversion of Paroxysmal 
to Chronic Atrial Fibrillation: Data From a 21-Year 
Community-Based Study## 849-7·363A
Obesity is Independently Associated With Increased 
Ventricular Systolic Tension: A Population-Based 
Study##982-199·336A
Obesity is Prevalent, and is a Signiﬁcant Additional 
Comorbidity in Children With Congenital and Acquired 
Heart Disease## 840-8·246A
Oxidative Stress Is a Mechanism Underlying the Obesity 
Related Risk of Atherosclerosis in Healthy Adults##935-
183·306A
Predictors of Sudden Cardiac Death in a Population With High 
Prevalences of Obesity and Diabetes: The Strong Heart 
Study##961-207·327A
Prognostic Value of Rubidium-82 Perfusion Positron Emission 
Tomography in Patients with Obesity## 812-7·115A
Regression of Left Ventricular Hypertrophy in Morbidly Obese 
Women Who Undergo Rapid Weight Loss: A Prospective 
Cardiovascular Magnetic Resonance (CMR) Imaging 
Study## 993-11·144A
Sex Differences in the Inﬂammatory Response to Leptin: 
Results From the Dallas Heart Study##959-188·323A
Symptomatic Obese Patients Undergoing 64-Slice Multi 
Detector Computed Tomography Are Younger and Have 
Lower Prevalence of Signiﬁcant Coronary Stenosis## 
970-9·126A
The Efﬁcacy of Continuous Positive Airway Pressure in Non-
Obese Patients With Obstructive Sleep Apnea and Heart 
Failure##964-59·56A
The Impact of Changes in Insulin Resistance After PCI on 
Lumen Narrowing##954-254·189A
Waist Circumference and Body Mass Index Are Both 
Independently Associated With Cardiovascular Disease. 
The International Day for the Evaluation of Abdominal 
Obesity (IDEA) Survey## 842-6·358A
Which Is the Best Predictor of Cardiovascular Events: 
Body Mass Index, Waist-to-hip Ratio, or Waist 
Circumference?##961-204·327A
Outcomes assessment
A Comprehensive Approach to the Development of Risk 
Adjustment Models for Fatal and Non Fatal Outcomes 
Following Contemporary PCI: A Report From the 
Blue Cross Blue Shield of Michigan Cardiovascular 
Consortium##923-150·252A
A Simple Multi-biomarker Model Does Not Predict Outcomes 
Better Than Single Biomarkers in Heart Failure##1032-
95·89A
A Small Pericardial Effusion is a Marker of Shortened 
Survival## 902-13·96A
After Adjustment for Confounding Variables, Treatment With 
Statin Therapy at Baseline but Not Low LDL-cholesterol 
Levels Results in Better Two-Year Outcome in Patients 
With Established Angiographic Coronary Disease##1026-
186·369A
Aldosterone Synthase Promoter Polymorphism Modulates 
Outcome In Black Patients With Heart Failure: Results 
From the A-HeFT Trial## 819-5·72A
An Insight From the National Registry of Myocardial 
Infarction on the Outcome of Elderly Patients with 
Cardiogenic Shock Complicating Acute Myocardial 
Infarction in the Modern Era##904-231·161A
Atrial septal Aneurysm Predicts Persistent Residual Shunt 
Following PFO Closure With CardioSEAL/STARFlex 
Occluder Device## 1017-3·152A
Beta 1 Adrenergic Receptor Gly389Arg Polymorphism and 
the Impact of Fixed-Dose Combination of Isosorbide 
Dinitrate/Hydralazine in Heart Failure: Results From the 
A-HeFT trial##986-60·67A
Bleeding Complications Predict Major Cardiovascular 
Outcomes in Non ST-Elevation Acute Coronary 
Syndromes: Results From the OASIS - 5 Trial##972-
224·195A
C-reactive Protein Concentrations at Emergency Department 
Presentation Strongly Predict One Year Mortality in 
Dyspneic Patients##986-89·67A
Can An Assessment of Subjective Well Being Predict 
Outcomes in Patients with Hypertension and Coronary 
Artery Disease? A Report from the INternational 
VErapamil-SR/Trandolapril Study (INVEST)##915-
212·300A
Can Nornal Myocardial Perfusion During Dobutamine Stress 
Echocardiography Predict a Good Long Term Prognosis 
in Women?## 1016-45·152A
Cardiovascular Events in Clinical Trials Involving Over 41,000 
Patients Evaluating the Cyclooxygenase-2 Inhibitor 
Celecoxib##1029-209·374A
CV Knowledge and Risk Perceptions Among Underserved 
Individuals at Increased Risk for Cardiovascular 
Disease## 834-4·263A
Death Causes in Hospitalized Heart Failure Patients With 
Preserved and Depressed Left Ventricular Systolic 
Function##1032-89·87A
Decision Support for Coronary Revascularization##1013-
146·266A
Depression Is Not Associated With Long-Term Mortality in 
a Representative Patient Population With Myocardial 
Infarction##974-244·200A
Despite Greater Co-Morbidities, Diabetes Does not Increase 
60-Day or 1-Year Post Stroke Mortality##961-208·327A
Distal Protection Devices During Percutaneous Coronary 
Intervention Are Effective in Reducing Death or 
Recurrent Myocardial Infarction in Saphenous Vein 
Grafts but Not in Acute Myocardial Infarction: A Meta-
analysis##923-148·251A
Effect of CKMB Elevation After Successful PCI on One-Year 
Mortality##971-220·194A
Effects of Left Ventricular Assist Devices With Different Flow 
Characteristics on Vasopressin Levels##988-105·71A
Effects of Perindopril on Cardiac Events in Revascularized 
Coronary Artery Disease Patients##999-251·218A
Elevated Right Atrial Pressure After Heart Transplantation Is 
Associated With Increased Long Term Mortality##990-
154·262A
Ethnic Differences in the Prognostic Value of Coronary Artery 
Calciﬁcation: Data from an Observational Cohort of 
14,812 Patients## 970-33·129A
Evidence Refuting the Obesity Paradox: Weight Loss 
Regardless of Obesity and Independent of Volume Status 
Predicts Outcome in Heart Failure Patients##964-95·58A
Financial Barriers to Health Care and Recovery After Acute 
Myocardial Infarction: A Prospective Registry Evaluating 
Myocardial Infarction: Event and Recovery (PREMIER) 
Study##923-153·253A
Gender Differences in Hospital Survival Rates for Medicare 
Beneﬁciaries Undergoing CABG: Hospital Performance 
Rankings Matter##990-152·262A
HDL Not Predictive of Longevity or Cardiovascular Events 
in Older Adults: Findings From the EPESE Study##968-
145·258A
Health Status and Clinical Outcomes After Myocardial 
Infarction at One-Year: A Comparison Between Patients 
Hospitalized With ST-Elevation Versus Non-ST-Elevation 
Myocardial Infarction##946-155·256A
How Much Reduction is Needed in BNP Levels to Reduce 
Future Clinical Events with Treatment During 
Hospitalization for Heart Failure?## 819-7·72A
Impact of Early Beta-Blocker Therapy for Acute Myocardial 
Infarction on In-Hospital Mortality## 857-7·235A
Impact of Restrictive Access to Clopidogrel Following 
Coronary Stent Implantation on Patient Health 
Outcomes## 811-8·257A
Impaired Nitrate-Mediated Dilatation Could Reﬂect 
Nitrate Tolerance and Predicted Need of 
Revascularization##1000-159·343A
Implantable Cardioverter-Deﬁbrillator FDA Recalls and Safety 
Alerts: Prevalence and Impact on Patient Mortality## 
818-8·20A
Improved Outcomes After In-Hospital Revascularization 
in the Elderly and Very Elderly with High-Risk Non-
ST-Elevation Acute Coronary Syndromes. The Global 
Registry of Acute Coronary Events##923-151·252A
Incidence and Not Timing of Death or Myocardial Infarction 
Differ According to Risk in Patients With Non-ST 
Elevation Acute Coronary Syndromes: Implications for 
Long-Term Treatment and Follow-Up## 830-4·207A
Incidence of, Predictors of, and Outcomes Related to 
Discontinuation of Thienopyridine Therapy at 1-Month 
After Coronary Stenting in AMI## 857-8·236A
Initial Heart Rate and Systolic Blood Pressure Provides 
Important Insights in the Risk-Stratiﬁcation of Age-related 
Mortality Among Patients Presenting With Cardiogenic 
Shock and Acute ST-Elevation Myocardial Infarction 
Treated With Fibrinolysis##931-251·177A
Is Incidence in Arrhythmias Different in LVADs With 
Continuous Versus Pulsatile Flow?##988-106·71A
Long-Term Mortality and Changing Cause of Death in Patients 
With Acute Myocardial Infarction in New Jersey 1986-
1998##1021-254·230A
Long-Term Prognosis of Patients With Isolate Myocardial 
Bridge##953-246·187A
Long-Term Result of Metabolic Syndrome with Patients 
Undergoing Coronary Artery Bypass Grafting##939-
207·311A
Loop Diuretic Dose Is Independently Associated With 
Increased Mortality in Advanced Heart Failure##919-
93·41A
Metabolic Syndrome Predicts Higher Cardiovascular Risk 
Independently of ECG Left Ventricular Hypertrophy: The 
LIFE Study## 848-3·360A
Modiﬁcation of a Simple Scoring System for Prediction of 
In-Hospital Mortality in Acute Coronary Syndromes: 
The Incremental Value of Cardiac Biomarkers in Risk 
Stratiﬁcation##1018-227·224A
Mortality, Cause of Death, and Coronary Endothelial Function 
During Long-Term Follow-Up Among Hypertensive 
African and Caucasian Americans## 841-5·356A
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Myocardial Infarction in Adolescents##1035-112·247A
Myocardial Infarction Presenting With Atypical Symptoms: 
Does the Absence of Chest Pain Predict Poor 
Outcomes?## 830-8·208A
Natural Catastrophic Events Are Associated With 
Increased Incidence and Severity of Acute Coronary 
Syndromes##928-223·171A
Natural History of Patients With Refractory Angina##1021-
255·231A
Outcome Of Prenatally Diagnosed Tricuspid Atresia: A 
Multicenter Experience##1035-114·248A
Outcomes in Cardiac Transplant Recipients Using Donor 
Allografts With Left Ventricular Hypertrophy##966-
105·60A
Paradoxical Increased Post Ischemic Stroke Mortality Among 
Whites in the Veteran Population:Does Access to Care 
Inﬂuence Outcomes?##916-251·166A
Partial False Lumen Thrombosis as a Predictor of Mortality 
in Patients with Type B Acute Aortic Dissection: 
Insights from The International Registry of Acute Aortic 
Dissection (IRAD)## 802-7·315A
Patient Knowledge and Statin Use##968-146·258A
Patient Satisfaction With a Home Based Program Designed to 
Treat Elderly Heart Failure Patients##1036-153·270A
Platelet Aspirin Resistance in an ED Population With 
Suspected Acute Coronary Syndromes##995-227·212A
Pregnancy Complications as Risk Factors for Cardiac-and All-
Cause Mortality##968-153·259A
Preoperative Exercise Capacity Predicts Survival and Persistent 
Symptoms After Surgery for Chronic Nonischemic Mitral 
Regurgitation##962-26·279A
Primary Percutaneous Coronary Intervention for Acute 
Myocardial Infarction in Women Versus Men 1995-
2004##952-235·184A
Relationship Between White Cell Count, Blood Sugar Level 
and Mortality in Acute Coronary Syndromes. The Global 
Registry of Acute Coronary Events##990-148·261A
Risk Assessment and Risk Reduction by Perindopril in Patients 
With Normal Left Ventricular Function or Previous 
Revascularization in the EUROPA study##1014-211·355A
Risk Assessment and Stratiﬁcation for Future Cardiac Events 
in Patients Admitted With Acute Coronary Syndrome 
Using a Novel Critical Pathway and Its Validation by 
Framingham Risk Score##916-253·167A
Symptomatic Obese Patients Undergoing 64-Slice Multi 
Detector Computed Tomography Are Younger and Have 
Lower Prevalence of Signiﬁcant Coronary Stenosis## 
970-9·126A
The Changing Characteristics and In-Hospital Mortality 
of Acute Myocardial Infarction in New Jersey 1986-
2002##928-227·172A
The Clinical Effectiveness of Clinical Practice Guidelines 
in Managing Acute Coronary Syndromes: A 10 Year 
Perspective##928-226·171A
The Cost-Effectiveness of Perindopril in Reducing 
Cardiovascular Events in Patients With Stable Coronary 
Artery Disease Using Data From the EUROPA 
Study##968-155·260A
The Effects of Statin Copayments and Statin Adherence on 
Medical Care Utilization and Expenditures## 834-5·263A
The Impact of Complete Revascularization on Long-
Term Outcomes in Elderly Patients With Coronary 
Artery Disease Undergoing Percutaneous Coronary 
Intervention##976-253·202A
The Impact of Medication Non-adherence on Hospitalization 
and Mortality Among Patients With Diabetes## 834-
7·264A
The Impact of Metabolic Syndrome and Diabetes on Long-
Term Outcomes Following Percutaneous Coronary 
Intervention##961-201·326A
The Impact of Reduced Left Ventricular Function on Long-
Term Outcomes in Diabetes Mellitus Patients With 
Coronary Artery Disease Undergoing Percutaneous 
Coronary Intervention##905-240·164A
The Independent and Combined Risks of Diabetes and Non-
Endstage Renal Impairment in Non ST-Segment Elevation 
Acute Coronary Syndromes## 830-3·207A
The Relationship Between Health Insurance and Long-Term 
Health Status Among Acute Myocardial Infarction 
Survivors: Results From the PREMIER Registry##946-
154·256A
Trends and Predictors of Outcome in Circulatory Arrest for 
Adult Cardiac Surgery: A Decade of Experience (1996-
2005)##940-25·275A
Trends in Survival Following a Diagnosis of Heart Failure## 
837-3·82A
Use of N-Terminal-pro-Brain Natriuretic Peptide as a 
Diagnostic and Prognostic Marker for Ischemic Heart 
Disease in Patients Presenting to a Rapid Access Chest 
Pain Clinic##1005-199·352A
Using Reference Equations, Percent Predicted Value (PPV), for 
the Six-Minute Walk Test: A Better Indicator of Severity 
of Heart Failure Condition
.
##964-92·57A
Valve Type and Long Term Outcomes After Aortic Valve 
Replacement in Older Patients## 824-4·281A
Oxygen consumption
Abnormal Blood Pressure Response to Exercise and 
Oxygen Consumption in Patients With Hypertrophic 
Cardiomyopathy##920-103·43A
Baseline Systolic Blood Pressure Predicts Response to Cardiac 
Resynchronization Therapy in Heart Failure Patients## 
969-142·24A
Blunted Hemodynamic Response and Reduced Oxygen 
Delivery With Exercise in Anemic Heart Failure 
Patients##986-53·65A
Moderate Weight Loss Decreases Heart Rate and Myocardial 
Oxygen Consumption and Cardiac Work in Obese Men 
and Women## 926-5·105A
Pacemaker, artiﬁcial
Antibiotic Proﬁlaxis is Essential in Surgical Procedures of 
Cardiac Implantable Devices## 969-135·23A
Aviodance of Left Ventricular Dyssynchrony Detected by 
Tissue Doppler Echocardiogrphy by Permanent Right 
Ventricular Septal Pacing in Patients With High-Grade 
Avtrioventricular Block## 969-139·23A
Development of Venous Stenosis and Occlusion After 
Pacemaker Implantation## 969-134·23A
Incidence and Prognosis of Pacemaker Lead Associated 
Masses: A Study of 1569 Transesophageal 
Echocardiograms## 1017-6·153A
Possibility of Electrical Bridging over AV Groove by the 
Artiﬁcial Epicardiac Accessory Pathway in a Rat Model 
of Atrio-Ventricular Block## 826-5 ·25A
Pacing
3D Contraction Front Mapping: Initial Experience With a 
Novel 3D Echo Technique to Visualise Left Ventricular 
Mechanical Contraction## 991-37·139A
Biventricular Pacing Mode is Associated With a Higher 
Mortality Rate in Cardiac Resynchronization 
Therapy##1008-55·77A
Comparison of Reverse Ventricular Remodeling Between 
Surgical Direct Epicardial and Tranvenous Coronary 
Sinus Lead Placement for Cardiac Resynchronization 
Therapy## 1015-125·32A
Comparison of Various Dyssynchrony Parameters of 
Echocardiography in the Canine Model of Heart Failure 
With Dyssynchrony## 948-9·118A
Coronary Sinus Lead Extraction Is Safe Even With Prolonged 
Lead Inplant Duration## 969-133·22A
Effect of Different Cardiac Resynchronization Therapy 
Pacing Modalities on Ventricular Tachycardia/Ventricular 
Fibrillation Events in Heart Failure Patients## 947-
125·14A
Effects of Verapamil on the Short-Term Electrophysiological 
Remodeling of Superior Vena Cava in Human## 924-
137·8A
Evaluation of Left Ventricle Pressure Derivative Enhanced 
by Multi Site Pacing in Patients With Heart Failure## 
969-132·22A
Evolution of Left Ventricular Function in Pediatric Patients 
With Permanent Right Ventricular Pacing for Isolated 
Congenital Heart Block: A Medium Term Follow-Up## 
969-141·24A
High-Septal Pacing Reduces Electrical Remodeling and 
Arrhythmogeneity in the Chronic Atrioventricular Block 
Dog## 826-3·25A
Improvement of Obstructive Sleep Apnea in Heart Failure 
Patients After Cardiac Resynchronization##964-90·57A
Incidence of Left Ventricular Dysfunction After Pacemaker 
Implantation for Complete Heart Block## 969-126·21A
Lack of Association Between QRS Duration and Cardiac 
Asynchrony in Candidates for Cardiac Resynchronization 
Therapy## 969-143·24A
Selective Secretion of MMP-8 and -9 in the Coronary 
Circulation in Parallel with BNP in Human Heart Failure 
## 819-4·72A
Successful Direct Left Atrial Pressure Monitoring and Fossal 
Pacing via an Implantable HEARTPOD Device in Animal 
Models##1008-60·78A
Patent foramen ovale
Assessment of the Markers of Platelet and Coagulation 
Activation Following Transcatheter Closure of 
Patent Foramen Ovale in Patients with Cryptogenic 
Stroke##945-115·240A
Novel Non-Implant Radiofrequency Energy Catheter Closure 
of Patent Foramen Ovale in Swine## 852-4·249A
PFO Closure With the Amplatzer, CardioSEAL-STARﬂex and 




-Adrenergic cAMP Signaling Is Uncoupled After Acute 
Treatment of Anthrax Lethal Toxin in Cardiomyocytes in 
Normal Rats##1032-99·89A
Comparative Pathologic Studies of Vascular Tissue Responses 
to Sirolimus-Eluting and Bare Metal Stent Implantation in 
Human Coronary Arteries##910-184·293A
Extraction of Latent, Computed Tomographic Images of 
Coronary Artery Plaque Components by Isotropic, Three-
Dimensional Wavelet Analysis## 970-29·128A
Mitral Annular Dilatation; Is It Active or Passive? A Cardiac 
MRI Study##971-219·194A
Pathological Analysis of the Culprit Lesions with Unique 
Intra Plaque Enhancement in Multislice Computed 
Tomography## 832-6·135A
Patient care
Achieving Rapid Myocardial Infarction Reperfusion 
With Percutaneous Coronary Intervention Remains a 
Challenge, Especially in Women, Elderly, and Minorities: 
Results From American Heart Association Get With the 
Guidelines## 815-8·193A
Device Erosions Are Not Associated With Systemic 
Infections## 969-136·23A
Effect of Enhanced External Counterpulsation on Erectile 
Dysfunction in Patients With Medically Refractory 
Angina##1022-218·232A
Enoxaparin Dosing and Bleeding in Real World Practice: 
Results From CRUSADE## 857-5·235A
Near Infra-red Spectroscopy is a Reliable Indicator of Systemic 
Perfusion for Unsedated Infants with Single Ventricle 
Physiology##989-109·242A
Patient Satisfaction With a Home Based Program Designed to 
Treat Elderly Heart Failure Patients##1036-153·270A
Patterns of Brain Natriuretic Peptide Utilization for Risk 
Stratiﬁcation of Patients With Non-ST-Segment Elevation 
Acute Coronary Syndromes##1019-240·227A
Prevalence and Predictors of Advance Directives in Patients in 
the Cardiac Care Unit##1036-155·271A
Sex-Related Differences in Non-Obstructive Coronary Artery 
Disease Among Patients With Non-ST-Segment Elevation 
Acute Coronary Syndromes: Results From the CRUSADE 
Quality Improvement Initiative##928-228·172A
The Association Between Hospital Guideline Adherence, 
Dosing Safety, and Patient Outcomes: Results From 
the CRUSADE Quality Improvement Initiative##946-
151·255A
Treatment and Outcomes of Acute Coronary Syndromes 
Among 5,577 Patients Aged ≥90 Years: Results 
From the CRUSADE National Quality Improvement 
Initiative##923-154·253A
What Aspects of Hospital Culture Inﬂuence Quality?## 811-
5·257A
Patterns of care in population
Are High-Risk Hypertensive Patients Prescribed Concomitant 
Statin Therapy? Prescription Patterns in Patients Initiating 
Antihypertensive Therapy in the United States##1021-
251·230A
Cardiology Specialty Care is Associated With Higher 
Quality Performance for Patients Admitted With Heart 
Failure##946-147·254A
Global Risk Factors and Treatment Intensity in Elderly Patients 
With Atherosclerosis: The Experience of the International 
REACH Registry##916-258·168A
Myocardial Infarction Presenting With Atypical Symptoms: 
Does the Absence of Chest Pain Predict Poor 
Outcomes?## 830-8·208A
The Clinical Effectiveness of Clinical Practice Guidelines 
in Managing Acute Coronary Syndromes: A 10 Year 
Perspective##928-226·171A
The Impact of Medication Non-adherence on Hospitalization 
and Mortality Among Patients With Diabetes## 834-
7·264A
The Relationship Between Health Insurance and Long-Term 
Health Status Among Acute Myocardial Infarction 
Survivors: Results From the PREMIER Registry##946-
154·256A
Pediatric cardiac surgery
A Novel Microaxial Venous Assist Device for Enhancing 
Pulmonary Flow and Reducing Venous Pressure Within 
the Total Cavopulmonary Connection: Computational 
Fluid Dynamics Studies##922-115·238A
Long-Term Outcomes of Patients With Tricuspid Atresia With 
Transposition or Normally Related Great Arteries##922-
110·237A
Mesenteric Regional Oximetry in Neonates Undergoing 
Cardiac Surgery: A New Assessment Methodology 
of Systemic Oxygen Delivery Using Near-Infared 
Spectroscopy##989-110·242A
Pulmonary Autograft Dilatation After Ross Procedure: 
Incidence of and Risk Factors##922-109·237A
Real-Time Three-Dimensional Echocardiography-guided 
Beating-heart Atrial Septal Defect Closure: The Next Step 
Toward Hybrid Procedures##922-111·237A
Right Ventricle to Pulmonary Artery Shunt Versus Modiﬁed 
Blalock-Taussig Shunt in Hypoplastic Left Heart 
Syndrome: Assessment and Outcome Through Stage 2 
Palliation##922-114·238A
Variant Coronary Artery Pattern and Ventricular Septal Defect 
Are Associated With Chronotropic Impairment Late After 
the Arterial Switch Operation##1035-115·248A
Pediatric cardiology
Acute Hemodynamic Effects of Right and Left Ventricular 
Pacing in the Normal Heart: Implications for Cardiac 
Pacing in Children##967-112·241A
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Atrial Septostomy Improves Survival in Primary Pulmonary 
Hypertension and Pulmonary Hypertension with 
Associated Congenital Heart Disease##945-113·239A
Attitudes Toward Management of the Hypoplastic Left Heart 
Syndrome Among Pediatric Nurses and Residents##1035-
113·248A
B-Natriuretic Peptide Levels Are Elevated in Single Ventricle 
Patients With Systemic Ventricular Failure but not With 
Cavopulmonary Failure##967-109·240A
B-Type Brain Natriuretic Peptide in Preterm Infants With 
Patent Ductus Arteriosus##967-110·240A
Bare Stenting of Obstructed Right Ventricle-to-Pulmonary 
Artery Conduits: A Fifteen-Year Experience##945-
112·239A
Congenital Heart Disease and Late Mortality Following 
Pediatric Heart Transplantation##967-115·241A
Dobutamine Stress Echocardiographic Assessment of Left 
Ventricular Function Long After Intervention for 
Coronary Artery Fistula##989-116·243A
Does Normalization for Body Size Variables Actually Work in 
a Pediatric Population?##989-114·243A
Epidemiologic Features of the Presentation of Critical 
Congenital Heart Disease: Implications for 
Screening##1035-109·247A
Evolution of Left Ventricular Function in Pediatric Patients 
With Permanent Right Ventricular Pacing for Isolated 
Congenital Heart Block: A Medium Term Follow-Up## 
969-141·24A
Evolution of the Paced and Nonpaced QRS Duration With 
Chronic Right Ventricular Pacing in Pediatric Patients 
With and Without Structural Heart Disease## 992-
128·27A
HMG-CoA Reductase Inhibitors Are Effective for Prevention 
of Acute Coronary Artery Injury in a Rabbit Model of 
Kawasaki disease##1011-110·244A
Long-Term Outcomes of Patients With Tricuspid Atresia With 
Transposition or Normally Related Great Arteries##922-
110·237A
Morphologic Ventricular Adaptations to Training in Young 
Soccer Players and Swimmers: An Echocardiographic 
Study## 902-5·95A
Myocardial Infarction in Adolescents##1035-112·247A
Near Infra-red Spectroscopy is a Reliable Indicator of Systemic 
Perfusion for Unsedated Infants with Single Ventricle 
Physiology##989-109·242A
Obesity is Prevalent, and is a Signiﬁcant Additional 
Comorbidity in Children With Congenital and Acquired 
Heart Disease## 840-8·246A
Peak Systolic Strain and Strain Rate in Children With 
Pulmonary Hypertension: A Tissue Doppler Study and 
Correlation With Cardiac Catheterization Data##936-
186·306A
Pediatric EKG: A Computer Aided Approach Reducing 
Common but Important Errors##1013-147·266A
Pediatric Impedance Cardiography: Is it reliable?##989-
111·242A
Prevalence and Risk Factors for Renal Insufﬁciency in 
Pediatric Heart Transplant Recipients: A Long-Term 
Follow-Up Study##967-116·242A
Real-Time 3-Dimensional Echocardiography for the 
Calculation of Left Ventricular Volumes in Fetuses 
With Aortic Stenosis Being Considered for In-Utero 
Intervention: An In-Vivo, and In-Vitro Validation Study## 
852-5·249A
Relation Between Plasma Brain Natriuretic Peptide, Right 
Ventricular Function and Exercise Capacity in Patients 
After Surgical Repair of Tetralogy of Fallot##967-
111·240A
Right Ventricle to Pulmonary Artery Shunt Versus Modiﬁed 
Blalock-Taussig Shunt in Hypoplastic Left Heart 
Syndrome: Assessment and Outcome Through Stage 2 
Palliation##922-114·238A
Risk Factors for Coronary Artery Involvement in Children 
After Kawasaki Disease## 840-9·247A
Three-Dimensional Tricuspid Annular Function Provides 
Insight Into the Mechanisms of Valve Regurgitation in 
Classic Hypoplastic Left Heart Syndrome## 839-5·146A
Tricuspid Annular and Septal Doppler Tissue Velocities are 
Reduced in Pediatric Heart Transplant Recipients##967-
114·241A
Variant Coronary Artery Pattern and Ventricular Septal Defect 
Are Associated With Chronotropic Impairment Late After 
the Arterial Switch Operation##1035-115·248A
Vasoreactive Response to Maternal Hyperoxygenation in the 
Fetus with Hypoplastic Left Heart Syndrome##1011-
109·244A
Peptides
B-Type Brain Natriuretic Peptide in Preterm Infants With 
Patent Ductus Arteriosus##967-110·240A
Brain Natriuretic Peptide and Systolic or Isolated Diastolic 
Heart Failure in the Community##942-92·48A
Brain Natriuretic Peptide Plasma Levels Combined to Diastolic 
Filling Pattern Predict Ventilatory Response to Exercise in 
Patients With Chronic Heart Failure## 902-11·96A
Delta Protein Kinase C Antagonist Given Systemically at 
Reperfusion is Cardioprotective##994-220·211A
Ghrelin Protects Myocardium Against Ischemia/Reperfusion 
Injury via Inhibiting Myocardial Apoptosis##937-
195·308A
Increased Plasma Concentrations of N-terminal Pro Brain 
Natriuretic Peptide is a More Sensitive Marker 
of Subclinical Diastolic Dysfunction and Arterial 
Remodeling in Hypertension: Analytical Performance 
Comparison With BNP##1028-200·372A
Modulation of BNP Release in Relation to Myocardial 
Scarring, Ischemia and Hibernation on PET in Patients 
With Chronic Heart Failure##919-52·38A
Percutaneous valve repair/replacement
Cribier-Edwards™ Aortic Bioprosthesis in the Pulmonic 
Position; Initial Animal Experience##945-110·239A
Percutaneous Pulmonary Valve Implantation: A Cost-Effective 
Strategy for Management of Right Ventricular Outﬂow 
Tract Dysfunction##945-114·239A
Percutaneous Septal Sinus Shortening (The PS3 SystemTM) 
Ameliorates Functional Mitral Regurgitation##1006-
19·282A
Reproducibility of Echocardiographic Assessments of Mitral 
Regurgitation for Percutaneous Endovascular Edge to 
Edge Repair## 902-31·98A
The Incidence of Aortic Regurgitation After Percutaneous 
Aortic Valve Implantation##1006-22·283A
Pericarditis
Microbiologic Trends of Purulent Pericarditis: A Single Center 
Experience from 1994 to 2004##1033-102·90A
Strain Imaging Can Differentiate Constriction From 
Restriction##1033-100·90A
Urgent Coronary Angiography Is Frequently Performed in 
Patients With Acute Pericarditis and ST Elevation##1033-
101·90A
Pericardium
A Small Pericardial Effusion is a Marker of Shortened 
Survival## 902-13·96A
Echocardiographic Epicardial Adipose Tissue as an Another 
Imaging Indicator of Visceral Adipose Tissue## 902-
10·96A
Peripheral vasculature
64-Slice Peripheral Computed Tomography Angiography: A 
Clinical Accuracy Evaluation## 970-18·128A
Carotid Stenting Induces Platelet Activation and a Pro-
inﬂammatory Response##1025-182·368A
Chronic Total Occlusions (CTO) in the Iliofemoral Arteries: 
Initial and Long-Term Outcomes##912-194·295A
Clinical Implication in Metabolic Syndrome and Ankle-
brachial Pressure Index as the Predictor of Cardiovascular 
Disease##983-211·339A
Combination of Mild Renal Insufﬁciency and Peripheral Artery 
Disease Accelerate Long-Term Events Risk in Patients 
With Chest Pain##911-190·294A
Contrast Ultrasound Perfusion Imaging: The Beginning 
of a New Era in the Diagnostic of Peripheral Artery 
Disease?## 802-6·315A
Durability of Endoluminal Stenting for Obstructive Lesions 
of the Subclavian Artery: Multicenter Registry in 
Japan##979-183·333A
LDL Control in Patients Undergoing Peripheral Arterial 
Revascularization Procedures Compared to Coronary 
Arterial Revascularization Procedures##968-151·259A
Local Delivery of Bone Marrow Derived Stromal Cells 
Engineered to Overexpress Prostacyclin Synthase 
Enhanced Collateral Perfusion in Hindlimb Ischemia## 
823-5·341A
Outcomes After Endovascular Therapy for Lesions Classiﬁed 
According to the Transatlantic Intersociety Consensus 
(TASC) Document##1002-180·348A
Plasma Asymmetric Dimethylarginine is an Independent 
Marker for the Presence and Severity of Peripheral Artery 
Disease##911-186·294A
Proteomic Proﬁling Reveals that Plasma Beta 2-Microglobulin 
is a Marker for Peripheral Arterial Disease## 802-4·314A
Self-Reported Peripheral Arterial Disease Predicts Risk of 
Combined Vascular Events Beyond the Framingham Risk 
Score in the Northern Manhattan Study##911-188·294A
Simultaneous Application of Prostaglandin E1 Enhances the 
Arteriogenesis by Sustained-release of Basic Fibroblast 
Growth Factor in the Rabbit Hindlimb Ischemic 
Model##912-191·295A
The Efﬁcacy and Safety of EECP in Patients with Peripheral 
Arterial Disease##1002-182·348A
Transplantation of Autologous Endothelial Progenitor Cells is 
Safe, Feasible and Effective for Vascular Regeneration 
in No-Option Patients with Chronic Critical Limb 
Ischemia##934-176·304A
Pharmacokinetics
Increasing Concentrations of Prasugrel’s Active Metabolite 
Produce Increased Inhibition of Platelet Aggregation## 
855-6·379A
Lipid Effects of Torcetrapib With and Without Atorvastatin 
Are Optimized by Morning Dosing: Results From 
Pharmacokinetic/Pharmacodynamic Analyses##1003-
186·349A
Pregnancy-associated Plasma Protein A: An Instant Rising 
Biomarker in Patients With ST-Elevation Myocardial 
Infarction##971-215·193A
Variability in the Recovery of Platelet Function After 
Discontinuation of Clopidogrel Therapy## 855-5·379A
Pharmacology
A New Concept of Local Paclitaxel Delivery for Prevention 
of Restenosis: Intracoronary Paclitaxel Delivery With the 
New Genie®-application Device##956-166·319A
A Novel Enoxaparin Regime for ST-Elevation Myocardial 
Infarction Patients Undergoing Primary Purcutaneous 
Coronary Intervention: Intravenous but Not Subcutaneous 
Enoxaparin Achieves Adequate Anti-Xa Levels##1020-
243·227A
Alteration in Iron Kinetics May Contribute to Doxorubicin 
Cardiotoxicity##987-100·70A
Angiotensin II Acutely Increases Diastolic Distensibility: 
A Protein Kinase C and Na+/H+ Exchanger-mediated 
Effect##1031-47·84A
AZD6140 Yields Additional Suppression of Platelet 
Aggregation in Patients With Acute Coronary Syndromes 
Previously Treated With Clopidogrel## 821-4·204A
Beneﬁcial Effects of Dual Angiotensin-II Suppression With 
ACE-inhibitor and Angiotensin Receptor Blocker on 
BNP, CRP and Glucose Regulation in Patients With 
Symptomatic Heart Failure##959-189·323A
Candesartan Improves Outcome in Patients With Low Ejection 
Fraction Heart Failure, Irrespective of Background Dose 
of ACE Inhibitor: An Analysis of the CHARM-Added 
Trial## 809-5·52A
Closed-loop Automated Drug Delivery to Optimize Systemic 
Arterial Pressure, Cardiac Output, and Left Heart Filling 
Pressure in Discompensated Heart Failure##1012-
148·265A
CYP2C19*2 Polymorphism Contributes to a Diminished 
Pharmacodynamic Response to Clopidogrel## 855-
7·380A
Effects of Single Nucletide Polymorphisms of Atherosclerosis 
Related Genes on Response to HMG-CoA Inhibitors After 
Acute Myocardial Infarction##914-202·297A
Multi Pharmacy Is a Predictor of DES Stent 
Thrombosis##1020-246·228A
Olmesartan Inhibits NF-κB Activity and Attenuates Hypoxia-
Induced Left Ventricular Remodeling in Apolipoprotein 
E-Knockout Mice##913-198·296A
Oral Nicorandil Improves Clinical Outcomes After Coronary 
Angioplasty in Patients With Renal Failure on 
Hemodialysis##959-187·323A
Pharmacogenetic Warfarin-Dosing Algorithm Is Substantially 
Improved When Both VKORC1 and CYP2C9 Gene 
Variants Are Considered##908-159·288A
Preprocedual Statin Administration Can Reduce Thrombosis 
Reaction in Both Acute Myocardial Infarction and Stable 
Angina - Histologic Evaluation## 855-4·379A
The Inﬂuence of Baseline Platelet Aggregation Response on 
Subsequent Inhibition of Aggregation Achieved With 
Clopidogrel or Prasugrel## 855-3·378A
Withdrawal Effect After 4-Year Statin Therapy on C-
reactive Protein Is Independent of LDL-cholesterol 
Change##1003-185·349A
Phonocardiography
Audioelectric Parameters are Superior to BNP for Detecting 
Hemodynamic Evidence of Heart Failure##986-90·67A
Phosphodiesterase inhibitors
Long- Term Sildenaﬁl Administration Improves Aortic 
Stiffness and Wave Reﬂections in Patients With Erectile 
Dysfunction of Vascular Origin##1026-188·370A
Physiology
Novel Velocity Vector Imaging Ultrasound Technique 
Demonstrates Asymmetric Deformation in the Normal 
Aortic Root## 925-38·102A
Quantitative Myocardial Magnetic Resonance Perfusion: 
Comparison With Invasive Physiologic Assessments and 
Quantitative Coronary Angiography## 993-17·145A
Rapamycin Therapy Improves Coronary Physiology After 
Cardiac Transplantation##944-105·51A
Reliability of Cardiac Index Monitoring With an Analysis of 
Peripheral Arterial Waveform During Varing Loading 
Condition in Vivo##1012-149·265A
The Haemodynamic Response to Changes in Atrioventricular 
and Interventricular Delay of Cardiac Resynchronization 
Therapy Closely Fits a Parabola, Which May Allow More 
Efﬁcient Optimization## 969-130·22A
Plaque
C-Reactive Protein and Plaque Composition in Patients with 
Stable Angina Pectoris (An Intravascular Ultrasound-
Virtual Histology Study)##1000-171·346A
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C-Reactive Protein May Be Absorbed Through Yellow Plaque 
and Lead to the Formation of Vulnerable Plaque##978-
178·332A
Clinical Feasibility of Quantitative Color-mapping of Shear 
Stress for Predicting Coronary Plaque Rupture Site With 
Use of Three-Dimensional Intravascular Ultrasound 
Imaging##951-225·182A
Collagen Content of Coronary Plaque Measured by 
Polarization Sensitive Optical Coherence Tomography 
(PS-OCT)## 948-32·121A
Combination Therapy With Motexaﬁn Gadolinium and 
Ascorbate Stabilizes Plaques in Fat-Fed Apolipoprotein E 
Knockout Mice##937-192·308A
Comparison between Culprit and Nonculprit Lesions in 
Patients with Multiple Plaque Ruptures and Acute 
Coronary Syndrome##951-231·183A
Comparison of Atherosclerotic Plaque Characteristics by IVUS 
and Multislice CT## 970-42·131A
Complex Plaques and Coronary Plaque Progression in Patients 
With Acute Myocardial Infarction##977-163·329A
Distal Embolism During Native Vessel and Vein Graft 
Coronary Intervention With a Vascular Protection Device: 
Predictors of High-Risk Lesions##995-229·213A
Dual-frequency Intravascular Ultrasound Imaging: A Novel 
Approach to Plaque Vulnerability## 948-30·120A
Effects of Percutaneous Transluminal Angioplasty (PTA) 
and Endovascular Brachytherapy(EVBT) on Vascular 
Remodeling of Human Femoropopliteal Artery: 2-Years 
Follow-Up by Noninvasive MR Plaque Imaging##1002-
183·349A
Extraction of Latent, Computed Tomographic Images of 
Coronary Artery Plaque Components by Isotropic, Three-
Dimensional Wavelet Analysis## 970-29·128A
Fluvastatin Reduces Coronary Plaque and Increases Lumen 
Volume: Assessment by Multislice CT## 970-11·126A
Impact of Elevated Troponin T level at Admission on the 
Non-Culprit Plaque Progression in Clinical Unstable 
Angina Pectoris: A Volumetric Intravascular Ultrasound 
Analysis##951-229·183A
Impact of Intra-plaque Enhancement in Multislice Computed 
Tomography on Coronary Flow After Percutaneous 
Coronary Intervention## 970-15·127A
Impact of Plaque Rupture on Myocardial Infarct Size in ST-
Elevation Anterior Acute Myocardial Infarction##995-
226·212A
Limitation of Angiography to Identify the Culprit Lesion 
in Acute Myocardial Infarction With Total Occlusion: 
Utility of Thermal Wire to Identify Culprit Lesion by 
Intravascular Ultrasound##951-228·183A
Pathological Analysis of the Culprit Lesions with Unique 
Intra Plaque Enhancement in Multislice Computed 
Tomography## 832-6·135A
Positron Emission Tomography Can Identify Arterial Segments 
with Vulnerable Plaque Leading to Arterial Thrombosis## 
926-7·106A
Predictors of Non-Calciﬁed Plaques of Coronary Arteries in 
422 Subjects by Multislice Computed Tomography Using 
Logistic Regression Models##930-242·175A
Pregnancy-associated Plasma Protein A: An Instant Rising 
Biomarker in Patients With ST-Elevation Myocardial 
Infarction##971-215·193A
Progression of Coronary Artery Stenosis during 6 Months Was 
Associated With the Number of Yellow Plaques Detected 
by Baseline Angioscopy##930-244·175A
Regression of Coronary Atherosclerotic Plaques Induced by 
Pioglitazone in Patients With Type 2 Diabetes Mellitus or 
Impaired Glucose Tolerance: Results From a Randomized 
Prospective Study Using Intravascular Ultrasound##914-
207·298A
Signiﬁcance of Lipid-content in Determining the Pattern 
of Coronary Arterial Remodeling: An Intravascular 
Ultrasound Study With Tissue Characterization by use of 
Wavelet Analysis##1024-177·367A
Skin Autoﬂuorescence Is Increased in Patients With Stable 
Coronary Artery Disease and Is Positively Associated 
With Serum Levels of Soluble Receptor for Advanced 
Glycation Endproducts## 850-3·221A
Statin Cools Down Temperature of Atherosclerotic Plaque 
in Patient With Coronary Artery Disease: Temperature 
Measurement and Intravasular Ultrasound Study##957-
173·320A
T Cell Receptor Signaling and Synapse Formation in T Cells 
From Patients With Acute Coronary Syndrome##977-
160·328A
Platelet inhibitors
A Comparison of Upstream Versus Downstream 
Administration of Glycoprotein 2b/3a Blockers in Patients 
With Non ST-Elevation Acs Who Are All Scheduled for 
Early Invasive Therapy## 843-5·220A
A Study of Platelet Function Following Selective and 






Anti-thrombotic Effect of Bivalirudin Compared With 
Eptiﬁbatide and Heparin in Diabetic Patients Undergoing 
Angioplasty: An Ex-vivo Human Study##1023-171·366A
Antiplatelet Treatment with P2Y
12
 Receptor Antagonist 
Decreases Blood Loss in a Canine CABG Model with 
Cardiopulmonary Bypass##955-258·190A
AZD6140 Yields Additional Suppression of Platelet 
Aggregation in Patients With Acute Coronary Syndromes 
Previously Treated With Clopidogrel## 821-4·204A
AZD6140 Yields Greater Inhibition of Platelet Aggregation 
Than Clopidogrel in Patients With Acute Coronary 
Syndromes Without Previous Clopidogrel Treatment## 
821-3·204A
Can Greater Inhibition of Platelet Aggregation be Tolerated? 
Evaluation of the Bleeding Risk of AZD6140 Compared 
with Clopidogrel (CLOP) in Patients with Acute Coronary 
Syndromes (ACS)##995-223·212A
Clinical Outcomes With AZD6140, an Oral Reversible ADP 
Receptor Antagonist, Compared With Clopidogrel in 
Patients With Acute Coronary Syndromes (ACS)##974-
242·199A
Clopidogrel Attenuates the Complications Associated 
With Poor Early Reperfusion in Patients With STEMI 
Undergoing Lysis in the CLARITY-TIMI 28##995-
228·213A
Clopidogrel Withdrawal Is Associated With Pro-Inﬂammatory 
Effects in Patients With Diabetes Mellitus##937-
196·308A
CYP2C19*2 Polymorphism Contributes to a Diminished 
Pharmacodynamic Response to Clopidogrel## 855-
7·380A
Effects of Aggrenox and Telmisartan Versus Clopidogrel 
and Aspirin in Combination on Platelet Activity in 
Diabetic Patients: An ex vivo Outlook to the PRoFESS 
Trial##1023-167·365A
High Dose Atorvastatin Does Not Impact the Efﬁcacy of 
Clopidogrel - A PROVE IT TIMI-22 Analysis## 855-
8·380A
Impact of Early Clopidogrel Use on Angiographic and Clinical 
Outcomes Following Coronary Artery Bypass Surgery: 
Findings from PREVENT IV##932-257·178A
Impact of Reduced Glomerular Filtration Rate on Outcomes 
in Patients With ST-Segment Elevation Myocardial 
Infarction Undergoing Fibrinolysis in CLARITY-TIMI 
28##904-222·159A
Increasing Concentrations of Prasugrel’s Active Metabolite 
Produce Increased Inhibition of Platelet Aggregation## 
855-6·379A
Monitoring Platelet Inhibition After Clopidogrel With 
VerifyNow-P2Y12® Rapid Analyzer: The VERIfy 
Thrombosis risk ASsessment (VERITAS) Study##908-
165·289A
On-site PCI Versus PCI After Transfer in Rural Germany: 
Network Logistics for Patients With ST-Elevation 
Myocardial Infarction (STEMI)##1021-256·231A
Platelet Reactivity in Coronary Artery Disease Patients with 
Depression: Are All Anti-Depressants Equal?##1005-
204·353A
Prevalence and Platelet Function Proﬁles of Clopidogrel Hypo-
responders Identiﬁed Following Drug Withdrawal##1023-
160·363A
Prevalence of Concomitant Suboptimal Responsiveness 
to Aspirin and Clopidogrel Treatment in Diabetic 
Patients##1023-162·364A
Recurrent Ischemia Detected by Continuous Electrocardiogram 
Recording After Percutaneous Coronary Intervention for 
Non-ST-Elevation Acute Coronary Syndromes##951-
222·182A
Reduced Platelet Sensitivity to Aspirin in Type 2 Diabetic 
Subjects Compared to Non-Diabetics##1023-165·364A
The Active Metabolite of Prasugrel (CS-747) Inhibits ADP-
Stimulated Thrombo-inﬂammatory Markers of Platelet 
Activation: Modulation by Other Blood Cells and 
Calcium, But Not by Aspirin##1023-161·364A
The Clinical Effectiveness of Clinical Practice Guidelines 
in Managing Acute Coronary Syndromes: A 10 Year 
Perspective##928-226·171A
The Effects of AZD6140, the First Oral Reversible ADP 
Receptor Antagonist, Compared With Clopidogrel on 
Biochemical Markers in Patients With Acute Coronary 
Syndromes (ACS)##974-245·200A
The Inﬂuence of Baseline Platelet Aggregation Response on 
Subsequent Inhibition of Aggregation Achieved With 
Clopidogrel or Prasugrel## 855-3·378A
Variability in the Recovery of Platelet Function After 
Discontinuation of Clopidogrel Therapy## 855-5·379A
Platelets
A Study of Platelet Function Following Selective and 






Anti-Thrombotic Properties of A Novel Nitric Oxide Donor 
(LA-419) in a Human Model of Thrombosis##908-
172·290A
Antiplatelet Treatment with P2Y
12
 Receptor Antagonist 
Decreases Blood Loss in a Canine CABG Model with 
Cardiopulmonary Bypass##955-258·190A
Aspirin Resistance Is Strongly Associated With Increased 
Platelet Turnover##908-170·290A
Carotid Stenting Induces Platelet Activation and a Pro-
inﬂammatory Response##1025-182·368A
Does Platelet Hyperactivity Exist After Off-Pump Compared 
to On-Pump Coronary Artery Bypass Surgery?##955-
259·190A
Genetic Polymorphisms on Platelet Glycoprotein Ia, Increase 
the Risk for Myocardial Infarction by Modifying Platelet 
Activation##908-164·289A
Impact of Enhanced Platelet Reactivity on Microvascular 
Reperfusion and Left Ventricular Remodeling in 
ST-segment Elevation Myocardial Infarction.##908-
168·290A
Inconsistency in the Prevalence of Platelet Aspirin Resistance 
as Measured by COX-1 Non-Speciﬁc Assays in Patients 
Treated With 81, 162 and 325 mg Aspirin##908-169·290A
Increased Platelet Sensitivity and Cyclooxygenase-2 
Expression in Aspirin Resistance##908-171·290A
Increased Platelet-Leukocyte Aggregation in Indian Asian 
Men: A Mechanism Contributing to Greater Cardiovasular 
Risk?##1023-163·364A
Platelet Aspirin Resistance in an ED Population With 
Suspected Acute Coronary Syndromes##995-227·212A
Platelet Aspirin Resistance in Patients With Coronary Artery 
Disease Is Rare at all Aspirin Doses When Measured by 
COX-1 Speciﬁc Assays##908-162·288A
Prevalence and Platelet Function Proﬁles of Clopidogrel Hypo-
responders Identiﬁed Following Drug Withdrawal##1023-
160·363A
Prevalence of Concomitant Suboptimal Responsiveness 
to Aspirin and Clopidogrel Treatment in Diabetic 
Patients##1023-162·364A
Protease Activated Receptor-1 Activation Causes Platelet 
Independent Venoconstriction in Vivo in Man##908-
167·289A
Restoration of Platelet Function on Clopidogrel-Treated 
Subjects## 857-6·235A
Role of Platelets in Homing of Endothelial Progenitor Cells to 
the Site of Vascular Injury##909-174·291A
The Active Metabolite of Prasugrel (CS-747) Inhibits ADP-
Stimulated Thrombo-inﬂammatory Markers of Platelet 
Activation: Modulation by Other Blood Cells and 
Calcium, But Not by Aspirin##1023-161·364A
The Role of Platelet Activity in Patients With Patent Versus 
Occluded Coronary Artery Bypass Grafts. Prague-4 Trial 
Subanalysis##1023-164·364A
Thrombocytopenia Is Associated With Adverse Outcomes 
Following Treatment With Either Enoxaparin or 
Unfractionated Heparin in Patients Presenting With Acute 
Coronary Syndromes: A TIMI 11B Substudy##1018-
225·223A
Total Circulating and Platelet Microparticles Are Elevated in 
Acute Pulmonary Embolism##958-183·322A
Transient Coronary Occlusion Stimulates Platelet Deposition 
and Microvascular Dysfunction in Remote Regions of 
the Heart: Relation to Platelet Activation Status##908-
166·289A
Variability in the Recovery of Platelet Function After 
Discontinuation of Clopidogrel Therapy## 855-5·379A
Point-of-services
Variability in the Recovery of Platelet Function After 
Discontinuation of Clopidogrel Therapy## 855-5·379A
Population studies
Association of the Deletion/Insertion Polymorphism of 
the Angiotensin-Converting Enzyme With Cardiac 
Conduction, Repolarization, and Function in A 
Population-based Study##918-50·37A
Coronary Heart Disease Events Preventable by Control 
of Blood Pressure and Lipids in U.S. Persons with 
Hypertension##915-210·299A
Do Loss-of-Function Mutations in Alpha 2 Adrenergic 
Receptor Subtypes Predispose to Hypertension in 
Blacks? Population-Level Data From the Dallas Heart 
Study##960-195·325A
Effect of Bariatric Surgery on Cardiovascular Risk Factors and 
Predicted Effect on Cardiovascular Events and Mortality 
in Class II-III Obesity## 842-8·358A
Even Mild Reductions in Baseline Hemoglobin Concentration 
Increase the Risk of Death Among Cardiovascular 
Patients With Normal Ejection Fraction and no History of 
Myocardial Infarction##935-180·305A
Gender and Racial Differences in Invasive Diagnostic and 
Interventional Cardiac Procedures in the Management 
of Acute Myocardial Infarction: 15-Year Trends in a 
Statewide Database##904-230·161A
Global Risk Assessment of U.S. Persons With the Metabolic 
Syndrome##939-204·310A
Lack of Relationship Between Body Mass Index and 
Atherogenic Dyslipidemia in Asian Indians##1026-
189·370A
Left Ventricular Size and Function and the Common Sodium 
Channel Polymorphism, H558R-SCN5A: A Population-
Based Association Study##918-47·37A
Lipid-Lowering Results From the First Large-Scale Trial 
of Statin Therapy in Hispanic-American Patients With 
Hypercholesterolemia: STARSHIP##1003-187·349A
Long-Term Mortality and Changing Cause of Death in Patients 
With Acute Myocardial Infarction in New Jersey 1986-
1998##1021-254·230A
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National Improvements in the Recognition and Treatment of 
Patients at Increased Coronary Risk: The National Health 
and Nutrition Examination Survey, 1999 - 2002##916-
260·169A
Obesity and the Metabolic Syndrome are Associated With 
Improved Survival in the Heart Failure Population##964-
57·56A
Prevalence, Treatment, and Control of Hypertension in U.S. 
Adults 2001-2002 Overall and With Metabolic Syndrome, 
Diabetes, Kidney Disease, Stroke or Coronary Artery 
Disease## 848-6·361A
Stratiﬁcation of Coronary Risk Beyond the Framingham Risk 
Classiﬁcation: Ultrasound Assessment of Subclinical 
Disease in a Multiethnic Population##983-208·338A
The Changing Age Distribution of Severe Congenital Heart 
Disease in the General Population##1035-110·247A
The Changing Characteristics and In-Hospital Mortality 
of Acute Myocardial Infarction in New Jersey 1986-
2002##928-227·172A
Potassium
Cardiac Kir2.x Channels in Homomeric and Heteromeric 
Composition Are Markedly Activated by Adrenergic 
β3-Receptors: Role of Protein Kinases A and C## 901-
128·2A
Incidence and Predictors of Hyperkalemia in Patients With 
Heart Failure - An Analysis of the Candesartan in Heart 
failure - Assessment of Reduction in Mortality and 
morbidity (CHARM) Program## 809-4·52A
Practice management
Clinical and Business Integration in a Pediatric/Congenital 
Heart Center##1036-145·269A
Improving Compliance With Heart Failure Core Measures: 
Michigan Heart Failure Discharge Document 
Initiative##990-145·260A
The SAMU Network Minimizes Treatment Delays for ST-
Elevation Myocardial Infarction: Insights From a Three-
Year Registry##973-239·199A
There Is No Objective Evidence That “Self-Referral” Is 
Responsible for Growth of Imaging Services Billed to the 
Medicare System.## 834-3·263A
What Are the Characteristics of Patients With Severe, 
Symptomatic, Mitral Regurgitation Who Are Denied 
Surgery?##917-19·272A
Pregnancy
Attitudes Toward Management of the Hypoplastic Left Heart 
Syndrome Among Pediatric Nurses and Residents##1035-
113·248A
Pregnancy Complications as Risk Factors for Cardiac-and All-
Cause Mortality##968-153·259A
Pregnancy Complications as Risk Factors for Coronary Artery 
Disease##1029-214·375A
Pressure-volume relation
Adult Mesenchymal Stem Cells From Patients With Ischemic 
Heart Disease Engraft in Ischemic Myocardium 
and Improve Left Ventricular Function in NOD/scid 
Mice##903-221·159A
Prevention
A Predisposition for the Metabolic Syndrome Increases 
Subclinical Inﬂammed Coronary Plaque Burden 
in Low Framingham Risk Women From a General 
Population##939-212·312A
Calculating LDL and Blood Pressure Goals Per ATP III and 
JNC VII Just Prior to an Ofﬁce Visit Helps Close the Gap 
Between Guidelines and Practice##1036-149·270A
Differences in Health Awareness Knowledge, Environmental 
Tobacco Smoke Exposure (ETS), and Body-Shape 
Perception Among Adolescents Based Upon Body Mass 
Index (BMI)##1035-111·247A
Differences in Improvement in Reliability of Care by Patient 
Age, Race, and Gender in Get With the Guidelines 
Coronary Artery Disease##946-148·254A
Does Gender Alter the Efﬁcacy of Implantable Cardioverter 
Deﬁbrillators?## 947-129·15A
Does the Presence of a Depressive State Contribute to 
Endothelial Dysfunction in Patients With Coronary Artery 
Disease?##1000-161·344A
Effects of Perindopril on Long-Term Clinical Outcome 
of Patients With Coronary Artery Disease and Left 
Ventricular Function##999-257·219A
Effects of Single Nucletide Polymorphisms of Atherosclerosis 
Related Genes on Response to HMG-CoA Inhibitors After 
Acute Myocardial Infarction##914-202·297A
NT-proBNP Predicts Perioperative Cardiac Events in Patients 
Undergoing Noncardiac Surgery##1005-200·352A
Plasma Concentration of Lipoprotein(a) and the Risk of Future 
Cardiovascular Disease in Women## 801-8·314A
Pregnancy Complications as Risk Factors for Coronary Artery 
Disease##1029-214·375A
Prevalence, Treatment, and Control of Hypertension in U.S. 
Adults 2001-2002 Overall and With Metabolic Syndrome, 
Diabetes, Kidney Disease, Stroke or Coronary Artery 
Disease## 848-6·361A
Stroke Prevention Technology for Patients With Non-Valvular 
AF - Worldwide Experience with the New WATCHMAN 
LAA System## 1015-143·36A
Prognosis
Abnormal Ventilatory Response to Exercise Predicts Mortality 
in Adult Congenital Heart Disease Patients## 840-5·246A
Additional Ballooning Versus no Additional Ballooning After 
Drug-Eluting Stent Implantation in Routine Clinical 
Practice##998-247·217A
Admission White Blood Cell Count and Plasma Glucose: A 
Simple and Useful Combination for Predicting In-Hospital 
Outcome After Acute Myocardial Infarction##1018-
230·224A
An On-Line, Evidence-Based Calculator of Mortality 
in Congestive Heart Failure Based on Clinical 
Variables##1012-152·266A
Anemia Predicts Long-Term Mortality and Cardiovascular 
Events in Japanese Patients Undergoing Elective 
Revascularization: From the Coronary Revascularization 
Demonstrating Outcome Study in Kyoto (CREDO-
kyoto)##954-247·187A
Beta Adrenergic Blockers Reduce the Risk of Mortality 
Associated with Elevated Troponin T in Patients with 
Acutely Decompensated Congestive Heart Failure##1032-
53·85A
Can Exercise Induced Heart Rate Variability Spectral 
Slopes Provide Insights Into Autonomic Activity and 
Prognosis?## 1017-10·154A
Can Exercise Myocardial Perfusion SPECT Continue to 
Predict Patient Outcomes Long After Testing? Results of a 
10-Year Follow-Up Analysis## 926-32·109A
Cardiac Troponin T in Heart Failure: Results from Val-
HeFT##986-58·66A
Cardiovascular Magnetic Resonance Identiﬁcation of Adverse 
Cardiovascular Prognosis in Women Versus Men With 
Known or Suspected Ischemic Heart Disease## 833-
3·136A
Changes in the 1-Year Survival After Hospital Discharge in 
Heart Failure Patients With Depressed Systolic Function 
in the Last Years. Had We Reached the Same in Men and 
Women?## 837-4·83A
Chronotropic Incompetence in Patients on Beta Blocker 
Referred for Stress Echocardiography: Superiority of 
Heart Rate Reserve Over 85% Maximum Predicted Heart 
Rate## 828-6·133A
Circulating Levels of Osteopontin Predicts Future Cardiac 
Events in Patients With Chronic Stable Angina## 801-
3·313A
Clinical Impact of Collateral Circulation on 30-Day Mortality 
for Acute Myocardial Infarction Complicating Heart 
Failure##951-226·182A
Combination of Mild Renal Insufﬁciency and Peripheral Artery 
Disease Accelerate Long-Term Events Risk in Patients 
With Chest Pain##911-190·294A
Comorbidities in Severe Aortic Valve Stenosis: Do Renal 
Dysfunction, Anemia or Diabetes Mellitus Predict Long-
Term Outcome?##1030-24·287A
Comparative Value of Resting Left Ventricular Dysfunction 
and Left Ventricular Response to Stress as Predictors 
of Cardiac Mortality in Patients Undergoing Gated 
Myocardial Perfusion SPECT## 812-8·116A
Comparison of a New Submaximal Prognostic Marker to the 
Duke Treadmill Score## 828-4·133A
Coronary Angiography Is a Strong Predictor of Cardiovascular 
Events in Patients With End-Stage Renal Disease##905-
237·163A
Death Causes in Hospitalized Heart Failure Patients With 
Preserved and Depressed Left Ventricular Systolic 
Function##1032-89·87A
Delayed Heart Rate Recovery After Adenosine Stress Testing 
With Supplemental Exercise Predicts Mortality## 926-
13·107A
Diabetes and Coronary Artery Disease Impose Similar 
Cardiovascular Morbidity and Mortality to Patients With 
End-Stage Renal Disease: A Seven-Year Follow-Up 
Study##905-234·162A
Direct Comparison of the Prognostic Value of Brain Natriuretic 
Peptide (BNP) and N-terminal ProBNP in a Large 
Population of Patients With Chronic and Symptomatic 
Heart Failure. The Valsartan In Heart Failure (Val-HeFT) 
Data## 819-3·71A
Do All Patients With ST-Segment Elevation Myocardial 
Infarction Beneﬁt From Invasive Treatment? The Simple 
Risk-Score Derived From PL-ACS Registry##973-
235·198A
Do Biomarkers Add Prognostic Information to Routine 
Measures of the Severity of Heart Failure?##986-59·66A
Do ECG Abnormalities Pose the Same Risk for Women and 
Men?## 992-123·26A
Do the Traditional Risk Factors of Vessel Size, Lesion Length 
and Diabetes Mellitus Predict Restenosis With TAXUS 
Stents? Insights From a TAXUS Meta-Analysis##954-
249·188A
Does Revascularization of Chronic Total Occlusion(CTO) 
Contribute to Improve the Long-Term Prognosis?##976-
252·202A
Does the Presence of a Depressive State Contribute to 
Endothelial Dysfunction in Patients With Coronary Artery 
Disease?##1000-161·344A
Does Tight Glycemic Control Improve Survival in Diabetic 
Patients With Chronic Heart Failure Started on Insulin 
Therapy?##964-55·55A
Dysmetabolic Status, and Not Obesity Per Se, Is Associated 
With Increased Cardiovascular Mortality in Patients With 
Stable Coronary Disease##939-208·311A
Effect of Nadir Hemoglobin During Hospital Course on the 
Long-Term Risk of Heart Failure and Death in Survivors 
of Acute Myocardial Infarction##953-245·187A
Effects of Single Nucletide Polymorphisms of Atherosclerosis 
Related Genes on Response to HMG-CoA Inhibitors After 
Acute Myocardial Infarction##914-202·297A
Elevated Cardiac Troponin is an Independent Predictor of in 
Hospital Mortality in the Medical Intensive Care Unit 
Patients##931-253·177A
Endothelial Dysfunction Accelerates Future Hypertensive 
Evolution and Causes Excess of Fatal Events## 853-
6·376A
Endothelial-dependent vasodilation and Prognosis in 
Postmenopausal Women## 853-3·376A
Evolution of the Prognosis of Hospitalized Heart Failure 
Patients With Depressed and Normal Systolic Function 
Between 1991 and 2001.##1032-59·87A
Fasting Glucose Is a Powerful Independent Risk Factor for 
Long-Term Mortality in Patients With Acute Myocardial 
Infarction. A Prospective Study## 830-5·207A
Fate of Patients With Reversibile, Non-ischemic Left 
Ventricular Systolic Dysfunction: Is IT Reasonable to 
Continue Anti-Heart Failure Medications?##919-97·42A
Gender Differences in Non-ST-Elevation Acute Coronary 
Syndromes##953-243·186A
Heart Rate Recovery is a Stronger Predictor of Mortality Than 
Chronotropic Index## 1017-9·154A
Identiﬁcation of Diabetics at High Risk of Mortality: A 10-
Year Follow-Up Analysis After Myocardial Perfusion 
SPECT## 926-10·106A
Impact of Age on the Prognostic Value of Cardiopulmonary 
Exercise Testing in Subjects with Heart Failure## 1017-
12·154A
Impact of Secondary Prevention Treatment With Atorvastatin, 
Simvastatin and Pravastatin After Acute Myocardial 
Infarction on One-Year Outcome in Current Clinical 
Practice: Results of Mitraplus##995-231·213A
Impaired Left Ventricular Systolic Function Predicts Increased 
One-Year Mortality Following Normal Positron Emission 
Tomography Stress Myocardial Perfusion Imaging## 
926-1·104A
Importance and Signiﬁcance of Baroreﬂex Sensitivity(BRS) 
to Predict Prognosis of Chronic Heart Failure With 
Preserved Systolic Function##919-92·40A
Ischemic Mitral Regurgitation Is an Independent Predictor 
of Heart Failure and Death in Survivors of Myocardial 
Infarction: A Prospective Study##962-19·277A
Long-Term Association of Brachial Artery Flow-mediated 
Vasodilation and Cardiovascular Events in Middle-Aged 
Subjects With no Apparent Heart Disease## 801-6·313A
Long-term Mortality Reasons and Predictors in Primary 
Coronary Angioplasty Population##973-237·198A
Loop Diuretic Dose Is Independently Associated With 
Increased Mortality in Advanced Heart Failure##919-
93·41A
Low Body Temperature at Hospital Discharge is a Marker 
of Poor Prognosis in Patients with Congestive Heart 
Failure##1032-94·88A
Low Serum Total Cholesterol Is Associated With Increased 
Mortality in Non-Ischemic Heart Failure##964-99·59A
Mid-regional Pro-atrial Natriuretic Peptide (MR-proANP) as 
a Novel and More Stable Prognostic Marker in Chronic 
Heart Failure (CHF)##986-54·65A
Mitral Annular Calciﬁcation Predicts Mortality and Coronary 
Artery Disease in Patients With End Stage Renal 
Disease## 902-39·100A
Outcome in Heart Failure and Narrow QRS Patients With and 
Without Left Ventricular Dyssynchrony## 902-36·99A
Oxygen Uptake Efﬁciency Slope and Survival in Patients With 
Systolic Heart Failure## 1017-15·155A
Prediction of Cardiac Events in Patients With Hypertrophic 
Cardiomyopathy: Usefulness of MIBG Myocardial 
Scintigraphy## 926-35·110A
Predictors of Death in Patients With Atrial Fibrillation: The 
Role of Echocardiography## 902-1·94A
Predictors of In-Hospital and Late (More Than Three Years) 
Death of Acute Myocardial Infarction Complicated by 
Cardiogenic Shock##931-250·176A
Predictors of Mortality in Adult Patients with Eisenmenger 
Physiology## 852-9·250A
Prognosis Value of Brain Natriuretic Peptide Kinetics During 
Cardiopulmonary Exercise Test in Chronic Heart Failure 
Patients##986-92·68A
Prognostic Role of Chronic Obstructive Pulmonary Disease 
in Congestive Heart Failure. Data From The IN-CHF 
Registry##964-89·57A
Prognostic Signiﬁcance of Inverted T Waves in Patients With 
Acute Pulmonary Embolism##958-182·322A
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Prognostic Value of Regional Left Ventricular Functional 
Assessment in Patients Undergoing Exercise or 
Pharmacologic Gated SPECT## 926-29·109A
Prognostic Value of Rubidium-82 Perfusion Positron Emission 
Tomography in Patients with Obesity## 812-7·115A
Prognostic Value of Serum Gamma-Glutamyl Transferase 
Activity in Coronary Artery Disease##1029-213·375A
Prognostic Value of Signal Average Electrocardiogram in 
Predicting the Occurrence of Atrial Fibrillation. A Meta-
Analysis## 992-134·28A
Prosthesis-Patient Mismatch Affects Long-Term Survival After 
Mechanical Aortic Valve Replacement## 824-5·282A
R Wave Frontal Plane Right Axis Deviation on the Admission 
Electrocardiogram in Patients With Acute Myocardial 
Infarction: A Strong Independent Predictor of Increased 
Mortality Both In-Hospital and in Early Follow-up##973-
233·197A
Refractory Angina Is Associated With Excessive Chest Pain 
but Not Excessive Cardiac Mortality##1029-206·374A
Regression of Left Ventricular Mass and Improvement in 
Left Ventricular Ejection Fraction Following Long-Term 
Aldosterone Receptor Antagonist Therapy in Patients with 
Chronic Systolic Heart Failure## 809-7·53A
Relationship of Cardiac Hemodynamics and Ventilatory 
Inefﬁciency, and Their Mortality Prediction in Patients 
With Heart Failure## 1017-16·155A
Serum Amyloid A Is a Better Predictor of Clinical Outcome 
Than C-reactive Protein in Non-ST-Segment Elevation 
Acute Coronary Syndrome##1019-233·225A
Short- and Long-term Outcomes of Cardiac Surgery for 
Observant Jehovah Witnesses##940-26·275A
Similar Hospital Mortality for Diabetics With NSTEMI as 
for Non-diabetics With STEMI: Results of the Acos 
Registry##1019-237·226A
The Impact of Several Inﬂammatory Indices on The Long-
Term Cardiovascular Mortality in Patients With Acute 
Coronary Syndromes##972-229·196A
The Impact of Tumor Necrosis Factor-alpha and 180-Day 
Mortality in Patients With Acute Decompensation of 
Severe Low-Output Chronic Heart Failure. Results From 
the Calcium Sensitizer or Other Inotrope or None in 
Acutely Decompensated CHF (CASINO) Study##1005-
198·352A
The Incidence of Provoked Spasm Using Acetylcholine 
Predicts Adverse Outcomes After Acute Myocardial 
Infarction## 830-6·208A
The Prognostic Value of Endoglin, a Marker of 
Neoangiogenesis, in Acute Myocardial Infarction## 
856-8·234A
The Prognostic Value of Peak Oxygen Consumption in Men 
and Women with Severe Systolic Heart Failure## 828-
5·133A
The Variable Natural History of Idiopathic Dilated 
Cardiomyopathy##1009-103·81A
Tumoral Marker Carbohydrate Antigen 125: An Emerging 
Prognostic Risk Factor in Heart Failure?##986-96·69A
Which Parameter Is Best to Quantify Electromechanical 
Dyssynchrony for Predicting Cardiac Events in Patients 
With Advanced Heart Failure?##1008-58·78A
Which Patients With Previous Bypass Surgery Beneﬁt Most 
From Repeat Revascularization?##976-256·203A
Prophylactic device therapy
Novel Non-Implant Radiofrequency Energy Catheter Closure 
of Patent Foramen Ovale in Swine## 852-4·249A
Prostacyclin
Local Delivery of Bone Marrow Derived Stromal Cells 
Engineered to Overexpress Prostacyclin Synthase 
Enhanced Collateral Perfusion in Hindlimb Ischemia## 
823-5·341A
Prostaglandins
Cyclooxygenase Products Sensitize Muscle Mechanoreceptors 
in Heart Failure Patients##986-99·69A
Nicotinic Acid-Induced Vasodilation in Mice Is Predominantly 
Mediated via the Prostagladin D
2
 Receptor 1## 845-
8·360A
Synergistic Effect of Cytochrome P450 Epoxygenase CYP2J2 
G-50T Polymorphism With Smoking on the Onset of 
Premature Myocardial Infarction## 822-8·341A
Prosthetic valves
A Prospective Randomized Trial of a Rapid Fibrinolytic 
Protocol for Left-sided Prosthetic Valve Thrombosis: 
Interim Analysis## 803-8·277A
Thrombolytic Therapy for Left-Sided Prosthetic Valve 
Theombosis## 844-6·285A
Valve Type and Long Term Outcomes After Aortic Valve 
Replacement in Older Patients## 824-4·281A
Pulmonary artery
Electrical Stimulation of Sympathetic Nervous System 
Delivered Through the Pulmonary Artery Increases 
Contractility##985-51·65A
End Diastolic Pulmonary Regurgitation Gradient Predicts 
Adverse Cardiovascular Outcomes: Data from the Heart 
and Soul Study## 902-18·98A
Freedom from Neoaortic Insufﬁciency: A Comparison of 
Classic Norwood and Norwood-Sano Procedures##922-
113·237A
Relationship Between Cardiopulmonary Exercise Testing and 
Pulmonary Pressures in Hypertrophic Cardiomyopathy## 
1017-30·156A
Sitaxsentan Improves Time to Clinical Worsening (TCW) 
in Patients With Pulmonary Arterial Hypertension 
(PAH)##936-189·307A
The Vasodilatory Action of Testosterone Is Independent of 
the Endothelium, Classic Androgen Receptor, Aromatase 
Activity, Nitric Oxide and Dilator Prostaglandins in 
Isolated Human Pulmonary Vessels##1000-163·344A
Pulmonary circulation
Calculation of Pulmonary Vascular Resistance Reclassiﬁes 
Patients Identiﬁed as Having Pulmonary Hypertension in 
Routine Echocardiography## 831-4·134A
Characterisation of the Vasodilatory Action of Testosterone in 
the Human Pulmonary Circulation##936-187·306A
Comparison of Autonomic Control Between Atrial Septal 
Defect and Ventricular Septal Defect Based on Heart Rate 
Variability and Respiration##1011-113·244A
Noninvasive Monitoring of Pulmonary Vascular Resistance 
Changes in Patients With Pulmonary Hypertension##936-
190·307A




Monitoring of Patients With Conﬁrmed Pulmonary Embolism 
Using NT-pro-Brain Natriuretic Peptide and Cardiac 
Troponin T##958-184·322A
Prognostic Signiﬁcance of Inverted T Waves in Patients With 
Acute Pulmonary Embolism##958-182·322A
Thrombolysis of Massive Pulmonary Embolism: Efﬁcacy and 
Safety of Adjunctive Therapy With Enoxaparin in Patients 
Older Than 75 Years##958-180·321A
Total Circulating and Platelet Microparticles Are Elevated in 
Acute Pulmonary Embolism##958-183·322A
Pulmonary function
Chronic Obstructive Pulmonary Disease Is an Independent 
Predictor of Death in Patients With Myocardial Infarction: 
An Analysis of the VALsartan In Acute myocardial 
iNfarcTion Trial (VALIANT)##998-250·217A
Improvement of Obstructive Sleep Apnea in Heart Failure 
Patients After Cardiac Resynchronization##964-90·57A
Pulmonary heart disease
Discrimination of Left Ventricular Radial Wall Motion 
Dyssynchrony From Contractile Synchronicity on 
the Basis of Displacement and Strain Imaging by 
Two-Dimensional Echocardiography in Patients With 
Pulmonary Hypertension## 948-12·119A
Early Alteration in Pulmonary Artery Distensibility Detected 
With Cardiac Magnetic Resonance in Pulmonary 
Hypertension## 993-9·143A
Evaluation of Cardiac Arrest During Severe Chronic 
Obstructive Pulmonary Disease (COPD) 
Exacerbations##931-252·177A
Impact of Pulmonary Hypertension on Left Ventricular Reverse 
Remodeling and Long-term Outcome in Patients with 
Cardiac Resynchronization Therapy## 1015-129·33A
Noninvasive Monitoring of Pulmonary Vascular Resistance 
Changes in Patients With Pulmonary Hypertension##936-
190·307A
Pulmonary Hypertension With Excessive Transpulmonary 
Gradients Among Mitral Stenotics: Prevalence and 
Clinical Outcome Following Percutaneous Balloon Mitral 
Commissurotomy##1006-21·283A
Sitaxsentan Improves Time to Clinical Worsening (TCW) 
in Patients With Pulmonary Arterial Hypertension 
(PAH)##936-189·307A
Pulmonary valve
Percutaneous Pulmonary Valve Implantation: A Cost-Effective 
Strategy for Management of Right Ventricular Outﬂow 
Tract Dysfunction##945-114·239A
Right Ventricular Remodeling as a Result of Pulmonary Valve 
Replacement in Adult Fallot Patients Is Closely Related to 
Baseline Right Ventricular Size##1011-115·244A
Pulmonary vein
In-Vivo Sympathetic Nerve Stimulation Induces Ectopic Beats 
and Focal Atrial Tachycardia from Thoracic Veins in 
Dogs: Insights From Sympathetic Nerve Recording and 
High Density Mapping## 901-132·3A
Myocardial Thickness and Pulmonary Vein Flow Impedance: 
Correlation During Fetal Life##989-112·242A
Pulmonary Vein Size Greater Than 1.7cm Measured on 
Transesophageal Echocardiography Predicts Recurrence 
of Atrial Fibrillation After Cardioversion## 1017-5·153A
QT interval
Changes in Parasympathetic Tone Result in QT-RR Interval 
Hysteresis during Exercise and Recovery## 813-5·13A
Effects of Angiotensin-Converting Enzyme Inhibitors on 
Interstitial Collagen and QTc Interval In Hypertensive 
Left Ventricular Hypertrophy##1028-203·373A
Gender Difference in the QT Interval and Ventricular 
Tachycardia or Fibrillation in MADIT II## 924-135·8A
Patients With Coronary Artery Disease that Suffer Sudden 
Cardiac Death Have Exaggerated Prolongation of 
Ventricular Repolarization: A Three-Year Community-
Wide Study## 924-126·6A
QTc Variability in Patients With Long QT Syndrome: The 
Importance of the Maximum QTc Value From Follow-
Up Electrocardiograms in Predicting Cardiac Events## 
992-124·26A
Signiﬁcant Relation of Corrected QT Dispersion to 
Improvement of Symptoms in Patients Who Received 
Cardiac Resynchronization Therapy##1008-92·79A
QT syndrome-inherited
ECG-Based Method for Identifying KvLQT1/KCNE1 
or HERG Mutation in Patients With The Long QT 
Syndrome## 813-7·13A
New in-vivo Canine Model of Drug-induced Long-QT
1
 
Syndrome: Beta-adrenergic Challenges Trigger Torsade 
De Pointes## 901-136·3A
QTc Variability in Patients With Long QT Syndrome: The 
Importance of the Maximum QTc Value From Follow-
Up Electrocardiograms in Predicting Cardiac Events## 
992-124·26A
Quality improvement
Catholic Healthcare Partners’ Closing the Gap for Heart Failure 
Initiative: A Large Multistate Health System Takes on the 
Challenge to Inprove Quality of Care## 847-3·267A
Differences in Improvement in Reliability of Care by Patient 
Age, Race, and Gender in Get With the Guidelines 
Coronary Artery Disease##946-148·254A
Evolution of the Prognosis of Hospitalized Heart Failure 
Patients With Depressed and Normal Systolic Function 
Between 1991 and 2001.##1032-59·87A
Mayo Clinic Fast Track Protocol for ST-Elevation Myocardial 
Infarction: Process Improvements to Minimize Treatment 
Delays## 847-7·268A
Practice Makes Perfect: ACC/AHA Guideline Adherence 
Is Higher in Hospitals With High Acute Myocardial 
Infarction Volume##946-150·255A
Practices and Opinions of Morticians Regarding Postmortem 
Implantable Device Analysis and Retrieval## 947-
124·14A
The Association Between Hospital Guideline Adherence, 
Dosing Safety, and Patient Outcomes: Results From 
the CRUSADE Quality Improvement Initiative##946-
151·255A
Treatment and Outcomes of Acute Coronary Syndromes 
Among 5,577 Patients Aged ≥90 Years: Results 
From the CRUSADE National Quality Improvement 
Initiative##923-154·253A
Quality of care
CABG and PCI Rates Differ Between Genders Even With 
Similar Coronary Anatomy: A Computer Based Patient 
Simulation Explores the Gender Gap##1013-145·266A
Clinical Outcomes of Patients Undergoing Percutaneous 
Coronary Intervention on Weekends as Compared With 
Weekdays##946-149·254A
Comparison of Factors Identiﬁed as Precipitating Heart Failure 
Hospital Admissions and Clinical Outcomes: A Report 
From OPTIMIZE-HF##990-153·262A
Impact of Restrictive Access to Clopidogrel Following 
Coronary Stent Implantation on Patient Health 
Outcomes## 811-8·257A
Management and Prognosis of Non ST-Segment Elevation 
ACS in Very Old Patients. The DESCARTES 
Registry##928-229·172A
Mayo Clinic Fast Track Protocol for ST-Elevation Myocardial 
Infarction: Process Improvements to Minimize Treatment 
Delays## 847-7·268A
Paradoxical Increased Post Ischemic Stroke Mortality Among 
Whites in the Veteran Population:Does Access to Care 
Inﬂuence Outcomes?##916-251·166A
Patient Safety Suffers at Nursing Shift Changes: Error 
Rate Peaks for Intravenous Unfractionated Heparin 
Administration##946-153·255A
Socioeconomic Differences in Use of Secondary Preventive 
Medication After Myocardial Infarction: A National 
Population-Based Study##1020-249·229A
Taking the Doctor Out of the Loop: The Impact of a Technician 
Led Follow-Up Clinic for Heart Valve Disease##1036-
150·270A
The Association Between Hospital Guideline Adherence, 
Dosing Safety, and Patient Outcomes: Results From 
the CRUSADE Quality Improvement Initiative##946-
151·255A
The Impact of Inpatient Quality of Care on Socioeconomic 
Disparities in Outcomes from Acute Myocardial 
Infarction## 811-7·257A
The MITRA-Score: A New Score for the Quality of Care 
in Patients With Acute ST Elevation Myocardial 
Infarction##973-232·197A
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The Oldest Old Patients Have a Lower Chance for Receiving 
Guidelines Recommended Atrial Fibrillation Therapy. 
The Experience of the Euro Heart Survey on Atrial 
Fibrillation##946-145·253A
What Aspects of Hospital Culture Inﬂuence Quality?## 811-
5·257A
Quality of life
A Comparison of Quality of Life Scores in Patients With Stable 
Angina Pectoris After Medical Treatment Compared With 
Angioplasty or Coronary Bypass Surgery: 48-Months 
of Follow-Up Outcomes of a Randomized Clinical Trial 
(MASS I I)##990-151·262A
African Americans With Chronic Angina: Risk Factors and 
Treatment Proﬁles Compared to Caucasians## 836-
8·210A
Attitudes Toward Management of the Hypoplastic Left Heart 
Syndrome Among Pediatric Nurses and Residents##1035-
113·248A
Can An Assessment of Subjective Well Being Predict 
Outcomes in Patients with Hypertension and Coronary 
Artery Disease? A Report from the INternational 
VErapamil-SR/Trandolapril Study (INVEST)##915-
212·300A
Depression Is Not Associated With Long-Term Mortality in 
a Representative Patient Population With Myocardial 
Infarction##974-244·200A
Effect of Enhanced External Counterpulsation on Erectile 
Dysfunction in Patients With Medically Refractory 
Angina##1022-218·232A
Evaluation of the Patient Global Assessment Questionnaire as a 
Health Status Measure for Heart Failure##990-146·260A
Five-Year Follow-Up in Patients With Endstage Coronary 
artery Disease After Treatment of Myocardial Ischemia 
With Cardiac Shock Wave##1022-258·233A
Physical and Mental Functioning and Health Outcome 
in Patients Enrolled in the Multicenter Automatic 
Deﬁbrillator Implantation Trial-II##919-54·38A
Randomized, Double-Blind, Placebo-controlled Study 
to Evaluate the Effect of two Dosing Regimens of 
Darbepoetin Alfa on Hemoglobin Response and 
Symptoms in Patients With Heart Failure and Anemia## 
816-5·61A
The Effects of Antidepressant Therapy on Depression 
and Quality of Life in Patients with Chronic Heart 
Failure##919-96·41A
The Relationship Between Health Insurance and Long-Term 
Health Status Among Acute Myocardial Infarction 
Survivors: Results From the PREMIER Registry##946-
154·256A
Quality performance measurement and improvement
ACC/AHA Performance Measures for Patients 
Hospitalized With HF: Are They Predictive of Clinical 
Outcomes?##946-152·255A
Cardiology Specialty Care is Associated With Higher 
Quality Performance for Patients Admitted With Heart 
Failure##946-147·254A
Comparison of Reperfusion Times in Patients Transferred 
for Primary Angioplasty for ST Elevation Myocardial 
Infarction Prior to and After Instituting a Regional 
Myocardial Infarction Alert Protocol## 847-8·268A
Computer Alert Increases Use of Prophylaxis for Patients at 
High Venous Thromboembolism Risk##958-185·322A
CV Knowledge and Risk Perceptions Among Underserved 
Individuals at Increased Risk for Cardiovascular 
Disease## 834-4·263A
Effect of CT Beathing Protocol on Attenuation Corrected 
SPECT Distribution in Normal Myocardium## 926-
16·108A
Gender Differences in Hospital Survival Rates for Medicare 
Beneﬁciaries Undergoing CABG: Hospital Performance 
Rankings Matter##990-152·262A
Impact of Novel Critical Care Pathway for Management of 
Acute Coronary Syndrome Leads to Markedly Improved 
Compliance With Guidelines and Decreased Angina 
Symptoms at 12-Month Follow-Up## 847-5·268A
Improved Prescription of Evidence-Based Medications and 
Maintenance of High Adherence to These Medications in 
Acute Coronary Syndrome Patients After Implementation 
of Guidelines Applied in Practice##946-146·254A
Improving Compliance With Heart Failure Core Measures: 
Michigan Heart Failure Discharge Document 
Initiative##990-145·260A
Patients’ Pill Burden Predicts Adherence to Antihypertensive 
and Lipid-lowering Therapy## 834-6·263A
Practice Makes Perfect: ACC/AHA Guideline Adherence 
Is Higher in Hospitals With High Acute Myocardial 
Infarction Volume##946-150·255A
Short- and Long-Term Prognosis of First Acute ST-Segment 
Elevation Myocardial Infarction in Older Women. The 
PPRIMM75 Registry##928-230·172A
Simple Risk Model to Predict Surgical Mortality in Acute Type 
A Aortic Dissection: The IRAD Score##940-21·274A
Temporal Trends in the Evaluation of Ejection Fraction in 
Patients Hospitalized With Acute Myocardial Infarction: 
Insights From the Worcester Heart Attack Study##973-
240·199A
The Fate of Randomized Trials Presented at the American 
College of Cardiology Meeting 1999-2002: What Follows 
the 15 Minute Presentation?##923-147·251A
Using Telemedicine to Decrease Cardiovascular Risk in 
Underserved Populations##968-148·258A
What Aspects of Hospital Culture Inﬂuence Quality?## 811-
5·257A
Radiation
Effects of Percutaneous Transluminal Angioplasty (PTA) 
and Endovascular Brachytherapy(EVBT) on Vascular 
Remodeling of Human Femoropopliteal Artery: 2-Years 
Follow-Up by Noninvasive MR Plaque Imaging##1002-
183·349A
Inﬂuence of Scan Protocols on Radiation Dose Estimates for 
Coronary 64-Slice CT Angiography## 807-3·113A
Radiation Dose and Predictable Cancer Risk in Multidetector-
Row Computed Tomography Coronary Angiography 
(CTCA)## 807-7·114A
Relationship of Shear Stress With In-Stent Restenosis: Bare 
Metal Stenting Versus Bare Metal Stenting and Adjunctive 
Brachytherapy##910-185·293A
Radioisotopes
Exercise Testing Is Feasible, Efﬁcacious and Cost-Effective 
in the Prediction of Cardiovascular Events in the Very 
Elderly as Compared With Dipyridamole Tc-99m 
Sestamibi Spect## 1017-13·155A
Radiation Dose and Predictable Cancer Risk in Multidetector-
Row Computed Tomography Coronary Angiography 
(CTCA)## 807-7·114A
Radionuclide imaging
64-Slice CT Angiography Is a Cost-saving Strategy for 
Patients With Mildly Abnormal Nuclear Stress Tests## 
807-4·113A
A Coronary Artery Calciﬁcation Score ≥ 400 Is Signiﬁcantly 
Associated With Myocardial Ischemia Independently of 
Framingham Risk Score##983-206·338A
An International, Prospective, Comparative Study of Adverse 
Events Associated With Pharmacologic Stress Alone and 
With Low-Level Exercise During SPECT Myocardial 
Perfusion Imaging## 926-8·106A
Can Exercise Myocardial Perfusion SPECT Continue to 
Predict Patient Outcomes Long After Testing? Results of a 
10-Year Follow-Up Analysis## 926-32·109A
Clinical Value of Hybrid PET/CT Cardiac Imaging: 
Complementary Roles of Multi-Detector CT Coronary 
Angiography and Stress PET Perfusion Imaging## 812-
5·115A
Comparative Value of Resting Left Ventricular Dysfunction 
and Left Ventricular Response to Stress as Predictors 
of Cardiac Mortality in Patients Undergoing Gated 
Myocardial Perfusion SPECT## 812-8·116A
Comparison and Co-Relation of Invasive and Noninvasive 
Methods of Ejection Fraction Measurement##919-53·38A
Comparison of Myocardial Contrast Echocardiography 
Versus Sestamibi Myocardial Perfusion Imaging in Early 
Diagnosis of Acute Coronary Syndrome## 827-5·132A
Diagnostic Performance of Combined Rubidium-82 Cardiac 
Positron Emission Tomography and X-Ray Computed 
Tomography (PET-CT) in the Detection of Coronary 
Artery Disease## 926-2·105A
Effect of CT Beathing Protocol on Attenuation Corrected 
SPECT Distribution in Normal Myocardium## 926-
16·108A
Evidence of Myocardial Adrenergic Innervation Abnormalities 
in Hyperlipidemic Subjects: The Effect of Statins## 
926-33·110A
Identiﬁcation of Diabetics at High Risk of Mortality: A 10-
Year Follow-Up Analysis After Myocardial Perfusion 
SPECT## 926-10·106A
Integrated SPECT/CT for the Assessment of Hemodinamically 
Signiﬁcant Coronary Artery Lesions## 812-6·115A
Nicorandil Can Affect Left Ventricular Geometry at the 
Chronic Phase of Myocardial Infarction: Assessment With 
ECG-gated Myocardial Perfusion Imaging## 926-4·105A
Non-invasive Evaluation of Regional Myocardial Strain and 
Activation of Matrix Metalloproteinases## 812-3·114A
Perfusion Defects in the Absence of Abnormal Wall Motion 
and Thickening Are Not Clinically Signiﬁcant in Chest 
Pain Patients Undergoing Acute Rest Myocardial 
Perfusion Imaging## 926-17·108A
Predicting Cardiac Event Risk by Combined Assessment of 
Cardiac Sympathetic Nerve Activity and Myocardial 
Perfusion in Patients With Implantable Cardioverter 
Deﬁbrillators## 926-3·105A
Prognostic Value of Cardiac Sympathetic Activity Evaluated 
by Scintigraphics 123I-MIBG Imaging Pre and Post 
Resynchronization Therapy## 926-30·109A
Reduced Septal Wall Thickness not Hypoperfusion is 
the Cause of Perfusion Defects on Single Photon 
Emission Computed Tomography in Patients With 
Left Bundle Branch Block Without Coronary Artery 
Disease: Comparison With Myocardial Contrast 
Echocardiography## 827-3·131A
Regional Left Ventricular Myocardial Contraction by 
Quantitative Automated 2D Strain Echocardiography 
and Thallium-201 Single-Photon Emission Computed 
Tomographic Perfusion Imaging## 948-15·119A
Renal Function Predicts Presence and Severity of Abnormal 
SPECT Myocardial Perfusion Imaging (MPI)##905-
239·163A
Serial Studies of Cardiac I-123 Metaiodobenzylguanidine 
Imaging Improve the Prediction of Cardiac Death in 
Patients With Chronic Heart Failure After Carvedilol 
Therapy: A Prospective Study## 926-9·106A
Up-Regulation of Pro-Platelet Basic Protein in Older Men 
with Obstructive Coronary Disease as Determined by 
Positron Emission Tomographic Perfusion Imaging: A 
New Noninvasive Marker for Coronary Artery Disease?## 
926-31·109A
Ventricular Dyssynchrony Assessment With Equilibrium 
Radionuclide Angiography Phase Analysis Predicts 
Outcome After Cardiac Resynchronization Therapy## 
969-128·21A
Receptors, B-adrenergic
Beta 1 Adrenergic Receptor Gly389Arg Polymorphism and 
the Impact of Fixed-Dose Combination of Isosorbide 
Dinitrate/Hydralazine in Heart Failure: Results From the 
A-HeFT trial##986-60·67A
Cardiac Kir2.x Channels in Homomeric and Heteromeric 
Composition Are Markedly Activated by Adrenergic 
β3-Receptors: Role of Protein Kinases A and C## 901-
128·2A
Upregulation of Functional Cardiac Beta
3
-Adrenergic 
Receptors and Chronic Anthrax Lethal Toxin-Induced 
Progressive Cardiac Depression: Insights Into the 
Underlying Molecular Mechanism##1007-51·76A
Receptors, endogenous substances
5-Fluorouracil Improves Postinfarct Left Ventricular 
Dysfunction due to Upregulated SDF-1, Mobilized CD34 
Positive Cells and Attenuated Fibrosis##927-219·170A
Cardiac P2X
4
 Receptors: A Physiologic Role in Mediating 
ATP-evoked Current and Regulation in Human Atrial 
Fibrillation## 901-135·3A
Molecular Dissection of Human LOX-1 Promoter: Nucleotides 
and Transcription Factors Requirement During 
Transactivation## 822-3·340A
Skin Autoﬂuorescence Is Increased in Patients With Stable 
Coronary Artery Disease and Is Positively Associated 
With Serum Levels of Soluble Receptor for Advanced 
Glycation Endproducts## 850-3·221A
Reentry
Microreentry as a Mechanism of Focal Atrial Tachycardia## 
947-142·18A
Reentry during Ventricular Fibrillation Is Less Common 
Intramurally than Epicardially in Swine## 901-138·4A
Rehabilitation
Characteristics Predicting Successful Weight Reduction in 
Overweight and Obese Post Infarction Patients## 849-
4·362A
Exercise Training in Addition to Cardiac Resynchronisation 
Therapy to Maximise Patient Beneﬁt## 1017-18·156A
The Effects of the Frequency of Exercise-Based Cardiac 
Rehabilitation on Glucose Tolerance and Lipid Levels in 
Patients With Acute Coronary Syndrome##916-254·167A
Renal circulation
Renal and Neurohormonal Effects of Intravenous and Intra-
Renal Nesiritide in Patients with Renal Insufﬁciency: A 
Multicenter, Randomized, Placebo-Controlled Trial## 
816-3·61A
Renal function
A Randomized Double Blind, Placebo Controlled Trial to 
Investigate the Effect of Intravenous N-Acetylcysteine 
in Preventing Renal Dysfunction Following 
Cardiopulmonary Bypass in High Risk Patients##940-
19·274A
Bedside Tool to Predict Risk of Postoperative Dialysis: 
Results in 358,296 Patients Undergoing Coronary Bypass 
Surgery##940-20·274A
Changes in Renal Function During Hospitalization for 
Worsening Heart Failure Predict Postdischarge Survival: 
An OPTIME-CHF Analysis##1032-60·87A
Chronic Kidney Disease Is a Powerful Predictor of Adverse 
Outcomes in Patients With Abnormal Myocardial 
Perfusion Imaging and Insigniﬁcant Coronary Artery 
Disease## 926-11·107A
Combination of Mild Renal Insufﬁciency and Peripheral Artery 
Disease Accelerate Long-Term Events Risk in Patients 
With Chest Pain##911-190·294A
Comorbidities in Severe Aortic Valve Stenosis: Do Renal 
Dysfunction, Anemia or Diabetes Mellitus Predict Long-
Term Outcome?##1030-24·287A
Comparison of Ultraﬁltration to Nesiritide Therapy as 
a Treatment Modality for Decompensated Heart 
Failure##1032-52·85A
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Coronary Angiography Is a Strong Predictor of Cardiovascular 
Events in Patients With End-Stage Renal Disease##905-
237·163A
Diabetes and Coronary Artery Disease Impose Similar 
Cardiovascular Morbidity and Mortality to Patients With 
End-Stage Renal Disease: A Seven-Year Follow-Up 
Study##905-234·162A
Diabetes, Renal Function, and Cardiovascular Risk Following 
Myocardial Infarction: Lessons From The VALsartan In 
Acute myocardial iNfarcTion Trial (VALIANT)##998-
249·217A
Effect of Statin Therapy on Renal Function in Hypertensive 
African Americans##981-192·335A
Elevated Blood Urea Nitrogen Level Predicts Cardiovascular 
Death in Patients Admitted for Decompensated Heart 
Failure Irrespective of the Presence of Left Ventricular 
Systolic Dysfunction##986-98·69A
Erythropoietin Therapy Improves Vascular Dysfunction in Pre-
dialysis Chronic Renal Failure Patients: A Novel Strategy 
for Atherosclerosis Prevention## 853-8·377A
Impact of Combination Evidence-based Medical Therapy on 
Mortality Following Myocardial Infarction in Patients 
With and Without Renal Dysfunction##904-228·161A
Impact of Reduced Glomerular Filtration Rate on Outcomes 
in Patients With ST-Segment Elevation Myocardial 
Infarction Undergoing Fibrinolysis in CLARITY-TIMI 
28##904-222·159A
Impact of Renal Dysfunction and Glucometabolic Status 
on One Year Mortality After Acute Myocardial 
Infarction##904-226·160A
Impact of Renal Insufﬁciency on the Long-Term Outcomes 
Following Percutaneous Coronary Intervention With 
Sirolimus-Eluting Stents##954-251·188A
Increased Mortality With Post-operative Renal Failure After 
Cardiac Transplant## 825-3·74A
Inﬂuence of Hemodialysis on the Blood Flow of AV Shunt 
and Contralateral Sides of Internal Thoracic Artery## 
902-42·101A
Intensive Lipid Lowering With Atorvastatin Is Associated 
With a Signiﬁcant Improvement in Renal Function: The 
Treating to New Targets (TNT) Study## 808-3·316A
Intra-Renal Infusion of BNP: A Novel Strategy to Overcome 
the Renal Resistance to BNP in Severe Experimental 
Heart Failure## 820-3·73A
Kidney Transplantation Leads to Improved Left Ventricular 
Ejection Fraction in Patients with Systolic Dysfunction 
and End Stage Renal Failure Compared to Medical 
Management Alone##1008-99·80A
Meta-Analysis of the Association of Anemia, Chronic 
Kidney Disease (CKD), and Cardiovascular Disease 
(CVD)##968-154·260A
N-terminal ProBNP is not Only Related to the Severity of 
Heart Failure##986-93·68A
Prevalence and Risk Factors for Renal Insufﬁciency in 
Pediatric Heart Transplant Recipients: A Long-Term 
Follow-Up Study##967-116·242A
Relationship Between Renal Function, Risk of Sudden Cardiac 
Death, and Beneﬁt of the Implanted Cardiac Deﬁbrillator 
in Post Myocardial Infarction Patients With Left 
Ventricular Dysfunction## 818-4·19A
Renal and Neurohormonal Effects of Intravenous and Intra-
Renal Nesiritide in Patients with Renal Insufﬁciency: A 
Multicenter, Randomized, Placebo-Controlled Trial## 
816-3·61A
Renal Dysfunction and New Onset Proteinuria Predict 
Mortality in Heart Transplant Patients After Replacement 
of Calcineurin Inhibitors With Sirolimus##944-106·51A
Renal Dysfunction Negates the Beneﬁt of Primary 
Percutaneous Coronary Intervention Over Fibrinolytic 
Therapy in the Treatment of ST Segment Elevation 
Myocardial Infarction##904-227·160A
Renal Function Predicts Presence and Severity of Abnormal 
SPECT Myocardial Perfusion Imaging (MPI)##905-
239·163A
Renal Insufﬁciency, Braunwald Class and Long-Term 
Outcomes in Patients Undergoing Coronary Artery Bypass 
Grafting for Acute Coronary Syndromes##975-248·201A
Renin-Angiotensin System Inhibition Improves Outcomes in 
Acute Coronary Syndrome Patients With Chronic Kidney 
Disease and Preserved Left Ventricular Function##974-
246·200A
Sirolimus as a Primary Immunosuppressant in Calcineurin-
Inhibitor induced Nephrotoxicity##944-107·51A
The Effect of Intensity of Intravenous Diuretic Dosing on 
Occurrence of Worsening Renal Function in Patients 
Hospitalized With Acute Decompensated Heart 
Failure##1032-90·87A
The Independent and Combined Risks of Diabetes and Non-
Endstage Renal Impairment in Non ST-Segment Elevation 
Acute Coronary Syndromes## 830-3·207A
The Safe Use of Aldosterone Antagonists in Patients With 
Chronic Heart Failure and Associated Chronic Kidney 
Disease Facilitated by a Protocol in an Outpatient 
Clinic##990-147·261A
Renin
Aliskiren, an Oral Renin Inhibitor, Provides Dose-Dependent 
Efﬁcacy, and Placebo-Like Tolerability in Patients With 
Hypertension##1027-191·370A
Prevention of Atrial Fibrillation Via Abrogation of the 
Renin-Angiotensin System: A Pooled Meta-Analysis of 
Randomized Controlled Clinical Trials## 924-140·9A
Renin-Angiotensin-Aldosterone System Antagonism Decreases 
the Incidence of Ventricular Dysrrhythmias Following 
Myocardial Infarction: Lessons From GUSTO-V##996-
240·215A
Superior Renin-Angiotensin-Aldosterone System (RAAS) 
Inhibiting Properties of a Novel Long-Acting ANP 
Designer Peptide Compared to Native ANP in Normal 
Dogs##919-94·41A
Reperfusion
A Phase 1/2 Trial of TG100-115, a Phosphatidylinositol-
3 Kinase Inhibitor, in Acute ST-Segment Elevation 
Myocardial Infarction Patients Treated by Percutaneous 
Coronary Intervention Indicates Acceptable Safety and 
Pharmacokinetics at the Initial Dose Level## 857-4·235A
Achieving Rapid Myocardial Infarction Reperfusion 
With Percutaneous Coronary Intervention Remains a 
Challenge, Especially in Women, Elderly, and Minorities: 
Results From American Heart Association Get With the 
Guidelines## 815-8·193A
Delta Protein Kinase C Antagonist Given Systemically at 
Reperfusion is Cardioprotective##994-220·211A
Impact of Plaque Rupture on Myocardial Infarct Size in ST-
Elevation Anterior Acute Myocardial Infarction##995-
226·212A
Inhibition of Serine Protease Activity at Reperfusion Reduces 
Postischemic Injury in a Closed-Chest Model of Acute 
Myocardial Infarction##927-221·170A
Insights Into the Change in Brain Natriuretic Peptide After ST-
Elevation Myocardial Infarction: Why Should it Be Better 
Than Baseline Brain Natriuretic Peptide?##973-236·198A
Myeloperoxidase May Contribute to the No-reﬂow 
Phenomenon in Patients With Acute Myocardial 
Infarction##972-226·196A
Percutaneous Coronary Intervention in Patients Receiving 
Only a Single Subcutaneous Dose of Enoxaparin: Results 
From the SYNERGY Trial##1020-244·228A




Pyrroloquinoline Quinone (PQQ) and/or Metoprolol Decrease 
Infarct Size and Improve Mitochondrial Function in a Rat 
Model of Ischemia/Reperfusion##994-216·210A
Rescue Percutaneous Coronary Intervention After Failed 
Fibrinolysis: A Meta-Analysis of Randomized Controlled 
Trials##929-234·173A
The SAMU Network Minimizes Treatment Delays for ST-
Elevation Myocardial Infarction: Insights From a Three-
Year Registry##973-239·199A
Usefulness of 2-dimensional Longitudinal Strain of Apical 
Septum to Predict Functional Recovery After Successful 
Primary Revascularization Procedure in Anterior Wall 
Myocardial Infarction## 948-5·117A
Repolarization
Noninvasive Electrophysiological Study of Ivabradine (NESI) 
in Patients With Dual Chamber Pacemakers: Effects on 
Ventricular Repolarization## 992-129·27A
Patients With Coronary Artery Disease that Suffer Sudden 
Cardiac Death Have Exaggerated Prolongation of 
Ventricular Repolarization: A Three-Year Community-
Wide Study## 924-126·6A
Repolarization Complexity is Increased in Left Ventricular 
Hypertrophy: The Strong Heart Study## 992-125·26A
Resource utilization
Healthcare Resource Utilization in Adults with Congenital 
Heart Disease: A Population-Based Study## 840-4·245A
Patterns and Predictors of Aspirin Use Among Patients on 
Chronic Anti-Inﬂammatory Drugs##1029-211·375A
Prospective, Randomized Controlled Trial Comparing 
the Effectiveness and Safety of a Vascular Closure 
Device and a Topically Applied Hemostatic System 
With Manual Compression in Patients Undergoing 
Cardiac Catheterization and Percutaneous Coronary 
Intervention##990-149·261A
Restenosis
A New Concept of Local Paclitaxel Delivery for Prevention 
of Restenosis: Intracoronary Paclitaxel Delivery With the 
New Genie®-application Device##956-166·319A
Blockade of RAGE With a New Fusion Protein Suppresses 
Neointimal Formation in Both Diabetic and Non-Diabetic 
Rats After Vascular Injury##956-171·320A
Detection of Angiographically Silent In-Stent Restenosis in 
Multislice Computed Tomography## 970-3·125A
Different Genetic Make-up of the Anti-inﬂammatory Il10-
gene Contributes to the Development of Restenosis After 
PCI##956-159·317A
Early and Subtle Neointimal Growth Detection Following 
Stent Implantation Using Optical Coherence Tomography 
and Intravascular Ultrasound and Histology##910-
181·293A
Effect of Amlodipine on the Restenosis and Clinical Outcome 
in Patients With Coronary Artery Disease After 
Angioplasty : Results From the Cardiovascular Events 
Follow-Up Trial in Kokura (CAVEFT-Kokura)##999-
255·218A
Intravascular Ultrasound Predictors and Their Cut-off Values 
for Angiographic Restenosis After Sirolimus-Eluting Stent 
Implantation##954-253·189A
Local Delivery of Evans Blue with Bare Metal Stent 
Can Prevents Restenosis as Same as Drug-eluting 
Stents##1022-215·231A
Low-dose Simvastatin Induces Positive Remodeling 
After Coronary Stenting in Normocholesterolemic 
Patients##1024-179·368A
Mortality Beneﬁt of Drug-Eluting Stent Use in Clinical 
Practice##928-225·171A
Multislice Computed Tomography in the Detection of 
Coronary In-Stent Restenosis## 970-32·129A
Polymer Based Paclitaxel-eluting Stents Are Superior to 
Non-polymer Based Paclitaxel-eluting Stents in the 
Treatment of De-novo Coronary Lesions: An Intravascular 
Ultrasound Study##956-165·318A
Predictors of Target Lesion Revascularization and Target 
Vessel Revascularization After Implantation of Sirolimus- 
Eluting Stent: Pooled Analysis From 6 Randomized Trials 
and Registries##954-248·187A
Prevalence and Clinical Impact of Angiographic Stent Fracture 
and Stent Hinge Movement After Sirolimus-eluting Stent 
(SES) Implantation in Complex PCI##976-257·203A
Randomized Comparison of Sirolimus Versus Bare Metal Stent 
Implantation in Bifurcation Lesions##1022-217·232A
Relationship Between Late Loss, Diameter Stenosis and Target 
Lesion Revascularization After Stent Implantation: An 
Examination of Surrogate Endpoints From a Pooled 
Analysis of Eight Large Randomized DES Trials##954-
250·188A
Relationship of Shear Stress With In-Stent Restenosis: Bare 
Metal Stenting Versus Bare Metal Stenting and Adjunctive 
Brachytherapy##910-185·293A
The Forkhead Transcription Factor, FOXO3a Controls Vascular 
Smooth Muscle Cells Proliferation through Modulation 
of an Angiogenic Immediate Early Gene, CYR61##933-
170·303A
Two-Year Intravascular Ultrasound Follow-Up After 
Implantation of Non-Polymeric Paclitaxel-Coated Stents: 
A Serial Volumetric Intravascular Ultrasound Analysis 
From the Asian Paclitaxel-Eluting Stent Clinical Trial 
(ASPECT)##954-255·189A
Revascularization
A Randomized Double Blind, Placebo Controlled Trial to 
Investigate the Effect of Intravenous N-Acetylcysteine 
in Preventing Renal Dysfunction Following 
Cardiopulmonary Bypass in High Risk Patients##940-
19·274A
Anemia Predicts Long-Term Mortality and Cardiovascular 
Events in Japanese Patients Undergoing Elective 
Revascularization: From the Coronary Revascularization 
Demonstrating Outcome Study in Kyoto (CREDO-
kyoto)##954-247·187A
Bayesian Application of Highly Sensitive C Reactive Protein 
Discriminates Risk of Death or Myocardial Infarction 
Among Simple Clinical Subroups of Patients Following 
Cardiac Catheterisation##983-212·339A
Better Guideline Compliance With Medical Therapy Seen in 
Patients With Prior Coronary Revascularization: Results 
From the Reduction of Atherothrombosis for Continued 
Health (REACH) Registry## 836-3·208A
Cardiovascular Risk Factors and Events in the Lumbee Native 
Americans of North Carolina##916-252·167A
Comparison of Reperfusion Times in Patients Transferred 
for Primary Angioplasty for ST Elevation Myocardial 
Infarction Prior to and After Instituting a Regional 
Myocardial Infarction Alert Protocol## 847-8·268A
Cost Beneﬁt Analysis of Treatment of Symptomatic 
Multivessel Coronary Disease With Preserved 
Left Ventricular Function. The Five-Year MASS II 
Report##999-254·218A
Echo-attenuation in the Target Lesion Before Perutaneous 
Coronary Intervention and Incidence of Angiographic 
Slow Flow##951-230·183A
Effects of Perindopril on Cardiac Events in Revascularized 
Coronary Artery Disease Patients##999-251·218A
Five-Year Follow-Up of the Medicine, Angioplasty or Surgery 
Study (mass-ii): A Randomized Controlled Clinical Trial 
of 3 Therapeutic Strategies for Multivessel Coronary 
Artery Disease##976-254·202A
Impact of Mitral Valve Anuloplasty Combined with 
Revascularization in Patients with Functional Ischemic 
Mitral Regurgitation##955-260·190A
Impact of the Viable Rim and Periprocedural Necrosis on 
Functional Recovery After Revascularization in Patients 
With Chronic Ischemic Heart Disease: A Quantitative 
Delayed Contrast Enhanced MRI Study## 993-7·143A
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Impaired Nitrate-Mediated Dilatation Could Reﬂect 
Nitrate Tolerance and Predicted Need of 
Revascularization##1000-159·343A
Improved Outcomes After In-Hospital Revascularization 
in the Elderly and Very Elderly with High-Risk Non-
ST-Elevation Acute Coronary Syndromes. The Global 
Registry of Acute Coronary Events##923-151·252A
Intravenous Nicorandil Immediately Before Percutaneous 
Coronary Intervention can Prevent Slow/no-reﬂow 
Phenomenon##995-222·212A
LDL Control in Patients Undergoing Peripheral Arterial 
Revascularization Procedures Compared to Coronary 
Arterial Revascularization Procedures##968-151·259A
Less Revascularization in Diabetic Patients With Silent 
Myocardial Ischemia Results Poor Survival Compared 
to Diabetic Patients With Symptomatic Coronary Artery 
Disease##905-236·163A
Myocardial Positive Preejection Velocity Accurately 
Detects Presence of Viable Myocardium and Predicts 
Recovery of Left Ventricular Function After Surgical 
Revascularization##954-252·188A
Outcome of Medical Management of Patients With Severe 
Multi Vesssel Coronary Artery Disease Unsuitable for 
Revascularization##999-258·219A
Persistent Reductions in Flow and Function After 
Revascularization of Swine With Hibernating 
Myocardium##949-216·179A
Prediction for Stent Underexpansion by Pre-procedural 
Multidetector Computed Tomography## 832-3·135A
Predictors of In-Hospital and Late (More Than Three Years) 
Death of Acute Myocardial Infarction Complicated by 
Cardiogenic Shock##931-250·176A
R Wave Frontal Plane Right Axis Deviation on the Admission 
Electrocardiogram in Patients With Acute Myocardial 
Infarction: A Strong Independent Predictor of Increased 
Mortality Both In-Hospital and in Early Follow-up##973-
233·197A
Radial Artery Patency in CABG and Factors Affecting Long 
Term Outcome##932-255·178A
Risk Score for Prediction of Major Bleeding After 
Percutaneous Coronary Intervention##1021-257·231A
Signiﬁcance of Small Dense Low-Density Lipoprotein-
Cholesterol Concentrations in Relation to the Coronary 
Events in Stable Ischemic Heart Disease##930-246·176A
Suppression of Osteoprotegerin as a Potential Mechanism of 
Healing After Coronary Intervention##1000-172·346A
Survival in Ischemic Cardiomyopathy: Medical Therapy is 
Superior to Revascularization in Patients With Limited 
Viability##1008-95·79A
The Inﬂuence of IIb/IIIa Agents on Mortality in Patients With 
Risk Factors for the Metabolic Syndrome Undergoing 
Percutaneous Coronary Revascularization##961-
199·326A
The Long-Term Outcomes of Patients With Severe Left 
Ventricular Dysfunction Following Coronary Artery 
Bypass Graft (CABG) Surgery##940-27·276A
Therapeutic Potential of Human Unrestricted Somatic Stem 
Cells Isolated from Placental Cord Blood for Concurrent 
Cardiomyogenesis and Vasculogenesis With Functional 
Regenerative Recovery Post Myocardial Infarction## 
814-6·191A
Time Course of Functional Recovery After Revascularization 
in Patients With Chronic Ischemic Left Ventricular 
Dysfunction: A Contrast Enhanced MRI Study## 833-
8·137A
Which Patients With Previous Bypass Surgery Beneﬁt Most 
From Repeat Revascularization?##976-256·203A
Rhythm disorders
Effect of Bundle Branch Block on Microvolt T-Wave 
Alternans## 924-129·6A
Outcome in Heart Failure and Narrow QRS Patients With and 
Without Left Ventricular Dyssynchrony## 902-36·99A
Patients With Severely Reduced Ejection Fractions and Atrial 
Fibrillation Have No Beneﬁt from Rhythm Control: An 
Analysis of the AFFIRM Study## 851-7·93A
Risk factors
Alteration in Iron Kinetics May Contribute to Doxorubicin 
Cardiotoxicity##987-100·70A
Anemia Predicts Long-Term Mortality and Cardiovascular 
Events in Japanese Patients Undergoing Elective 
Revascularization: From the Coronary Revascularization 
Demonstrating Outcome Study in Kyoto (CREDO-
kyoto)##954-247·187A
Association of Variant Alleles of Paraoxonase and Endothelial 
Nitric Oxide Synthase Genes With Early Onset of First 
Myocardial Infarction##1021-253·230A
Automated Pericardial Fat Quantiﬁcation in CT Data##1012-
145·264A
Baseline Characteristics Associated With Embolism in 
Infective Endocarditis##984-26·281A
Bayesian Application of Highly Sensitive C Reactive Protein 
Discriminates Risk of Death or Myocardial Infarction 
Among Simple Clinical Subroups of Patients Following 
Cardiac Catheterisation##983-212·339A
Bedside Tool to Predict Risk of Postoperative Dialysis: 
Results in 358,296 Patients Undergoing Coronary Bypass 
Surgery##940-20·274A
Blacks Are Less Susceptible to Atrial Fibrillation Despite an 
Adverse Risk Proﬁle: A Meta-Analysis## 1015-130·33A
Cardiovascular Risk Assessment can Be Improved Using 
Components of the Metabolic Syndrome and Other Risk 
Markers: The European Concerted Action Project## 
842-4·357A
Cardiovascular Risk Factors and Events in the Lumbee Native 
Americans of North Carolina##916-252·167A
Clinical Implication in Metabolic Syndrome and Ankle-
brachial Pressure Index as the Predictor of Cardiovascular 
Disease##983-211·339A
Clinical Signiﬁcance of Large and Small Low-Density 
Lipoprotein-Cholesterol Concentrations in Patients 
With Various Types of Coronary Heart Diseases##1014-
212·355A
Combination Statin and Fibrate Therapy Improves Lipoprotein 
Subparticle Proﬁles in Diabetic Patients With Mixed 
Dyslipidemia: The DIACOR Study##1014-210·355A
Computer Alert Increases Use of Prophylaxis for Patients at 
High Venous Thromboembolism Risk##958-185·322A
Congenital Heart Disease and Late Mortality Following 
Pediatric Heart Transplantation##967-115·241A
Coronary Disease Prevalence on Stress Imaging in Patients 
With NCEP Deﬁned Metabolic Syndrome versus 
Traditional Risk Factors##961-200·326A
Cumulative Adverse Effects of Upper Respiratory Tract 
Infections on Carotid Artery Elasticity in Children With 
Type 1 Diabetes Mellitus##935-181·305A
CV Knowledge and Risk Perceptions Among Underserved 
Individuals at Increased Risk for Cardiovascular 
Disease## 834-4·263A
Detecting Depression in Cardiac Patients: Description of an 
Innovative System and Preliminary Findings Related to 
Gender and Age##1005-205·353A
Diabetes Mellitus Subjects Have Immune System Alterations 
Similar to That of Patients With Unstable Angina: A 
Clue to Explain Their High Cardiovascular Risk?##972-
231·197A
Differences in Health Awareness Knowledge, Environmental 
Tobacco Smoke Exposure (ETS), and Body-Shape 
Perception Among Adolescents Based Upon Body Mass 
Index (BMI)##1035-111·247A
Different Effects of Rosuvastatin and Simvastatin on 
Myocardial High-Energy Phosphate Metabolism## 
993-6·143A
Do Biomarkers Add Prognostic Information to Routine 
Measures of the Severity of Heart Failure?##986-59·66A
Early Results of a Nurse-Based Outpatient Telemedicine 
Project for Patients After Acute Coronary 
Syndrome##1036-151·270A
Effect of Post Fat Loading Remnant Like Particles-Cholesterol 
on Prognosis in Patients With Coronary Artery 
Disease##1014-214·355A
Enoxaparin Dosing and Bleeding in Real World Practice: 
Results From CRUSADE## 857-5·235A
Ezetimibe/Simvastatin Versus Atorvastatin for Attainment of 
Apolipoprotein B and C-Reactive Protein Goals: A VYVA 
Substudy##981-194·335A
Gender Difference in the Impact of Multiple Cardiovascular 
Risk Factors on the Femoral Artery Intima-Media 
Thickness in Asymptomatic Young Adults: The Bogalusa 
Heart Study##1000-169·346A
Global Risk Factors and Treatment Intensity in Elderly Patients 
With Atherosclerosis: The Experience of the International 
REACH Registry##916-258·168A
High Hemoglobin was Associated With Cardiovascular 
Events, Low Hemoglobin With All-Cause Mortality, and 
Large Fall in Hemoglobin With Both in Patients With 
Hypertension and Left Vetricular Hypertrophy. The LIFE 
Study## 848-5·361A
Hypertension and Hypercholesterolemia: Achievement 
of Treatment Targets in a Primary Prevention 
Population##1014-213·355A
Impact of High HDL Cholesterol on Hospital and 1-Year-
Mortality of Patients With Acute Myocardial Infarction: 
Results of the ACOS Registry##996-232·213A
Impact of Triglyceride Lowering on HDL-c: Is There a 
Continuum of HDL-c Increase Beyond Fasting TG < 150 
mg/dl?## 849-5·362A
Improvement of Metabolic Parameters with Rimonabant 
Beyond the Effect Attributable to Weight Loss Alone: 
Pooled 1-Year Data from the RIO (Rimonabant In Obesity 
and Related Metabolic Disorders) Program## 849-3·362A
Inappropriate Left Ventricular Mass Identiﬁes Hypertensive 
Patients With High-Risk Cardiac Phenotype## 835-
8·343A
Incidence and Not Timing of Death or Myocardial Infarction 
Differ According to Risk in Patients With Non-ST 
Elevation Acute Coronary Syndromes: Implications for 
Long-Term Treatment and Follow-Up## 830-4·207A
Inhalation of Combustion-derived Air Pollution Impairs 
Endogenous Fibrinolysis in Patients With Ischemic Heart 
Disease##908-160·288A
Lack of Relationship Between Body Mass Index and 
Atherogenic Dyslipidemia in Asian Indians##1026-
189·370A
Left Ventricle Concentric Remodeling: A First Step of 
Impaired Cardiac Performance in Middle Aged Subjects 
With Masked Hypertension##960-198·325A
Limitation of Ankle-Brachial Blood Pressure Index for 
Diagnosis of Peripheral Vascular Disease in Young and 
Middle Age Adults: The Bogalusa Heart Study##911-
189·294A
Lipid Parameters and Risk of Ischemic Stroke in Type 2 









 is an Independent 
Marker for Coronary Endothelial Dysfunction in 
Humans##1000-160·344A
Metabolic Syndrome Predicts Higher Cardiovascular Risk 
Independently of ECG Left Ventricular Hypertrophy: The 
LIFE Study## 848-3·360A
National Improvements in the Recognition and Treatment of 
Patients at Increased Coronary Risk: The National Health 
and Nutrition Examination Survey, 1999 - 2002##916-
260·169A
Natural Catastrophic Events Are Associated With 
Increased Incidence and Severity of Acute Coronary 
Syndromes##928-223·171A
Osteoprotegerin as a Novel Biomarker of Atherosclerosis: 
Independent Association With Coronary Artery Calcium 
in the Dallas Heart Study## 801-4·313A
Outcome of Medical Management of Patients With Severe 
Multi Vesssel Coronary Artery Disease Unsuitable for 
Revascularization##999-258·219A
Overall Myocardial Perfusion Changes by Positron Emission 
Tomography Throughout the Entire Coronary Vascular 
Tree but Not Changes Limited to the Region With the 
Most Severe Baseline Defect Predict Coronary Events## 
926-15·108A
Oxidative Stress Is a Mechanism Underlying the Obesity 
Related Risk of Atherosclerosis in Healthy Adults##935-
183·306A
Pioglitazone Is Superior to Metformin or Glibenclamide in 
Recducing Markers of Cardiovascular Risk in Patients 
With Type-2-diabetes Mellitus##905-238·163A
Prediction of Adverse Clinical Outcomes in Unprotected Left 
Main Coronary Artery Stenting Using Risk Stratiﬁcation 
System of EuroSCORE##997-243·216A
Predictors of Death in Patients With Atrial Fibrillation: The 
Role of Echocardiography## 902-1·94A
Predictors of Mortality in Patients Receiving Implantable 
Deﬁbrillators## 947-132·16A
Predictors of Stent Thrombosis After Drug-Eluting Stents 
Implantation During Long-Term Follow-Up##956-
164·318A
Prevalence of Metabolic Syndrome in Patients < 45 Years Old 
With Acute Coronary Syndrome Presenting for Emergent 
Primary Percutaneous Intervention##997-244·216A
Prognostic Value of Serum Gamma-Glutamyl Transferase 
Activity in Coronary Artery Disease##1029-213·375A
Progressive Decrease in Large and Small Artery Elasticity With 
the Presence of Multiple Components of the Metabolic 
Syndrome##939-210·312A
Pulmonary Autograft Dilatation After Ross Procedure: 
Incidence of and Risk Factors##922-109·237A
Reappraisal of Conventional Coronary Heart Disease Risk 
Factors using Novel Statistical Approaches: A Critical Re-
analysis of Framingham Data##916-255·167A
Reduction of Atherothrombosis for Continued Health 
(REACH) Registry Results: 1-Year Cardiovascular Event 
Rates in a Global Contemporary Registry of Over 68,000 
outpatients with Atherothrombosis##916-256·168A
Risk Factors for Cardiovascular Disease in Patients with 
Prediabetes## 842-3·357A
Risk Factors for Coronary Artery Involvement in Children 
After Kawasaki Disease## 840-9·247A
Risk of Hemorrhagic Stroke in Atrial Fibrillation: Is There an 
Ethnic Difference in Its Incidence and in the Effect of 
Warfarin?## 849-8·363A
Stress Echocardiography is More Cost-effective Than Stress 
Electrocardiography for Risk Stratiﬁcation of Troponin 
Negative Acute Chest Pain Patients: A Prospective 
Randomised Controlled Trial## 806-4·112A
Subclinical Coronary Atherosclerotic Burden and High-
Sensitive CRP Levels Frequently Do Not Match 
Framingham Risk Scores in a General Population##983-
207·338A
The Impact of Cardiovascular Risk Factors on Oxidative Stress 
in Humans##1005-203·353A
The Impact of Changes in Insulin Resistance After PCI on 
Lumen Narrowing##954-254·189A
Triple-Therapy with a Statin, Fibrate and Ezetimibe Safely 
Allows More Diabetic Patients with Mixed Dyslipidemias 
to Reach NCEP Guidelines: An Analysis of The DIACOR 
Study## 808-6·316A
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Unrecognized Myocardial Infarction: The Association With 
Cardiopulmonary Symptoms and Mortality is Mediated 
Via Echocardiographic Abnormalities of Global 
Dysfunction Instead of Regional Dysfunction. The 
Olmsted County Heart Function Study##950-215·180A
Waist Circumference and Body Mass Index Are Both 
Independently Associated With Cardiovascular Disease. 
The International Day for the Evaluation of Abdominal 
Obesity (IDEA) Survey## 842-6·358A
Risk factors, gender-related
A Predisposition for the Metabolic Syndrome Increases 
Subclinical Inﬂammed Coronary Plaque Burden 
in Low Framingham Risk Women From a General 
Population##939-212·312A
Contributions of Endogenous Androgens Versus Age and Waist 
Circumference to Coronary Plaque and Remodeling in 
Women: A Report From the NHLBI-Sponsored Women’s 
Ischemia Syndrome Evaluation (WISE) Study##957-
178·321A
Impact of a Novel Hormone Therapy, Drospirenone and 17-
beta Estradiol, on Clinic and Ambulatory Blood Pressure 
in Postmenopausal Women with Hypertension##1027-
197·372A
Marked Risk Reduction in Coronary Heart Disease, Stroke and 
Total Mortality in Women ≥60 Years Old With Low-Dose 
Pravastatin for Primary Prevention in the Management of 
Elevated Cholesterol in the Primary Prevention Group of 
Adult Japanese (MEGA) Study##1014-208·354A
Pregnancy Complications as Risk Factors for Coronary Artery 
Disease##1029-214·375A
The Relationship Between soluble-Intercellular Adhesion 
Molecule - 1 and Race/Ethnicity##935-184·306A
The Triglyceride/High Density Lipoprotein Ratio Predicts All-
Cause Mortality in Women## 808-8·317A
Risk prediction
A Calculated Glomerular Filtration Rate or a Simple Serum 
Creatinine: Which is the Better Predictor of Mortality in 
Patients with Coronary Artery Disease?##983-203·337A
A Coronary Artery Calciﬁcation Score ≥ 400 Is Signiﬁcantly 
Associated With Myocardial Ischemia Independently of 
Framingham Risk Score##983-206·338A
A Predisposition for the Metabolic Syndrome Increases 
Subclinical Inﬂammed Coronary Plaque Burden 
in Low Framingham Risk Women From a General 
Population##939-212·312A
Abnormal Heart Rate Variability is a Powerful Independent 
Predictor of Long-Term Cardiovascular Mortality in the 
Elderly: The Cardiovascular Health Study## 992-136·28A
Alcohol-Associated Hypertension and Risk of Cardiovascular 
Hospitalizations##915-213·300A
An On-Line, Evidence-Based Calculator of Mortality 
in Congestive Heart Failure Based on Clinical 
Variables##1012-152·266A
Antibiotic Proﬁlaxis is Essential in Surgical Procedures of 
Cardiac Implantable Devices## 969-135·23A
Association of TIMI Risk Score and Extent of Coronary 
Artery Disease in Patients With ST-Elevation Myocardial 
Infarction: A CLARITY TIMI-28 Substudy##1018-
221·222A
Austrian Risk Score for Carotid Stenting: A 3-Year Follow-
Up##980-185·333A
Baseline Characteristics Associated With Embolism in 
Infective Endocarditis##984-26·281A
Bayesian Application of Highly Sensitive C Reactive Protein 
Discriminates Risk of Death or Myocardial Infarction 
Among Simple Clinical Subroups of Patients Following 
Cardiac Catheterisation##983-212·339A
Blunted Heart Rate Response as a Predictor of Cardiac Death 
in Patients Undergoing Dipyridamole Stress Technitium-
99m Sestamibi Gated Single Photon Emission Computed 
Tomography Myocardial Perfusion Imaging## 926-
18·108A
Cardiovascular Risk Assessment can Be Improved Using 
Components of the Metabolic Syndrome and Other Risk 
Markers: The European Concerted Action Project## 
842-4·357A
Cardiovascular Risk Classiﬁcation in Hypertensive Patients 
With or Without Metabolic Syndrome: Results From the 
ICEBERG Study##939-209·311A
Chronic Kidney Disease Is a Powerful Predictor of Adverse 
Outcomes in Patients With Abnormal Myocardial 
Perfusion Imaging and Insigniﬁcant Coronary Artery 
Disease## 926-11·107A
Clinical Feasibility of Quantitative Color-mapping of Shear 
Stress for Predicting Coronary Plaque Rupture Site With 
Use of Three-Dimensional Intravascular Ultrasound 
Imaging##951-225·182A
Cocaine-Related Chest Pain-Utility of TIMI Risk Stratiﬁcation 
and Effects of Beta Blockers on Outcome##1029-
205·373A
Comparison of Factors Identiﬁed as Precipitating Heart Failure 
Hospital Admissions and Clinical Outcomes: A Report 
From OPTIMIZE-HF##990-153·262A
Comparison of the TIMI and GRACE Risk Scores in the 
Canadian Acute Coronary Syndromes II Registry: Simpler 
Is Not Necessarily Better##1018-226·224A
Concurrent Evaluation of Novel Cardiac Biomarkers in ACS: 
Myelopyroxidase, sCD40L, C-reactive Protein and Risk 
of Death or Recurrent Ischemia in TACTICS-TIMI 
18##972-227·196A
Coronary Calciﬁcation and Left Atrial Size Are of Additive 
Incremental Value to the Framingham Risk Score for the 
Prediction of Cardiovascular Events##983-204·337A
Coronary Heart Disease Events Preventable by Control 
of Blood Pressure and Lipids in U.S. Persons with 
Hypertension##915-210·299A
Detecting Depression in Cardiac Patients: Description of an 
Innovative System and Preliminary Findings Related to 
Gender and Age##1005-205·353A
Differences in Health Awareness Knowledge, Environmental 
Tobacco Smoke Exposure (ETS), and Body-Shape 
Perception Among Adolescents Based Upon Body Mass 
Index (BMI)##1035-111·247A
Dipyridamole-Exercise Tc-99m Sestamibi Gated Single-Photon 
Emission Computed Tomography Provides Effective Risk 
Stratiﬁcation of Elderly Patients## 926-6·106A
Do All Patients With ST-Segment Elevation Myocardial 
Infarction Beneﬁt From Invasive Treatment? The Simple 
Risk-Score Derived From PL-ACS Registry##973-
235·198A
Effect of Bariatric Surgery on Cardiovascular Risk Factors and 
Predicted Effect on Cardiovascular Events and Mortality 
in Class II-III Obesity## 842-8·358A
Effect of Bundle Branch Block on Microvolt T-Wave 
Alternans## 924-129·6A
Electrogram Features Are Superior to Clinical Characteristics 
for Predicting Atrial Fibrillation After Coronary Artery 
Bypass Graft Surgery## 813-3·12A
Evaluation of the TIMI Risk Index in a Multi-continental 
Population of 19,103 Patients With STEMI in the 
ExTRACT-TIMI 25 Trial##1018-222·223A
Even Mild Reductions in Baseline Hemoglobin Concentration 
Increase the Risk of Death Among Cardiovascular 
Patients With Normal Ejection Fraction and no History of 
Myocardial Infarction##935-180·305A
Fondaparinux Versus Enoxaparin in Patients With Acute 
Coronary Syndromes Without ST-Segment Elevation: 
Impact of Risk According to the GRACE Score##1018-
223·223A
Global Risk Assessment of U.S. Persons With the Metabolic 
Syndrome##939-204·310A
HDL Not Predictive of Longevity or Cardiovascular Events 
in Older Adults: Findings From the EPESE Study##968-
145·258A
Hemoglobin and N-Terminal Pro-brain Natriuretic Peptide: 
Independent and Synergistic Predictors of Mortality in 
Patients With Acute Heart Failure##1032-97·89A
Impact of Chronic, Daily Antiplatelet Therapy on Embolic 
Events in Infective Endocarditis##984-19·279A
Impaired Left Ventricular Systolic Function Predicts Increased 
One-Year Mortality Following Normal Positron Emission 
Tomography Stress Myocardial Perfusion Imaging## 
926-1·104A
Impaired Nitrate-Mediated Dilatation Could Reﬂect 
Nitrate Tolerance and Predicted Need of 
Revascularization##1000-159·343A
Improved Risk Stratiﬁcation in Primary Prevention by 
Utilizing the Impact of Life Style Factors for the 
Calculation of Cardiovascular Risk in Three Different 
Scoring Systems##1036-148·269A
Increased Bleeding Risk in Fibrinolytic Treatment of STEMI-
Register of Information and Knowledge About Swedish 
Heart Intensive Care Admissions (RIKS-HIA) 2002-
2004##904-225·160A
Increased Sudden Death Risk Conferred by LVH is 
Independent of Age and Left Ventricular Dysfunction: 
A Three-Year Community-Wide Study in Patients with 
Established Signiﬁcant Coronary Artery Disease## 924-
134·8A
Investigation of the Relation Between the New AHA/CDC C-
Reactive Protein Cutpoints and Cardiovascular Outcomes 
and Incident Diabetes in Patients With Stable Coronary 
Disease: A PEACE Substudy## 850-8·222A




 is an Independent 
Marker for Coronary Endothelial Dysfunction in 
Humans##1000-160·344A
Lipoprotein-Associated Phospholipase A2 (LpPLA2) Measured 
30 Days Post-Acute Coronary Syndrome Independently 
Predicts Risk of Long-Term Cardiovascular Outcomes: A 
PROVE-IT TIMI-22 Substudy## 830-7·208A
Living Alone and Atypical Clinical Presentation Are 
Associated With Higher Mortality in Patients With all 
Components of the Acute Coronary Syndrome##953-
244·186A
Low Body Temperature at Hospital Discharge is a Marker 
of Poor Prognosis in Patients with Congestive Heart 
Failure##1032-94·88A
Lower Plasma High-Density Lipoprotein Remains an 
Important Independent Predictor of Death or Non-Fatal 
Myocardial Infarction Among Statin Treated Patients 
Following Cardiac Catheterisation##1003-188·350A
Microalbuminuria Is Associated With Severe Angiographic 
Coronary Artery Disease in Diabetics and Non-
Diabetics## 842-5·358A
Modiﬁcation of a Simple Scoring System for Prediction of 
In-Hospital Mortality in Acute Coronary Syndromes: 
The Incremental Value of Cardiac Biomarkers in Risk 
Stratiﬁcation##1018-227·224A
NT-proBNP Predicts Perioperative Cardiac Events in Patients 
Undergoing Noncardiac Surgery##1005-200·352A
Persistence of Depression at Four Months After Myocardial 
Infarction Is Not Associated With Increased Long-Term 
Mortality##1005-206·354A
Physical Functioning at Baseline Is a Strong Independent 
Predictor of Long-Term Mortality After Myocardial 
Infarction##916-257·168A
Predictors of Mortality After Discharge in Patients 
Hospitalized with Heart Failure: An Analysis from the 
Organized Program to Initiate Lifesaving Treatment in 
Hospitalized Patients with Heart Failure (OPTIMIZE-
HF)## 837-5·83A
Pregnancy Complications as Risk Factors for Cardiac-and All-
Cause Mortality##968-153·259A
Prognostic Value of Regional Left Ventricular Functional 
Assessment From Stress Tc-99m Sestamibi Gated 
SPECT## 926-34·110A
Prognostic Value of Signal Average Electrocardiogram in 
Predicting the Occurrence of Atrial Fibrillation. A Meta-
Analysis## 992-134·28A
Progressive Decrease in Large and Small Artery Elasticity With 
the Presence of Multiple Components of the Metabolic 
Syndrome##939-210·312A
Prolonged Heparin Exposure, Development of 
Thrombocytopenia, Use of GP IIb/IIIa Inhibitors, and 
History of Renal Dysfunction Predict Moderate or 
Severe Bleeding: A Report From the Complications 
After Thrombocytopenia Caused by Heparin (CATCH) 
Registry##923-146·251A
Prospective Evaluation of New and Old Criteria for the 
Metabolic Syndrome## 850-7·222A
QRS Duration and Microvolt T Wave Alternans Testing in 
Patients With Ischemic Cardiomyopathy## 924-123·5A
Repolarization Complexity is Increased in Left Ventricular 
Hypertrophy: The Strong Heart Study## 992-125·26A
Risk Assessment and Risk Reduction by Perindopril in Patients 
With Normal Left Ventricular Function or Previous 
Revascularization in the EUROPA study##1014-211·355A
Risk Assessment and Stratiﬁcation for Future Cardiac Events 
in Patients Admitted With Acute Coronary Syndrome 
Using a Novel Critical Pathway and Its Validation by 
Framingham Risk Score##916-253·167A
Risk Scores Combining the Complete Blood Count and Basic 
Metabolic Proﬁle Are Highly Predictive of Death in 
Both Independent Training and Test Populations##961-
205·327A
Self-Reported Peripheral Arterial Disease Predicts Risk of 
Combined Vascular Events Beyond the Framingham Risk 
Score in the Northern Manhattan Study##911-188·294A
Stratiﬁcation of Coronary Risk Beyond the Framingham Risk 
Classiﬁcation: Ultrasound Assessment of Subclinical 
Disease in a Multiethnic Population##983-208·338A
Subclinical Coronary Atherosclerotic Burden and High-
Sensitive CRP Levels Frequently Do Not Match 
Framingham Risk Scores in a General Population##983-
207·338A
Sudden Cardiac Death Risk Prediction is Enhanced When 
Clinical Characteristics and Left Ventricular Ejection 
Fraction Are Evaluated Together Rather Than Relying on 
Left Ventricular Ejection Fraction Alone##983-209·339A
The Metabolic Syndrome but Not Estimated Insulin Resistance 
Is Associated With Higher-Risk of Adverse Clinical 
Outcomes Among Medically Managed Patients Following 
Cardiac Catheterisation##939-206·311A
The Prognostic Value of Pharmacologic Nuclear Stress Testing 
in Elderly Patients Undergoing Moderate to High-Risk 
Surgery## 926-14·107A
The TIMI Risk Index for Myocardial Infarction Predicts 
Post-MI LV Ejection Fraction: A CLARITY - TIMI 28 
Substudy##1018-228·224A
Toward More Predictable Repair of Regurgitant Aortic Valves: 
A Logical, Segmental Approach##917-24·273A
Use of N-Terminal-pro-Brain Natriuretic Peptide as a 
Diagnostic and Prognostic Marker for Ischemic Heart 
Disease in Patients Presenting to a Rapid Access Chest 
Pain Clinic##1005-199·352A
Usefulness of a New Risk Score to Identify Patients With Non-
ST-Segment Elevation Acute Coronary Syndromes Who 
Beneﬁt From an Invasive Treatment Strategy##1018-
224·223A
Which Is the Best Predictor of Cardiovascular Events: 
Body Mass Index, Waist-to-hip Ratio, or Waist 
Circumference?##961-204·327A
Septal defects
Atrial septal Aneurysm Predicts Persistent Residual Shunt 
Following PFO Closure With CardioSEAL/STARFlex 
Occluder Device## 1017-3·152A
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Serotonin
Coronary Hypersensitivity to Serotonin in Cardiac Transplant 
Recipients. Relation to Vessel Wall Morphology and 
Effect of Vitamin C##1010-107·82A
Platelet Reactivity in Coronary Artery Disease Patients with 
Depression: Are All Anti-Depressants Equal?##1005-
204·353A
Shock
An Insight From the National Registry of Myocardial 
Infarction on the Outcome of Elderly Patients with 
Cardiogenic Shock Complicating Acute Myocardial 
Infarction in the Modern Era##904-231·161A
Initial Heart Rate and Systolic Blood Pressure Provides 
Important Insights in the Risk-Stratiﬁcation of Age-related 
Mortality Among Patients Presenting With Cardiogenic 
Shock and Acute ST-Elevation Myocardial Infarction 
Treated With Fibrinolysis##931-251·177A
Predictors of In-Hospital and Late (More Than Three Years) 
Death of Acute Myocardial Infarction Complicated by 
Cardiogenic Shock##931-250·176A
Role of Inducible NO in Sepsis Related Hemodynamic 
Impairment Assessed by High-frequency 
Echocardiography in a Murine Model##1031-51·85A
Serial Echocardiograms in Patients With Cardiogenic Shock: 
Analysis of the Shock Trial## 805-5·111A
Signal averaging
Long History and Frequent Episodes of Paroxysmal 
Atrial Fibrillation in Patients Without Structural 
Heart Disease Do Not Lead to Deterioration of Atrial 
Electrophysiology## 992-135·28A
Methodological Issues of QRS Duration Measurements in 
Candidates for Cardiac Resynchronization Therapy## 
992-138·29A
Prognostic Value of Signal Average Electrocardiogram in 
Predicting the Occurrence of Atrial Fibrillation. A Meta-
Analysis## 992-134·28A
Signal transduction
Amlodipine Modulates the MEK1 and ERK Pathway to 
Induce Vascular Smooth Muscle Cell Differentiation In 
Vivo##956-169·319A
Bay 11-7082, an Inhibitor of NF-κB, Improves Post-Ischemic 
Ventricular Dysfunction in Rats##949-220·180A
Curcumin Protects TNF-α-Induced Inﬂammatory Responses 
via NF-κB Inhibition in Endothelial Cells##933-163·301A
Down-regulation of ζ-chain in CD4+ T-cells and in Natural 
Killer Cells in Patients With Acute Coronary Syndrome 
(ACS)##977-159·328A
Enhanced Expression of Leptin, Leptin Receptor, and Leptin 
Signaling in the Failing Human Heart##913-200·297A
Improvement of Left Ventricular Function With 
Intramyocardial Injections of Hepatocyte Growth Factor 
Naked DNA Plasmid in Dogs With Heart Failure Is 
Associated With Normalization of Cardiac Sarcoplasmic 
Reticulum Calcium Cycling Proteins## 823-3·341A
Inhibition of Protein Synthesis via mTOR Dependent Pathway 
Prevents Adverse Left Ventricular Remodeling and 
Reduces Infarct Size After Experimental Myocardial 
Infarction## 820-7·74A
Lipopolysaccharide Induces CXCR6 Expression in Human 
Coronary Artery Smooth Muscle Cells in TLR4 
Dependent Myd88-TIRAP-TRIF-TRAF6 Mediated 
ERK1/2 Activation##933-160·301A
Myocyte Bag-1 Provides Endogenous Cardioprotection 
Following Relocation From the Cytoplasm to the Nuclei 
in the Rat Heart Exposed to in vivo Ischemia/Reperfusion 
Injury##994-219·211A
NECA at Reperfusion Limits Infarction and Inhibits Formation 
of the Mitochondrial Permeability Transition Pore by 
Activating PI3 Kinase, p70S6 Kinase, and GSK-3β##927-
220·170A
The Anti-Proliferative Effect on Vascular Smooth Muscle Cells 
by Rosiglitazone Is Mediated by Inhibition of the Akt-
mTOR-p70S6K Pathway## 845-6·359A
The Functional Interaction Between CREB and C/EBPb 
Mediate beta AR Stimulation Induced IL-18 Binding 
Protein Expression in Cardiomyocytes##1031-49·84A
Sleep apnea
Acute Effect of Continuous Positive Airway Pressure on 
Nocturnal Variation of Atrial Natriuretic Peptide 
Levels in Heart Failure Patients with Obstructive Sleep 
Apnea##964-91·57A
Characteristics of Heart Rate Changes in Response to Sleep-
Disordered Breathing among Cardiac Patients## 992-
132·27A
Impact of Obstructive Sleep Apnea for the Impairment of Left 
Ventricular Diastolic Function##964-93·57A
Myocardial Contractile Reserve Is Depressed in Patients With 
Obstructive Sleep Apnea##964-60·56A
Obstructive Sleep Apnea Impairs Arterial Stiffness in 
Hypertensive Patients: Potential Additive Effects to 
Atherosclerosis##915-211·299A
Prevalence of Sleep Disordered Breathing in 700 State of 
the Art Treated Patients With Symptomatic Chronic 
Heart Failure: Implications for Cardiopulmonary 
Function##964-58·56A
The Efﬁcacy of Continuous Positive Airway Pressure in Non-
Obese Patients With Obstructive Sleep Apnea and Heart 
Failure##964-59·56A
Typical Atrial Flutter is Associated with Obstructive Sleep 
Apnea## 1015-132·33A
Sleep disorders
Prevalence of Sleep Disordered Breathing in 700 State of 
the Art Treated Patients With Symptomatic Chronic 
Heart Failure: Implications for Cardiopulmonary 
Function##964-58·56A
Smoking
Gentic Polymorphism G894T Modiﬁes the Smoking-
Associated Risk for Myocardial Infarction in Young 
Individuals##983-210·339A
Implications of Passive Cigarette Smoking on the Severity and 
Prognosis of Patients With Acute Coronary Syndromes: 
The Greek Study of ACS (The GREECS)##928-222·171A
Improved Risk Stratiﬁcation in Primary Prevention by 
Utilizing the Impact of Life Style Factors for the 
Calculation of Cardiovascular Risk in Three Different 
Scoring Systems##1036-148·269A
Intensive Multicomponent Smoking Cessation Intervention 
Decreases Mortality in Hospitalized High-Risk Cardiac 
Smokers##1029-212·375A
Selective Cyclooxygenase-2 Inhibition by Celecoxib Abrogates 
the Acute Smoking-Induced Vascular Dysfunction## 
841-3·356A
Synergistic Effect of Cytochrome P450 Epoxygenase CYP2J2 
G-50T Polymorphism With Smoking on the Onset of 
Premature Myocardial Infarction## 822-8·341A
Sodium
Conivaptan, a Novel Arginine Vasopressin Antagonist, 
Increased Serum Sodium Concentration in Patients 
With Heart Failure and Euvolemic or Hypervolemic 
Hyponatremia## 816-7·62A
ST segments
Clopidogrel Attenuates the Complications Associated 
With Poor Early Reperfusion in Patients With STEMI 
Undergoing Lysis in the CLARITY-TIMI 28##995-
228·213A
Comparison of Reperfusion Times in Patients Transferred 
for Primary Angioplasty for ST Elevation Myocardial 
Infarction Prior to and After Instituting a Regional 
Myocardial Infarction Alert Protocol## 847-8·268A
In-Hospital Outcomes in Patients With ACS Treated With 
Sirolimus and Paclitaxel Drug Eluting Stents: Experience 
From the ACC-NCDR Database##923-155·253A
Protection of Distal Embolization in High-Risk Patients 
With Acute ST-Segment Elevation Myocardial 
Infarction##952-241·186A
Recurrent Ischemia Detected by Continuous Electrocardiogram 
Recording After Percutaneous Coronary Intervention for 
Non-ST-Elevation Acute Coronary Syndromes##951-
222·182A
ST-Elevation in Lead aVR During Exercise Testing Should Not 
Be Ignored## 992-131·27A
Stent
Prolonged Adenovirus and Adeno-associated Virus-mediated 
Gene Delivery to Rabbit Iliac Arteries Using Gene-
Eluting Stents: A Direct Comparison##934-177·304A
A Comprehensive Approach to the Development of Risk 
Adjustment Models for Fatal and Non Fatal Outcomes 
Following Contemporary PCI: A Report From the 
Blue Cross Blue Shield of Michigan Cardiovascular 
Consortium##923-150·252A
A New Concept of Local Paclitaxel Delivery for Prevention 
of Restenosis: Intracoronary Paclitaxel Delivery With the 
New Genie®-application Device##956-166·319A
A Randomized Trial Comparing Primary PCI With or Without 
On-Site Surgery for Acute Myocardial Infarction in the 
Netherlands: From Randomization to Clinical Practice## 
815-6·193A
Additional Ballooning Versus no Additional Ballooning After 
Drug-Eluting Stent Implantation in Routine Clinical 
Practice##998-247·217A
Bare Stenting of Obstructed Right Ventricle-to-Pulmonary 
Artery Conduits: A Fifteen-Year Experience##945-
112·239A
Blood Transfusion in Patients Undergoing Primary 
Percutaneous Coronary Intervention for Acute Myocardial 
Infarction: Analysis From the CADILLAC Trial##996-
241·215A
Carotid Angioplasty and Stenting under Protection. Short Term 
Outcomes in High and Low Risk Patients##979-180·332A
Combining Warfarin and Antiplatelet Therapy After Coronary 
Stenting in the Global Registry of Acute Coronary Events: 
Is it Safe and Effective to Use Just One Antiplatelet 
Agent?##923-149·252A
Comparative Evaluation of Postangioplasty Systemic 
Inﬂammatory and Oxidative Stress Response of 
Sirolimus-eluting and Bare Metal Stents## 850-4·221A
Comparative Pathologic Studies of Vascular Tissue Responses 
to Sirolimus-Eluting and Bare Metal Stent Implantation in 
Human Coronary Arteries##910-184·293A
Coronary Sinus Stent Implantation Improves Ischemic Mitral 
Valve Regurgitation: An Experimental Study##1006-
23·283A
Detection of Angiographically Silent In-Stent Restenosis in 
Multislice Computed Tomography## 970-3·125A
Do the Traditional Risk Factors of Vessel Size, Lesion Length 
and Diabetes Mellitus Predict Restenosis With TAXUS 
Stents? Insights From a TAXUS Meta-Analysis##954-
249·188A
Drug-Eluting Stent Supported Percutaneous Coronary 
Intervention for Unprotected Left Main Disease##928-
224·171A
Drug-Eluting Stent Thrombosis: Real-World Incidence and 
Potential Predictors of Stent Thrombosis.##995-230·213A
Durability of Endoluminal Stenting for Obstructive Lesions 
of the Subclavian Artery: Multicenter Registry in 
Japan##979-183·333A
Early and Late Stent Thrombosis After Paclitaxel-Eluting 
Stents: Analysis From the Integrated TAXUS Randomized 
Trial Program## 843-8·221A
Early and Subtle Neointimal Growth Detection Following 
Stent Implantation Using Optical Coherence Tomography 
and Intravascular Ultrasound and Histology##910-
181·293A
Effect of CKMB Elevation After Successful PCI on One-Year 
Mortality##971-220·194A
ELOCAS Registry - 5-Year Results of Carotid Stenting in High 
Volume Centers in Patients with Asymptomatic Carotid 
Stenosis##980-189·334A
Evaluation of Neointimal Hyperplasia by Optical Coherence 
Tomography at Six-Month After Sirolimus-Eluting Stent 
Deployment##956-162·318A
Impact of Restrictive Access to Clopidogrel Following 
Coronary Stent Implantation on Patient Health 
Outcomes## 811-8·257A
In-Hospital Outcomes in Patients With ACS Treated With 
Sirolimus and Paclitaxel Drug Eluting Stents: Experience 
From the ACC-NCDR Database##923-155·253A
Incidence of, Predictors of, and Outcomes Related to 
Discontinuation of Thienopyridine Therapy at 1-Month 
After Coronary Stenting in AMI## 857-8·236A
Increased In-Stent Neo-Intimal Hyperplasia after Stem Cell 
Mobilization by Granulocyte-Colony Stimulating Factor 
in Bare Stent, but Not in Drug-Eluting Stent in a Porcine 
Myocardial Infarct Model##1020-250·229A
Increasing Occurrence of Multivessel Intervention and 
Multiple Stent Placement From 1999 to 2004. The Global 
Registry of Acute Coronary Events##990-150·261A
Intravascular Ultrasound Predictors and Their Cut-off Values 
for Angiographic Restenosis After Sirolimus-Eluting Stent 
Implantation##954-253·189A
Is the Non-inferiority Claim for Bivalirudin in Percutaneous 
Coronary Intervention Warranted? REPLACE-2 
Revisited##923-145·251A
Late Angiographic Stent Thrombosis (LAST) After Bare-Metal 
Stent Versus Drug-Eluting Stent Implantation##956-
160·317A
Late- Acquired Incomplete Apposition After Drug-eluting 
Stents: Frequency and Potencial for Late Stent 
Thrombosis##1023-168·365A
Local Delivery of Evans Blue with Bare Metal Stent 
Can Prevents Restenosis as Same as Drug-eluting 
Stents##1022-215·231A
Long-Term Follow-Up Patients with ST-Segment Elevation 
Acute Myocardial Infarction Treated with Sirolimus-
Eluting Stent and Paclitaxel-Eluting Stent##976-
255·202A
Long-Term Results of Carotid Stent Implantation Up to 11-
Years in Patients With Carotid Stenosis##979-182·333A
Low-dose Simvastatin Induces Positive Remodeling 
After Coronary Stenting in Normocholesterolemic 
Patients##1024-179·368A
Micro-Computed Tomographic Scanning of Stented Coronary 
Arteries Is Feasible, and Image Analysis Reliably 
Quantiﬁes the Coronary Vasa Vasorum Density##956-
172·320A
Minimally Invasive Direct Coronary Artery Bypass (midcab) 
Surgery Versus Bare-metal Stenting in Isolated Proximal 
LAD-Stenosis: 5-Year Follow-up##976-258·203A
Mortality Beneﬁt of Drug-Eluting Stent Use in Clinical 
Practice##928-225·171A
Multi Pharmacy Is a Predictor of DES Stent 
Thrombosis##1020-246·228A
Multislice Computed Tomography in the Detection of 
Coronary In-Stent Restenosis## 970-32·129A
Multislice Spiral Computed Tomography for the Evaluation of 
Stent Patency after Left Main Coronary Artery Stenting: 
A Comparison with Conventional Coronary Angiography 
and Intravascular Ultrasound## 832-4·135A
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Neointimal Hyperplasia But Not Pathological Vascular Wall 
Structural Changes (Fibrin Deposition and Inﬂammation) 
Inﬂuence Maximal Vasodilation in Porcine Coronary 
Arteries 1-Month After Implantation of Stents##910-
182·293A
Optimal Antiplatelet Therapy After DES Implantation in 
Patients Requiring Long-Term Anticoagulation##999-
256·219A
Outcomes of Stent Implantation for Native and Recurrent 
Coarctation of the Aorta (COA): Classiﬁcation and 
Implications of Aortic Wall Injury##945-111·239A
Overlapping Sirolimus-Eluting Stents: Analysis From the 
Matrix Registry##976-259·203A
Paclitaxel-Eluting Stents Implanted in De-Endothelialized 
Coronary Arteries for 180 Days Did Not Cause Luminal 
Thrombi Using Standard Antiplatelet Therapy##956-
167·319A
Percent Plaque Area at the Edge of Sirolimus-Eluting 
Stent Predicts Restenosis in Small Vessel Coronary 
Arteries##956-163·318A
Percutaneous Transluminal Angioplasty of the Subclavian 
Arteries##1002-184·349A
Polymer Based Paclitaxel-eluting Stents Are Superior to 
Non-polymer Based Paclitaxel-eluting Stents in the 
Treatment of De-novo Coronary Lesions: An Intravascular 
Ultrasound Study##956-165·318A
Prediction of Adverse Clinical Outcomes in Unprotected Left 
Main Coronary Artery Stenting Using Risk Stratiﬁcation 
System of EuroSCORE##997-243·216A
Predictors of Stent Thrombosis After Drug-Eluting Stents 
Implantation During Long-Term Follow-Up##956-
164·318A
Predictors of Target Lesion Revascularization and Target 
Vessel Revascularization After Implantation of Sirolimus- 
Eluting Stent: Pooled Analysis From 6 Randomized Trials 
and Registries##954-248·187A
Prevalence and Clinical Impact of Angiographic Stent Fracture 
and Stent Hinge Movement After Sirolimus-eluting Stent 
(SES) Implantation in Complex PCI##976-257·203A
Randomized Comparison of Sirolimus Versus Bare Metal Stent 
Implantation in Bifurcation Lesions##1022-217·232A
Randomized Trial of Sirolimus- Versus Paclitaxel-Eluting 
Stents for the Treatment of Acute ST-Elevation 
Myocardial Infarction##952-232·184A
Relationship Between Late Loss, Diameter Stenosis and Target 
Lesion Revascularization After Stent Implantation: An 
Examination of Surrogate Endpoints From a Pooled 
Analysis of Eight Large Randomized DES Trials##954-
250·188A
Relationship of Shear Stress With In-Stent Restenosis: Bare 
Metal Stenting Versus Bare Metal Stenting and Adjunctive 
Brachytherapy##910-185·293A
Risk Score for Prediction of Major Bleeding After 
Percutaneous Coronary Intervention##1021-257·231A
Rotational Atherectomy With Sirolimus Eluting Stents Versus 
Rotational Atherectomy With Bare Metal Stents for 
Complex Coronary Calciﬁc Lesions##956-161·317A
Routine Percutaneous Coronary Intervention in Elderly 
Patients With Cardiogenic Shock Complicating Acute 
Myocardial Infarction##952-236·185A
The Impact of Changes in Insulin Resistance After PCI on 
Lumen Narrowing##954-254·189A
The Safety and Outcome of the Multiple, Very Long Sirolimus-
Eluting Stent Implantation in the the Real World Clinical 
Practice##976-260·203A
Two-Year Intravascular Ultrasound Follow-Up After 
Implantation of Non-Polymeric Paclitaxel-Coated Stents: 
A Serial Volumetric Intravascular Ultrasound Analysis 
From the Asian Paclitaxel-Eluting Stent Clinical Trial 
(ASPECT)##954-255·189A
Unprotected Left Main Bifurcation Lesion: Impact of Drug-
Eluting Stents (Cypher)##952-239·185A
Use of Percutaneous Coronary Intervention Versus Coronary 
Artery Bypass Surgery for Patients With Acute Coronary 
Syndromes and Multivessel Coronary Disease in the 
Drug-Eluting Stent Era: Data From the CRUSADE 
Quality Improvement Initiative## 821-6·205A
Yellow Color Plaques Were Still Observed Among the 
Sirolimus Eluting Stent Struts at 3 and 6-Month Follow-
Up Via Coronary Angioscope##910-183·293A
Stress testing
64-Slice CT Angiography Is a Cost-saving Strategy for 
Patients With Mildly Abnormal Nuclear Stress Tests## 
807-4·113A
Chronic Kidney Disease Is a Powerful Predictor of Adverse 
Outcomes in Patients With Abnormal Myocardial 
Perfusion Imaging and Insigniﬁcant Coronary Artery 
Disease## 926-11·107A
Color M-mode Strain Rate Stress Echocardiography Predicts 
Prognosis in Patients Evaluated for Coronary Disease## 
948-40·123A
Colour-coded Tissue Tracking Is an Accurate, Fast, and Simple 
Tool for Identiﬁcation of Non-ischemic Patients in the 
Hand of Inexperienced Stress Echocardiography Reader## 
948-44·124A
Comparison and Co-Relation of Invasive and Noninvasive 
Methods of Ejection Fraction Measurement##919-53·38A
Dipyridamole-Exercise Tc-99m Sestamibi Gated Single-Photon 
Emission Computed Tomography Provides Effective Risk 
Stratiﬁcation of Elderly Patients## 926-6·106A
Dobutamine Stress Echocardiographic Assessment of Left 
Ventricular Function Long After Intervention for 
Coronary Artery Fistula##989-116·243A
Fragmented QRS (rsr` Pattern and Its Variants; QRS duration 
<120 ms) Predicts Signiﬁcant Cardiac Events and 
Mortality in Patients Undergoing Stress Testing##1029-
207·374A
Fragmented QRS on 12-lead ECG Represents Increased 
Cardiac Events and Mortality in Diabetic Patients With 
Abnormal Myocardial Perfusion Scan##1029-208·374A
Incremental Diagnostic Value of High-Frequency QRS 
Analysis for Identifying Stress-Induced Ischemia## 
828-3·132A
Incremental Prognostic Value of Transient Ischemic Left 
Ventricular Cavity Dilatation on Stress Echocardiography 
Over Historical, Clinical, Resting and Stress 
Echocardiographic Variables## 948-43·123A
Lack of Correlation Between Coronary Artery Calcium and 
Myocardial Perfusion Imaging## 926-12·107A
Left Coronary Artery Flow Reserve Measured 
Transthoracically Improves the Diagnostic Value of 
Routine Dipirydamole-Atropine Stress Echocardiogram## 
948-41·123A
Performance Characteristics of Stress Testing in Contemporary 
Practice: Comparison to Angiography##968-150·259A
Performance Characteristics of Stress Testing in Contemporary 
Practice: Long-term Prognosis##968-147·258A
Prognostic Value of Regional Left Ventricular Functional 
Assessment From Stress Tc-99m Sestamibi Gated 
SPECT## 926-34·110A
Prognostic Value of Regional Left Ventricular Functional 
Assessment in Patients Undergoing Exercise or 
Pharmacologic Gated SPECT## 926-29·109A
ST-Elevation in Lead aVR During Exercise Testing Should Not 
Be Ignored## 992-131·27A
Subendocardial LV Strain Measurements During ATP 
Infusion## 846-5·148A
Survival After Coronary Revascularization, With and Without 
Mitral Valve Repair, in Patients With Ischemic Mitral 
Regurgitation. Importance of Pre-operative Myocardial 
Viability##962-21·278A
The OPTIMIZE Trial: A Randomized Cross-Over Trial of 
Dobutamine Echocardiography, With and Without 
Deﬁnity™ Evaluating the Effect of Contrast on the 
Accuracy of Diagnosing Coronary Artery Disease## 
806-6·112A
The Prognostic Value of Pharmacologic Nuclear Stress Testing 
in Elderly Patients Undergoing Moderate to High-Risk 
Surgery## 926-14·107A
Ventilation Efﬁciency for Monitoring CHF Therapy: A Need 
for Method Standardization## 1017-29·156A
Wall Motion Score by Stress Echocardiography Is Superior to 
Angiographic Jeopardy Score for Risk Stratiﬁcation and 
Prognosis## 948-46·124A
Stroke
Adverse Clinical Outcomes in Left-sided Infective 
Endocarditis Complicated Intravenous Drug Addict##984-
27·281A
Are There Gender Differences in Risk of Ischemic Stroke in 
Patients with Atrial Fibrillation Who Are Anticoagulated? 
Results from the AFFIRM Trial## 804-6·10A
Assessment of the Markers of Platelet and Coagulation 
Activation Following Transcatheter Closure of 
Patent Foramen Ovale in Patients with Cryptogenic 
Stroke##945-115·240A
Atrial septal Aneurysm Predicts Persistent Residual Shunt 
Following PFO Closure With CardioSEAL/STARFlex 
Occluder Device## 1017-3·152A
Baseline Characteristics Associated With Embolism in 
Infective Endocarditis##984-26·281A
Cardiovascular Events in Clinical Trials Involving Over 41,000 
Patients Evaluating the Cyclooxygenase-2 Inhibitor 
Celecoxib##1029-209·374A
Despite Greater Co-Morbidities, Diabetes Does not Increase 
60-Day or 1-Year Post Stroke Mortality##961-208·327A
Does Hormone Therapy Impact Stroke Risk Among Women 
With Atrial Fibrillation?Results from the AFFRIM trial## 
1015-131·33A
Effects of Aggrenox and Telmisartan Versus Clopidogrel 
and Aspirin in Combination on Platelet Activity in 
Diabetic Patients: An ex vivo Outlook to the PRoFESS 
Trial##1023-167·365A
ELOCAS Registry - 5-Year Results of Carotid Stenting in High 
Volume Centers in Patients with Asymptomatic Carotid 
Stenosis##980-189·334A
Evolution in Stroke Risk Factors and Medications Over 20-
Year Population-based Stroke Registry##935-179·305A
Impact of Chronic, Daily Antiplatelet Therapy on Embolic 
Events in Infective Endocarditis##984-19·279A
Lipid Parameters and Risk of Ischemic Stroke in Type 2 
Diabetes Mellitus: The Strong Heart Study##1003-
190·350A
Long-Term Results of Carotid Stent Implantation Up to 11-
Years in Patients With Carotid Stenosis##979-182·333A
Monitoring Platelet Inhibition After Clopidogrel With 
VerifyNow-P2Y12® Rapid Analyzer: The VERIfy 
Thrombosis risk ASsessment (VERITAS) Study##908-
165·289A
Paradoxical Increased Post Ischemic Stroke Mortality Among 
Whites in the Veteran Population:Does Access to Care 
Inﬂuence Outcomes?##916-251·166A
Reduction of Atherothrombosis for Continued Health 
(REACH) Registry Results: 1-Year Cardiovascular Event 
Rates in a Global Contemporary Registry of Over 68,000 
outpatients with Atherothrombosis##916-256·168A
Risk of Hemorrhagic Stroke in Atrial Fibrillation: Is There an 
Ethnic Difference in Its Incidence and in the Effect of 
Warfarin?## 849-8·363A
Risk of Ischemic Stroke in Atrial Fibrillation: Is There an 
Ethnic Difference in Its Incidence and in the Efﬁcacy of 
Warfarin?## 1015-140·35A
Stroke Prevention Technology for Patients With Non-Valvular 
AF - Worldwide Experience with the New WATCHMAN 
LAA System## 1015-143·36A
Trends and Predictors of Outcome in Circulatory Arrest for 
Adult Cardiac Surgery: A Decade of Experience (1996-
2005)##940-25·275A
Warfarin Therapy Initiated Before Transesophageal 
Echocardiography Detected Left Atrial Thrombus Is More 
Beniﬁcial Than When Started After## 1017-2·152A
Stroke volume
Increased Arterial Stiffness: A Major Determinant of the 
White-Coat Effect##982-197·336A
Role of Volume Load in Heritability of Left Ventricular Mass: 
The Hypergen Offspring Study## 835-3·342A
The Accuracy of Real-Time Three-Dimensional 
Echocardiographic Derived Flow Volumes With 
Increasing Depth: An in Vitro Study## 991-46·141A
Sudden death
Changes in Parasympathetic Tone Result in QT-RR Interval 
Hysteresis during Exercise and Recovery## 813-5·13A
Cooling Blankets Are Effective for Achieving Therapeutic 
Hypothermia and Improving Survival-to-discharge 
Following Cardiac Arrest for Patients With All 
Arrhythmia Types##906-245·165A
Do Ventricular Tachyarrhythmias From a Failing Heart Need 
More Energy to Convert?## 947-123·14A
Effect of Bundle Branch Block on Microvolt T-Wave 
Alternans## 924-129·6A
How Reliable Are Pre-Hospital and Admission ECGs to 
Predict Recent Coronary Artery Occlusion in Patients 
With Successfully Resuscitated Out-Of-Hospital Cardiac 
Arrest?##906-241·164A
Is There a Role for Implantable Cardioverter-Deﬁbrillator 
Therapy for the Primary Prevention of Sudden Death in 
Patients With Chronic Kidney Disease?## 818-5·19A
Patients With Coronary Artery Disease that Suffer Sudden 
Cardiac Death Have Exaggerated Prolongation of 
Ventricular Repolarization: A Three-Year Community-
Wide Study## 924-126·6A
Predictors of Sudden Cardiac Death in a Population With High 
Prevalences of Obesity and Diabetes: The Strong Heart 
Study##961-207·327A
QRS Duration and Microvolt T Wave Alternans Testing in 
Patients With Ischemic Cardiomyopathy## 924-123·5A
Regression of Electrocardiographic Left Ventricular 
Hypertrophy by Both Cornell Voltage-Duration Product 
and Sokolow-Lyon Voltage During Antihypertensive 
Therapy is Associated With Decreased Incidence of 
Sudden Cardiac Death: The LIFE Study## 848-4·360A
Relationship Between Renal Function, Risk of Sudden Cardiac 
Death, and Beneﬁt of the Implanted Cardiac Deﬁbrillator 
in Post Myocardial Infarction Patients With Left 
Ventricular Dysfunction## 818-4·19A
Sudden Cardiac Arrest with Normal Ejection Fraction: How 
Often Is Coronary Ischemia the Trigger?## 924-130·7A
Sudden Cardiac Death in Athletes: Rates of 
Deﬁbrillation##906-243·165A
Use of Semiautomatic Deﬁbrillators by Minimally Trained 
Lay Persons in Cardiac Emergencies: Is It Safe?##906-
244·165A
Superoxide dismutase
The CYBA Genotype Is Associated With Altered NADPH 
Oxidase Activity in Patients With Cardiovascular 
Disease## 822-7·340A
Supraventricular tachycardia
Remote Radiofrequency Ablation of Left Sided Accessory 
Pathways Using the Retrograde Transaortic Approach: 
A Comparison of Catheters With Different Magnetic 
Mass## 901-142·5A
Validation of an Electrocardiographic Predictive Regression 
Model for the Differential Diagnosis of Paroxysmal 
Junctional Tachycardias in Patients Without 
Preexcitation## 992-137·29A
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Syncope
Genotype of the Beta-Adrenergic Receptor Polymorphism 
Was a Strong Risk Factors for Neurally Mediated 
Syncope##913-201·297A
Systole
Usefulness and Cost Effectiveness of Squatting Stress 
Echocardiography in the Diagnosis of Coronary Artery 
Disease## 948-37·122A
Tech assessment
A Virtual Classroom is Superior to Traditional Training in 
Teaching Cardiac Auscultation##1013-148·267A
Early Results of a Nurse-Based Outpatient Telemedicine 
Project for Patients After Acute Coronary 
Syndrome##1036-151·270A
The Impact of an Electronic Stethoscope as a Patient Simulator 
in Cardiac Auscultation##1013-150·267A
Tetralogy of fallot
Bare Stenting of Obstructed Right Ventricle-to-Pulmonary 
Artery Conduits: A Fifteen-Year Experience##945-
112·239A
Relation Between Plasma Brain Natriuretic Peptide, Right 
Ventricular Function and Exercise Capacity in Patients 
After Surgical Repair of Tetralogy of Fallot##967-
111·240A
Right Ventricular Remodeling as a Result of Pulmonary Valve 
Replacement in Adult Fallot Patients Is Closely Related to 
Baseline Right Ventricular Size##1011-115·244A
Thrombin inhibitors
A Phase-I Study to Assess the Antithrombotic Properties 
of DU-176b: An Orally Active Direct Factor-Xa 
Inhibitor##908-161·288A
Anti-thrombotic Effect of Bivalirudin Compared With 
Eptiﬁbatide and Heparin in Diabetic Patients Undergoing 
Angioplasty: An Ex-vivo Human Study##1023-171·366A
Percutaneous Coronary Intervention in Patients Receiving 
Only a Single Subcutaneous Dose of Enoxaparin: Results 
From the SYNERGY Trial##1020-244·228A
The Efﬁcacy and Safety of Fondaparinux Versus Enoxaparin 
in Non-ST Elevation ACS: Impact of Renal Dysfunction 
(OASIS 5)##972-222·195A
Thromboembolism
A Phase-I Study to Assess the Antithrombotic Properties 
of DU-176b: An Orally Active Direct Factor-Xa 
Inhibitor##908-161·288A
Atrial Fibrillation: Bridging of Chronically Anticoagulated 
Patients With Low Molecular Weight Heparin Prior to 
Interventional Procedures: Experience in 455 Patients 
From the Brave-registry## 849-6·362A
Better Coronary Flow in Culprit Lesions With Deep 
Echo Attenuation Treated by Directional Coronary 
Atherectomy##995-225·212A
Cerebrovascular Thromboembolic Events After Mitral Valve 
Repair: Implication for Treatment of Patients with Mitral 
Regurgitation##917-25·273A
Computer Alert Increases Use of Prophylaxis for Patients at 
High Venous Thromboembolism Risk##958-185·322A
Long-Term Follow-Up in Patients With Percutaneous Left 
Atrial Appendage Transcatheter Occlusion System 
(PLAATO): Risk of Thrombus Formation and 
Development of Pulmonary Venous Obstruction After 
Percutaneous Left Atrial Appendage Occlusion## 1015-
142·36A
Low Molecular Weight Heparin in Chronically Anticoagulated 
Patients After Mechanical Valve Replacement Prior to 
Interventions With High-Risk of Bleeding: Experience in 
104 Patients From the BRAVE-Registry## 824-7·282A
Massive Pulmonary Embolism##958-181·322A
Persistence of Iatrogenic Atrial Septal Defect after 
Pulmonary Vein Isolation with Transseptal Puncture - an 
Underestimated Risk?## 992-141·29A
The Incidence of Thromboembolism in Patients With NYHA 
Class II and III Heart Failure: An Analysis From the 
Sudden Cardiac Death in Heart FailureTrial (SCD-
HeFT)##919-58·39A
Venous Thromboembolic Prophylaxis in Hospitalized Heart 
Failure Patients: Missing in Action?##1032-58·86A
Thrombolysis
A Prospective Randomized Trial of a Rapid Fibrinolytic 
Protocol for Left-sided Prosthetic Valve Thrombosis: 
Interim Analysis## 803-8·277A
Evaluation of the TIMI Risk Index in a Multi-continental 
Population of 19,103 Patients With STEMI in the 
ExTRACT-TIMI 25 Trial##1018-222·223A
Hospitalization Costs of Tenecteplase-Facilitated Angioplasty 
Versus Thrombolysis-Alone in Acute Myocardial 
Infarction##929-239·174A
Impact of Time to Presentation and Reperfusion Modality on 
the Efﬁcacy of Adenosine During Reperfusion Therapy 
for Acute Myocardial Infarction: The AMISTAD-2 
Trial##929-241·175A
Lower Mortality With Paramedics Interpreting the 
Electrocardiogram Coupled to Primary Percutaneous 
Angioplasty for ST-Segment Elevation Myocardial 
Infarction## 815-7·193A
Massive Pulmonary Embolism##958-181·322A
Renal Dysfunction Negates the Beneﬁt of Primary 
Percutaneous Coronary Intervention Over Fibrinolytic 
Therapy in the Treatment of ST Segment Elevation 
Myocardial Infarction##904-227·160A
Rescue Angioplasty Versus Conservative Treatment in 
Patients with Failed Fibrinolysis- No Late Survival 
Beneﬁt. The Final Analysis of the Middlesbrough 
Early Revascularisation to Limit Infarction (MERLIN) 
Randomised Trial##929-232·173A
Rescue Percutaneous Coronary Intervention After Failed 
Fibrinolysis: A Meta-Analysis of Randomized Controlled 
Trials##929-234·173A
Strong Impact of Mechanical Coronary Intervention on 
Cardiac Rupture After Acute Myocardial Infarction: The 
Kochi Acute Myocardial Infarction (KAMI) Study##952-
238·185A
The SAMU Network Minimizes Treatment Delays for ST-
Elevation Myocardial Infarction: Insights From a Three-
Year Registry##973-239·199A
Thrombolysis of Massive Pulmonary Embolism: Efﬁcacy and 
Safety of Adjunctive Therapy With Enoxaparin in Patients 
Older Than 75 Years##958-180·321A
Thrombolytic Therapy for Left-Sided Prosthetic Valve 
Theombosis## 844-6·285A
Thrombosis
A Phase-I Study to Assess the Antithrombotic Properties 
of DU-176b: An Orally Active Direct Factor-Xa 
Inhibitor##908-161·288A
A Prospective Randomized Trial of a Rapid Fibrinolytic 
Protocol for Left-sided Prosthetic Valve Thrombosis: 
Interim Analysis## 803-8·277A
Added Ramipril to Simvastatin Shows Additive Effects on 
Tissue Factor Activity and Prothrombin Fragment 1+2 in 
Patients With Type 2 Diabetes##1023-172·366A
Anti-Thrombotic Properties of A Novel Nitric Oxide Donor 
(LA-419) in a Human Model of Thrombosis##908-
172·290A
Antiplatelet Effects of Angiotensin-Converting Enzyme 
(ACE) Inhibitors and Angiotensin II Subtype 1 Receptor 
Blockers (ARBs): Modiﬁed Ex Vivo Platelet Aggregation 
of 374 Cardiovascular Patients##1023-166·365A
Assessment of Coronary Red and White Thrombus by Optical 
Coherence Tomography##908-163·289A
AZD6140 Yields Greater Inhibition of Platelet Aggregation 
Than Clopidogrel in Patients With Acute Coronary 
Syndromes Without Previous Clopidogrel Treatment## 
821-3·204A
Cardiac Amyloidosis is Associated with a High Frequency of 
Intracardiac Thrombus Formation##1009-104·81A
Discrimination of Human Coronary Thrombus Types by 
Optical Coherence Tomography in Vitro## 843-6·220A
Drug-Eluting Stent Thrombosis: Real-World Incidence and 
Potential Predictors of Stent Thrombosis.##995-230·213A
Early and Late Stent Thrombosis After Paclitaxel-Eluting 
Stents: Analysis From the Integrated TAXUS Randomized 
Trial Program## 843-8·221A
Early Initiation Of Low-Dose Atorvastatin Treatment After 
An Acute ST-Elevated Myocardial Infarction, Decreases 
Inﬂammatory Response And Stimulates Antithrombotic 
Mechanisms##996-234·214A
Impact of Enhanced Platelet Reactivity on Microvascular 
Reperfusion and Left Ventricular Remodeling in 
ST-segment Elevation Myocardial Infarction.##908-
168·290A
Improved Visualization of Thrombus Using tPA-Encapsulated 
Echogenic Liposomes## 1016-35·149A
Inconsistency in the Prevalence of Platelet Aspirin Resistance 
as Measured by COX-1 Non-Speciﬁc Assays in Patients 
Treated With 81, 162 and 325 mg Aspirin##908-169·290A
Increased Platelet-Leukocyte Aggregation in Indian Asian 
Men: A Mechanism Contributing to Greater Cardiovasular 
Risk?##1023-163·364A
Increased Presence of Pro-Coagulant Apoptotic Bodies in 
Lipid-Rich and Vulnerable Atheroma: A Vehicle to 
Propagate Cell Death and Pro-Coagulant Potential?##977-
165·329A
Inhalation of Combustion-derived Air Pollution Impairs 
Endogenous Fibrinolysis in Patients With Ischemic Heart 
Disease##908-160·288A
Late Angiographic Stent Thrombosis (LAST) After Bare-Metal 
Stent Versus Drug-Eluting Stent Implantation##956-
160·317A
Late- Acquired Incomplete Apposition After Drug-eluting 
Stents: Frequency and Potencial for Late Stent 
Thrombosis##1023-168·365A
Limitation of Angiography to Identify the Culprit Lesion 
in Acute Myocardial Infarction With Total Occlusion: 
Utility of Thermal Wire to Identify Culprit Lesion by 
Intravascular Ultrasound##951-228·183A
Multi Pharmacy Is a Predictor of DES Stent 
Thrombosis##1020-246·228A
Paclitaxel-Eluting Stents Implanted in De-Endothelialized 
Coronary Arteries for 180 Days Did Not Cause Luminal 
Thrombi Using Standard Antiplatelet Therapy##956-
167·319A
Plasma Levels of Fibrinogen, Plasminogen Activator Inhibitor 
-1, and Von Willebrand Factor Are Increased in Patients 
With Erectile Dysfunction##1023-170·365A
Platelet Aspirin Resistance in Patients With Coronary Artery 
Disease Is Rare at all Aspirin Doses When Measured by 
COX-1 Speciﬁc Assays##908-162·288A
Positron Emission Tomography Can Identify Arterial Segments 
with Vulnerable Plaque Leading to Arterial Thrombosis## 
926-7·106A
Predictors of Stent Thrombosis After Drug-Eluting Stents 
Implantation During Long-Term Follow-Up##956-
164·318A
Preprocedual Statin Administration Can Reduce Thrombosis 
Reaction in Both Acute Myocardial Infarction and Stable 
Angina - Histologic Evaluation## 855-4·379A
Prevalence and Platelet Function Proﬁles of Clopidogrel Hypo-
responders Identiﬁed Following Drug Withdrawal##1023-
160·363A
Prevalence of Concomitant Suboptimal Responsiveness 
to Aspirin and Clopidogrel Treatment in Diabetic 
Patients##1023-162·364A
Should Anticoagulation Be Used During Routine Diagnostic 
Coronary Angiography?##1023-169·365A
The Efﬁcacy and Safety of Fondaparinux Versus Enoxaparin 
in Non-ST Elevation ACS: Impact of Renal Dysfunction 
(OASIS 5)##972-222·195A
Thrombospondin-4 A387p Polymorphism Is not Associated 
With Markers of Vascular Function and Incidence of 
Myocardial Infarction##933-159·300A
Thyroid hormones
The Outcomes of Thyrotoxicosis Related New-Onset Atrial 
Fibrillation## 804-5·10A
Thyroid Dysfunction is More Prevalent in Cardiomyopathy 
Patients Than in the General Population##986-95·68A
Thyroid Hormone Protects the Heart Against Ischaemia-
Reperfusion Injury Through a Redox Regulated Survival 
Signaling##949-219·180A
Thyroid Hormone Receptors α1 and β1 Are Downregulated 
in the Post-infarcted Rat Heart: Consequences on the 
Response to Ischaemia-reperfusion##949-218·179A
Tomography
A Novel Plasmid Vector for Quantitative and Noninvasive 
Positron-Emission Tomography Imaging of the 
Therapeutic Cardiac Transgene Expression ## 812-4·115A
A Predisposition for the Metabolic Syndrome Increases 
Subclinical Inﬂammed Coronary Plaque Burden 
in Low Framingham Risk Women From a General 
Population##939-212·312A
Anatomical Remodeling of Left Atria in Subjects with 
Chronic and Paroxysmal Atrial Fibrillation Evaluated by 
Multislice Computed Tomography## 1015-138·35A
Antinanobacterial Antibody Titer Is an Independent Risk 
Factor for Coronary Artery Calciﬁcation##1000-167·345A
Assessment of Myocardial Perfusion and Wall Motion 
Abnormalities During Adenosine Stress Multi-detector 
Computed Tomography Perfusion Imaging## 970-
41·131A
Association of Low Fetuin-A and Inﬂammation With the 
Severity of Aortic Valve Calciﬁcation##1030-26·287A
Automated Pericardial Fat Quantiﬁcation in CT Data##1012-
145·264A
Coronary Artery Lesions with Intra-plaque Enhancement in 
Multidetector Spiral Computed Tomography## 970-
6·125A
Coronary Imaging With Multi-detector Computed 
Tomography: A Meta-analysis## 970-12·126A
Correlation Between 16-Slice Multidectector Computed 
Tomography and Intravscular Ultrasound in Patients 
With Ambiguous Left Main Coronary Artery Stenosis## 
970-34·129A
Detection of Angiographically Silent In-Stent Restenosis in 
Multislice Computed Tomography## 970-3·125A
Discrimination of Human Coronary Thrombus Types by 
Optical Coherence Tomography in Vitro## 843-6·220A
Effect of CT Beathing Protocol on Attenuation Corrected 
SPECT Distribution in Normal Myocardium## 926-
16·108A
Evaluation of Robotic Coronary Surgery by Intraoperative 
Angiography in Combination With Postoperative 
Multislice Computer Tomography##932-254·177A
Extraction of Latent, Computed Tomographic Images of 
Coronary Artery Plaque Components by Isotropic, Three-
Dimensional Wavelet Analysis## 970-29·128A
Identiﬁcation of Plaque Composition in Multislice Computed 
Tomography## 970-35·129A
Identiﬁcation of Plaque Types and Distribution Patterns 
by Multi-detector Computed Tomography Enhances 
Prediction of Clinically Signiﬁcant Coronary Artery 
Disease## 970-30·128A
Image Quality of 64-Slice Multi-Detector Computed 
Tomography Coronary Angiography in Heart Transplant 
Recipients## 970-37·130A
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Impact of Intra-plaque Enhancement in Multislice Computed 
Tomography on Coronary Flow After Percutaneous 
Coronary Intervention## 970-15·127A
Impact of Mesenchymal Stem Cell Therapy on Scar 
Composition and Cardiac Regional Function##903-
220·159A
Impaired Left Ventricular Systolic Function Predicts Increased 
One-Year Mortality Following Normal Positron Emission 
Tomography Stress Myocardial Perfusion Imaging## 
926-1·104A
Inﬂuence of Scan Protocols on Radiation Dose Estimates for 
Coronary 64-Slice CT Angiography## 807-3·113A
Intraindividual Comparison of Radiation Dose Exposure 
between Multislice Computed Tomography and 
Conventional Coronary Angiography## 970-31·128A
Multislice Computed Tomography in Detection of Coronary 
Artery Disease in Heart Transplant Patients## 970-7·126A
Multislice Computed Tomography in the Detection of 
Coronary In-Stent Restenosis## 970-32·129A
Multislice Spiral Computed Tomography for the Evaluation of 
Stent Patency after Left Main Coronary Artery Stenting: 
A Comparison with Conventional Coronary Angiography 
and Intravascular Ultrasound## 832-4·135A
Noninvasive Coronary Angiography: Agreement of 64-Slice 
Cardiovascular Computed Tomography and Selective 
Catheter Angiography## 970-13·127A
Pathological Analysis of the Culprit Lesions with Unique 
Intra Plaque Enhancement in Multislice Computed 
Tomography## 832-6·135A
Prediction for Stent Underexpansion by Pre-procedural 
Multidetector Computed Tomography## 832-3·135A
Predictors of Non-Calciﬁed Plaques of Coronary Arteries in 
422 Subjects by Multislice Computed Tomography Using 
Logistic Regression Models##930-242·175A
Progression of Calciﬁed Coronary Atherosclerosis: Role 
of Traditional Risk Factors, CRP, and Non-calciﬁed 
Atherosclerosis## 970-16·127A
Quantitative Assessment of Left Ventricular Size and Function: 
Side-by-Side Comparison of Three-Dimensional 
Echocardiography and Computed Tomography Against 
Magnetic Resonance Reference## 991-38·139A
Signiﬁcance of Calciﬁed and Non Calciﬁed Plaques of 
Coronary Arteries for Presence of Myocardial Infarction 
Evaluated by Multislice Computed Tomography## 970-
43·131A
Study of Coronary Calcium Score by Multislice Computed 
Tomography in Relation to Endothelial Function, C-
Reactive Protein, and Interleukin-6 in Asymptomatic 
Individuals## 970-36·129A
Symptomatic Obese Patients Undergoing 64-Slice Multi 
Detector Computed Tomography Are Younger and Have 
Lower Prevalence of Signiﬁcant Coronary Stenosis## 
970-9·126A
Usefulness of 64-slice Multi Detector Computed Tomography 
to Improve Diagnostic Yield in Patients With Chest Pain 
and Negative or Equivocal Exercise Treadmill Tests## 
807-6·114A
Transplantation
Adult Mesenchymal Stem Cells From Patients With Ischemic 
Heart Disease Engraft in Ischemic Myocardium 
and Improve Left Ventricular Function in NOD/scid 
Mice##903-221·159A
Cardiac Pacemaker Precursor Cells Can Be Obtained From 
Human Endometrial Mesenchymal Stem Cells for 
Biological Pacemaker Cell Transplantation.## 901-
131·2A
Cause of Death and Serum Cardiac Troponin Levels Predict 
Cardiac Function in Heart Transplant Donors##966-
106·60A
Congenital Heart Disease and Late Mortality Following 
Pediatric Heart Transplantation##967-115·241A
Coronary Blood Flow and Coronary Flow Reserve by Contrast-
Enhanced Transthoracic Echocardiography Predict Long-
Term Outcome in Heart Transplantation##1010-105·82A
Coronary Hypersensitivity to Serotonin in Cardiac Transplant 
Recipients. Relation to Vessel Wall Morphology and 
Effect of Vitamin C##1010-107·82A
Elevated Right Atrial Pressure After Heart Transplantation Is 
Associated With Increased Long Term Mortality##990-
154·262A
Image Quality of 64-Slice Multi-Detector Computed 
Tomography Coronary Angiography in Heart Transplant 
Recipients## 970-37·130A
Increased Mortality With Post-operative Renal Failure After 
Cardiac Transplant## 825-3·74A
Intramyocardial Bone Marrow Stem Cells Transplantation 
for Non-ischemic Dilated Cardiomyopathy: 4 Months 
Follow-up##903-215·158A
Is Adenosine Pharmacologic Stress Testing Safe in Cardiac 
Transplant Patients?##1010-106·82A
Kidney Transplantation Leads to Improved Left Ventricular 
Ejection Fraction in Patients with Systolic Dysfunction 
and End Stage Renal Failure Compared to Medical 
Management Alone##1008-99·80A
Measurement of Cardiac Output by Real-Time 3-D 
Echocardiography in Patients Undergoing Assessment for 
Cardiac Transplantation## 991-45·141A
Multislice Computed Tomography in Detection of Coronary 
Artery Disease in Heart Transplant Patients## 970-7·126A
Outcomes in Cardiac Transplant Recipients Using Donor 
Allografts With Left Ventricular Hypertrophy##966-
105·60A
Post-transplant Ischemic Injury Is Associated With Increased 
AlloMap Gene Expression Score##1034-107·91A
Prevalence and Risk Factors for Renal Insufﬁciency in 
Pediatric Heart Transplant Recipients: A Long-Term 
Follow-Up Study##967-116·242A
Rapamycin Therapy Improves Coronary Physiology After 
Cardiac Transplantation##944-105·51A
Renal Dysfunction and New Onset Proteinuria Predict 
Mortality in Heart Transplant Patients After Replacement 
of Calcineurin Inhibitors With Sirolimus##944-106·51A
Sirolimus as a Primary Immunosuppressant in Calcineurin-
Inhibitor induced Nephrotoxicity##944-107·51A
Subclinical Left Ventricular Abnormalities Predict Outcome in 
Chronic Kidney Disease and Are Reversible With Renal 
Transplantation## 925-44·104A
The Risk of Primary Allograft Failure Using Hearts From 
Older Donors##966-107·60A
Tricuspid Annular and Septal Doppler Tissue Velocities are 
Reduced in Pediatric Heart Transplant Recipients##967-
114·241A
Tricuspid regurgitation
Determinants of the Severity of Functional Tricuspid 
Regurgitation: The Emerging Role of the Right 
Ventricular Geometry## 844-7·285A
End Diastolic Pulmonary Regurgitation Gradient Predicts 
Adverse Cardiovascular Outcomes: Data from the Heart 
and Soul Study## 902-18·98A
Factors Associated With Development of Signiﬁcant Tricuspid 
Regurgitation Late After Successful Left-sided Valve 
Surgery## 803-9·277A
Initial Experience of New Three-Dimensional Annuloplasty 
Ring for Functional Tricuspid Regurgitation##917-
27·273A
Three-Dimensional Tricuspid Annular Function Provides 
Insight Into the Mechanisms of Valve Regurgitation in 
Classic Hypoplastic Left Heart Syndrome## 839-5·146A
Tricuspid valve
Concurrent Percutaneous Balloon Valvuloplasties in Combined 
Rheumatic Mitral and Tricuspid Stenosis: Our Experience 
of Different Techniques##1006-25·284A
Echocardiographic Parameters of Right Heart Function in 
Patients With Symptoms of Heart Failure## 902-41·101A
Intravenous Heroin Increases the Risk of Right-sided Infective 
Endocarditis Compared to Other Intravenous Drugs of 
Abuse##984-23·280A
Outcome Of Prenatally Diagnosed Tricuspid Atresia: A 
Multicenter Experience##1035-114·248A
Troponin
A Simple Multi-biomarker Model Does Not Predict Outcomes 
Better Than Single Biomarkers in Heart Failure##1032-
95·89A
Acute Coronary Syndrome With Troponin Elevation But 
Non-Signiﬁcant Coronary Artery Disease: A Benign 
Condition?##975-247·201A
Aging Modiﬁes Cardiac Phenotype of Mice Expressing 
Familial Hypertrophic Cardiomyopathy Linked Troponin 
T Mutants##965-100·59A
Cardiac Troponin T in Heart Failure: Results from Val-
HeFT##986-58·66A
Cardiospeciﬁcity of the 3rd Generation Cardiac Troponin T 
Assay After a 216 km Ultra-Endurance Marathon Run in 
the Death Valley##950-219·181A
Do Biomarkers Add Prognostic Information to Routine 
Measures of the Severity of Heart Failure?##986-59·66A
Elevated Cardiac Troponin is an Independent Predictor of in 
Hospital Mortality in the Medical Intensive Care Unit 
Patients##931-253·177A
Elevation of Cardiac Troponin T in Infective Endocarditis 
Predicts an Adverse Outcome##984-20·280A
Field Triage Directly to the Catheter Laboratory Safely Reduce 
Time to Reperfusion and Infarct Size in Patients With ST-
Elevation Myocardial Infarction## 815-5·192A
Impact of Elevated Troponin T level at Admission on the 
Non-Culprit Plaque Progression in Clinical Unstable 
Angina Pectoris: A Volumetric Intravascular Ultrasound 
Analysis##951-229·183A
Isolated Elevation in Troponin-T Following Percutaneous 
Coronary Intervention Is Associated With Higher Long-
Term Mortality## 850-5·221A
Monitoring of Patients With Conﬁrmed Pulmonary Embolism 
Using NT-pro-Brain Natriuretic Peptide and Cardiac 
Troponin T##958-184·322A
Right Ventricular Injury and Dysfunction During Endurance 
Sports## 1017-32·157A
Risk Prediction With Cardiac Troponin T Versus Biochemical 
Markers Associated With Cardiac Remodeling##959-
191·324A
Soluble Tumour Necrosis Factor-related Apoptosis Inducing 
Ligand is Low Early in the Presentation of Acute 
Coronary Syndromes and Is Inversely Correlated With 
C-Reactive Protein and Troponin T##971-217·194A
Ultrasonic diagnosis
Association Between Carotid Intima-Media Thickness and 
Aortic Arch Plaque Thickness in the Elderly##980-
188·334A
Contrast Ultrasound Perfusion Imaging: The Beginning 
of a New Era in the Diagnostic of Peripheral Artery 
Disease?## 802-6·315A
Do Duplex Ultrasound Velocities Accurately Reﬂect 
Angiographic Stenosis in Recently Stented Carotid 
Arteries?##1025-184·369A
Gender Difference in the Impact of Multiple Cardiovascular 
Risk Factors on the Femoral Artery Intima-Media 
Thickness in Asymptomatic Young Adults: The Bogalusa 
Heart Study##1000-169·346A
Improved Visualization of Thrombus Using tPA-Encapsulated 
Echogenic Liposomes## 1016-35·149A
Intravascular Ultrasound-Based Imaging of Vasa Vasorum 
for the Detection of Vulnerable Atherosclerotic 
Plaque##1012-146·264A
Real-Time 3-Dimensional Echocardiography for the 
Calculation of Left Ventricular Volumes in Fetuses 
With Aortic Stenosis Being Considered for In-Utero 
Intervention: An In-Vivo, and In-Vitro Validation Study## 
852-5·249A
Role of the Middle and Anterior Cerebral Arteries Assessment 
After Internal Carotid Artery Stenting##980-186·334A
Use of Portable Ultrasound to Measure Carotid Intima-Media 
Thickness##1025-180·368A
Usefulness of Arterial Stiffness Evaluation for the Differential 
Diagnosis of Hypertrophic Cardiomyopathy From 
Hypertensive Heart Disease##920-102·43A
Unstable angina
A Comparison of Upstream Versus Downstream 
Administration of Glycoprotein 2b/3a Blockers in Patients 
With Non ST-Elevation Acs Who Are All Scheduled for 
Early Invasive Therapy## 843-5·220A
A Routine Intervention Strategy in Patients With Non-ST 
Segment Elevation Acute Coronary Syndromes Is Not 
Superior to a Selective Intervention Strategy: A Meta-
Analysis of Randomized Controlled Trials## 811-4·257A
Acute Coronary Syndrome With Troponin Elevation But 
Non-Signiﬁcant Coronary Artery Disease: A Benign 
Condition?##975-247·201A
Acute Coronary Syndromes Do Not Lower Lipid Levels##959-
186·323A
AZD6140 Yields Additional Suppression of Platelet 
Aggregation in Patients With Acute Coronary Syndromes 
Previously Treated With Clopidogrel## 821-4·204A
AZD6140 Yields Greater Inhibition of Platelet Aggregation 
Than Clopidogrel in Patients With Acute Coronary 
Syndromes Without Previous Clopidogrel Treatment## 
821-3·204A
Combining Warfarin and Antiplatelet Therapy After Coronary 
Stenting in the Global Registry of Acute Coronary Events: 
Is it Safe and Effective to Use Just One Antiplatelet 
Agent?##923-149·252A
Comparison of Myocardial Contrast Echocardiography 
Versus Sestamibi Myocardial Perfusion Imaging in Early 
Diagnosis of Acute Coronary Syndrome## 827-5·132A
Comparison of the TIMI and GRACE Risk Scores in the 
Canadian Acute Coronary Syndromes II Registry: Simpler 
Is Not Necessarily Better##1018-226·224A
Compliance With Contemporary Guidelines for Non-ST-
Elevation Acute Coronary Syndromes: Inﬂuence on 
Outcome and Interaction With Risk Stratiﬁcation## 
811-6·257A
Concurrent Evaluation of Novel Cardiac Biomarkers in ACS: 
Myelopyroxidase, sCD40L, C-reactive Protein and Risk 
of Death or Recurrent Ischemia in TACTICS-TIMI 
18##972-227·196A
Diabetes Mellitus Subjects Have Immune System Alterations 
Similar to That of Patients With Unstable Angina: A 
Clue to Explain Their High Cardiovascular Risk?##972-
231·197A
Early Invasive Versus Conservative Management in Non ST 
Elevation Acute Coronary Syndromes: A Metanalysis## 
821-7·205A
Effects of Irbesartan and Perindopril on Endothelial Function 
and Inﬂammatory Process in Patients With Coronary 
Artery Disease and Stable Angina Pectoris##1019-
236·226A
Elevated Levels of Neopterin Show a Positive Relationship 
With the Severity of Acute Coronary Syndromes##1018-
229·224A
Enhanced Expression of Natriuretic Peptide Receptors in 
Accumulated Neutrophils and Macrophages at the 
Sites of Coronary Unstable Plaques in Acute Coronary 
Syndromes##972-223·195A
Failure to Use Percutaneous Coronary Intervention in Patients 
With an Acute Coronary Syndrome and Congestive 
Heart Failure. The Global Registry of Acute Coronary 
Events##1032-56·86A
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Fondaparinux Is Associated With Substantially Less Major 
Bleeding and Vascular Access Site Complications 
Compared With Enoxaparin in Patients With Acute 
Coronary Syndrome Undergoing Percutaneous Coronary 
Intervention: Insights from the OASIS 5 Trial## 821-
5·205A
Fondaparinux Is Associated With Substantially Less Major 
Bleeding and Vascular Access Site Complications 
Compared With Enoxaparin in Patients With Acute 
Coronary Syndrome Undergoing Percutaneous Coronary 
Intervention: Insights from the OASIS 5 Trial## 821-
5·205A
Fondaparinux Versus Enoxaparin in Patients With Acute 
Coronary Syndromes Without ST-Segment Elevation: 
Impact of Risk According to the GRACE Score##1018-
223·223A
Gender Differences in Non-ST-Elevation Acute Coronary 
Syndromes##953-243·186A
Incidence and Not Timing of Death or Myocardial Infarction 
Differ According to Risk in Patients With Non-ST 
Elevation Acute Coronary Syndromes: Implications for 
Long-Term Treatment and Follow-Up## 830-4·207A
Increasing Occurrence of Multivessel Intervention and 
Multiple Stent Placement From 1999 to 2004. The Global 
Registry of Acute Coronary Events##990-150·261A
Late Clinical Outcomes With Aspirin, Coumadin or Both 
After Acute Coronary Syndromes (Late Outcomes of the 
ASPECT-2 Trial)##999-259·219A
Living Alone and Atypical Clinical Presentation Are 
Associated With Higher Mortality in Patients With all 
Components of the Acute Coronary Syndrome##953-
244·186A
Management and Prognosis of Non ST-Segment Elevation 
ACS in Very Old Patients. The DESCARTES 
Registry##928-229·172A
Modiﬁcation of a Simple Scoring System for Prediction of 
In-Hospital Mortality in Acute Coronary Syndromes: 
The Incremental Value of Cardiac Biomarkers in Risk 
Stratiﬁcation##1018-227·224A
RANTES Is an Independent Determinant of Outcome in 
Patients With Unstable Angina Pectoris##1019-235·225A
Relationship Between White Cell Count, Blood Sugar Level 
and Mortality in Acute Coronary Syndromes. The Global 
Registry of Acute Coronary Events##990-148·261A
Renal Insufﬁciency, Braunwald Class and Long-Term 
Outcomes in Patients Undergoing Coronary Artery Bypass 
Grafting for Acute Coronary Syndromes##975-248·201A
Resting Magnetocardiography Detects Ischemia With 




 type IIA Levels Are Increased in 
the Coronary Circulation of Patients With Acute Coronary 
Syndromes##1019-232·225A
Serum Amyloid A Is a Better Predictor of Clinical Outcome 
Than C-reactive Protein in Non-ST-Segment Elevation 
Acute Coronary Syndrome##1019-233·225A
Soluble Tumour Necrosis Factor-related Apoptosis Inducing 
Ligand is Low Early in the Presentation of Acute 
Coronary Syndromes and Is Inversely Correlated With 
C-Reactive Protein and Troponin T##971-217·194A
T Cell Receptor Signaling and Synapse Formation in T Cells 
From Patients With Acute Coronary Syndrome##977-
160·328A
Usefulness of a New Risk Score to Identify Patients With Non-
ST-Segment Elevation Acute Coronary Syndromes Who 
Beneﬁt From an Invasive Treatment Strategy##1018-
224·223A
Valvular disease
Adverse Clinical Outcomes in Left-sided Infective 
Endocarditis Complicated Intravenous Drug Addict##984-
27·281A
Bicuspid Aortic Valve Phenotype Predicts Aortic Elastic 
Properties## 803-6·276A
Comparison of Computed Tomography Coronary Angiography 
with Conventional Coronary Angiography for the 
Detection of Signiﬁcant Coronary Lesions in the Pre-
Operative Valve Surgery Patient## 970-8·126A
Concurrent Percutaneous Balloon Valvuloplasties in Combined 
Rheumatic Mitral and Tricuspid Stenosis: Our Experience 
of Different Techniques##1006-25·284A
Factors Associated With Development of Signiﬁcant Tricuspid 
Regurgitation Late After Successful Left-sided Valve 
Surgery## 803-9·277A
First Experience With a New Self Expanding Aortic Valve 
Prosthesis for Percutaneous Treatment of Aortic Valve 
Disease in High Risk Patients##1006-27·284A
Human Degenerative Valve Disease is Associated with 
Upreguation of Lrp5 Receptor Mediated Bone 
Formation## 844-3·284A
Impact of Antiphospholipid Antibodies on Cardiovascular 
Disease in Systemic Lupus Erythematosus## 803-7·277A
Ischemic Mitral Regurgitation Is an Independent Predictor 
of Heart Failure and Death in Survivors of Myocardial 
Infarction: A Prospective Study##962-19·277A
Long-Term Outcome of Asymptomatic Bicuspid Aortic Valve 
in the Community## 803-5·276A
Multidetector Row Computed Tomography and Magnetic 
Resonance Imaging Can Accurately Estimate Aortic Valve 
Area as Compared to Transthoracic and Transesophageal 
Echocardiography## 970-17·128A
Nadroparin Versus Unfractionated Heparin for Anticoagulation 
of all Cause Atrial Fibrillation: Final Results of the 
NADROPAF Trial## 1015-141·35A
Percutaneous Edge-to-Edge Mitral Valve Repair Using the 
Evalve® MitraClip™: Initial Experience With Functional 
Mitral Regurgitation in the EVEREST I Trial##1006-
20·283A
Prospective Determination of the Prevalence of Clinically 
Unapparent Cerebral Embolization in Patients With Left-
Sided Infective Endocarditis##984-21·280A
The Impact of an Electronic Stethoscope as a Patient Simulator 
in Cardiac Auscultation##1013-150·267A
Three-Dimensional Imaging Surpasses Conventional 
Transesophageal Echocardiography for Preoperative 
Conceptualization in Mitral Valve Prolapse## 991-
32·138A
Three-Dimensional Tricuspid Annular Function Provides 
Insight Into the Mechanisms of Valve Regurgitation in 
Classic Hypoplastic Left Heart Syndrome## 839-5·146A
Toward More Predictable Repair of Regurgitant Aortic Valves: 
A Logical, Segmental Approach##917-24·273A
Valvular Heart Disease Surveillance in the United States, 1980-
2000## 803-4·276A
Valvuloplasty
Concurrent Percutaneous Balloon Valvuloplasties in Combined 
Rheumatic Mitral and Tricuspid Stenosis: Our Experience 
of Different Techniques##1006-25·284A
Favorable Effects of Additional Mitral Valve Repair on 
Ischemic Mitral Regurgitation and Left Ventricular 
Remodeling##917-21·272A
Favourable Effect of Mitral Balloon Valvuloplasty on the 
Incidence of Atrial Fibrillation in Patients With Severe 
Mitral Stenosis##1006-24·283A
First Experience With a New Self Expanding Aortic Valve 
Prosthesis for Percutaneous Treatment of Aortic Valve 
Disease in High Risk Patients##1006-27·284A
Inﬂuence of Mitral Valve Morphology and Functional 
Disorder on the Repair of Functional Ischemic Mitral 
Insufﬁciency##917-22·272A
Initial Experience of New Three-Dimensional Annuloplasty 
Ring for Functional Tricuspid Regurgitation##917-
27·273A
Pulmonary Hypertension With Excessive Transpulmonary 
Gradients Among Mitral Stenotics: Prevalence and 
Clinical Outcome Following Percutaneous Balloon Mitral 
Commissurotomy##1006-21·283A
Regression of Severe Infundibular Stenosis and Severe 
Tricuspid Regurgitation After Pulmonary Balloon 
Valvuloplasty Long-Term (Up to 17-Years) Outcome 
of Pulmonary Balloon Valvuloplasty in Adults##945-
116·240A
Vascular biology
A Novel Double-Shelled Microsphere Targeted to 
Leukocyte Adhesion Molecules Adheres to Inﬂamed 
Microcirculation in Vivo## 1016-34·149A
A Novel Method for Enumerating Circulating Endothelial 
Progenitor Cells Based on ALDH Activity##933-
165·302A
Amlodipine Modulates the MEK1 and ERK Pathway to 
Induce Vascular Smooth Muscle Cell Differentiation In 
Vivo##956-169·319A
Blockade of RAGE With a New Fusion Protein Suppresses 
Neointimal Formation in Both Diabetic and Non-Diabetic 
Rats After Vascular Injury##956-171·320A
C-Reactive Protein and Pro-Inﬂammatory Cytokines Are 
Elevated in Men With Erectile Dysfunction of Vascular 
Origin## 854-8·378A
Combination Statin and Fibrate Therapy Improves Lipoprotein 
Subparticle Proﬁles in Diabetic Patients With Mixed 
Dyslipidemia: The DIACOR Study##1014-210·355A
COMP-angiopoietin 1 Enhances the Engraftment of the 
Mobilized Peripheral Blood Stem Cells to Ischemic Tissue 
by Induction of Adhesion Molecules## 856-6·234A
Effects of High-Dose Atorvastatin on HDL Anti-inﬂammatory/
Pro-inﬂammatory Function and Disease Activity in 
Patients With Rheumatoid Arthritis: Results of the Statin 
Anti-Rheumatic Activity (SARA) Pilot Study## 854-
6·378A
Effects of Mental Stress on Brachial-Ankle Pulse Wave 
Velocity##1001-175·347A
Expression and Function of Toll-like Receptors in Different 
Vascular Beds: Towards Understanding Target Tissue 
Susceptibility in Vascular Inﬂammation## 802-3·314A
Increased Dilator Response to Nitrate in Contrast to 
Decreased Flow Mediated Dilatation in Migraineurs: 
An Ultrasonographic Evaluation of Brachial Artery## 
841-7·357A
Inﬂammatory Activation During Coronary By-pass Surgery 
and the Effect of High Dose Statin Plus ACE-inhibitor 
Treatment## 845-3·359A
Lectin-like Oxidized LDL Receptor-1 (LOX-1) as a Novel 
Receptor for Remnant-like Lipoprotein Particles (RLPs) 
in Vascular Smooth Muscle Cells## 822-4·340A
Lipoprotein-associated Phospholipase A2 (Lp-PLA2) in 
Chronic Kidney Disease: Results From the RRI-CKD 
Study## 854-7·378A
Low-dose Erythropoietin Treatment Preserves Cardiac 
Function and Mobilizes Endothelial Progenitor Cells in 
Rats With Ischemic Heart Failure## 820-8·74A
Osteoprotegerin as a Novel Biomarker of Atherosclerosis: 
Independent Association With Coronary Artery Calcium 
in the Dallas Heart Study## 801-4·313A
Percutaneous Coronary Intervention Increases Endothelial 
Progenitor Cell Mobilisation in Patients With Ischemic 
Heart Disease##910-179·292A
Preserved Epicardial Coronary Endothelial Function by 
Inhibition of δ Protein Kinase C in a Porcine Acute 
Myocardial Infarction Model##1020-245·228A
Procollagen Type III Amino-terminal Peptide (PIIINP) and 
Surrogates of Ventricular/Vascular Stiffness in Chronic 
Kidney Disease##1001-177·347A
Protease Activated Receptor-1 Activation Causes Platelet 
Independent Venoconstriction in Vivo in Man##908-
167·289A
Proteasome Inhibition: A New Road to Coronary 
Atherogenesis?##977-166·329A
Proteomic Proﬁling Reveals that Plasma Beta 2-Microglobulin 
is a Marker for Peripheral Arterial Disease## 802-4·314A
Regulation of Endothelial Progenitor Cell (EPC) Survival and 
Vasculogenesis by Peroxisome Proliferator-activated 
Receptor-Delta (PPAR-δ) Activation## 823-6·342A
Role of Platelets in Homing of Endothelial Progenitor Cells to 
the Site of Vascular Injury##909-174·291A
Synergistic Interaction Between Hypercholesterolemia and 
Diabetes Signaling Through Phosphatidylinositol 3-
Kinase/Akt/PKB and Nuclear Factor kB in a Porcine 
Model of Coronary Atherosclerosis##977-169·330A
The Anti-Proliferative Effect on Vascular Smooth Muscle Cells 
by Rosiglitazone Is Mediated by Inhibition of the Akt-
mTOR-p70S6K Pathway## 845-6·359A
The Effect of Ramipril and Valsartan on Aortic Stiffness and 
Wave Reﬂections in Patients With Successful Coarctation 
Repair##1011-116·244A
The Forkhead Transcription Factor, FOXO3a Controls Vascular 
Smooth Muscle Cells Proliferation through Modulation 
of an Angiogenic Immediate Early Gene, CYR61##933-
170·303A
The Reduction of Inﬂammatory Biomarkers by Statin, Fibrate, 
and Combination Therapy Among Diabetic Patients With 
Mixed Dyslipidemia: The DIACOR Study## 854-5·377A
The Relation Between Aortic Distensibility and Calciﬁed 
Aortic Atherosclerosis: Cardiovascular MRI and CT 
Correlations##1000-166·345A
The Relationship Between soluble-Intercellular Adhesion 
Molecule - 1 and Race/Ethnicity##935-184·306A
Thrombospondin-4 A387p Polymorphism Is not Associated 
With Markers of Vascular Function and Incidence of 
Myocardial Infarction##933-159·300A
Toll-like Receptors in Giant Cell Arteritis: Differential Effects 
of TLR4 and TLR5 Ligation##933-167·302A
Vascular surgery
Femoral Pseudoaneurysms: Management with Percutaneous 
Thrombin Injections##1002-181·348A
Long-Term Outcomes of Elective Abdominal Aortic Aneurysm 
Repair in Octogenarians##940-22·274A
Vasoconstriction
Protease Activated Receptor-1 Activation Causes Platelet 
Independent Venoconstriction in Vivo in Man##908-
167·289A
Vasodilation
Increased Dilator Response to Nitrate in Contrast to 
Decreased Flow Mediated Dilatation in Migraineurs: 
An Ultrasonographic Evaluation of Brachial Artery## 
841-7·357A
Nicotinic Acid-Induced Vasodilation in Mice Is Predominantly 
Mediated via the Prostagladin D
2
 Receptor 1## 845-
8·360A
Noninvasive Assessment of Coronary Vasodilating Capacity 
Using Freehand 3D Echocardiography With Rotational 
Scanning## 991-40·140A
Testosterone, Estrogen, and Coronary Function in Women: A 
Report From the NHLBI-Sponsored Women’s Ischemia 
Syndrome Evaluation (WISE) Study##1024-173·366A
The Vasodilatory Action of Testosterone Is Independent of 
the Endothelium, Classic Androgen Receptor, Aromatase 
Activity, Nitric Oxide and Dilator Prostaglandins in 
Isolated Human Pulmonary Vessels##1000-163·344A
Urocortin 2 Infusion in Healthy Humans Induces 
Marked Hemodynamic, Neurohormonal, and Renal 
Responses##938-203·310A
Vasodilator agents
Comparison of the effects of Nicorandil and Cocktail 
to Prevent Radial Artery Spasm During Coronary 
Angiography##979-181·332A
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Isosorbide Dinitrate-Hydralazine Decreased Blood Pressure 
in Patients with High But Not Low Blood Pressure 
and Improved Survival Independent of Baseline Blood 
Pressure in African American Heart Failure Trial## 
809-3·52A
Neointimal Hyperplasia But Not Pathological Vascular Wall 
Structural Changes (Fibrin Deposition and Inﬂammation) 
Inﬂuence Maximal Vasodilation in Porcine Coronary 
Arteries 1-Month After Implantation of Stents##910-
182·293A
Vasopressin
Coadministration of the V2 Receptor Antagonist Tolvaptan and 
B-Type Natriuretic Peptide Enhances Water and Sodium 
Excretion Without Adversely Affecting Renal Function: A 
Physiologic Approach to Sodium and Water Retention in 
Experimental Heart Failure##913-199·297A
Conivaptan, a Novel Arginine Vasopressin Antagonist, 
Increased Serum Sodium Concentration in Patients 
With Heart Failure and Euvolemic or Hypervolemic 
Hyponatremia## 816-7·62A
Effects of Left Ventricular Assist Devices With Different Flow 
Characteristics on Vasopressin Levels##988-105·71A
Ventilation
Abnormal Ventilatory Response to Exercise Predicts Mortality 
in Adult Congenital Heart Disease Patients## 840-5·246A
Ventilation Efﬁciency for Monitoring CHF Therapy: A Need 
for Method Standardization## 1017-29·156A
Ventricular action potential
Hydrogen Peroxide-Induced Arrhythmogenic Activity and 
Contractile Dysfunction of Ventricular Myocytes is 
Reduced by a Blocker of Late Sodium Current## 901-
130·2A
Ventricular arrhythmia
Cardiac Resynchronization Therapy Reduces the Need 
for Shocks in Patients With Automated Implantable 
Cardioverter Deﬁbrillators## 947-135·17A
Circadian, Daily, and Seasonal Distributions of Ventricular 
Tachyarrhythmias in Patients With Implantable 
Cardioverter-Deﬁbrillator## 901-137·4A
Conditional Expression of a Gain of Function Alpha-5 
Integrin in Adult Mouse Heart Increases Ventricular 
Automaticity## 901-127·1A
Do All Phenotypic Forms of Outﬂow Tract Arrhythmias Have 
a Similar Mechanism?## 924-124·5A
High-Septal Pacing Reduces Electrical Remodeling and 
Arrhythmogeneity in the Chronic Atrioventricular Block 
Dog## 826-3·25A
Intracoronary Human Bone Marrow Stem Cell Transplantation 
in Acute Myocardial Infarction and Ventricular 
Arrhythmias##921-106·44A
Intracoronary Infusion of Gd3+ Into the Ischemic Region Does 
not Suppress Phase Ib Ventricular Arrhythmias After 
Coronary Occlusion in Swine##950-220·181A
Left Atrial Size Can Identify the Highest Risk Multicenter 
Automatic Deﬁbrillator Implantation Trial-II Patients for 
Ventricular Arrhythmic Events## 805-8·111A
Myocardial Fibrosis assessed by Contrast-Enhanced 
Cardiovascular Magnetic Resonance and Prevalence of 
Malignant Ventricular Arrhythmias in Arrhythmogenic 
Right Ventricular Cardiomyopathy## 924-132·7A
QRS Duration and Microvolt T Wave Alternans Testing in 
Patients With Ischemic Cardiomyopathy## 924-123·5A
Radiofrequency Catheter Ablation of Frequent, Idiopathic 
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